	data source	chemical_type	chemical name	pubchem id	smile	disease name	gene symbol	variant	chromosome	position	ref allele	alt allele	label
0	pharmgkb	Drug	meloxicam	5281106	CC1=CN=C(S1)N/C(=C\2/C(=O)C3=CC=CC=C3S(=O)(=O)N2C)/O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13					Metabolism/PK
1	pharmgkb	Drug	lornoxicam	5282204	CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=C(S1(=O)=O)C=C(S3)Cl		CYP2C9	CYP2C9*1, CYP2C9*3, CYP2C9*13					Metabolism/PK
2	pharmgkb	Drug	siponimod	44599207			CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Metabolism/PK
3	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs17376848	1	97450068	A	G	Toxicity
4	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	M166V	1	97699535	T	C	Toxicity
5	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	C29R	1	97883329	A	G	Toxicity
6	pharmgkb	Drug	dexlansoprazole	9578005	CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Metabolism/PK
7	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	over-anticoagulation	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11					Toxicity
8	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	V732I	1	97305364	C	T	Toxicity
9	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	I543V	1	97515839	T	C	Toxicity
10	pharmgkb		atazanavir,atazanavir / ritonavir			HIV Infections,Hyperbilirubinemia	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*36, UGT1A1*37					Toxicity
11	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	dose reduction	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C					Dosage
12	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs17376848	1	97450068	A	G	Toxicity
13	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	S534N	1	97515865	C	T	Toxicity
14	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	I543V	1	97515839	T	C	Toxicity
15	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	S534N	1	97515865	C	T	Toxicity
16	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	C29R	1	97883329	A	G	Toxicity
17	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	V732I	1	97305364	C	T	Toxicity
18	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F2	V433M	19	15879621	C	T	Dosage
19	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung	EGFR	L858R	7	55191822	T	R	Efficacy
20	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	Q172H	19	41006936	G	W	Metabolism/PK
21	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9923231	16	31096368	C	D	Dosage
22	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2		NUDT15	R139C	13	48045719	C	T	Dosage
23	pharmgkb	Drug	hydrocodone	5284569	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4		CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*17, CYP2D6*41					Metabolism/PK
24	pharmgkb	Drug	tropisetron	656665		Vomiting	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN					Efficacy
25	pharmgkb	Drug	ibuprofen	3672	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Metabolism/PK
26	pharmgkb	Drug, Metabolite	desipramine	2995	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10					Metabolism/PK
27	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	S1251N	7	117642472	G	A	Efficacy
28	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	G1244V	7	117642451	G	W	Efficacy
29	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	D110H	7	117530953	G	Y	Efficacy
30	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	L206W	7	117535285	T	G	Efficacy
31	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs397508759	7	117534363	G	W	Efficacy
32	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R117G	7	117530974	C	D	Efficacy
33	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	D110E	7	117530955	C	A	Efficacy
34	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R74W	7	117509089	C	T	Efficacy
35	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	P67L	7	117509069	C	T	Efficacy
36	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R1070W	7	117611649	C	T	Efficacy
37	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R1070Q	7	117611650	G	M	Efficacy
38	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	S977F	7	117606695	C	K	Efficacy
39	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs78060119	1	97573943	C	A	Toxicity
40	pharmgkb	Drug	rasburicase			Hemolysis,Methemoglobinemia	G6PD	G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham					Toxicity
41	pharmgkb	Drug	flurbiprofen	3394	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29					Metabolism/PK
42	pharmgkb	Drug	trimipramine	5584	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C	Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6					Metabolism/PK
43	pharmgkb	Drug	tenoxicam	5312154	CN1/C(=C(/NC2=CC=CC=N2)\O)/C(=O)C3=C(S1(=O)=O)C=CS3		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Metabolism/PK
44	pharmgkb	Drug	tropisetron	656665			CYP2D6	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10					Metabolism/PK
45	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	R592W	1	97450190	G	A	Other
46	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	Y186C	1	97699474	T	C	Toxicity
47	pharmgkb	Drug	celecoxib	2662	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13					Metabolism/PK
48	pharmgkb	Drug	piroxicam	5280452	CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=CC=CC=C3S1(=O)=O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Metabolism/PK
49	pharmgkb	Drug	ivacaftor / lumacaftor	71494926	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs113993960	7	117559592	CTT	-	Efficacy
50	pharmgkb	Drug	ivacaftor / tezacaftor	72722243	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C.CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F	Cystic Fibrosis	CFTR	rs113993960	7	117559592	CTT	-	Efficacy
51	pharmgkb	Drug	flucloxacillin	21319	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	drug-induced liver injury	HLA-B	HLA-B*57:01					Toxicity
52	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	V732I	1	97305364	C	T	Other
53	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	V335L	1	97593343	C	W	Other
54	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	rs72549303	1	97450066	G	-	Other
55	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	Y186C	1	97699474	T	C	Other
56	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	rs78060119	1	97573943	C	A	Other
57	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	V995F	1	97079071	C	A	Other
58	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	R235W	1	97691776	G	A	Other
59	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	rs72549309	1	97740415	ATGA	-	Other
60	pharmgkb	Drug Class	hormonal contraceptives for systemic use			Thrombosis	F5	R534L	1	169549811	C	T	Toxicity
61	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Toxicity
62	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7		UGT1A1	UGT1A1*1, UGT1A1*28					Dosage
63	pharmgkb	Drug	desflurane	42113	C(C(F)(F)F)(OC(F)F)F	Malignant Hyperthermia	CACNA1S	R1086H	1	201060815	C	W	Toxicity
64	pharmgkb	Drug	desflurane	42113	C(C(F)(F)F)(OC(F)F)F	Malignant Hyperthermia	CACNA1S	R174W	1	201091993	G	A	Toxicity
65	pharmgkb	Drug	trimipramine	5584	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C		CYP2C19	CYP2C19*1, CYP2C19*2					Metabolism/PK
66	pharmgkb	Drug, Metabolite	desipramine	2995	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder,Depressive Disorder, Major	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6					Toxicity
67	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R328W	19	38448673	C	W	Toxicity
68	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R401C	19	38451842	C	K	Toxicity
69	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R533C	19	38455471	C	D	Toxicity
70	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	I4893T	19	38584989	T	C	Toxicity
71	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	G341R	19	38448712	G	M	Toxicity
72	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R44C	19	38440829	C	T	Toxicity
73	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	T4821I	19	38580094	C	T	Toxicity
74	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2458L	19	38500655	G	W	Toxicity
75	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2163H	19	38494565	G	M	Toxicity
76	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2458C	19	38500654	C	T	Toxicity
77	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	Y522S	19	38455359	A	S	Toxicity
78	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2435L	19	38499997	G	W	Toxicity
79	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R614C	19	38457545	C	T	Toxicity
80	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	G2434R	19	38499993	G	A	Toxicity
81	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2163C	19	38494564	C	T	Toxicity
82	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	H4833Y	19	38580114	C	T	Toxicity
83	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	C35R	19	38440802	T	C	Toxicity
84	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R4861H	19	38580440	G	A	Toxicity
85	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R552W	19	38455528	C	T	Toxicity
86	pharmgkb	Drug	enflurane	3226	C(C(OC(F)F)(F)F)(F)Cl	Malignant Hyperthermia	CACNA1S	R174W	1	201091993	G	A	Toxicity
87	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	I403M	19	38451850	C	K	Toxicity
88	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	G2375A	19	38499731	G	C	Toxicity
89	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	G248R	19	38446710	G	H	Toxicity
90	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R614H	19	38457546	G	W	Toxicity
91	pharmgkb	Drug	enflurane	3226	C(C(OC(F)F)(F)F)(F)Cl	Malignant Hyperthermia	CACNA1S	R1086H	1	201060815	C	W	Toxicity
92	pharmgkb	Drug	halothane	3562	C(C(F)(F)F)(Cl)Br	Malignant Hyperthermia	CACNA1S	R1086H	1	201060815	C	W	Toxicity
93	pharmgkb	Drug	isoflurane	3763	C(C(F)(F)F)(OC(F)F)Cl	Malignant Hyperthermia	CACNA1S	R1086H	1	201060815	C	W	Toxicity
94	pharmgkb	Drug	halothane	3562	C(C(F)(F)F)(Cl)Br	Malignant Hyperthermia	CACNA1S	R174W	1	201091993	G	A	Toxicity
95	pharmgkb	Drug	isoflurane	3763	C(C(F)(F)F)(OC(F)F)Cl	Malignant Hyperthermia	CACNA1S	R174W	1	201091993	G	A	Toxicity
96	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F	Malignant Hyperthermia	CACNA1S	R1086H	1	201060815	C	W	Toxicity
97	pharmgkb	Drug	methoxyflurane	4116	COC(C(Cl)Cl)(F)F		CACNA1S	R1086H	1	201060815	C	W	Toxicity
98	pharmgkb	Drug	methoxyflurane	4116	COC(C(Cl)Cl)(F)F	Malignant Hyperthermia	CACNA1S	R174W	1	201091993	G	A	Toxicity
99	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F	Malignant Hyperthermia	CACNA1S	R174W	1	201091993	G	A	Toxicity
100	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Malignant Hyperthermia	CACNA1S	R1086H	1	201060815	C	W	Toxicity
101	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Malignant Hyperthermia	CACNA1S	R174W	1	201091993	G	A	Toxicity
102	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	E3104K	19	38512321	G	A	Toxicity
103	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R163C					Toxicity
104	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	V2168M	19	38494579	G	A	Toxicity
105	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	V4849I	19	38580403	G	A	Toxicity
106	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	G3990V	19	38543832	G	T	Toxicity
107	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	rs121918596	19	38499646	GAG	-	Toxicity
108	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	T2206M	19	38496283	C	K	Toxicity
109	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	Y4791C	19	38580004	A	G	Toxicity
110	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2336H	19	38499223	G	A	Toxicity
111	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	A2428T	19	38499975	G	A	Toxicity
112	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	L4833V	19	38580370	C	G	Toxicity
113	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2355W	19	38499670	C	T	Toxicity
114	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2452W	19	38500636	C	T	Toxicity
115	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2508G	19	38500898	C	K	Toxicity
116	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2508H	19	38500899	G	A	Toxicity
117	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R163H	19	38444212	G	W	Toxicity
118	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	A2350T	19	38499655	G	A	Toxicity
119	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2454C	19	38500642	C	T	Toxicity
120	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R2454H	19	38500643	G	A	Toxicity
121	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	R592W	1	97450190	G	A	Toxicity
122	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Inflammatory Bowel Diseases,Myelosuppression	NUDT15	R139C	13	48045719	C	T	Toxicity
123	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	CYP2B6*1, CYP2B6*2, CYP2B6*6, CYP2B6*18, CYP2B6*38					Toxicity
124	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11					Toxicity
125	pharmgkb	Drug	abacavir	441300	C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N	Drug Hypersensitivity,HIV Infections	HLA-B	HLA-B*57:01					Toxicity
126	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9923231	16	31096368	C	D	Dosage
127	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	Q172H	19	41006936	G	W	Toxicity
128	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*58:01					Toxicity
129	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	S1255P	7	117642483	T	M	Efficacy
130	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	G178R	7	117534318	G	A	Efficacy
131	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	G551S	7	117587805	G	A	Efficacy
132	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	E56K	7	117509035	G	A	Efficacy
133	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	S549N	7	117587800	G	W	Efficacy
134	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	G1349D	7	117664770	G	A	Efficacy
135	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R352Q	7	117540285	G	A	Efficacy
136	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	A455E	7	117548795	C	W	Efficacy
137	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	D579A	7	117590409	A	S	Efficacy
138	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	S945L	7	117603708	C	T	Efficacy
139	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	F1052L	7	117611595	T	S	Efficacy
140	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	K1060T	7	117611620	A	C	Efficacy
141	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	A1067P	7	117611640	G	M	Efficacy
142	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	G551D	7	117587806	G	A	Efficacy
143	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R347L	7	117540270	G	H	Efficacy
144	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	F1074L	7	117611663	T	A	Efficacy
145	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	S549R	7	117587801	T	S	Efficacy
146	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	D1152H	7	117614699	G	C	Efficacy
147	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	D1270N	7	117642528	G	W	Efficacy
148	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	S549R	7	117587799	A	C	Efficacy
149	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9, CYP2B6*18, CYP2B6*28					Metabolism/PK
150	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R117H	7	117530975	G	H	Efficacy
151	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	CYP2B6*1, CYP2B6*6, CYP2B6*26					Dosage
152	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,telaprevir			Hepatitis C, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
153	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C	IFNL3	rs12979860	19	39248147	C	T	Efficacy
154	pharmgkb		boceprevir,peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
155	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	M166V	1	97699535	T	C	Toxicity
156	pharmgkb		FOLFIRI,irinotecan			Neutropenia	UGT1A1	UGT1A1*1, UGT1A1*28					Toxicity
157	pharmgkb	Drug	fluvoxamine	3404	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14					Metabolism/PK
158	pharmgkb	Drug	amitriptyline	2160	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41					Toxicity
159	pharmgkb	Drug	amitriptyline	2160	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41					Metabolism/PK
160	pharmgkb	Drug	clomipramine	2801	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	Depressive Disorder, Major	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6					Toxicity
161	pharmgkb	Drug	clomipramine	2801	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	Depressive Disorder, Major,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41					Metabolism/PK
162	pharmgkb	Drug	imipramine	3696	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6					Toxicity
163	pharmgkb	Drug	imipramine	3696	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*4, CYP2D6*5					Dosage
164	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN					Toxicity
165	pharmgkb	Drug	doxepin	667477	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41					Metabolism/PK
166	pharmgkb	Drug	imipramine	3696	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5					Metabolism/PK
167	pharmgkb	Drug	nortriptyline	4543	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10					Toxicity
168	pharmgkb	Drug	nortriptyline	4543	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17					Metabolism/PK
169	pharmgkb	Drug	voriconazole	71616	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Metabolism/PK
170	pharmgkb	Drug	lansoprazole	3883	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	Gastroesophageal Reflux	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9, CYP2C19*17					Metabolism/PK
171	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Cardiovascular Diseases	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Efficacy
172	pharmgkb	Drug	pantoprazole	4679	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Metabolism/PK
173	pharmgkb	Drug	atomoxetine	54841	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6					Toxicity
174	pharmgkb	Drug	atomoxetine	54841	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*92, CYP2D6*96					Metabolism/PK
175	pharmgkb	Drug	flecainide	3356	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	Arrhythmias, Cardiac	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36					Metabolism/PK
176	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*41					Metabolism/PK
177	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*10x2, CYP2D6*11, CYP2D6*17, CYP2D6*21, CYP2D6*36, CYP2D6*41					Efficacy
178	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	cardiotoxicity,Respiratory Insufficiency	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN					Toxicity
179	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Heart Failure	CYP2D6	CYP2D6*1, CYP2D6*4					Dosage
180	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*31, CYP2D6*35, CYP2D6*41					Metabolism/PK
181	pharmgkb	Drug	haloperidol	3559	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17					Metabolism/PK
182	pharmgkb	Drug	propafenone	4932	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O	Arrhythmias, Cardiac,Tachycardia	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36					Metabolism/PK
183	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Psychotic Disorders,Schizophrenia	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14					Metabolism/PK
184	pharmgkb	Drug	clomipramine	2801	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl	Mental Disorders	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Metabolism/PK
185	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major,Mental Disorders	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Metabolism/PK
186	pharmgkb	Drug	imipramine	3696	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder,Depressive Disorder, Major	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Metabolism/PK
187	pharmgkb	Drug	omeprazole	4594	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	Esophagitis,Gastroesophageal Reflux,Helicobacter Infections,Peptic Ulcer	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Efficacy
188	pharmgkb	Drug	omeprazole	4594	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	Gastroesophageal Reflux	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*9, CYP2C19*10, CYP2C19*17, CYP2C19*24, CYP2C19*26					Metabolism/PK
189	pharmgkb	Drug	lansoprazole	3883	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F	Gastroesophageal Reflux,Helicobacter Infections	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Efficacy
190	pharmgkb	Drug	pantoprazole	4679	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC	Helicobacter Infections,Ulcer	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Efficacy
191	pharmgkb	Drug	zuclopenthixol	5311507	C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	Schizophrenia	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4					Metabolism/PK
192	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*10, CYP2C19*17, CYP2C19*19, CYP2C19*25, CYP2C19*26					Metabolism/PK
193	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	D949V	1	97082391	T	A	Other
194	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	D949V	1	97082391	T	A	Toxicity
195	pharmgkb	Prodrug	tegafur	5386		Neoplasms	DPYD	D949V	1	97082391	T	A	Toxicity
196	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	D949V	1	97082391	T	A	Toxicity
197	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs3918290	1	97450058	C	K	Toxicity
198	pharmgkb	Prodrug	tegafur	5386		Neoplasms	DPYD	rs3918290	1	97450058	C	K	Toxicity
199	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs3918290	1	97450058	C	K	Toxicity
200	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	rs3918290	1	97450058	C	K	Other
201	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	I560N	1	97515787	A	Y	Other
202	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	I560N	1	97515787	A	Y	Toxicity
203	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	I560N	1	97515787	A	Y	Toxicity
204	pharmgkb	Prodrug	tegafur	5386		Neoplasms	DPYD	I560N	1	97515787	A	Y	Toxicity
205	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	V515I	1	97515923	C	T	Other
206	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	T768K	1	97234991	G	T	Other
207	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Leukopenia,Neutropenia	NUDT15	NUDT15*1, NUDT15*2, NUDT15*3					Toxicity
208	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	NUDT15	NUDT15*1, NUDT15*2, NUDT15*3					Dosage
209	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	dose reduction	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*9					Dosage
210	pharmgkb	Drug	tobramycin	36294	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N	Ototoxicity	MT-RNR1	rs267606617					Toxicity
211	pharmgkb	Drug	amikacin	37768	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N	Ototoxicity	MT-RNR1	rs267606617					Toxicity
212	pharmgkb	Drug	gentamicin	3467	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	Ototoxicity	MT-ND1	rs267606617					Toxicity
213	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-RNR1	rs267606617					Toxicity
214	pharmgkb	Drug	streptomycin	19649	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs267606617					Toxicity
215	pharmgkb	Drug	kanamycin	6032	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N	Ototoxicity	MT-RNR1	rs267606617					Toxicity
216	pharmgkb	Drug	kanamycin	6032	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N	Ototoxicity	MT-RNR1	rs267606619					Toxicity
217	pharmgkb	Drug	streptomycin	19649	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs267606619					Toxicity
218	pharmgkb	Drug	gentamicin	3467	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	Ototoxicity	MT-RNR1	rs267606619					Toxicity
219	pharmgkb	Drug	tobramycin	36294	C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N	Ototoxicity	MT-RNR1	rs267606619					Toxicity
220	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-RNR1	rs267606619					Toxicity
221	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-RNR1	rs267606618					Toxicity
222	pharmgkb	Drug	gentamicin	3467	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	Ototoxicity	MT-RNR1	rs267606618					Toxicity
223	pharmgkb	Drug	kanamycin	6032	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N	Ototoxicity	MT-RNR1	rs267606618					Toxicity
224	pharmgkb	Drug	streptomycin	19649	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs267606618					Toxicity
225	pharmgkb	Drug	ondansetron	4595	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Vomiting	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35xN					Efficacy
226	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Cardiovascular Diseases	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*4, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11					Dosage
227	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11, CYP2C9*13, CYP2C9*14, CYP2C9*16, CYP2C9*29, CYP2C9*31, CYP2C9*33, CYP2C9*37, CYP2C9*39, CYP2C9*42, CYP2C9*43, CYP2C9*45, CYP2C9*50, CYP2C9*52, CYP2C9*55					Metabolism/PK
228	pharmgkb	Drug	aripiprazole	60795	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Psychotic Disorders,schizoaffective disorder,Schizophrenia	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41					Metabolism/PK
229	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	heart transplantation,hemopoietic stem cell transplant,Kidney Transplantation,liver transplantation,lung transplantation	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7					Dosage
230	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41					Metabolism/PK
231	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*36, CYP2D6*41					Metabolism/PK
232	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9923231	16	31096368	C	D	Dosage
233	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*17, CYP2D6*40					Efficacy
234	pharmgkb	Drug	hydrocodone	5284569	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	Pain	CYP2D6	CYP2D6*5, CYP2D6*17					Efficacy
235	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Pain,Pain, Postoperative	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17					Efficacy
236	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Cardiovascular Diseases,Ischemic Attack, Transient,Stroke	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17					Efficacy,Toxicity
237	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Metabolism/PK
238	pharmgkb		simvastatin,simvastatin acid				SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
239	pharmgkb	Drug	lovastatin	53232	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Toxicity
240	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Toxicity
241	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	statin-related myopathy	SLCO1B1	V174A	12	21178615	T	C	Toxicity
242	pharmgkb	Drug	lovastatin	53232	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	statin-related myopathy	SLCO1B1	V174A	12	21178615	T	C	Toxicity
243	pharmgkb		lovastatin,lovastatin acid				SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
244	pharmgkb		lovastatin,lovastatin acid				SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Metabolism/PK
245	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Hypercholesterolemia	SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
246	pharmgkb	Drug	pitavastatin	5282452			SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37					Metabolism/PK
247	pharmgkb	Drug	pitavastatin	5282452			SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
248	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	statin-related myopathy	SLCO1B1	V174A	12	21178615	T	C	Toxicity
249	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
250	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	statin-related myopathy	SLCO1B1	V174A	12	21178615	T	C	Toxicity
251	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Toxicity
252	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Toxicity
253	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37					Metabolism/PK
254	pharmgkb		simvastatin,simvastatin acid				SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Metabolism/PK
255	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	statin-related myopathy	SLCO1B1	V174A	12	21178615	T	C	Toxicity
256	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
257	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	statin-related myopathy	SLCO1B1	V174A	12	21178615	T	C	Toxicity
258	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Toxicity
259	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
260	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37					Metabolism/PK
261	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Metabolism/PK
262	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Metabolism/PK
263	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	statin-related myopathy	SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Toxicity
264	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02					Toxicity
265	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,Stevens-Johnson Syndrome	HLA-A	HLA-A*31:01					Toxicity
266	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	heart transplantation,hematopoietic stem cell transplantation,Kidney Transplantation,lung transplantation	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7					Metabolism/PK
267	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder,Depressive Disorder, Major	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Metabolism/PK
268	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4					Toxicity
269	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42		CYP3A4	CYP3A4*1, CYP3A4*20, CYP3A4*22					Metabolism/PK
270	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2		TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*4, TPMT*6, TPMT*9, TPMT*12					Toxicity
271	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02					Toxicity
272	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02, HLA-B*15:11					Toxicity
273	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epidermal Necrolysis, Toxic,Epilepsy,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02					Toxicity
274	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15					Toxicity
275	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs56038477	1	97573863	C	T	Toxicity
276	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs56038477	1	97573863	C	T	Toxicity
277	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	rs75017182	1	97579893	G	Y	Other
278	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	DPYD	rs75017182	1	97579893	G	Y	Toxicity
279	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs75017182	1	97579893	G	Y	Toxicity
280	pharmgkb	Drug	vortioxetine	9966051	CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C		CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*10					Metabolism/PK
281	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Mental Disorders	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Metabolism/PK
282	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl		CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9					Metabolism/PK
283	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder,Obsessive-Compulsive Disorder	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10					Metabolism/PK
284	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	agitation,Alcohol-Related Disorders,cardiotoxicity,Depression,Depressive Disorder,Depressive Disorder, Major,Drug Toxicity,dysphoria,Edema,Nausea,Obsessive-Compulsive Disorder,Tachycardia,Vomiting	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*81					Toxicity
285	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41					Metabolism/PK
286	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Leukopenia,Myelosuppression	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*6					Toxicity
287	pharmgkb	Drug	doxepin	667477	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31		CYP2C19	CYP2C19*1, CYP2C19*2					Metabolism/PK
288	pharmgkb	Drug	amitriptyline	2160	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major,Mental Disorders	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Metabolism/PK
289	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
290	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	over-anticoagulation	VKORC1	rs9923231	16	31096368	C	D	Toxicity
291	pharmgkb		FOLFIRI,irinotecan			Diarrhea	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28					Toxicity
292	pharmgkb		FOLFIRI,irinotecan			Neutropenia	UGT1A1	UGT1A1*1, UGT1A1*6					Toxicity
293	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
294	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
295	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL4	rs11322783	19	39248514	T	-	Efficacy
296	pharmgkb		interferons,peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL3	rs8099917	19	39252525	T	G	Efficacy
297	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	over-anticoagulation	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Toxicity
298	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Dosage
299	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs8050894	16	31093188	C	K	Dosage
300	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	16	31093557	G	M	Dosage
301	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs2359612	16	31092475	A	G	Dosage
302	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs7294	16	31091000	C	T	Dosage
303	pharmgkb		Drugs For Treatment Of Tuberculosis,isoniazid			drug-induced liver injury,Hepatitis, Toxic,Toxic liver disease,Tuberculosis	NAT2	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5D, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*12A, NAT2*13A, NAT2*14A					Toxicity
304	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*12, CYP2A6*13, CYP2A6*14, CYP2A6*15, CYP2A6*17, CYP2A6*19, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*38, CYP2A6*46					Metabolism/PK
305	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C,HIV Infections	IFNL3	rs11881222	19	39244283	A	G	Efficacy
306	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,telaprevir			Hepatitis C, Chronic	IFNL3	rs8099917	19	39252525	T	G	Efficacy
307	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	time to therapeutic inr	VKORC1	rs9923231	16	31096368	C	D	Efficacy
308	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	time in therapeutic range	VKORC1	rs9923231	16	31096368	C	D	Efficacy
309	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	SLC19A1	H27R	21	45537880	T	S	Efficacy
310	pharmgkb	Drug	dapsone	2955	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Leprosy,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*13:01					Toxicity
311	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	Q172H	19	41006936	G	W	Metabolism/PK
312	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28					Metabolism/PK
313	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Hypercholesterolemia,Myocardial Infarction	ABCG2	Q141K	4	88131171	G	Y	Efficacy
314	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neutropenia	UGT1A1	rs10929302	2	233757136	G	A	Toxicity
315	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation,Proteinuria	CYP3A4	rs4646437	7	99767460	G	A	Metabolism/PK
316	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A5	CYP3A5*1, CYP3A5*3					Dosage
317	pharmgkb	Drug	methazolamide	4100	CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*59:01					Toxicity
318	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Atrial Fibrillation,heart valve replacement	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13, CYP2C9*14					Efficacy
319	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	16	31093557	G	M	Dosage
320	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	VKORC1	rs9923231	16	31096368	C	D	Toxicity
321	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	16	31093557	G	M	Dosage
322	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10					Dosage
323	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs2884737	16	31094233	A	C	Dosage
324	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	Atrial Fibrillation	CYP4F2	V433M	19	15879621	C	T	Dosage
325	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A5	CYP3A5*1, CYP3A5*3					Dosage
326	pharmgkb	Drug	salmeterol	5152	C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O	Asthma	ADRB2	R16G	5	148826877	G	A	Efficacy
327	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	CYP2B6	I328T	19	41012316	T	C	Toxicity
328	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage,over-anticoagulation,time above therapeutic range	VKORC1	rs9923231	16	31096368	C	D	Toxicity
329	pharmgkb	Drug Class	hmg coa reductase inhibitors			statin-related myopathy	SLCO1B1	V174A	12	21178615	T	C	Toxicity
330	pharmgkb	Drug	captopril	44093	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	Diabetes Mellitus, Type 2,Heart Failure,Pulmonary Disease, Chronic Obstructive	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
331	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C		CYP2B6	CYP2B6*1, CYP2B6*2, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22, CYP2B6*30					Metabolism/PK
332	pharmgkb	Drug	mirtazapine	4205	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6					Metabolism/PK
333	pharmgkb	Drug	rabeprazole	5029	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Metabolism/PK
334	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*18					Metabolism/PK
335	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Toxicity
336	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,Organ Transplantation	CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22					Dosage
337	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	D36Y	16	31094624	C	W	Dosage
338	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*40:01					Toxicity
339	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7					Metabolism/PK
340	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Drug Toxicity,hematotoxicity,Leukopenia,Lymphoma,mucositis,Neoplasms,Neutropenia,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma,primary central nervous system lymphoma,Thrombocytopenia,Toxic liver disease	MTHFR	A222V	1	11796321	G	A	Toxicity
341	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid,Arthritis, Psoriatic,Arthritis, Rheumatoid,Drug Toxicity	MTHFR	A222V	1	11796321	G	A	Toxicity
342	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*13:01, HLA-B*15:02, HLA-B*38:02					Toxicity
343	pharmgkb	Drug	isoniazid	3767	C1=CN=CC=C1C(=O)NN	Tuberculosis	NAT2	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6A, NAT2*6B, NAT2*6J, NAT2*6O, NAT2*7A, NAT2*7B, NAT2*7G, NAT2*12A, NAT2*13A, NAT2*14A					Metabolism/PK
344	pharmgkb	Drug Class	antiepileptics			Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02					Toxicity
345	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	CYP3A4	rs2242480	7	99763843	C	T	Dosage
346	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,laparoscopic sleeve gastrectomy,liver transplantation,lung transplantation	CYP3A4	CYP3A4*1, CYP3A4*18, CYP3A4*20, CYP3A4*22					Metabolism/PK
347	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation	CYP3A4	rs2242480	7	99763843	C	T	Metabolism/PK
348	pharmgkb	Drug	methazolamide	4100	CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*01:02					Toxicity
349	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CES1	G144E	16	55823658	C	T	Efficacy
350	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CES1	G144E	16	55823658	C	T	Metabolism/PK
351	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	SCN1A	rs3812718	2	166053034	C	T	Dosage
352	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-C	HLA-C*03:02					Toxicity
353	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ATIC	rs4673993	2	215347616	T	M	Efficacy
354	pharmgkb	Drug	etanercept			Arthritis, Psoriatic,Arthritis, Rheumatoid,Crohn Disease,Inflammation,Psoriasis,Spondylitis, Ankylosing	TNF	rs1800629	6	31575254	G	A	Efficacy
355	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4		HLA-DRB1	HLA-DRB1*01:01					Toxicity
356	pharmgkb	Drug Class	Platinum compounds			Neoplasms	XRCC1	Q399R	19	43551574	T	C	Efficacy
357	pharmgkb	Drug	erlotinib	176870	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	Adenocarcinoma,Carcinoma, Non-Small-Cell Lung,Drug Resistance,Lung Neoplasms	EGFR	T790M	7	55181378	C	T	Efficacy
358	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	D398N	15	78590583	G	A	Toxicity
359	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Exanthema,Hypersensitivity,Stevens-Johnson Syndrome	HLA-C	HLA-C*04:01					Toxicity
360	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	ALDH2	E457K	12	111803962	G	A	Toxicity
361	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	HLA-DPB1	HLA-DPB1*03:01					Toxicity
362	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Disease,Hyperlipidemias	APOE	R176C	19	44908822	C	T	Efficacy
363	pharmgkb		peginterferon alfa-2b,ribavirin			Anemia,Hepatitis C, Chronic	ITPA	P32T	20	3213196	C	R	Toxicity
364	pharmgkb	Drug Class	Ace Inhibitors, Plain			Angioedema	XPNPEP2	rs3788853	X	129736814	C	A	Toxicity
365	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension,Hypertension	ADD1	G460W	4	2904980	G	W	Efficacy
366	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Drug Resistance	EGFR	T790M	7	55181378	C	T	Efficacy
367	pharmgkb		peginterferon alfa-2b,ribavirin			Anemia,Hepatitis C, Chronic	ITPA	rs7270101	20	3213247	A	C	Toxicity
368	pharmgkb	Drug	rituximab			Arthritis, Rheumatoid,Neuromyelitis Optica	FCGR3A	F175V	1	161544752	A	B	Efficacy
369	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Disease,Myocardial Infarction	KIF6	W170R	6	39357302	A	G	Efficacy
370	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*06:02, HLA-C*07:27, HLA-C*08:01					Toxicity
371	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity,Stevens-Johnson Syndrome	HLA-A	HLA-A*33:03					Toxicity
372	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	EPAS1	rs7557402	2	46376532	C	R	Toxicity
373	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	CSRP3	rs983332	1	87666697	G	T	Efficacy
374	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	ARAP2	rs437943	4	35370476	T	C	Efficacy
375	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	CST5	rs6138150	20	23866372	T	C	Efficacy
376	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MAFB	rs6028945	20	40192165	G	W	Efficacy
377	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MAFB	rs6071980	20	40239936	T	C	Efficacy
378	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs11188072	10	94759304	C	T	Dosage
379	pharmgkb	Drug Class	diuretics			Hypertension,Myocardial Infarction	ADD1	G460W	4	2904980	G	W	Efficacy
380	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	DRD3	G9S	3	114171968	C	T	Efficacy
381	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	UGT1A10	S7A	2	233693023	T	G	Dosage
382	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	SLC19A1	rs9977268	21	45487373	C	T	Efficacy
383	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Coronary Artery Disease	PTGS2	rs20417	1	186681189	C	K	Efficacy
384	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		ABCB1	I1145M	7	87509329	A	K	Dosage
385	pharmgkb		dexamethasone,doxorubicin,vincristine			Multiple Myeloma	ABCB1	I1145M	7	87509329	A	K	Efficacy
386	pharmgkb	Drug	dicloxacillin	18381	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O		ABCB1	I1145M	7	87509329	A	K	Other
387	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	ABCB1	I1145M	7	87509329	A	K	Toxicity
388	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC2	V1188E	10	99836239	T	A	Toxicity
389	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		ABCB1	rs1128503	7	87550285	A	G	Other
390	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	ERCC1	rs11615	19	45420395	A	G	Toxicity
391	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	GSTP1	I105V	11	67585218	A	G	Efficacy
392	pharmgkb		fluorouracil,leucovorin,oxaliplatin			Colorectal Neoplasms	ERCC2	rs13181	19	45351661	T	R	Efficacy,Toxicity
393	pharmgkb		dexamethasone,doxorubicin,vincristine			Multiple Myeloma	ABCB1	S893A	7	87531302	A	Y	Efficacy
394	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Breast Neoplasms	ABCB1	S893A	7	87531302	A	Y	Other
395	pharmgkb	Drug	digoxin	30322	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O		ABCB1	S893A	7	87531302	A	Y	Other
396	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough,Hypertension	PTGER3	rs11209716	1	70911967	T	C	Toxicity
397	pharmgkb		Antivirals for treatment of HIV infections, combinations,ritonavir			HIV Infections,Hypertriglyceridemia	APOE	R176C	19	44908822	C	T	Toxicity
398	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Neoplasms	SLCO1B3	rs11045585	12	20892760	A	G	Toxicity
399	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough,Hypertension	MME	rs2016848	3	155140896	G	A	Toxicity
400	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F		DRD2	rs1799978	11	113475629	T	C	Toxicity
401	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3		ESR2	rs4986938	14	64233098	C	T	Toxicity
402	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough,Hypertension	BDKRB2	rs8012552	14	96222430	C	T	Toxicity
403	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		STX4	rs10871454	16	31036758	C	T	Dosage
404	pharmgkb	Drug	trastuzumab			Breast Neoplasms,Drug Toxicity	ERBB2	I655V	17	39723335	A	K	Toxicity
405	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	V29L	16	31094645	C	A	Dosage
406	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	V45A	16	31094596	A	G	Dosage
407	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	R58G	16	31094558	T	C	Dosage
408	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	L128R	16	31091243	A	C	Dosage
409	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		ABCB1	S400N	7	87550493	C	W	Other
410	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	HLA-C	rs9461684	6	31285667	C	T	Toxicity
411	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	SLCO1B1	P155T	12	21176879	C	W	Efficacy
412	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3		ESR1	rs9340799	6	151842246	A	G	Toxicity
413	pharmgkb		antidepressants,mirtazapine,venlafaxine			Depressive Disorder, Major	TPH2	rs10879346	12	71958055	C	T	Efficacy
414	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A	rs5760410	22	24419438	G	M	Toxicity
415	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MOB3B	rs868856	9	27489253	A	G	Efficacy
416	pharmgkb		Platinum compounds,taxanes			Ovarian Neoplasms	ABCB1	S893A	7	87531302	A	Y	Toxicity
417	pharmgkb	Drug Class	topoisomerase I inhibitors			Neoplasms	EGFR	rs712829	7	55019062	G	Y	Efficacy
418	pharmgkb	Drug	geldanamycin	46936377	C[C@@H]1C[C@H]([C@@H]([C@@H](/C=C(\[C@H]([C@@H](/C=C\C=C(/C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)\C)OC)OC(=O)N)/C)C)O)OC	Neoplasms	EGFR	rs712829	7	55019062	G	Y	Efficacy
419	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	DTNBP1	rs2619538	6	15664978	A	T	Toxicity
420	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	ALOX5	rs2115819	10	45405641	A	G	Efficacy
421	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	LTA4H	rs2660845	12	96044775	G	M	Efficacy
422	pharmgkb		olanzapine,risperidone			Alzheimer Disease	HTR2A	rs6313	13	46895805	G	A	Efficacy
423	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	ADRB3	W64R	8	37966280	A	G	Toxicity
424	pharmgkb		olanzapine,perphenazine			Schizophrenia	RGS4	rs2842030	1	163070705	G	W	Efficacy
425	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	RGS4	rs2842030	1	163070705	G	W	Efficacy
426	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	LEP	rs4731426	7	128242017	G	H	Toxicity
427	pharmgkb		Platinum compounds,taxanes			Ovarian Neoplasms	ABCB1	S893A	7	87531302	A	Y	Toxicity
428	pharmgkb	Drug	cetuximab			Colorectal Neoplasms	CCND1	rs9344	11	69648142	G	A	Efficacy
429	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	DTNBP1	rs742105	6	15572843	C	T	Efficacy
430	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Colitis, Ulcerative	ABCB1	S893A	7	87531302	A	Y	Efficacy
431	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Autistic Disorder	ABCB1	rs1128503	7	87550285	A	G	Efficacy
432	pharmgkb	Drug	amiodarone	2157	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	Torsades de Pointes	KCNH2	R444G	7	150950216	G	M	Toxicity
433	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	T151I	8	63026205	G	A	Toxicity
434	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	C9orf72	rs774359	9	27561051	T	C	Efficacy
435	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Breast Neoplasms,Neutropenia	CBR3	C4S	21	36135203	G	M	Efficacy,Toxicity
436	pharmgkb	Drug	daunorubicin	30323	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O	Drug Toxicity	NRP2	rs10932125	2	205787576	C	G	Other
437	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Carcinoma, Non-Small-Cell Lung,Neoplasms	CYP3A	T185S	7	99768470	G	C	Dosage
438	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	RGS4	rs951439	1	163063901	C	K	Efficacy
439	pharmgkb		antipsychotics,olanzapine,perphenazine,quetiapine,ziprasidone			Schizophrenia	RGS4	rs951439	1	163063901	C	K	Efficacy
440	pharmgkb	Drug	propofol	4943	CC(C)C1=C(C(=CC=C1)C(C)C)O		UGT1A9	D256N	2	233672700	G	A	Toxicity
441	pharmgkb		prednisone,tacrolimus			Organ Transplantation,Transplantation	ABCB1	I1145M	7	87509329	A	K	Other
442	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N		BAG6	rs750332	6	31639273	C	T	Toxicity
443	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	C9orf72	rs3849942	9	27543283	T	M	Efficacy
444	pharmgkb	Drug	erlotinib	176870	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	Neoplasms	EGFR	rs712829	7	55019062	G	Y	Efficacy
445	pharmgkb	Drug	rofecoxib	5090	CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3		PTGS2	rs20417	1	186681189	C	K	Efficacy
446	pharmgkb	Drug	sildenafil	5212	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Erectile Dysfunction	ACE	rs4343	17	63488670	G	A	Efficacy
447	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs4086116	10	94947445	C	T	Dosage
448	pharmgkb		amlodipine,chlorthalidone			Cardiovascular Diseases,Coronary Disease,Stroke	NPPA	rs5065	1	11846011	A	G	Efficacy
449	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Disease	PPARA	rs4253778	22	46234737	G	Y	Efficacy
450	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MOB3B	rs2814707	9	27536399	C	K	Efficacy
451	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	GBP6	rs928655	1	89384015	G	M	Efficacy
452	pharmgkb	Drug Class	anthracyclines and related substances			Precursor Cell Lymphoblastic Leukemia-Lymphoma	CAT	rs10836235	11	34439157	C	K	Toxicity
453	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		SLCO1B1	N130H	12	21176804	A	K	Other
454	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		CYP2C8	R139K	10	95067273	C	W	Other
455	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		CYP2C8	K297R	10	95038992	T	C	Other
456	pharmgkb		fluvoxamine,milnacipran,paroxetine			Depressive Disorder, Major	HTR1A	rs10042486	5	63965502	C	T	Efficacy
457	pharmgkb	Drug	haloperidol	3559	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	DTNBP1	rs909706	6	15660640	T	C	Efficacy
458	pharmgkb	Drug	iloperidone	71360		Acquired Long QT Syndrome (aLQTS)	NRG3	rs4933824	10	82059369	T	G	Toxicity
459	pharmgkb	Drug	iloperidone	71360		Acquired Long QT Syndrome (aLQTS)	NUBPL	rs7142881	14	31624342	G	A	Toxicity
460	pharmgkb	Drug	iloperidone	71360		Acquired Long QT Syndrome (aLQTS)	CELF4	rs4799915	18	37348676	C	T	Toxicity
461	pharmgkb	Drug	iloperidone	71360		Acquired Long QT Syndrome (aLQTS)	CERKL	rs993648	2	181591267	C	T	Toxicity
462	pharmgkb	Drug	verapamil	2520	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Acquired Long QT Syndrome (aLQTS)	NOS1AP	rs10918594	1	162060898	C	G	Toxicity
463	pharmgkb	Drug	verapamil	2520	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Acquired Long QT Syndrome (aLQTS)	NOS1AP	rs10494366	1	162115895	G	T	Toxicity
464	pharmgkb	Drug Class	Measles vaccines				TLR3	L412V	4	186082920	C	K	Efficacy
465	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders,Substance-Related Disorders	PICK1	rs2076369	22	38067645	T	R	Toxicity
466	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	DTNBP1	rs3213207	6	15627871	T	C	Toxicity
467	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	CHST3	rs4148945	10	72009832	C	T	Efficacy,Toxicity
468	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	CHST3	rs4148943	10	72009749	C	T	Efficacy
469	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Carcinoma, Non-Small-Cell Lung	PIK3CA	rs870995	3	179195218	C	A	Dosage
470	pharmgkb	Drug Class	antipsychotics			Schizophrenia	CLCN6	A222V	1	11796321	G	A	Toxicity
471	pharmgkb		Bisphosphonates,clodronate,etidronic acid,risedronate,tiludronate			Osteitis Deformans	IL1B	rs16944	2	112837290	A	G	Efficacy
472	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Transplantation	CYP2B6	K262R	19	41009358	A	G	Toxicity
473	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Autistic Disorder	DRD3	G9S	3	114171968	C	T	Efficacy
474	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Autistic Disorder	HTR2A	rs6311	13	46897343	C	T	Efficacy
475	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	TYMS	rs2853539	18	659829	A	K	Efficacy
476	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Schizophrenia	DRD3	rs167771	3	114157428	G	W	Toxicity
477	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Rectal Neoplasms	GSTP1	I105V	11	67585218	A	G	Toxicity
478	pharmgkb		carboplatin,paclitaxel			Carcinoma, Non-Small-Cell Lung,Neoplasms	DSCAM	rs9981861	21	40043117	T	C	Efficacy
479	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Lymphoma, Non-Hodgkin	ABCC2	C1515Y	10	99851537	G	A	Toxicity
480	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	CHST3	rs730720	10	72013004	C	T	Efficacy
481	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	PPARD	rs6922548	6	35385746	A	G	Efficacy
482	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	ABCC6	R1268Q	16	16157742	C	T	Toxicity
483	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	PPARD	rs1883322	6	35402029	C	W	Efficacy
484	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	CHST3	rs12418	10	72013256	G	A	Efficacy
485	pharmgkb	Drug Class	Platinum compounds			Ovarian Neoplasms	CD3EAP	Q506K	19	45409478	C	D	Efficacy
486	pharmgkb		antidepressants,citalopram,fluoxetine			Depressive Disorder, Major	SERPINE1	rs2227631	7	101126257	A	G	Efficacy
487	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Breast Neoplasms	CYP3A4	rs2740574	7	99784473	C	T	Toxicity
488	pharmgkb	Drug	pramipexole	59868	CCCN[C@@H]1CCC2=C(C1)SC(=N2)N	Parkinson Disease	DRD3	G9S	3	114171968	C	T	Efficacy
489	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C		NR1I2	rs2472677	3	119799570	C	T	Other
490	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs165599	22	19969258	G	A	Efficacy
491	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	GRM3	rs724226	7	86696058	A	B	Efficacy
492	pharmgkb	Drug	ritonavir	392622	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	HIV Infections,Hyperlipidemias	APOC3	rs5128	11	116832924	G	C	Toxicity
493	pharmgkb	Drug	rosiglitazone	77999	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	Diabetes Mellitus, Type 2	LPIN1	rs10192566	2	11750302	C	G	Efficacy
494	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	TCF7L2	rs12255372	10	113049143	G	W	Efficacy
495	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	ABCC1	rs119774	16	15992976	C	T	Efficacy
496	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	ABCC1	T1337A	16	16134392	A	G	Efficacy
497	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	ABCC1	rs2238476	16	16120015	G	A	Efficacy,Toxicity
498	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	ABCG2	rs17731538	4	88134227	G	A	Efficacy
499	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Drug Toxicity,Psoriasis	ABCC1	rs246240	16	16025167	A	G	Toxicity
500	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	ABCG2	rs13120400	4	88112375	T	C	Efficacy
501	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension	APOB	T98I	2	21041028	G	A	Efficacy
502	pharmgkb		atorvastatin,pravastatin,simvastatin			Myalgia unspecified	HTR3B	rs2276307	11	113933165	A	G	Toxicity
503	pharmgkb	Drug	caffeine	2519	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	Myocardial Infarction	CYP1A2	rs762551	15	74749576	C	A	Toxicity
504	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	rs12248560	10	94761900	C	W	Dosage
505	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	FPGS	rs1544105	9	127800446	C	T	Efficacy
506	pharmgkb	Drug	nitrous oxide				MTHFR	A222V	1	11796321	G	A	Toxicity
507	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		CYP2C8	rs1113129	10	95051288	G	M	Toxicity
508	pharmgkb		atorvastatin,hmg coa reductase inhibitors,pravastatin,simvastatin			Myalgia unspecified	HTR7	rs1935349	10	90834586	C	T	Toxicity
509	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	NALCN	rs7992226	13	101145489	A	G	Other
510	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ARID5B	rs10821936	10	61963818	C	T	Other
511	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Drug Toxicity	MTHFR	F435L	1	11794400	G	A	Toxicity
512	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	GGH	C6R	8	63038753	A	G	Efficacy
513	pharmgkb		antipsychotics,clozapine,olanzapine			Schizophrenia	DRD2	rs1079598	11	113425552	A	G	Toxicity
514	pharmgkb	Drug Class	Antihypertensives And Diuretics In Combination				NOS3	rs2070744	7	150992991	C	T	Efficacy
515	pharmgkb		antidepressants,desipramine,fluoxetine			Depression,Depressive Disorder, Major	BDNF	rs61888800	11	27700731	G	T	Efficacy
516	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	TCF7L2	rs290487	10	113149972	C	T	Efficacy
517	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Arrhythmias, Cardiac,Drug Toxicity,Lymphoma, Non-Hodgkin	ABCC2	V1188E	10	99836239	T	A	Toxicity
518	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Arrhythmias, Cardiac,Drug Toxicity,Lymphoma, Non-Hodgkin	ABCC1	G671V	16	16079375	G	T	Toxicity
519	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Congenital Abnormalities,Craniofacial Abnormalities	EPHX1	Y113H	1	225831932	T	C	Toxicity
520	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Congenital Abnormalities,Craniofacial Abnormalities	EPHX1	H139R	1	225838705	A	K	Toxicity
521	pharmgkb	Drug	etoposide	36462	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O		SLIT1	rs2784917	10	97169185	A	G	Toxicity
522	pharmgkb	Drug	fexofenadine	3348	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O		ABCB1	I1145M	7	87509329	A	K	Dosage
523	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	PPARD	rs7769719	6	35394748	G	M	Efficacy
524	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	CYP4B1	R10W	1	46813503	C	T	Toxicity
525	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	CHST3	rs4148950	10	72011948	G	A	Efficacy,Toxicity
526	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	CHST3	rs4148947	10	72010359	T	C	Efficacy
527	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	PPARD	rs3734254	6	35427233	C	T	Efficacy
528	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	SLC10A2	rs2301159	13	103045378	G	A	Toxicity
529	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	SPG7	T503A	16	89546715	A	G	Toxicity
530	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	ATP7A	V767L	X	78013005	G	C	Toxicity
531	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	PPARD	rs2016520	6	35411001	C	T	Efficacy
532	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	NAT2	G286E	8	18400860	G	A	Toxicity
533	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	SULT1C4	D5E	2	108378352	C	G	Efficacy
534	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	RPL13	R688Q	16	89553920	G	A	Toxicity
535	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Carcinoma, Non-Small-Cell Lung	PRDX4	rs518329	X	23677119	T	C	Dosage
536	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Carcinoma, Non-Small-Cell Lung	EPHX1	H139R	1	225838705	A	K	Dosage
537	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Carcinoma, Non-Small-Cell Lung	XRCC4	rs1382368	5	83155256	C	T	Dosage
538	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	ADM	rs11042725	11	10303778	C	A	Efficacy
539	pharmgkb		antidepressants,citalopram,fluoxetine			Depressive Disorder, Major	SERPINE1	rs1799889	7	101126430	A	G	Efficacy
540	pharmgkb	Drug	clodronate	25419	C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl	Osteitis Deformans	VDR	rs731236	12	47844974	A	G	Efficacy
541	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A	rs3761422	22	24430704	T	C	Toxicity
542	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A	rs2267076	22	24434627	T	C	Toxicity
543	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Cystitis,Transplantation	CYP2B6	R22C	19	40991369	C	T	Toxicity
544	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil,methotrexate			Breast Neoplasms	NOS3	rs2070744	7	150992991	C	T	Efficacy
545	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Inflammatory Bowel Diseases	DDRGK1	P32T	20	3213196	C	R	Efficacy
546	pharmgkb	Drug	erlotinib	176870	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC	Neoplasms	EGFR	rs712829	7	55019062	G	Y	Toxicity
547	pharmgkb		budesonide,flunisolide,fluticasone propionate,glucocorticoids,nedocromil,triamcinolone			Asthma	GLCCI1	rs37973	7	7968245	G	M	Efficacy
548	pharmgkb	Drug	verapamil	2520	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Hypertension	KCNIP1	E65K	5	170383792	C	T	Efficacy
549	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Anxiety Disorders	DRD3	rs963468	3	114144040	G	A	Efficacy
550	pharmgkb	Drug	leflunomide	3899	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	Arthritis, Rheumatoid	ESR1	rs9340799	6	151842246	A	G	Efficacy
551	pharmgkb		conjugated estrogens,medroxyprogesterone				ESR1	rs9340799	6	151842246	A	G	Efficacy
552	pharmgkb		atenolol,verapamil			Coronary Artery Disease,Hypertension	CACNA1C	rs1051375	12	2679713	G	A	Efficacy
553	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension,Kidney Diseases,Nephrosclerosis	GRK4	A142V	4	3004316	C	D	Efficacy
554	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O		ABCC10	rs9349256	6	43436773	G	A	Toxicity
555	pharmgkb		interferon alfa-2a, recombinant,peginterferon alfa-2b			Hepatitis C, Chronic	IDO1	rs9657182	8	39908329	C	K	Toxicity
556	pharmgkb		interferon beta-1a,interferon beta-1b				HLA-DQA1	rs9272105	6	32632222	G	A	Efficacy
557	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids			Acute coronary syndrome	AGT	rs943580	1	230701298	G	A	Toxicity
558	pharmgkb		amoxicillin,clavulanate			Drug Toxicity	HLA-DQB1	F41Y	6	32665055	A	Y	Toxicity
559	pharmgkb	Drug	coumarin				CYP2A6	L160H	19	40848628	A	T	Other
560	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs28399433	19	40850474	A	B	Other
561	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	UGT1A10	T181A	2	233693545	A	G	Dosage
562	pharmgkb	Drug Class	antipsychotics			tardive dyskinesia	COMT	V158M	22	19963748	G	A	Toxicity
563	pharmgkb	Drug	coumarin				CYP2A6	rs28399433	19	40850474	A	B	Other
564	pharmgkb		cyclophosphamide,doxorubicin			Breast Neoplasms	CYP2B6	Q172H	19	41006936	G	W	Dosage
565	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	R485L	19	40843827	C	R	Other
566	pharmgkb		Antihypertensives,Antihypertensives And Diuretics In Combination,diuretics			Hypertension	NOS3	rs2070744	7	150992991	C	T	Efficacy
567	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Hepatic Veno-Occlusive Disease,Transplantation	CYP2B6	Q172H	19	41006936	G	W	Toxicity
568	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	GGH	rs3758149	8	63039169	G	A	Efficacy
569	pharmgkb	Drug Class	antipsychotics			Schizophrenia	COMT	V158M	22	19963748	G	A	Other
570	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP3A	rs2740574	7	99784473	C	T	Other
571	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		CYP2C8	K297R	10	95038992	T	C	Other
572	pharmgkb		atorvastatin,hmg coa reductase inhibitors,rosuvastatin			Muscular Diseases	COQ2	rs6535454	4	83269878	A	G	Toxicity
573	pharmgkb	Drug	cerivastatin	446156	CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC	Rhabdomyolysis	RYR2	rs2819742	1	237826822	A	K	Toxicity
574	pharmgkb	Drug	amiodarone	2157	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	Long QT Syndrome	NOS1AP	rs10919035	1	162274222	C	T	Toxicity
575	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SHMT1	L474F	17	18328782	G	A	Toxicity
576	pharmgkb		calcium channel blockers,nitrendipine			Essential hypertension	KCNH2	rs1137617	7	150951110	A	B	Efficacy
577	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		CYP2C8	R139K	10	95067273	C	W	Dosage
578	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder, Major	GABRQ	I478L	X	152652814	A	Y	Efficacy
579	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O		CYP2D6	rs5030655	22	42129084	A	-	Efficacy
580	pharmgkb		mirtazapine,venlafaxine			Depression	TPH2	rs1487278	12	72007071	T	C	Efficacy
581	pharmgkb		citalopram,fluoxetine			Depressive Disorder, Major	GSK3B	rs334558	3	120094435	A	G	Efficacy
582	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	CACNG2	rs2284017	22	36700882	T	C	Efficacy
583	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O		CYP2D6	rs3892097	22	42128945	C	T	Efficacy
584	pharmgkb	Drug Class	antidepressants			Depression	FKBP5	rs3800373	6	35574699	C	A	Efficacy
585	pharmgkb	Drug	zoledronate	68740	C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O	Neoplasms,Osteonecrosis	FDPS	rs2297480	1	155309691	T	G	Toxicity
586	pharmgkb		antidepressants,Selective serotonin reuptake inhibitors,venlafaxine			Depressive Disorder, Major	GABRA6	rs1992647	5	161684168	G	A	Efficacy
587	pharmgkb		antidepressants,Selective serotonin reuptake inhibitors,venlafaxine			Depressive Disorder, Major	GABRP	L7V	5	170788634	T	C	Efficacy
588	pharmgkb		antidepressants,Selective serotonin reuptake inhibitors,venlafaxine			Depressive Disorder, Major	GRIA3	rs3761555	X	123182584	T	C	Efficacy
589	pharmgkb		antidepressants,Selective serotonin reuptake inhibitors,venlafaxine			Depressive Disorder, Major	GRIA3	rs3761554	X	123183391	T	C	Efficacy
590	pharmgkb		antidepressants,Selective serotonin reuptake inhibitors,venlafaxine			Depressive Disorder, Major	GRIA3	rs502434	X	123403426	T	C	Efficacy
591	pharmgkb		antidepressants,benzodiazepine derivatives,mirtazapine,Selective serotonin reuptake inhibitors			Depressive Disorder, Major	GAL	rs948854	11	68682735	C	T	Efficacy
592	pharmgkb		escitalopram,nortriptyline			Depressive Disorder, Major	BDNF	rs962369	11	27712873	T	C	Toxicity
593	pharmgkb	Drug	cangrelor	9854012	CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F		P2RY12	rs9859552	3	151373208	G	W	Efficacy
594	pharmgkb	Drug	hydroxyurea	3657	C(=O)(N)NO	Thalassemia	MAP3K5	rs9376230	6	136781227	C	A	Efficacy
595	pharmgkb	Drug	hydroxyurea	3657	C(=O)(N)NO	Thalassemia	MAP3K5	rs9483947	6	136784262	C	T	Efficacy
596	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	CRY1	rs8192440	12	107001328	A	K	Efficacy
597	pharmgkb		amitriptyline,citalopram,paroxetine,venlafaxine			Depressive Disorder	ABCB1	rs7787082	7	87527735	G	A	Efficacy
598	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	DRD1	rs4532	5	175443147	C	T	Efficacy
599	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	GSK3B	rs334558	3	120094435	A	G	Efficacy
600	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	OR52J2P	rs2499984	11	5040311	A	G	Efficacy
601	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	CACNG2	rs2284018	22	36701519	C	K	Efficacy
602	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	GSTM3	rs1799735					Toxicity
603	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	IL12A	rs568408	3	159995680	G	A	Toxicity
604	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs8832	16	27364466	A	G	Efficacy
605	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	BDNF	rs7934165	11	27710436	G	A	Dosage
606	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	BDNF	rs1491850	11	27728178	T	C	Dosage
607	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	NR1D1	rs2314339	17	40096959	C	T	Efficacy
608	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation,Organ Transplantation	IMPDH1	rs2278294	7	128400645	C	T	Efficacy
609	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs2120266	9	84841436	G	A	Dosage
610	pharmgkb		artesunate,primaquine,pyrimethamine,sulfadoxine				G6PD	V68M	X	154536002	C	T	Toxicity
611	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs2289658	9	84948455	T	C	Dosage
612	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Leukopenia	IMPDH1	rs2278294	7	128400645	C	T	Toxicity
613	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs4358872	9	84986054	T	G	Dosage
614	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs1948308	9	85001342	G	A	Dosage
615	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs2378676	9	85004508	A	Y	Dosage
616	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NTRK2	rs4877900	9	85017403	C	K	Dosage
617	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	ANKK1	A239T	11	113396099	G	A	Dosage
618	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	DRD2	rs2283265	11	113414814	C	A	Dosage
619	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	NGF	rs2239622	1	115295088	A	K	Dosage
620	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	BDNF	rs10835210	11	27674363	C	R	Dosage
621	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	GSK3B	rs6438552	3	119912967	A	G	Efficacy
622	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	TPH1	rs1800532	11	18026269	G	T	Efficacy
623	pharmgkb	Drug	cytarabine	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia, Myeloid, Acute,Neoplasms	CDA	rs532545	1	20588679	C	W	Efficacy
624	pharmgkb	Drug	cytarabine	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia, Myeloid	CDA	rs532545	1	20588679	C	W	Toxicity
625	pharmgkb	Drug	cytarabine	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O		CDA	rs602950	1	20589038	A	G	Toxicity
626	pharmgkb	Drug	cytarabine	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O		CDA	rs3215400	1	20589097	C	-	Toxicity
627	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs2236196	20	63346204	G	M	Other
628	pharmgkb	Drug	muraglitazar			Diabetes Mellitus,Edema,Hyperlipidemias	ADRB1	G389R	10	114045297	G	C	Toxicity
629	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	GNB3	rs5443	12	6845711	C	T	Toxicity
630	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	HTR2A	rs6313	13	46895805	G	A	Toxicity
631	pharmgkb	Drug	nortriptyline	4543	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depression,Depressive Disorder,Depressive Disorder, Major,Hypotension	ABCB1	I1145M	7	87509329	A	K	Toxicity
632	pharmgkb	Drug	verapamil	2520	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Coronary Artery Disease,Hypertension	KCNIP1	V110L	5	170378952	C	K	Efficacy
633	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	DRD3	G9S	3	114171968	C	T	Efficacy
634	pharmgkb	Drug	oxaliplatin	6857599	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	Colorectal Neoplasms	ABCB1	I1145M	7	87509329	A	K	Efficacy
635	pharmgkb	Drug	oxaliplatin	6857599	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	Colorectal Neoplasms	ABCB1	rs1128503	7	87550285	A	G	Efficacy
636	pharmgkb	Drug	nitroprusside	11963622	[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+4]		ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
637	pharmgkb	Drug	acetylcholine	187	CC(=O)OCC[N+](C)(C)C		ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
638	pharmgkb	Drug	nifedipine	4485	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	Hypertension	SLC14A2	V750F	18	45672918	G	W	Efficacy
639	pharmgkb	Drug	nifedipine	4485	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	Hypertension	SLC14A2	A880T	18	45682394	G	A	Efficacy
640	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	S543R	20	63349782	G	M	Other
641	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		CYP1A2	rs762551	15	74749576	C	A	Efficacy
642	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		HTR2A	rs7997012	13	46837850	A	G	Toxicity
643	pharmgkb	Drug	midazolam	4192	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		CYP3A4	T185S	7	99768470	G	C	Other
644	pharmgkb	Drug	nemonapride			Schizophrenia	ANKK1	E713K	11	113400106	G	A	Toxicity
645	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs17880887	16	31099180	G	T	Dosage
646	pharmgkb	Drug	nitrous oxide				MTHFR	E429A	1	11794419	T	G	Toxicity
647	pharmgkb	Drug	verapamil	2520	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC		ABCB1	I1145M	7	87509329	A	K	Other
648	pharmgkb	Drug	spironolactone	5833	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C	Heart Failure	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
649	pharmgkb	Drug	spironolactone	5833	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C		ACE	rs4343	17	63488670	G	A	Efficacy
650	pharmgkb	Drug	sumatriptan	5358	CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C	Cluster Headache	GNB3	rs5443	12	6845711	C	T	Efficacy
651	pharmgkb		cisplatin,cyclophosphamide,doxorubicin,methotrexate,vincristine			Osteosarcoma	ABCC3	rs4148416	17	50676062	C	T	Efficacy
652	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs762551	15	74749576	C	A	Dosage,Toxicity
653	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	BDNF	V66M	11	27658369	C	T	Efficacy
654	pharmgkb	Drug	prasugrel	6918456	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	Acute coronary syndrome	CYP2C19	rs4244285	10	94781859	G	M	Efficacy
655	pharmgkb		cyclosporine,mycophenolate mofetil			Kidney Transplantation	ABCB1	S893A	7	87531302	A	Y	Efficacy
656	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Colonic Neoplasms	WNT5B	rs2010851	12	1647476	C	A	Other
657	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus	NEUROD1	T45S	2	181678728	T	C	Efficacy
658	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus	PAX4	R129W	7	127614533	G	W	Efficacy
659	pharmgkb	Drug	bucindolol	51045	CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O	Heart Failure	ADRA2C	rs61767072	4	3767570	GGGGCGGGGCCG	-	Efficacy
660	pharmgkb	Drug	sulfamethoxazole	5329	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	HIV Infections	GCLC	rs761142	6	53527310	A	C	Toxicity
661	pharmgkb	Drug Class	Alkylating Agents			Neoplasms	EGFR	rs712829	7	55019062	G	Y	Efficacy
662	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		ABCB1	N21H	7	87600124	T	C	Other
663	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		ABCB1	A999S	7	87516598	C	W	Other
664	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	LDLR	rs688	19	11116926	C	T	Efficacy
665	pharmgkb		docetaxel,thalidomide			Prostatic Neoplasms	CHST3	rs1871450	10	72012256	G	H	Efficacy,Toxicity
666	pharmgkb		antipsychotics,clozapine,olanzapine			Schizophrenia	DRD2	rs6277	11	113412737	G	A	Toxicity
667	pharmgkb	Drug	tolbutamide	5505	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	P489S	10	94989020	C	T	Other
668	pharmgkb	Drug	verapamil	2520	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC		ABCB1	S893A	7	87531302	A	Y	Other
669	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		CYP2C9	I359L	10	94981296	A	S	Efficacy
670	pharmgkb	Drug	muraglitazar			Diabetes Mellitus,Edema,Hyperlipidemias	REN	rs2368564	1	204155737	C	K	Toxicity
671	pharmgkb	Drug	muraglitazar			Diabetes Mellitus,Edema,Hyperlipidemias	EDN1	K198N	6	12296022	G	T	Toxicity
672	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Myocardial Infarction	P2RY1	rs1065776	3	152835839	C	T	Efficacy
673	pharmgkb		clomipramine,lithium,nefazodone,paroxetine,venlafaxine			Depression	ABCB1	S893A	7	87531302	A	Y	Toxicity
674	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	NR1D1	rs2071427	17	40098239	C	T	Efficacy
675	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	FSIP1	rs7179742	15	39770852	A	G	Toxicity
676	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	CEP68	G74S	2	65069664	G	A	Toxicity
677	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PPARG	rs3856806	3	12434058	C	T	Toxicity
678	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	IL4	rs2243250	5	132673462	C	T	Toxicity
679	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	ADORA1	rs2228079	1	203129147	T	G	Toxicity
680	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Coronary Artery Disease	GP6	P219A	19	55025227	G	A	Efficacy
681	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	FCER1G	rs11587213	1	161215085	A	G	Toxicity
682	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		IL1B	rs1143627	2	112836810	G	A	Toxicity
683	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TBXA2R	rs1131882	19	3595925	G	A	Toxicity
684	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Myocardial Infarction	ITGA2	rs1062535	5	53055583	G	A	Efficacy
685	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		NTRK1	rs2768759	1	156882671	A	S	Efficacy
686	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		HNMT	rs1050891	2	138014190	A	G	Toxicity
687	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs9332096	10	94937118	C	T	Dosage
688	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C		VEGFA	rs833061	6	43769749	C	K	Toxicity
689	pharmgkb	Drug	erythromycin	12560	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O		ABCC2	rs717620	10	99782821	C	T	Other
690	pharmgkb		raloxifene,tamoxifen			Breast Neoplasms	ZNF423	rs8060157	16	49796293	A	G	Efficacy
691	pharmgkb	Drug, Ion	calcium	271	[Ca+2]		VDR	rs731236	12	47844974	A	G	Efficacy
692	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		F13A1	V35L	6	6318562	C	W	Efficacy
693	pharmgkb		citalopram,escitalopram			Depressive Disorder, Major	FKBP5	rs9380524	6	35621293	C	W	Efficacy
694	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CYP2B6	CYP2B6*1, CYP2B6*5					Efficacy
695	pharmgkb	Drug, Metabolite	desipramine	2995	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	MC1R	V92M	16	89919532	G	M	Efficacy
696	pharmgkb	Drug, Metabolite	desipramine	2995	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	MC1R	rs2228478	16	89920200	A	G	Efficacy
697	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT1A9	M33T	2	233672032	T	M	Toxicity
698	pharmgkb	Drug	doxepin	667477	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31		CYP2C9	CYP2C9*1, CYP2C9*3					Efficacy
699	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl		PPARA	rs135543	22	46159422	C	T	Efficacy
700	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl		PPARA	rs135550	22	46157339	T	C	Efficacy
701	pharmgkb		fluvoxamine,milnacipran,paroxetine			Depressive Disorder, Major	HTR1A	rs1364043	5	63955024	T	G	Efficacy
702	pharmgkb	Drug Class	antidepressants			Depressive Disorder	GRIK4	rs12800734	11	120966045	G	A	Efficacy
703	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Diabetes Mellitus,Hypertension	KCNJ1	rs12795437	11	128860981	G	C	Toxicity
704	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	CYP2C9	rs12782374	10	94935594	G	A	Dosage
705	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Anxiety Disorders,Depressive Disorder, Major	CRHR1	rs242941	17	45815154	A	C	Efficacy
706	pharmgkb	Drug	fluvoxamine	3404	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	COMT	V158M	22	19963748	G	A	Efficacy
707	pharmgkb		cyclosporine,mycophenolate mofetil			Kidney Transplantation	IL10	rs1800872	1	206773062	T	G	Efficacy
708	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	SLCO1B3	M233I	12	20862826	G	A	Other
709	pharmgkb	Drug	lovastatin	53232	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		CETP	rs708272	16	56962376	G	A	Efficacy
710	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
711	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Coronary Artery Disease	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
712	pharmgkb		atorvastatin,quinapril			Coronary Artery Disease	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
713	pharmgkb		cyclophosphamide,doxorubicin			Breast Neoplasms	CYP2B6	R487S	19	41016810	C	D	Toxicity
714	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		FMO1	rs12720462	1	171248552	C	A	Other
715	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		FMO3	E308G	1	171114102	A	G	Other
716	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		FMO1	rs7877	1	171285751	C	T	Other
717	pharmgkb	Drug	thalidomide	5426	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	Multiple Myeloma	ERCC1	K261R	19	45408744	A	C	Efficacy
718	pharmgkb	Drug	thalidomide	5426	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	Multiple Myeloma	XRCC5	rs1051685	2	216205653	A	G	Efficacy
719	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs10509680	10	94974582	G	T	Dosage
720	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		PRSS53	rs17886199	16	31093126	A	G	Dosage
721	pharmgkb	Drug	thalidomide	5426	C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O	Multiple Myeloma	GSTT1	rs4630					Toxicity
722	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs4918758	10	94937495	T	C	Dosage
723	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs61162043	16	31102913	A	G	Dosage
724	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		SREBF1	rs60282872	17	17836851	C	-	Efficacy
725	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	SCAP	V798F	3	47418189	C	T	Efficacy
726	pharmgkb	Drug	ABT-751			Neoplasms	UGT1A4	P24T	2	233718890	C	W	Other
727	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough	BDKRB2	rs8016905	14	96209596	A	B	Toxicity
728	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease	TLR4	D99G	9	117713024	A	K	Efficacy
729	pharmgkb		folic acid,methotrexate			Arthritis, Rheumatoid	TLR4	D99G	9	117713024	A	K	Toxicity
730	pharmgkb	Drug Class	Ace Inhibitors, Plain			Coronary Artery Disease	AGTR1	rs5186	3	148742201	A	C	Efficacy,Toxicity
731	pharmgkb	Drug	pitavastatin	5282452			SLCO1B1	N130H	12	21176804	A	K	Other
732	pharmgkb	Drug Class	Ace Inhibitors, Plain				ABO	rs495828	9	133279294	T	G	Toxicity
733	pharmgkb		Alkylating Agents,cisplatin			Neoplasms	ESR1	rs2207396	6	152061247	G	A	Toxicity
734	pharmgkb	Drug	amphetamine	3007	C[C@@H](CC1=CC=CC=C1)N		OPRM1	rs510769	6	154040884	C	T	Efficacy
735	pharmgkb	Drug	amphetamine	3007	C[C@@H](CC1=CC=CC=C1)N		OPRM1	rs2281617	6	154166286	C	T	Other
736	pharmgkb	Drug Class	antipsychotics				CYP2D6	rs5030655	22	42129084	A	-	Toxicity
737	pharmgkb	Drug Class	antipsychotics			Schizophrenia	RGS2	rs4606	1	192812042	C	K	Toxicity
738	pharmgkb		atenolol,verapamil			Coronary Artery Disease,Hypertension	NR1H3	rs11039149	11	47255124	A	G	Toxicity
739	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		UGT1A3	UGT1A3*1, UGT1A3*2					Efficacy
740	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Inflammatory Bowel Diseases	AOX1	N1135S	2	200661607	A	G	Efficacy
741	pharmgkb		bevacizumab,fluorouracil,irinotecan,leucovorin			Colorectal Neoplasms	SHMT1	L474F	17	18328782	G	A	Efficacy
742	pharmgkb		bortezomib,dexamethasone,melphalan,prednisone				CTLA4	rs4553808	2	203866282	A	G	Toxicity
743	pharmgkb		bupropion,nicotine				DRD1	rs2168631	5	175448999	G	W	Efficacy
744	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease	MTTP	rs1800591	4	99574331	G	T	Efficacy
745	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hyperlipoproteinemia Type II	MTTP	rs1800591	4	99574331	G	T	Efficacy
746	pharmgkb		bupropion,nicotine				DRD1	rs11749035	5	175456049	C	T	Efficacy
747	pharmgkb		bupropion,nicotine				DRD1	rs11746641	5	175439088	T	G	Efficacy
748	pharmgkb	Drug	nortriptyline	4543	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	UST	rs2500535	6	149008131	A	K	Efficacy
749	pharmgkb	Prodrug	zidovudine	35370	CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]		UGT2B7	rs28365062	4	69098553	A	K	Other
750	pharmgkb	Prodrug	zidovudine	35370	CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]	HIV Infections	ABCC4	rs11568695	13	95044286	C	T	Other
751	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia,Myalgia unspecified	ABCB1	I1145M	7	87509329	A	K	Toxicity
752	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Artery Disease,Myalgia unspecified	ABCB1	I1145M	7	87509329	A	K	Toxicity
753	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		AGTR1	A192T	3	148741522	G	A	Efficacy
754	pharmgkb	Drug Class	corticosteroids			Asthma	DCAF4	rs7160796	14	72927906	G	C	Efficacy
755	pharmgkb	Drug Class	corticosteroids			Crohn Disease	FKBP5	rs4713916	6	35702206	A	B	Efficacy
756	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	CYP2E1	rs6413432	10	133535040	T	A	Efficacy
757	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	CYP2E1	rs2070676	10	133537633	G	C	Efficacy,Toxicity
758	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia,Myalgia unspecified	ABCB1	S893A	7	87531302	A	Y	Toxicity
759	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		CYP1A2	R456H	15	74754904	G	A	Other
760	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		CYP1A2	I386V	15	74752237	A	K	Other
761	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HTR3A	rs1150226	11	113974819	A	G	Efficacy
762	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Coronary Disease	SLCO1B1	rs4149081	12	21225087	G	A	Efficacy
763	pharmgkb	Drug	dexmedetomidine	68602	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C		PRKCB	rs9922316	16	23898631	T	R	Other
764	pharmgkb	Drug	dexmedetomidine	68602	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C		ADRA2A	rs1800544	10	111076745	G	C	Other
765	pharmgkb	Drug	disulfiram	3117	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	DRD2	rs2283265	11	113414814	C	A	Efficacy
766	pharmgkb	Drug	disulfiram	3117	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	ANKK1	E713K	11	113400106	G	A	Efficacy
767	pharmgkb	Drug Class	diuretics			Nephrosclerosis	PDE4D	rs702553	5	60440946	A	T	Efficacy
768	pharmgkb		dolasetron,granisetron				NOS1AP	rs10494366	1	162115895	G	T	Toxicity
769	pharmgkb		calcein,lopinavir				ABCC2	C1515Y	10	99851537	G	A	Other
770	pharmgkb	Drug	lopinavir	92727	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	HIV Infections	ABCC2	C1515Y	10	99851537	G	A	Efficacy
771	pharmgkb		folic acid,vitamin b-complex, plain			Migraine with Aura	MTRR	I49M	5	7870860	A	G	Efficacy
772	pharmgkb	Drug	mitotane	4211	C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl	Adrenocortical Carcinoma	CYP2B6	Q172H	19	41006936	G	W	Other
773	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Artery Disease,Hypercholesterolemia	ABCG8	D19N	2	43839108	G	M	Efficacy
774	pharmgkb	Drug	midazolam	4192	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		POR	A503V	7	75985688	C	T	Other
775	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Myalgia unspecified	CYP3A5	CYP3A5*1, CYP3A5*3					Efficacy,Toxicity
776	pharmgkb		carboplatin,paclitaxel			Ovarian Neoplasms	MAD1L1	R466H	7	1936821	C	T	Efficacy
777	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hyperlipidemias	CYP3A4	CYP3A4*1, CYP3A4*4					Efficacy
778	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	CYBA	Y72N	16	88646828	A	K	Other
779	pharmgkb	Drug	haloperidol	3559	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	SLC6A5	rs2298826	11	20638211	G	A	Toxicity
780	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	CETP	rs4783961	16	56960982	G	A	Efficacy
781	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	ABCB1	rs1922242	7	87544351	A	T	Efficacy
782	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	CETP	V422I	16	56982180	G	M	Efficacy
783	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	CETP	V422I	16	56982180	G	M	Efficacy
784	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		HMGCR	rs17238540	5	75359673	T	G	Efficacy
785	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		HMGCR	rs17238540	5	75359673	T	G	Efficacy
786	pharmgkb		atorvastatin,fluvastatin,hmg coa reductase inhibitors,lovastatin,pravastatin,simvastatin				HMGCR	rs17238540	5	75359673	T	G	Efficacy
787	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		HMGCR	rs17244841	5	75347030	A	T	Efficacy
788	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		HMGCR	rs17244841	5	75347030	A	T	Efficacy
789	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease,Myocardial Infarction	MTHFR	A222V	1	11796321	G	A	Efficacy
790	pharmgkb	Drug Class	hmg coa reductase inhibitors			Acute coronary syndrome	CXCL5	rs352046	4	73998833	G	H	Efficacy
791	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Acute coronary syndrome	TNF	rs1800629	6	31575254	G	A	Other
792	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Myocardial Ischemia	F3	rs3917643	1	94536311	T	C	Efficacy
793	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Disease	ABCA1	R219K	9	104858586	C	T	Efficacy
794	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Diabetes Mellitus,Hypertension,Vascular Diseases	NPC1L1	rs17655652	7	44541392	T	C	Efficacy
795	pharmgkb		atorvastatin,pravastatin,simvastatin			Hyperlipidemias	ABCA1	rs12003906	9	104883196	G	T	Efficacy
796	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	SCARB1	rs5888	12	124800202	A	K	Efficacy
797	pharmgkb	Drug Class	hmg coa reductase inhibitors			Colonic Neoplasms	HMGCR	rs12654264	5	75352778	A	T	Other
798	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		LPL	rs328	8	19962213	C	G	Efficacy
799	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOA1	rs964184	11	116778201	G	C	Efficacy
800	pharmgkb		docetaxel,gemcitabine,paclitaxel,Platinum compounds,vinorelbine			Carcinoma, Non-Small-Cell Lung	CASP7	T19N	10	113679810	C	K	Efficacy
801	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	ABCB1	rs7787082	7	87527735	G	A	Efficacy
802	pharmgkb	Drug	candesartan	2541	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Heart Failure	AGTR1	rs5186	3	148742201	A	C	Efficacy
803	pharmgkb		atenolol,irbesartan			Essential hypertension	EDN1	K198N	6	12296022	G	T	Efficacy
804	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	AGT	rs5051	1	230714126	C	K	Efficacy
805	pharmgkb		amlodipine,chlorthalidone,lisinopril			Hypertension	ACE	rs4291	17	63476833	T	M	Efficacy
806	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	SCARB1	G2S	12	124863717	C	T	Efficacy
807	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	SLCO1B1	rs4149015	12	21130388	G	M	Toxicity
808	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	ABCC2	I1324M	10	99844450	C	K	Toxicity
809	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Metabolic Syndrome	CRP	rs3091244	1	159714875	G	W	Efficacy
810	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742435	3	45699371	G	A	Toxicity
811	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742423	3	45691938	A	K	Toxicity
812	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742421	3	45691023	T	G	Toxicity
813	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742417	3	45689959	C	T	Toxicity
814	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2742390	3	45715230	G	A	Toxicity
815	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Mental Disorders	DRD2	rs2440390	11	113416156	T	C	Toxicity
816	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	GABRA1	rs2290732	5	161897892	A	K	Efficacy
817	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2251954	3	45690292	T	C	Toxicity
818	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs2245705	3	45708230	T	C	Toxicity
819	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	KCNQ1	rs2237895	11	2835964	A	Y	Efficacy
820	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	KCNQ1	rs2237892	11	2818521	C	T	Efficacy
821	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	ABCG2	V12M	4	88139962	C	T	Toxicity
822	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	ABCA1	K1587R	9	104800523	T	C	Efficacy
823	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	ABCA1	R219K	9	104858586	C	T	Efficacy
824	pharmgkb		docetaxel,gemcitabine,paclitaxel,Platinum compounds,vinorelbine			Carcinoma, Non-Small-Cell Lung	CASP7	T244S	10	113729393	C	G	Efficacy
825	pharmgkb	Drug	captopril	44093	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	Hypertension	ACE2	rs2106809	X	15599938	A	G	Efficacy
826	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SACM1L	rs1969624	3	45693326	T	C	Toxicity
827	pharmgkb	Drug	benazepril	5362124	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Essential hypertension	MTR	D919G	1	236885200	A	G	Efficacy
828	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertrophy, Left Ventricular	APOB	R3638Q	2	21005955	C	T	Efficacy
829	pharmgkb	Drug	dobutamine	36811	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O		ADRB1	G389R	10	114045297	G	C	Efficacy
830	pharmgkb	Drug	disulfiram	3117	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	MTHFR	A222V	1	11796321	G	A	Efficacy
831	pharmgkb	Drug Class	Enzymes			Stroke	F12	rs1801020	5	177409531	A	G	Efficacy
832	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertrophy, Left Ventricular	ADRA2A	rs1800545	10	111077780	G	A	Efficacy
833	pharmgkb		fentanyl,morphine,opioids,oxycodone			Neoplasms	RHBDF2	rs12948783	17	76503318	G	H	Efficacy
834	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	COL26A1	rs17135437	7	101472713	C	T	Toxicity
835	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Metabolic Syndrome	CRP	rs1417938	1	159714396	T	M	Efficacy
836	pharmgkb		docetaxel,gemcitabine,paclitaxel,Platinum compounds,vinorelbine			Carcinoma, Non-Small-Cell Lung	CASP7	rs12415607	10	113678445	C	A	Efficacy
837	pharmgkb		docetaxel,gemcitabine,paclitaxel,Platinum compounds,vinorelbine			Carcinoma, Non-Small-Cell Lung	CASP7	rs4353229	10	113729830	T	C	Efficacy
838	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	HTR2A	rs6313	13	46895805	G	A	Toxicity
839	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCG2	Q141K	4	88131171	G	Y	Toxicity
840	pharmgkb	Drug	sirolimus	6436030	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	ABCB1	rs1128503	7	87550285	A	G	Toxicity
841	pharmgkb		gemcitabine,Platinum compounds			Carcinoma, Non-Small-Cell Lung	CASP7	rs1127687	10	113730350	G	A	Efficacy
842	pharmgkb		paclitaxel,Platinum compounds			Carcinoma, Non-Small-Cell Lung	CASP7	rs1127687	10	113730350	G	A	Efficacy
843	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		UGT1A	rs10929303	2	233772770	T	C	Other
844	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O	Liver Failure, Acute	UGT1A	rs10929303	2	233772770	T	C	Toxicity
845	pharmgkb	Drug	iloperidone	71360		Schizophrenia	CYP2D6	P34A	22	42130692	G	A	Toxicity
846	pharmgkb		capecitabine,docetaxel			Breast Neoplasms	CYP1A1	I462L	15	74720644	T	C	Efficacy
847	pharmgkb	Drug	sirolimus	6436030	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	ABCB1	I1145M	7	87509329	A	K	Toxicity
848	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		UGT1A	rs1042640	2	233772898	G	H	Other
849	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O	Liver Failure, Acute	UGT1A	rs1042640	2	233772898	G	H	Toxicity
850	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		UGT1A	rs8330	2	233772999	G	C	Other
851	pharmgkb	Drug	mirtazapine	4205	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	Depression	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7					Other
852	pharmgkb	Drug	mirtazapine	4205	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	Depression	CYP2B6	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7					Efficacy
853	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Mental Disorders	HTR2C	rs1414334	X	114903581	C	G	Toxicity
854	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neoplasms	SLCO1B1	V174A	12	21178615	T	C	Toxicity
855	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	ABCC2	V417I	10	99804058	G	A	Other
856	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	ABCC4	rs9561765	13	95030989	G	A	Efficacy
857	pharmgkb		adalimumab,etanercept,infliximab			Arthritis, Psoriatic	TNFRSF1A	rs767455	12	6341779	T	C	Efficacy
858	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	NOD2	R675W	16	50712015	C	T	Efficacy
859	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2C19	CYP2C19*1, CYP2C19*2					Efficacy
860	pharmgkb	Drug	digoxin	30322	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O		ABCB1	rs1128503	7	87550285	A	G	Other
861	pharmgkb	Drug Class	Enzymes			Stroke	A2M	I1000V	12	9079672	T	C	Efficacy
862	pharmgkb	Drug	benazepril	5362124	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Hypertension	PRCP	E133D	11	82853252	T	R	Efficacy
863	pharmgkb	Drug	prasugrel	6918456	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs12407843	1	156903935	G	M	Efficacy
864	pharmgkb	Drug	prasugrel	6918456	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs77235035	1	156908005	C	W	Efficacy
865	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depression	HTR1B	rs130058	6	77463564	T	R	Other
866	pharmgkb		antidepressants,citalopram,fluvoxamine,paroxetine,sertraline,venlafaxine				ABCB1	rs2235040	7	87536434	C	T	Toxicity
867	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs2470890	15	74755085	T	C	Efficacy
868	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs2472304	15	74751897	G	A	Efficacy
869	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs4646425	15	74750940	C	T	Efficacy
870	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	CYP1A2	rs4646427	15	74753351	T	C	Efficacy
871	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		SLC22A1	G401S	6	160139792	G	A	Other
872	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		SLC22A1	rs35167514	6	160139849	A	-	Other
873	pharmgkb		antidepressants,fluvoxamine,paroxetine,Selective serotonin reuptake inhibitors,sertraline			Depressive Disorder,Depressive Disorder, Major	HTR1A	rs6295	5	63962738	C	G	Efficacy
874	pharmgkb		amitriptyline,citalopram,paroxetine,venlafaxine			Depression	ABCB1	rs10280101	7	87524269	A	S	Efficacy
875	pharmgkb		amitriptyline,citalopram,paroxetine,venlafaxine			Depression	ABCB1	rs10248420	7	87535670	A	K	Efficacy
876	pharmgkb		amitriptyline,citalopram,paroxetine,venlafaxine			Depression	ABCB1	rs11983225	7	87532204	T	C	Efficacy
877	pharmgkb		amitriptyline,citalopram,paroxetine,venlafaxine			Depression	ABCB1	rs12720067	7	87540040	C	T	Efficacy
878	pharmgkb		amitriptyline,citalopram,paroxetine,venlafaxine			Depression	ABCB1	rs2235040	7	87536434	C	T	Efficacy
879	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	DRD3	G9S	3	114171968	C	T	Efficacy
880	pharmgkb		citalopram,fluoxetine,paroxetine,sertraline			Depressive Disorder, Major	SRP19	rs495794	5	112865397	A	S	Efficacy
881	pharmgkb		citalopram,fluoxetine,paroxetine,sertraline			Depressive Disorder, Major	REEP5	rs153560	5	112918680	G	W	Efficacy
882	pharmgkb		citalopram,fluoxetine,paroxetine,sertraline			Depressive Disorder, Major	REEP5	rs153549	5	112900600	A	G	Efficacy
883	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2C19	CYP2C19*1, CYP2C19*2					Dosage
884	pharmgkb		amodiaquine,pyrimethamine,sulfadoxine			Malaria,Malaria, Falciparum	G6PD	V68M	X	154536002	C	T	Toxicity
885	pharmgkb	Drug	trimipramine	5584	CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C		CYP2C9	CYP2C9*1, CYP2C9*3					Other
886	pharmgkb	Drug	prasugrel	6918456	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs3737224	1	156909788	C	T	Efficacy
887	pharmgkb	Drug	prasugrel	6918456	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs41273215	1	156912167	C	T	Efficacy
888	pharmgkb	Drug	prasugrel	6918456	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	rs822441	1	156913204	G	H	Efficacy
889	pharmgkb	Drug	prasugrel	6918456	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4		PEAR1	N848K	1	156913423	C	W	Efficacy
890	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP1A2	rs2069526	15	74749000	T	G	Toxicity
891	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP1A2	rs4646425	15	74750940	C	T	Toxicity
892	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP1A2	rs4646427	15	74753351	T	C	Toxicity
893	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Anxiety Disorders	DRD3	rs324026	3	114172195	C	T	Efficacy
894	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Anxiety Disorders	DRD3	rs324023	3	114166548	T	C	Efficacy
895	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Anxiety Disorders	DRD3	rs167770	3	114160715	G	A	Efficacy
896	pharmgkb		clomipramine,liothyronine,lithium,nefazodone,venlafaxine			Depression	HTR1B	rs130058	6	77463564	T	R	Toxicity
897	pharmgkb		amitriptyline,citalopram,paroxetine,venlafaxine			Depressive Disorder, Major	ABCB1	rs4148740	7	87522787	A	G	Efficacy
898	pharmgkb		amitriptyline,citalopram,paroxetine,venlafaxine			Depressive Disorder, Major	ABCB1	rs2235067	7	87520606	C	T	Efficacy
899	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Drug Toxicity	GRIN2B	rs1806201	12	13564574	G	A	Toxicity
900	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Drug Toxicity	GRIN2B	rs1806201	12	13564574	G	A	Toxicity
901	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Drug Toxicity	HTR2A	rs6313	13	46895805	G	A	Toxicity
902	pharmgkb		clomipramine,nefazodone,paroxetine,venlafaxine			Depression	FKBP5	rs1360780	6	35639794	T	M	Toxicity
903	pharmgkb		carboplatin,cisplatin			Lung Neoplasms	AKT1	rs1130214	14	104793397	C	A	Efficacy
904	pharmgkb		carboplatin,cisplatin,fluorouracil			Uterine Cervical Neoplasms	SLC19A1	rs12659	21	45531642	A	G	Efficacy
905	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Deafness,Ototoxicity,Testicular Neoplasms	GSTM1	GSTM1 non-null, GSTM1 null					Toxicity
906	pharmgkb	Drug	dobutamine	36811	CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O		GNAS	rs62205366	20	58903138	T	C	Efficacy
907	pharmgkb	Drug	captopril	44093	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	Diabetes Mellitus, Type 2	AGTR1	rs5186	3	148742201	A	C	Efficacy
908	pharmgkb		amisulpride,antipsychotics,olanzapine,quetiapine,risperidone			Schizophrenia	HTR1A	rs10042486	5	63965502	C	T	Efficacy
909	pharmgkb	Drug Class	antidepressants			Depression	TGFBR3	rs12082710	1	91689780	T	M	Efficacy
910	pharmgkb	Drug Class	antipsychotics			Schizophrenia	ZNF804A	rs1344706	2	184913701	A	Y	Efficacy
911	pharmgkb	Drug	enalapril	5362032	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertrophy, Left Ventricular	ADRB2	Q27E	5	148826910	G	Y	Efficacy
912	pharmgkb		benazepril,imidapril			Essential hypertension	CYP11B2	rs1799998	8	142918184	A	G	Efficacy
913	pharmgkb	Drug	benazepril	5362124	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Hypertension	AGT	rs7079	1	230702585	G	T	Efficacy
914	pharmgkb		bevacizumab,ranibizumab			Macular Degeneration	VEGFA	rs3025000	6	43778432	C	T	Efficacy
915	pharmgkb	Drug	candesartan	2541	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	CYP11B2	rs1799998	8	142918184	A	G	Efficacy
916	pharmgkb		carboplatin,cisplatin			Lung Neoplasms	EIF3A	rs3740556	10	119080683	G	A	Efficacy
917	pharmgkb	Drug	cytarabine	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O		CDA	A70T	1	20604981	G	A	Other
918	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	ABCB1	rs10248420	7	87535670	A	K	Efficacy
919	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HTR3A	rs1062613	11	113975284	T	C	Efficacy
920	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HTR3A	rs2276302	11	113979418	G	A	Efficacy
921	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Diabetes Mellitus	PPARA	rs4253778	22	46234737	G	Y	Efficacy
922	pharmgkb	Drug	flunisolide	82153	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O	Asthma	TBXT	G177D	6	166165782	C	T	Efficacy
923	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F		DCK	I24F	4	70993905	A	K	Other
924	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs1110470	16	27325106	G	A	Efficacy
925	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs3024530	16	27339366	A	G	Efficacy
926	pharmgkb	Drug	pitrakinra			Asthma	IL4R	I75L	16	27344882	A	B	Efficacy
927	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs2239347	16	27347700	A	C	Efficacy
928	pharmgkb	Drug	pitrakinra			Asthma	IL4R	rs1029489	16	27364896	A	G	Efficacy
929	pharmgkb	Drug	rituximab			Arthritis, Rheumatoid	TGFB1	R25Q	19	41352971	C	K	Efficacy
930	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	Carcinoma, Non-Small-Cell Lung	SLCO1B1	V174A	12	21178615	T	C	Dosage
931	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	SV2C	rs11960832	5	76219161	C	T	Efficacy
932	pharmgkb	Drug, Biological Intermediate	l-tryptophan	6305	C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N		SLC22A2	S270A	6	160249250	A	C	Other
933	pharmgkb	Drug	memantine	4054	CC12CC3CC(C1)(CC(C3)(C2)N)C	Dementia	NR1I2	rs1523130	3	119780660	T	C	Other
934	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		PPARA	rs4823613	22	46202410	A	G	Efficacy
935	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		PPARA	rs4253728	22	46214170	G	A	Efficacy
936	pharmgkb	Drug	talinolol				ABCB1	I1145M	7	87509329	A	K	Other
937	pharmgkb		carboplatin,docetaxel,paclitaxel			Ovarian Neoplasms	OPRM1	rs544093	6	154136358	G	T	Toxicity
938	pharmgkb		carboplatin,docetaxel,paclitaxel			Ovarian Neoplasms	BCL2	rs2849380	18	63312127	C	T	Toxicity
939	pharmgkb		carboplatin,docetaxel,paclitaxel			Ovarian Neoplasms	SOX10	rs139887	22	37975389	G	Y	Toxicity
940	pharmgkb		citalopram,escitalopram			Depressive Disorder	GRK5	rs915120	10	119430601	T	C	Efficacy
941	pharmgkb		citalopram,escitalopram			Depressive Disorder	RFK	rs11144870	9	76389297	C	T	Efficacy
942	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	WNK1	rs880054	12	879392	C	T	Efficacy
943	pharmgkb	Drug Class	antipsychotics			Schizophrenia	HSPG2	rs878949	1	21900598	T	C	Toxicity
944	pharmgkb	Drug Class	antipsychotics			Schizophrenia	HSPG2	rs2445142	1	21899250	G	M	Toxicity
945	pharmgkb	Drug Class	antipsychotics			Schizophrenia	GABRG3	rs2061051	15	27275664	G	A	Toxicity
946	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	ADRB2	R16G	5	148826877	G	A	Toxicity
947	pharmgkb		anthracyclines and related substances,taxanes			Breast Neoplasms	ABCB1	I1145M	7	87509329	A	K	Efficacy
948	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PRKCA	rs4791040	17	66791455	T	C	Efficacy
949	pharmgkb		antipsychotics,chlorpromazine,fluphenazine,thioridazine,trifluoperazine			Schizophrenia	CYP1A2	rs762551	15	74749576	C	A	Toxicity
950	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Neoplasms	UGT1A9	rs17868320	2	233669782	C	T	Toxicity
951	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	MEX3C	rs17751934					Toxicity
952	pharmgkb		fluorouracil,oxaliplatin			Colorectal Neoplasms,Drug Toxicity	PARD3B	rs17626122	2	205609288	T	C	Toxicity
953	pharmgkb	Drug Class	antineoplastic agents			Pancreatic Neoplasms	DPYD	rs1760217	1	97137438	A	G	Efficacy
954	pharmgkb		cisplatin,irinotecan			Carcinoma, Small Cell	DCBLD1	rs17574269	6	117494965	A	G	Efficacy
955	pharmgkb	Drug Class	antineoplastic agents			Pancreatic Neoplasms	SERPINA3	rs17091162	14	94622895	C	A	Efficacy
956	pharmgkb	Drug	nortriptyline	4543	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depression	SLC39A14	rs17060812	8	22371315	C	T	Efficacy
957	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	RBMS3	rs17024608	3	29913199	A	G	Efficacy
958	pharmgkb		cisplatin,irinotecan			Carcinoma, Small Cell	ABCC4	rs16950650	13	95123178	C	T	Efficacy
959	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	ABCC4	rs1678387	13	95065652	T	C	Toxicity
960	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	CSRNP3	rs7588295	2	165551001	A	G	Toxicity
961	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	ALDH1A2	rs12903202	15	58014595	A	K	Efficacy
962	pharmgkb		lansoprazole,omeprazole,rabeprazole			Helicobacter Infections	IL1B	rs16944	2	112837290	A	G	Efficacy
963	pharmgkb	Drug	salbutamol	2083	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	CLOCK	rs1522113	4	55465604	G	A	Efficacy
964	pharmgkb	Drug Class	Thiazides, plain			Essential hypertension	SLC12A3	rs13306673	16	56867019	C	T	Efficacy
965	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	SLC30A8	R276W	8	117172544	C	W	Efficacy
966	pharmgkb		peginterferon alfa-2b,ribavirin			Hepatitis C	OASL	rs12819210	12	121020597	C	T	Efficacy
967	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Transplantation	TPMT	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C					Toxicity
968	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Myocardial Infarction	PEAR1	rs12041331	1	156899922	G	A	Toxicity
969	pharmgkb		cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin			Leukemia, Myeloid, Acute	SLC22A12	rs11231825	11	64592802	T	C	Toxicity
970	pharmgkb		cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin			Leukemia, Myeloid, Acute	CYP2E1	rs2070673	10	133527063	A	T	Toxicity
971	pharmgkb		cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin			Leukemia, Myeloid, Acute	SULT2B1	L198V	19	48592808	C	T	Toxicity
972	pharmgkb		cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin			Leukemia, Myeloid, Acute	CYP2E1	F421L	10	133537858	C	K	Toxicity
973	pharmgkb		cytarabine,fludarabine,gemtuzumab ozogamicin,idarubicin			Leukemia, Myeloid, Acute	SLCO1B1	V174A	12	21178615	T	C	Toxicity
974	pharmgkb		citalopram,fluoxetine,paroxetine,sertraline			Depressive Disorder, Major	ABCB1	rs28401781	7	87519012	C	T	Efficacy
975	pharmgkb		amitriptyline,citalopram,fluoxetine,paroxetine,sertraline,venlafaxine			Depression,Depressive Disorder, Major	ABCB1	rs4148739	7	87531733	T	C	Efficacy
976	pharmgkb	Drug	sirolimus	6436030	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	CYP3A4	rs2740574	7	99784473	C	T	Other
977	pharmgkb	Drug	timolol	33624	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5					Other
978	pharmgkb	Drug	didanosine	50599	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	HIV Infections	XDH	rs1594160	2	31356103	A	C	Toxicity
979	pharmgkb	Drug	didanosine	50599	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	HIV Infections	XDH	rs1429376	2	31365695	A	Y	Toxicity
980	pharmgkb	Drug	didanosine	50599	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	HIV Infections	NT5C2	rs11191561	10	103109774	C	G	Toxicity
981	pharmgkb	Drug	didanosine	50599	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O	HIV Infections	NT5C2	rs11598702	10	103138228	T	S	Toxicity
982	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		DRD2	rs1124493	11	113411573	T	G	Other
983	pharmgkb	Drug	lovastatin	53232	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		CYP2D6	CYP2D6*1, CYP2D6*5, CYP2D6*10					Other
984	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	SLC19A1	H27R	21	45537880	T	S	Efficacy
985	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	SLCO1B1	N130H	12	21176804	A	K	Efficacy
986	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	CDA	rs602950	1	20589038	A	G	Toxicity
987	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	ABCB1	I1145M	7	87509329	A	K	Efficacy
988	pharmgkb	Drug	nifedipine	4485	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	Pregnancy	CYP3A5	rs776746	7	99672916	T	C	Other
989	pharmgkb	Drug	methacholine	1993	CC(C[N+](C)(C)C)OC(=O)C	Asthma	ADRB2	R16G	5	148826877	G	A	Efficacy
990	pharmgkb	Drug	sipoglitazar	9825652	CCOC1=NN(C=C1CCC(=O)O)CC2=CC=C(C=C2)OCC3=CSC(=N3)C4=CC=CC=C4		UGT2B15	UGT2B15*1, UGT2B15*2					Efficacy
991	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A4	L292P	7	99764003	A	G	Other
992	pharmgkb		bumetanide,furosemide,torasemide				NPPA-AS1	V32M	1	11847591	C	T	Efficacy
993	pharmgkb	Drug	indinavir	5362440	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	HIV Infections	UGT1A1	G71R	2	233760498	G	A	Toxicity
994	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Cardiovascular Diseases	IL6	rs1800795	7	22727026	C	G	Efficacy
995	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC22A5	rs2631372	5	132367886	G	C	Efficacy
996	pharmgkb	Drug	carvedilol	2585	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Angina Pectoris,Heart Failure	UGT1A1	G71R	2	233760498	G	A	Other
997	pharmgkb		carboplatin,cisplatin			Carcinoma, Non-Small-Cell Lung	AKT1	rs2494752	14	104797271	A	G	Efficacy
998	pharmgkb		cladribine,cytarabine			Leukemia, Myeloid, Acute	RRM2	rs5030743	2	10123747	C	K	Efficacy
999	pharmgkb		cladribine,cytarabine			Leukemia, Myeloid, Acute	RRM2B	rs1265138	8	102187808	A	G	Efficacy
1000	pharmgkb		cladribine,cytarabine			Leukemia, Myeloid, Acute	RRM1	rs2898950	11	4082830	A	C	Efficacy
1001	pharmgkb		cladribine,cytarabine			Leukemia, Myeloid, Acute	RRM1	rs1561876	11	4092165	G	H	Efficacy
1002	pharmgkb		cladribine,cytarabine			Leukemia, Myeloid, Acute	RRM1	rs1042919	11	4138534	A	T	Efficacy
1003	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Leukopenia,Neoplasms	ABCC11	rs7194667	16	48208987	T	G	Toxicity
1004	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl		PPARA	rs9626730	22	46166284	T	C	Efficacy
1005	pharmgkb	Drug Class	Drugs used in alcohol dependence			Alcoholism	GATA4	rs13273672	8	11754872	T	C	Efficacy
1006	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	KCNJ1	rs11600347	11	128863419	C	A	Toxicity
1007	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	SFRP5	rs11189381	10	97803441	T	C	Toxicity
1008	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	rs1105525	5	80654689	C	K	Efficacy
1009	pharmgkb		adalimumab,etanercept,infliximab,Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	PTPRC	rs10919563	1	198731313	G	A	Efficacy
1010	pharmgkb	Drug	amiodarone	2157	CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I	Long QT Syndrome	NOS1AP	rs10800397	1	162267300	C	K	Toxicity
1011	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids			Acute coronary syndrome	CDKN2B-AS1	rs10757274	9	22096056	A	G	Toxicity
1012	pharmgkb	Drug	debrisoquine	2966	C1CN(CC2=CC=CC=C21)C(=N)N		CYP2D6	rs1080985	22	42132375	G	M	Other
1013	pharmgkb		cisplatin,fluorouracil,oxaliplatin			Stomach Neoplasms	VEGFA	rs25648	6	43771240	C	K	Efficacy
1014	pharmgkb	Drug	zonisamide	5734	C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-A	HLA-A*02:07					Toxicity
1015	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C	IFNL3	K70R	19	39244466	T	C	Efficacy
1016	pharmgkb	Drug Class	antipsychotics			Schizophrenia	BDNF-AS	rs10501087	11	27648561	T	C	Efficacy
1017	pharmgkb	Drug Class	antipsychotics			Schizophrenia	BDNF	V66M	11	27658369	C	T	Efficacy
1018	pharmgkb	Drug Class	antipsychotics			Schizophrenia	BDNF	rs11030104	11	27662970	A	G	Efficacy
1019	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Prostatic Neoplasms	VEGFA	rs2010963	6	43770613	C	G	Efficacy
1020	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	SLCO2B1	R168Q	11	75172532	G	W	Efficacy
1021	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MOB3B	rs7046653	9	27490969	A	K	Efficacy
1022	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	SLC29A1	rs9394992	6	44228255	C	T	Toxicity
1023	pharmgkb		carboplatin,cisplatin			Carcinoma, Non-Small-Cell Lung	SLC31A1	rs7851395	9	113240184	A	G	Efficacy
1024	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	TBC1D32	rs7740004	6	120535057	T	A	Toxicity
1025	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O		SLCO1B3	M233I	12	20862826	G	A	Other
1026	pharmgkb		carboplatin,cisplatin,docetaxel,erlotinib,gefitinib,paclitaxel				MAP3K1	rs726501	5	56832039	G	A	Efficacy
1027	pharmgkb		cyclophosphamide,doxorubicin				SLC22A16	V252A	6	110442672	A	G	Dosage
1028	pharmgkb		atorvastatin,simvastatin				ABCC2	rs717620	10	99782821	C	T	Dosage
1029	pharmgkb	Drug	sildenafil	5212	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Erectile Dysfunction	VEGFA	rs699947	6	43768652	A	Y	Efficacy
1030	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C		VEGFA	rs699947	6	43768652	A	Y	Toxicity
1031	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids				AGT	M268T	1	230710048	A	G	Toxicity
1032	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O		TNFAIP3	rs6920220	6	137685367	G	A	Efficacy
1033	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		STK39	rs6749447	2	168184876	T	G	Efficacy
1034	pharmgkb		bupropion,nicotine			Tobacco Use Disorder	EPB41	rs6702335	1	29084738	A	G	Efficacy
1035	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Diabetes Mellitus,Hypertension	KCNJ1	rs658903	11	128858172	T	R	Toxicity
1036	pharmgkb	Drug Class	antipsychotics			tardive dyskinesia	HTR2A	rs6311	13	46897343	C	T	Efficacy
1037	pharmgkb		carboplatin,cyclophosphamide,thiotepa				ALDH1A1	rs6151031	9	72953468	-	CTGGTGAGGAGAGAACC	Toxicity
1038	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7		TOP1	rs6072262	20	41076355	G	A	Toxicity
1039	pharmgkb	Drug	eculizumab				C5	R891H	9	120997683	C	T	Efficacy
1040	pharmgkb	Drug	glyburide	3488	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	Anemia, Hemolytic	G6PD	G6PD A- 202A_376G, G6PD B (reference)					Toxicity
1041	pharmgkb	Drug	glyburide	3488	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	Diabetes Mellitus, Type 2	G6PD	S188F	X	154534419	G	A	Toxicity
1042	pharmgkb	Drug	chloramphenicol	298	C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]	Anemia, Hemolytic,Hemolysis	G6PD	G6PD A- 202A_376G, G6PD B (reference)					Toxicity
1043	pharmgkb	Drug	phenazopyridine	4756	C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N	Anemia, Hemolytic,Hemolysis	G6PD	G6PD B (reference), G6PD Mediterranean Haplotype					Toxicity
1044	pharmgkb	Drug	nitrofurantoin	5353830	C1C(=O)NC(=O)N1/N=C\C2=CC=C(O2)[N+](=O)[O-]	Anemia, Hemolytic,Hemolysis	G6PD	G6PD A- 202A_376G, G6PD B (reference)					Toxicity
1045	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	ABCB1	I1145M	7	87509329	A	K	Efficacy
1046	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms,Neutropenia	CDA	A70T	1	20604981	G	A	Toxicity
1047	pharmgkb	Drug	ondansetron	4595	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Alcoholism	SLC6A4	rs1042173	17	30197993	A	C	Efficacy
1048	pharmgkb	Drug	clomipramine	2801	CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl		SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Toxicity
1049	pharmgkb	Drug	ondansetron	4595	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Alcoholism	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
1050	pharmgkb	Drug	enalapril	5362032	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertension	NR3C2	V180I	4	148436323	C	T	Efficacy
1051	pharmgkb		antidepressants,antiepileptics,Beta Blocking Agents,calcium channel blockers			Headache Disorders,Migraine with Aura,Migraine without Aura	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Other
1052	pharmgkb	Drug Class	opioids			Pain	COMT	rs4633	22	19962712	C	T	Other
1053	pharmgkb	Drug Class	opioids			Pain	COMT	rs6269	22	19962429	A	G	Other
1054	pharmgkb	Drug Class	opioids			Pain	COMT	rs4818	22	19963684	C	K	Other
1055	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	EPHX1	Y113H	1	225831932	T	C	Toxicity
1056	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	ADH1C	I350V	4	99339632	T	M	Efficacy
1057	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	TPMT	Y240C	6	18130687	T	S	Efficacy
1058	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	MUTYH	V22M	1	45334484	C	T	Toxicity
1059	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	NAT2	I114T	8	18400344	T	C	Toxicity
1060	pharmgkb	Drug	platinum			Ovarian Neoplasms	ERCC5	D1104H	13	102875652	G	C	Efficacy
1061	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	LIG3	rs1052536	17	35004556	C	T	Toxicity
1062	pharmgkb		clozapine,olanzapine			Schizophrenia	GCG	rs13429709	2	162141450	T	C	Other
1063	pharmgkb	Drug	rhodamine 123				ABCB1	I1145M	7	87509329	A	K	Other
1064	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	DCK	rs4694362	4	71028147	C	T	Toxicity
1065	pharmgkb		anastrozole,letrozole			Neoplasms	ESR1	rs2234693	6	151842200	T	C	Toxicity
1066	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	SLC28A3	rs7867504	9	84305321	T	M	Other
1067	pharmgkb		cytarabine,idarubicin			Leukemia, Myeloid, Acute	DCK	rs80143932	4	70993476	C	D	Efficacy
1068	pharmgkb		asparaginase,cyclophosphamide,cytarabine,daunorubicin,dexamethasone,doxorubicin,leucovorin,mercaptopurine,methotrexate,pegaspargase,prednisone,thioguanine,vincristine				GATA3	rs3824662	10	8062245	C	W	Efficacy
1069	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		FPGS	rs7856096	9	127804260	A	G	Dosage
1070	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	BMP5	rs41271330	6	55774230	G	A	Efficacy
1071	pharmgkb	Drug	diltiazem	39186	CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC	Hypertension	PLCD3	rs12946454	17	45130754	A	T	Efficacy
1072	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs264663	2	159053694	T	S	Toxicity
1073	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs274618	7	86642700	T	M	Other
1074	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs1990040	7	86683758	A	G	Other
1075	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs13242038	7	86685104	C	T	Other
1076	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs724226	7	86696058	A	B	Other
1077	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs2189814	7	86702440	T	M	Other
1078	pharmgkb	Drug	dimercaprol	3080	C(C(CS)S)O	Hemolysis,Lead Poisoning, Nervous System, Childhood	G6PD	G6PD A- 202A_376G, G6PD B (reference)					Toxicity
1079	pharmgkb	Drug	ciprofloxacin	2764	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O	Anemia, Hemolytic	G6PD	G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham					Toxicity
1080	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Hemolysis	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham					Toxicity
1081	pharmgkb	Drug	sulfadoxine	17134	COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N	Hemolysis	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham					Toxicity
1082	pharmgkb	Drug	sulfasalazine	5359476	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	Hemolysis	G6PD	G6PD A- 202A_376G, G6PD B (reference)					Toxicity
1083	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity	HLA-DRB1	HLA-DRB1*14:01					Toxicity
1084	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity	HLA-DRB1	HLA-DRB1*09:01					Toxicity
1085	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	MYLIP	N342I	6	16145094	A	G	Efficacy
1086	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTHFR	rs1476413	1	11792243	C	T	Efficacy
1087	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTHFR	rs17421511	1	11797731	G	A	Efficacy
1088	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ATIC	rs16853826	2	215340444	G	A	Toxicity
1089	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ATIC	rs10197559	2	215321102	C	T	Toxicity
1090	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	DHFR	rs1643650	5	80644324	T	C	Efficacy
1091	pharmgkb		gemcitabine,paclitaxel			Breast Neoplasms	SLC29A1	rs747199	6	44226608	G	C	Efficacy
1092	pharmgkb	Drug	vincristine	5978	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Drug Toxicity,Neurotoxicity Syndromes	CAPG	rs3770102	2	85410714	G	H	Toxicity
1093	pharmgkb	Drug	vincristine	5978	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs4728709	7	87604286	G	A	Toxicity
1094	pharmgkb	Drug	vincristine	5978	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	I1145M	7	87509329	A	K	Efficacy
1095	pharmgkb	Drug	vincristine	5978	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Neurotoxicity Syndromes	ACTG1	rs1135989	17	81510981	G	A	Toxicity
1096	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	HLA-DRB1	HLA-DRB1*03:01					Toxicity
1097	pharmgkb		debrisoquine,dextromethorphan				CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*15					Other
1098	pharmgkb		debrisoquine,sparteine				CYP2D6	CYP2D6*1, CYP2D6*5, CYP2D6*8					Other
1099	pharmgkb	Drug	debrisoquine	2966	C1CN(CC2=CC=CC=C21)C(=N)N		CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*38					Other
1100	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Exanthema	HLA-C	HLA-C*03:02					Toxicity
1101	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	HLA-DRB1	HLA-DRB1*15:02					Toxicity
1102	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	HLA-DRB1	HLA-DRB1*13:02					Toxicity
1103	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	PSORS1C3	rs3094188	6	31174468	C	A	Toxicity
1104	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	POU5F1	rs3130501	6	31168676	A	G	Toxicity
1105	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	POU5F1	rs3130931	6	31167111	T	M	Toxicity
1106	pharmgkb		debrisoquine,dextromethorphan,sparteine				CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*44					Other
1107	pharmgkb	Drug	sparteine				CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*7, CYP2D6*8, CYP2D6*11, CYP2D6*12, CYP2D6*41, CYP2D6*59, CYP2D6*62					Other
1108	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neoplasms	KCNQ5	rs9351963	6	73040138	A	C	Toxicity
1109	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Neoplasms	BCL2L11	rs724710	2	111150114	T	M	Efficacy
1110	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Organ Transplantation	PPARA	rs4823613	22	46202410	A	G	Other
1111	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	ATP7B	rs9535828	13	51999286	G	H	Efficacy
1112	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	ATP7B	rs9535826	13	51991990	T	S	Efficacy
1113	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		NR1I2	rs2276706	3	119782460	G	A	Other
1114	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		NR1I2	rs3814058	3	119818444	T	C	Other
1115	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRD1	rs2236861	1	28813244	G	A	Other
1116	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	GAL	rs948854	11	68682735	C	T	Other
1117	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs9479757	6	154090209	G	A	Other
1118	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	PTGS2	rs4648287	1	186674818	A	G	Toxicity
1119	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	PLA2G4A	rs10157410	1	186978092	G	C	Toxicity
1120	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	GALNT2	rs2144297	1	230128097	T	S	Toxicity
1121	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	GALNT2	rs2144300	1	230159169	C	T	Other
1122	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	ABCB1	rs3213619	7	87600877	A	G	Toxicity
1123	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	ABCB1	rs10267099	7	87649444	G	A	Toxicity
1124	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	FTO	rs12595985	16	53842839	C	W	Toxicity
1125	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	FTO	rs9940629	16	53970899	A	G	Toxicity
1126	pharmgkb		Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan				HTR2A	rs6305	13	46892487	G	A	Toxicity
1127	pharmgkb		Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan			Substance Withdrawal Syndrome	DBH	rs1611115	9	133635393	T	C	Other
1128	pharmgkb		Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan				BDNF	V66M	11	27658369	C	T	Other
1129	pharmgkb		Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan				DRD2	rs6275	11	113412755	A	G	Other
1130	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	HLA-A	HLA-A*02:01					Toxicity
1131	pharmgkb	Drug	itopride				FMO3	E95K	1	171107825	G	A	Other
1132	pharmgkb	Drug	itopride				FMO3	E308G	1	171114102	A	G	Other
1133	pharmgkb	Drug Class	hmg coa reductase inhibitors			Asthma	HLA-G	rs1063320	6	29830972	C	K	Efficacy
1134	pharmgkb	Drug	dextromethorphan	5360696	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC		CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*13, CYP2D6*31, CYP2D6*69, CYP2D6*100, CYP2D6*101					Other
1135	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity	HLA-B	HLA-B*48:01					Toxicity
1136	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Drug Hypersensitivity,Stevens-Johnson Syndrome	HLA-C	HLA-C*08:01					Toxicity
1137	pharmgkb		azathioprine,mercaptopurine			Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis	HLA-DRB1	HLA-DRB1*07:01					Toxicity
1138	pharmgkb		azathioprine,mercaptopurine			Drug Toxicity,Inflammatory Bowel Diseases,Pancreatitis	HLA-DQA1	HLA-DQA1*02:01					Toxicity
1139	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease,Myocardial Infarction	ITGB3	L59P	17	47283364	T	C	Efficacy
1140	pharmgkb	Drug	trichloroethylene	6575	C(=C(Cl)Cl)Cl	Drug Hypersensitivity	HLA-B	HLA-B*13:01					Toxicity
1141	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*13:02					Toxicity
1142	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*15:18					Toxicity
1143	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*15:19					Toxicity
1144	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*15:27					Toxicity
1145	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*27:09					Toxicity
1146	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*38:02					Toxicity
1147	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C	HLA-B	HLA-B*38:01					Efficacy
1148	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*48:04					Toxicity
1149	pharmgkb	Drug Class	antiepileptics			Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*58:01					Toxicity
1150	pharmgkb	Drug	acetazolamide	1986	CC(=O)NC1=NN=C(S1)S(=O)(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*59:01					Toxicity
1151	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*59:01					Toxicity
1152	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	ABCB1	I1145M	7	87509329	A	K	Other
1153	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCC2	V417I	10	99804058	G	A	Toxicity
1154	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	P83L	16	31091268	G	A	Dosage
1155	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	P83L	16	31091268	G	A	Dosage
1156	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	D36Y	16	31094624	C	W	Dosage
1157	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs55894764	16	31094694	C	W	Dosage
1158	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs17878544	16	31096606	T	C	Dosage
1159	pharmgkb		amoxicillin,clavulanate				HLA-B	HLA-B*18:01					Toxicity
1160	pharmgkb	Drug	sulfasalazine	5359476	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	drug reaction with eosinophilia and systemic symptoms	HLA-B	HLA-B*39:01					Toxicity
1161	pharmgkb	Drug	sulfasalazine	5359476	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	drug reaction with eosinophilia and systemic symptoms	HLA-B	HLA-B*13:01					Toxicity
1162	pharmgkb	Drug	sulfasalazine	5359476	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	drug reaction with eosinophilia and systemic symptoms	HLA-B	HLA-B*15:05					Toxicity
1163	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		PPARA	rs4253728	22	46214170	G	A	Dosage
1164	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		UGT1A9	rs2003569	2	233759291	G	A	Efficacy
1165	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CNR1	rs6454674	6	88163211	T	G	Other
1166	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CNR1	rs806368	6	88140381	T	C	Other
1167	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Psychotic Disorders	NR1I2	rs7643645	3	119806650	A	G	Metabolism/PK
1168	pharmgkb	Drug	bevacizumab			Macular Degeneration	CFH	H402Y	1	196690107	C	T	Dosage
1169	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3		E2F7	rs310786	12	77042368	C	T	Efficacy
1170	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	E2F7	rs310786	12	77042368	C	T	Toxicity
1171	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CREB1	rs889895	2	207534205	A	G	Efficacy
1172	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		GSTM3	rs1799735					Metabolism/PK
1173	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		ANKK1	E713K	11	113400106	G	A	Metabolism/PK
1174	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Hypotension	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6					Toxicity
1175	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Fatigue	TPMT	TPMT*1, TPMT*3A, TPMT*3C					Toxicity
1176	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Fatigue	UGT1A1	UGT1A1*1, UGT1A1*28					Toxicity
1177	pharmgkb	Drug	galantamine	9651	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O	Dementia	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41					Metabolism/PK
1178	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	SLC22A1	M408V	6	160139813	A	S	Efficacy
1179	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	XBP1	rs2269577	22	28800769	G	C	Efficacy,Toxicity
1180	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs58425034	19	41009060	G	C	Other
1181	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	HTR1A	rs6295	5	63962738	C	G	Efficacy
1182	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O		ABCC2	rs12762549	10	99861014	C	K	Toxicity,Metabolism/PK
1183	pharmgkb	Drug	deferiprone	2972	CC1=C(C(=O)C=CN1C)O	beta-Thalassemia	UGT1A6	S7A	2	233693023	T	G	Efficacy,Toxicity
1184	pharmgkb		clozapine,olanzapine			Schizophrenia	TBC1D1	rs9852	4	38137403	C	T	Toxicity
1185	pharmgkb	Drug	ethanol	702	CCO		ADH1B	H48R	4	99318162	T	S	Metabolism/PK
1186	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N		SLC22A1	rs72552763	6	160139851	GAT	-	Metabolism/PK
1187	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung	DHFR	rs442767	5	80655677	G	T	Toxicity
1188	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	SLCO1B1	V174A	12	21178615	T	C	Toxicity
1189	pharmgkb	Drug	atomoxetine	54841	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SLC6A2	rs3785143	16	55661194	C	T	Efficacy
1190	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Psychotic Disorders	ABCB1	I1145M	7	87509329	A	K	Other
1191	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		TBXA2R	rs4523	19	3595796	A	G	Efficacy
1192	pharmgkb	Drug	bevacizumab			Macular Degeneration	CXCL8	rs4073	4	73740307	A	T	Efficacy
1193	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	CYP2C8	rs11572076	10	95067393	C	T	Toxicity
1194	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	DAPK1	rs11141915	9	87620879	A	C	Toxicity
1195	pharmgkb	Drug	rituximab			Lupus Erythematosus, Systemic	IL2	rs6822844	4	122588266	G	T	Efficacy
1196	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Leukemia, Lymphocytic, Chronic, B-Cell	CYP2B6	CYP2B6*1, CYP2B6*6					Efficacy,Toxicity
1197	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	BDNF	rs7124442	11	27655494	C	K	Efficacy
1198	pharmgkb		efavirenz,nelfinavir			HIV Infections	ABCB1	I1145M	7	87509329	A	K	Efficacy,Toxicity
1199	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Sarcoma	GSTA1	rs3957357	6	52803889	A	G	Efficacy
1200	pharmgkb		bevacizumab,pegaptanib,ranibizumab			Choroidal Neovascularization	VEGFA	rs2010963	6	43770613	C	G	Efficacy
1201	pharmgkb	Drug	ustekinumab			Psoriasis	HLA-C	HLA-C*06:02					Efficacy
1202	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	DPYD	rs76387818	1	97073844	G	A	Toxicity
1203	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	DPYD	rs12022243	1	97397224	C	T	Toxicity
1204	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	ENOSF1	rs2741171	18	700687	T	S	Toxicity
1205	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	GRIN1	rs1126442	9	137156924	G	A	Toxicity
1206	pharmgkb		dextroamphetamine,methylphenidate			Attention Deficit Disorder with Hyperactivity	DRD1	rs4532	5	175443147	C	T	Toxicity
1207	pharmgkb		fluticasone propionate,montelukast			Asthma	CA10	rs967676	17	51882949	T	C	Efficacy
1208	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression	IL11	rs1126757	19	55368504	C	K	Efficacy
1209	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Stomach Neoplasms	EGFR	rs2293347	7	55201223	C	T	Efficacy
1210	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Autism Spectrum Disorder	DRD3	G9S	3	114171968	C	T	Efficacy
1211	pharmgkb	Drug Class	egfr inhibitors			Carcinoma, Non-Small-Cell Lung,Colorectal Neoplasms,Neoplasms,Pancreatic Neoplasms	EGFR	R521K	7	55161562	G	H	Toxicity
1212	pharmgkb		cetuximab,irinotecan,panitumumab			Colorectal Neoplasms	AREG	rs1353295	4	74463405	G	A	Efficacy
1213	pharmgkb		cetuximab,irinotecan,panitumumab			Colorectal Neoplasms	AREG	rs13104811	4	74529595	G	A	Efficacy
1214	pharmgkb		cetuximab,irinotecan,panitumumab			Colorectal Neoplasms	AREG	rs9996584	4	74556244	A	G	Efficacy
1215	pharmgkb		cetuximab,irinotecan,panitumumab			Colorectal Neoplasms	AREG	rs11942466	4	74556361	C	A	Efficacy
1216	pharmgkb		cetuximab,irinotecan,panitumumab			Colorectal Neoplasms	EGFR	rs712829	7	55019062	G	Y	Efficacy
1217	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neoplasms	UGT1A1	UGT1A1*60					Efficacy
1218	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	CYP3A5	rs776746	7	99672916	T	C	Dosage,Toxicity
1219	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	HLA-DPB1	HLA-DPB1*04:01					Toxicity
1220	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids			anaphylactoid reaction	HLA-DRB1	HLA-DRB1*11:01					Toxicity
1221	pharmgkb	Drug	tiotropium	5487426	C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]	Asthma	ADRB2	R16G	5	148826877	G	A	Efficacy
1222	pharmgkb	Drug	topiramate	5284627	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C	Alcohol-Related Disorders	GRIK1	rs2832407	21	29595188	C	W	Efficacy,Metabolism/PK
1223	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Prostatic Neoplasms	ORM2	S1184P	9	114341693	A	K	Metabolism/PK
1224	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	KCNJ11	K23Q	11	17388025	T	M	Efficacy
1225	pharmgkb		benazepril,imidapril			Hypertension	AGT	rs5051	1	230714126	C	K	Efficacy
1226	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	ABCC2	V417I	10	99804058	G	A	Metabolism/PK
1227	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC3	rs3738948	2	127260487	A	S	Efficacy
1228	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	XPA	rs1800975	9	97697296	T	S	Efficacy
1229	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC4	rs1799801	16	13948101	T	C	Efficacy
1230	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	APLF	rs3213239	19	43576908	-	GGCC	Efficacy
1231	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC2	rs13181	19	45351661	T	R	Toxicity
1232	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	CXXC4	rs4413407	4	104472204	A	K	Efficacy
1233	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	WNT5B	rs12819505	12	1647499	A	G	Efficacy
1234	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	WIF1	rs10878232	12	65128867	T	V	Efficacy
1235	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	AXIN2	rs11868547	17	65527485	G	H	Efficacy
1236	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	AXIN2	rs4541111	17	65538420	C	A	Efficacy
1237	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Agranulocytosis	MTR	rs3768142	1	236865264	G	T	Toxicity
1238	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CRHR1	rs28364032	17	45834976	G	A	Efficacy
1239	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression	NEDD4L	rs520210	18	58140841	G	A	Efficacy
1240	pharmgkb	Drug	rosiglitazone	77999	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	Diabetes Mellitus, Type 2	PAX4	rs6467136	7	127524904	A	K	Efficacy
1241	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	DHFR	I79L	5	80654962	A	K	Toxicity
1242	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung	GGH	T151I	8	63026205	G	A	Toxicity
1243	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	FOLR3	R98C	11	72139084	C	T	Efficacy
1244	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	SLC19A1	rs3788189	21	45516669	T	G	Efficacy
1245	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	SLC19A1	rs914232	21	45532836	T	C	Efficacy
1246	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	ABCB1	I1145M	7	87509329	A	K	Toxicity
1247	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC2	rs1052555	19	45352266	G	A	Efficacy
1248	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Drug Hypersensitivity	HLA-B	HLA-B*51:01					Toxicity
1249	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		CYP2D6	rs28360521	22	42132969	C	T	Toxicity
1250	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	EXO1	E589Q	1	241878999	G	A	Efficacy
1251	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	UMPS	rs2291078	3	124740091	T	A	Efficacy
1252	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	UMPS	I446V	3	124743977	A	G	Efficacy
1253	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	UMPS	rs3772810	3	124744112	A	G	Efficacy
1254	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	REV3L	R2684Q	6	111322635	C	T	Efficacy
1255	pharmgkb	Drug	carvedilol	2585	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Heart Failure	ADRB2	Q27E	5	148826910	G	Y	Efficacy
1256	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	ABCB1	rs17160359	7	87717503	G	W	Efficacy
1257	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	DLG5	P1481Q	10	77811115	G	H	Efficacy
1258	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	PTEN	rs17431184	10	87960494	T	C	Efficacy
1259	pharmgkb		capecitabine,fluorouracil			Neoplasm Metastasis	CYP19A1	W39R	15	51242798	A	G	Efficacy
1260	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma	CHIA	G102R	1	111314586	G	M	Toxicity
1261	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O	Liver Failure, Acute	UGT1A	rs8330	2	233772999	G	C	Toxicity
1262	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma	SLC30A9	M50L	4	42001654	A	S	Toxicity
1263	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma	HLA-DPB1	rs3097671	6	33079835	G	C	Toxicity
1264	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	HLA-DPB1	I94L	6	33080851	A	Y	Toxicity
1265	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	HLA-DPB1	M105V	6	33080884	A	G	Toxicity
1266	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	HLA-DPB2	rs3129294	6	33116894	A	C	Toxicity
1267	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	TSC1	rs7862221	9	132906834	T	C	Toxicity
1268	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	THRA	rs11819745	10	37501484	G	W	Toxicity
1269	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	CAPN10	rs3792269	2	240592062	A	G	Efficacy
1270	pharmgkb	Drug	latanoprost	5282380	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	Glaucoma, Open-Angle	PTGS1	rs10306114	9	122370243	A	G	Efficacy
1271	pharmgkb	Drug	latanoprost	5282380	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	Glaucoma, Open-Angle	ABCC4	G187W	13	95210754	C	A	Efficacy
1272	pharmgkb	Drug	pioglitazone	4829	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	Diabetes Mellitus	ADIPOQ	rs2241766	3	186853103	T	S	Efficacy
1273	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	SOD2	V16A	6	159692840	A	G	Toxicity
1274	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors,Leukemia, Myelogenous, Chronic, BCR-ABL Positive	SLC22A4	L503F	5	132340627	C	T	Efficacy
1275	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	SP1	rs2683511	12	53410706	C	T	Efficacy,Metabolism/PK
1276	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	PPARA	rs149711321	22	46198138	T	C	Efficacy,Metabolism/PK
1277	pharmgkb	Drug Class	hmg coa reductase inhibitors				CELSR2	rs646776	1	109275908	C	T	Efficacy
1278	pharmgkb	Drug Class	hmg coa reductase inhibitors				SLCO1B1	rs2900478	12	21215863	T	A	Efficacy
1279	pharmgkb		insulin recombinant,zinc acetate				SLC30A8	R276W	8	117172544	C	W	Efficacy
1280	pharmgkb		interferon alfa-2a, recombinant,interferon alfa-2b, recombinant,ribavirin			Hepatitis C, Chronic,HIV Infections	FTO	rs9939609	16	53786615	T	A	Efficacy
1281	pharmgkb	Drug	caffeine	2519	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	Abortion, Spontaneous	CYP1A2	CYP1A2*1A, CYP1A2*1F					Toxicity
1282	pharmgkb	Drug	clonidine	2803	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	Liver Cirrhosis	GNB3	rs5443	12	6845711	C	T	Efficacy
1283	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	GSTT1	GSTT1 non-null, GSTT1 null					Efficacy
1284	pharmgkb		Antihypertensives,Beta Blocking Agents			Heart Diseases	GRK5	Q41L	10	119326585	A	T	Efficacy
1285	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs2054675	19	40989850	T	C	Toxicity
1286	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs3786547	19	41000286	T	C	Toxicity
1287	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HRH3	rs3787430	20	62216366	C	K	Efficacy
1288	pharmgkb	Drug	rituximab			Arthritis, Rheumatoid	TGFB1	P10R	19	41353016	G	M	Efficacy
1289	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis	TNFRSF10A	R209T	8	23201811	C	G	Efficacy
1290	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC22A5	rs2631367	5	132369766	C	G	Efficacy
1291	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	UGT1A6	T181A	2	233693545	A	G	Toxicity
1292	pharmgkb	Drug	haloperidol	3559	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	COMT	V158M	22	19963748	G	A	Toxicity
1293	pharmgkb		lamivudine,lopinavir,ritonavir,zidovudine			HIV Infections	ABCC1	rs212091	16	16142793	T	M	Efficacy
1294	pharmgkb	Drug	eculizumab			paroxysmal nocturnal hemoglobinuria	CR1	H1658R	1	207580276	A	G	Efficacy
1295	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs35864111	6	43768801	-	G	Efficacy
1296	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs13207351	6	43770057	A	K	Efficacy
1297	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCG2	rs12505410	4	88109689	T	S	Efficacy
1298	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCG2	rs13120400	4	88112375	T	C	Efficacy
1299	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCG2	rs2725252	4	88140758	C	W	Efficacy
1300	pharmgkb	Drug, Biological Intermediate	levodopa	6047	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	Parkinson Disease	HOMER1	rs4704559	5	79517086	A	G	Toxicity
1301	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Atrial Fibrillation	GGCX	rs2592551	2	85553008	G	A	Dosage
1302	pharmgkb	Drug	busulfan	2478	CS(=O)(=O)OCCCCOS(=O)(=O)C	hemopoietic stem cell transplant	CYP2C19	rs12248560	10	94761900	C	W	Metabolism/PK
1303	pharmgkb	Drug	busulfan	2478	CS(=O)(=O)OCCCCOS(=O)(=O)C	hemopoietic stem cell transplant	CYP2C9	R144C	10	94942290	C	T	Metabolism/PK
1304	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	CYP2B6	Q172H	19	41006936	G	W	Efficacy,Toxicity
1305	pharmgkb	Drug Class	corticosteroids			Asthma	HDAC1	rs1741981	1	32290838	T	M	Efficacy
1306	pharmgkb	Drug	sulfasalazine	5359476	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O	Arthritis, Rheumatoid	ABCG2	Q141K	4	88131171	G	Y	Efficacy
1307	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	SLC22A1	L160F	6	160130172	G	H	Efficacy,Metabolism/PK
1308	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	rs3806598	2	233671246	A	C	Metabolism/PK
1309	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	rs2741049	2	233673188	T	C	Metabolism/PK
1310	pharmgkb		donepezil,galantamine,rivastigmine			Alzheimer Disease	CHRNA7	rs6494223	15	32104256	C	T	Efficacy
1311	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A4	rs4646437	7	99767460	G	A	Efficacy,Metabolism/PK
1312	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative,Inflammatory Bowel Diseases	IL1B	rs4848306	2	112840530	G	A	Efficacy
1313	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative	IL1RN	rs4251961	2	113116890	T	C	Efficacy
1314	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Crohn Disease,Inflammatory Bowel Diseases	TLR9	rs352139	3	52224356	T	C	Efficacy
1315	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative	TLR2	rs4696480	4	153685974	T	A	Efficacy
1316	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Crohn Disease	TLR2	rs1816702	4	153688371	T	C	Efficacy
1317	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Inflammatory Bowel Diseases	TLR2	rs3804099	4	153703504	T	C	Efficacy
1318	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative	CD14	rs2569190	5	140633331	A	G	Efficacy
1319	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative,Inflammatory Bowel Diseases	IL17A	rs2275913	6	52186235	G	A	Efficacy
1320	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative,Inflammatory Bowel Diseases	TNFAIP3	rs6927172	6	137681038	C	D	Efficacy
1321	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Colitis, Ulcerative,Inflammatory Bowel Diseases	IL6	rs10499563	7	22720869	T	C	Efficacy
1322	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Inflammatory Bowel Diseases	TLR4	rs5030728	9	117712004	G	A	Efficacy
1323	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Inflammatory Bowel Diseases	CNPY4	rs1554973	9	117718534	T	C	Efficacy
1324	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Crohn Disease,Inflammatory Bowel Diseases	TNFRSF1A	rs4149570	12	6342424	A	B	Efficacy
1325	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Crohn Disease,Inflammatory Bowel Diseases	IFNG	rs2430561	12	68158742	T	A	Efficacy
1326	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	KCNQ1	rs2237895	11	2835964	A	Y	Toxicity
1327	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	IL10	rs1800896	1	206773552	T	C	Dosage
1328	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	IL10	rs1800872	1	206773062	T	G	Dosage
1329	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	IL10	rs1800871	1	206773289	A	G	Dosage
1330	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCB1	I1145M	7	87509329	A	K	Toxicity
1331	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	CMPK1	rs11211524	1	47367541	A	C	Efficacy
1332	pharmgkb	Drug Class	hmg coa reductase inhibitors				ABCB1	I1145M	7	87509329	A	K	Other
1333	pharmgkb	Drug	methylphenobarbital	8271	CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*16					Metabolism/PK
1334	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	CDA	rs1048977	1	20618562	C	T	Other
1335	pharmgkb	Drug	vitamin e	14985	CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O		CYP4F2	V433M	19	15879621	C	T	Metabolism/PK
1336	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C		BCHE	T271M	3	165830222	G	A	Toxicity
1337	pharmgkb	Drug	isoproterenol	3779	CC(C)NCC(C1=CC(=C(C=C1)O)O)O		ADRB2	R16G	5	148826877	G	A	Other
1338	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	NTRK2	rs10465180	9	84777667	C	T	Efficacy
1339	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	NTRK2	rs1778929	9	84707625	T	C	Efficacy
1340	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	FKBP5	rs1360780	6	35639794	T	M	Efficacy
1341	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	TRAF3IP2	rs76228616	6	111601300	G	C	Toxicity
1342	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TAPBP	rs1059288	6	33299895	A	G	Toxicity
1343	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TAPBP	T260R	6	33305078	G	C	Toxicity
1344	pharmgkb		dasatinib,imatinib				ABCG2	A528T	4	88097518	C	T	Other
1345	pharmgkb		dasatinib,imatinib				ABCG2	L525R	4	88097526	A	C	Other
1346	pharmgkb		dasatinib,imatinib,nilotinib				ABCG2	D296H	4	88115014	C	G	Other
1347	pharmgkb		dasatinib,imatinib,nilotinib				ABCG2	F208S	4	88121701	A	G	Other
1348	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5		ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
1349	pharmgkb		dasatinib,imatinib,nilotinib				ABCG2	V12M	4	88139962	C	T	Other
1350	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		STX4	rs10871454	16	31036758	C	T	Dosage
1351	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs4086116	10	94947445	C	T	Dosage
1352	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		FMO1	M1T	1	171258077	T	C	Other
1353	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		FMO1	rs7877	1	171285751	C	T	Other
1354	pharmgkb	Drug	XK469	148183	CC(C(=O)O)OC1=CC=C(C=C1)OC2=CN=C3C=CC(=CC3=N2)Cl		AOX1	rs10931910	2	200659013	A	K	Metabolism/PK
1355	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	RRAS2	rs11023197	11	14359452	G	A	Efficacy
1356	pharmgkb		gemcitabine,Platinum compounds			Mesothelioma	RRM1	rs11030918	11	4094257	T	C	Toxicity
1357	pharmgkb	Drug	celecoxib	2662	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	Colorectal Neoplasms	ALOX12	rs11078659	17	7000625	G	M	Efficacy,Toxicity
1358	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		UGT2B10	N481D	4	68830733	A	G	Metabolism/PK
1359	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PTGIR	rs1126510	19	46620526	A	G	Toxicity
1360	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	OCRL	rs113165732	X	129576236	C	K	Other
1361	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Anxiety Disorders	HTR1B	rs11568817	6	77463665	A	C	Toxicity
1362	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	PAPLN	rs11628713	14	73255067	C	T	Toxicity
1363	pharmgkb	Drug	verapamil	2520	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Hypertension	NR1H3	rs12221497	11	47259102	G	A	Toxicity
1364	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2C19	rs12768009	10	94766108	G	A	Metabolism/PK
1365	pharmgkb		gemcitabine,Platinum compounds			Mesothelioma	RRM1	rs12806698	11	4094744	C	A	Toxicity
1366	pharmgkb	Drug Class	hmg coa reductase inhibitors				CFAP44	rs13064411	3	113327793	A	G	Efficacy
1367	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PTGER2	rs1353411	14	52314383	G	A	Toxicity
1368	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	E390Q	19	40844766	C	K	Metabolism/PK
1369	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	R265Q	19	40846912	C	K	Metabolism/PK
1370	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	V68M	19	40849959	C	T	Metabolism/PK
1371	pharmgkb		peginterferon alfa-2a,ribavirin			Hepatitis C	VDR	rs1544410	12	47846052	C	D	Toxicity
1372	pharmgkb	Drug, Biological Intermediate	levodopa	6047	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	Cocaine-Related Disorders	DBH	rs1611115	9	133635393	T	C	Efficacy
1373	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukemia, B-Cell, Acute	ABCC4	rs9516519	13	95020203	T	S	Toxicity
1374	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42		CYP3A5	rs776746	7	99672916	T	C	Metabolism/PK
1375	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids			Acute coronary syndrome	PTGS1	rs10306135	9	122375416	A	T	Toxicity
1376	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		THBD	rs1042580	20	23046984	T	C	Toxicity
1377	pharmgkb	Drug Class	radiotherapy			pneumonitis	CDK1	rs10711	10	60794716	T	G	Toxicity
1378	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		FGD4	rs10771973	12	32640040	G	A	Toxicity
1379	pharmgkb	Drug Class	radiotherapy				PRKCE	rs11125035	2	45828910	T	A	Toxicity
1380	pharmgkb		Ace Inhibitors, Plain,Angiotensin II Antagonists,Beta Blocking Agents,digoxin,diuretics,spironolactone			Heart Failure	NOS3	D298E	7	150999023	T	R	Efficacy
1381	pharmgkb	Drug	enalapril	5362032	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O		BDKRB2	rs1799722	14	96204802	C	T	Efficacy
1382	pharmgkb		enalapril,imidapril,lisinopril			Cough,Essential hypertension	BDKRB2	rs1799722	14	96204802	C	T	Toxicity
1383	pharmgkb	Drug Class	Bisphosphonates			Osteonecrosis	KCNT2	rs1886629	1	196185768	C	T	Toxicity
1384	pharmgkb	Drug	sildenafil	5212	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Erectile Dysfunction	NOS3	rs2070744	7	150992991	C	T	Efficacy
1385	pharmgkb		adalimumab,etanercept,infliximab,Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	TRAF1	rs3761847	9	120927961	G	A	Efficacy
1386	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Spondylitis, Ankylosing	TNF	rs1799964	6	31574531	T	C	Efficacy
1387	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	ALDH5A1	H180Y	6	24503362	C	T	Efficacy
1388	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CCL2	rs2857657	17	34256113	G	C	Efficacy
1389	pharmgkb	Drug	phenobarbital	4763	CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2	Epilepsy	ABCB1	I1145M	7	87509329	A	K	Efficacy
1390	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depression	CYP2C19	rs4244285	10	94781859	G	M	Toxicity
1391	pharmgkb	Drug	etravirine	193962	CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N	HIV Infections	CYP2C19	rs4244285	10	94781859	G	M	Metabolism/PK
1392	pharmgkb	Drug	atomoxetine	54841	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SLC6A2	rs12708954	16	55697687	C	A	Efficacy
1393	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F		ALG10	rs1705772	12	34021821	G	A	Toxicity
1394	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		FMO3	V194M	1	171110939	G	A	Efficacy
1395	pharmgkb	Drug Class	Ace Inhibitors, Plain				ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Toxicity
1396	pharmgkb		olanzapine,risperidone			Schizophrenia	DRD2	rs1799978	11	113475629	T	C	Efficacy
1397	pharmgkb		interferons,ribavirin			Hepatitis C	BCL2	A43T	18	63318540	C	T	Efficacy
1398	pharmgkb		adalimumab,etanercept,infliximab			Arthritis, Rheumatoid	IL6	rs1800795	7	22727026	C	G	Efficacy
1399	pharmgkb	Drug	timolol	33624	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O		ADRB1	S49G	10	114044277	A	G	Efficacy
1400	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		EPHX1	rs1877724	1	225825654	C	T	Dosage
1401	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder	ABCB1	S893A	7	87531302	A	Y	Efficacy
1402	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PTGER2	rs2075797	14	52313933	C	G	Toxicity
1403	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	GDNF	rs2216711	5	37828742	G	M	Efficacy
1404	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC2	rs8187707	10	99850776	C	T	Toxicity
1405	pharmgkb	Drug	vardenafil	110634	CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C		CYP3A5	rs776746	7	99672916	T	C	Metabolism/PK
1406	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	PTGER3	rs7551789	1	71049286	A	T	Toxicity
1407	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	ACE	rs4292	17	63476980	C	T	Toxicity
1408	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	ACE	rs4291	17	63476833	T	M	Toxicity
1409	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TLR3	L412V	4	186082920	C	K	Toxicity
1410	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		AGT	rs5050	1	230714140	T	S	Toxicity
1411	pharmgkb		olanzapine,quetiapine,risperidone,ziprasidone			Schizophrenia	EIF2AK4	rs2412459	15	40003758	C	T	Efficacy
1412	pharmgkb	Drug	haloperidol	3559	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Schizophrenia	EIF2AK4	rs2412459	15	40003758	C	T	Efficacy
1413	pharmgkb	Drug	celecoxib	2662	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	Colorectal Neoplasms	IL23R	rs7518660	1	67219760	G	A	Toxicity
1414	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT2B7	rs7438135	4	69095621	G	A	Toxicity
1415	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid	SLC16A7	T445S	12	59779575	A	K	Efficacy
1416	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N		SLC47A2	rs34834489	17	19716951	G	A	Metabolism/PK
1417	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	SLC22A1	rs36056065	6	160139876	GTAAGTTG	-	Toxicity
1418	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	FLT4	T494A	5	180624003	T	M	Efficacy
1419	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	FLT4	R1324L	5	180603313	C	D	Efficacy
1420	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Coronary Disease	SLCO1B1	rs4149081	12	21225087	G	A	Efficacy
1421	pharmgkb		topiramate,zonisamide				CA12	rs4984241	15	63331264	A	G	Other
1422	pharmgkb		cytarabine,idarubicin			Leukemia, Myeloid, Acute	NT5C3A	rs3750117	7	33021334	A	G	Efficacy
1423	pharmgkb		topiramate,zonisamide				CA12	rs2306719	15	63341039	T	C	Other
1424	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder, Major	DRD2	rs2734833	11	113422198	G	A	Efficacy
1425	pharmgkb	Drug	verapamil	2520	CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	Coronary Artery Disease,Hypertension	NR1H3	S99R	11	47260473	C	T	Toxicity
1426	pharmgkb	Drug	celecoxib	2662	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	Colorectal Neoplasms	PTGES	rs2302821	9	129739602	A	C	Toxicity
1427	pharmgkb	Drug	fexofenadine	3348	CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O		SLCO2B1	S464F	11	75196537	C	T	Metabolism/PK
1428	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	GDNF	rs2973049	5	37818037	T	C	Efficacy
1429	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		HNF4A	rs3212198	20	44415722	C	K	Dosage
1430	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Psychotic Disorders	AHR	rs4410790	7	17244953	T	C	Metabolism/PK
1431	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder	TPH2	rs4570625	12	71938143	G	T	Efficacy
1432	pharmgkb	Drug Class	thiazolidinediones			Diabetes Mellitus, Type 2	AQP2	rs296766	12	49957170	T	C	Toxicity
1433	pharmgkb	Drug Class	hmg coa reductase inhibitors				ADAMTS1	rs402007	21	26845001	C	K	Efficacy
1434	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	TCF7L2	rs4132670	10	113008012	G	A	Toxicity
1435	pharmgkb	Drug	celecoxib	2662	CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F	Colorectal Neoplasms	PTGER4	rs4133101	5	40679465	T	C	Toxicity
1436	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	TNFRSF1B	rs3397	1	12207235	C	T	Efficacy
1437	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	TNFRSF1B	rs1061631	1	12208442	G	A	Efficacy
1438	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	TCF7L2	rs4506565	10	112996282	A	K	Toxicity
1439	pharmgkb	Drug	naltrexone	5360515	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	OPRD1	rs4654327	1	28863626	G	A	Efficacy
1440	pharmgkb	Drug	entacapone	5281081	CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N	Parkinson Disease	COMT	V158M	22	19963748	G	A	Efficacy
1441	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CACNA1C	rs1006737	12	2236129	G	A	Toxicity
1442	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	GRIN3A	rs10121600	9	101615721	C	T	Other
1443	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		COL26A1	rs10279545	7	101527747	T	C	Toxicity
1444	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	ARRB2	rs1045280	17	4719343	C	T	Other
1445	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs1044397	20	63349752	C	T	Other
1446	pharmgkb		methylprednisolone,prednisolone			Kidney Transplantation	ABCB1	I1145M	7	87509329	A	K	Toxicity
1447	pharmgkb	Drug	etoposide	36462	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
1448	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCC2	I1324M	10	99844450	C	K	Metabolism/PK
1449	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	SLCO1A2	rs3764043	12	21335070	C	T	Metabolism/PK
1450	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	GPR83	rs3758785	11	94398973	A	G	Efficacy
1451	pharmgkb	Drug	candesartan	2541	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Essential hypertension	GPR83	rs3758785	11	94398973	A	G	Efficacy
1452	pharmgkb	Drug Class	Ace Inhibitors, Plain			Hypertension	AGTR1	rs5182	3	148741608	C	T	Toxicity
1453	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	RORA	rs809736	15	61037589	A	G	Efficacy
1454	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	DTNBP1	rs760761	6	15650901	G	A	Efficacy
1455	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CACNA1C	rs10848635	12	2207029	T	A	Toxicity
1456	pharmgkb		citalopram,escitalopram			Depressive Disorder, Major	GLDC	rs10975641	9	6556839	C	K	Efficacy
1457	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CRHR2	rs2270007	7	30660356	G	C	Efficacy
1458	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		IL1B	rs16944	2	112837290	A	G	Efficacy
1459	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Hyperlipidemias	CYP3A5	rs776746	7	99672916	T	C	Toxicity
1460	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Toxic liver disease	CYP3A5	rs776746	7	99672916	T	C	Toxicity
1461	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Ovarian Neoplasms	ABCB1	S893A	7	87531302	A	Y	Efficacy
1462	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Coronary Disease	LEPR	Q223R	1	65592830	A	G	Efficacy
1463	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hyperlipidemias	LEPR	Q223R	1	65592830	A	G	Efficacy
1464	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Transplantation	ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
1465	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs11045872	12	21219410	A	K	Metabolism/PK
1466	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs11045821	12	21179489	G	A	Metabolism/PK
1467	pharmgkb	Drug	lovastatin	53232	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		SLCO1B1	rs2291073	12	21172880	T	G	Efficacy
1468	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	SLCO1B1	rs4149032	12	21164857	C	T	Metabolism/PK
1469	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SLCO1B1	rs4149036	12	21174806	C	A	Efficacy
1470	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	COMT	V158M	22	19963748	G	A	Efficacy
1471	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Obsessive-Compulsive Disorder	SLC1A1	rs301434	9	4582082	C	K	Efficacy
1472	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Obsessive-Compulsive Disorder	SLC1A1	rs301435	9	4582843	T	C	Efficacy
1473	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Obsessive-Compulsive Disorder	SLC1A1	rs3087879	9	4586808	G	C	Efficacy
1474	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	CHAT	D7N	10	49616071	G	A	Efficacy
1475	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		DRD2	rs2734841	11	113411054	A	B	Toxicity
1476	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		DRD2	rs2734842	11	113409552	G	C	Toxicity
1477	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	CHAT	A120T	10	49616573	G	A	Efficacy
1478	pharmgkb		clozapine,olanzapine,risperidone			Schizophrenia	DRD2	rs4436578	11	113436043	C	T	Toxicity
1479	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	CYP3A43	rs472660	7	99862484	G	A	Metabolism/PK
1480	pharmgkb	Drug Class	Influenza vaccines			Narcolepsy	HLA-DQB1	HLA-DQB1*06:02					Toxicity
1481	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HLA-DRB3	HLA-DRB3*02:02					Toxicity
1482	pharmgkb	Drug	ticlopidine	5472	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl		HLA-B	HLA-B*44:03					Toxicity
1483	pharmgkb	Drug	methylene blue	6099		Anemia, Hemolytic,Hemolysis,Protein Deficiency	G6PD	G6PD A- 202A_376G, G6PD B (reference)					Efficacy,Toxicity
1484	pharmgkb	Drug	ticlopidine	5472	C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl	Toxic liver disease	HLA-C	HLA-C*14:03					Toxicity
1485	pharmgkb	Drug	pazopanib	11525740		Carcinoma, Renal Cell	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*37					Toxicity
1486	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	SLC22A11	rs11231809	11	64535478	T	A	Efficacy
1487	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCC1	rs246240	16	16025167	A	G	Efficacy
1488	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCC1	rs3784864	16	16031468	G	A	Efficacy
1489	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	MICB	rs3828913	6	31498018	C	A	Efficacy
1490	pharmgkb		deleobuvir,faldaprevir			Hepatitis C, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
1491	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	SLC29A1	rs760370	6	44233216	A	G	Efficacy
1492	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	TCF7L2	rs7917983	10	112973123	T	C	Toxicity
1493	pharmgkb	Drug	propofol	4943	CC(C)C1=C(C(=CC=C1)C(C)C)O		CYP2B6	Q172H	19	41006936	G	W	Dosage
1494	pharmgkb	Drug	antithymocyte globulin			Kidney Transplantation	FCGR3A	F175V	1	161544752	A	B	Other
1495	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*59					Dosage
1496	pharmgkb	Drug Class	Pertussis vaccines				TLR4	rs2770150	9	117700861	A	G	Efficacy
1497	pharmgkb	Drug Class	Pertussis vaccines				TLR4	D99G	9	117713024	A	K	Efficacy
1498	pharmgkb	Drug	daunorubicin	30323	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O	Leukemia, Myeloid, Acute	NOS3	D298E	7	150999023	T	R	Efficacy
1499	pharmgkb	Drug	melphalan	4053	C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl	Multiple Myeloma	SLC7A5	rs4240803	16	87855597	G	H	Toxicity
1500	pharmgkb	Drug	naltrexone	5360515	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	DBH	rs1611115	9	133635393	T	C	Efficacy
1501	pharmgkb		clozapine,olanzapine			schizoaffective disorder,Schizophrenia	MTHFR	E429A	1	11794419	T	G	Toxicity
1502	pharmgkb	Drug	salvianolic acid b	6441188	C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=C3[C@H]([C@@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O	Coronary Disease	NOS3	D298E	7	150999023	T	R	Efficacy
1503	pharmgkb		capecitabine,radiotherapy			Rectal Neoplasms	AREG	rs11942466	4	74556361	C	A	Efficacy
1504	pharmgkb		capecitabine,radiotherapy			Rectal Neoplasms	ERCC1	rs11615	19	45420395	A	G	Efficacy
1505	pharmgkb	Drug Class	antipsychotics				COMT	V158M	22	19963748	G	A	Toxicity
1506	pharmgkb	Drug Class	antipsychotics				COMT	V158M	22	19963748	G	A	Toxicity
1507	pharmgkb	Metabolite	cotinine	854019	CN1[C@@H](CCC1=O)C2=CN=CC=C2		NAT1	rs13253389	8	18214398	A	B	Metabolism/PK
1508	pharmgkb	Drug	rocuronium	441290	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		SLCO1B1	N130H	12	21176804	A	K	Efficacy
1509	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		ABCB1	N21H	7	87600124	T	C	Toxicity
1510	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC4	rs7317112	13	95271269	A	G	Toxicity
1511	pharmgkb	Drug	adalimumab			Crohn Disease	ATG16L1	rs10210302	2	233250193	C	W	Efficacy
1512	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	LEPR	Q223R	1	65592830	A	G	Toxicity
1513	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	ANKK1	E713K	11	113400106	G	A	Toxicity
1514	pharmgkb	Biological Intermediate	bilirubin	5280352	CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C\4/C(=C(C(=O)N4)C=C)C	Colorectal Neoplasms	UGT1A	rs11563250	2	233774704	A	G	Metabolism/PK
1515	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	UGT1A	rs11563250	2	233774704	A	G	Toxicity
1516	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	CYP2C9	rs1934969	10	94988738	A	T	Metabolism/PK
1517	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms	SOD2	V16A	6	159692840	A	G	Toxicity
1518	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms	CYP2C8	rs1113129	10	95051288	G	M	Toxicity
1519	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms	ERCC1	Q506K	19	45409478	C	D	Toxicity
1520	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	ERCC1	rs11615	19	45420395	A	G	Toxicity
1521	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	familial hypercholesterolemia	POR	A503V	7	75985688	C	T	Efficacy
1522	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	HTR1A	rs6295	5	63962738	C	G	Efficacy
1523	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	COMT	V158M	22	19963748	G	A	Efficacy
1524	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	HSD11B1	rs846908	1	209685108	A	G	Metabolism/PK
1525	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	HSD11B1	rs4844880	1	209697571	A	T	Metabolism/PK
1526	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	HSD11B1	rs846910	1	209701909	A	G	Metabolism/PK
1527	pharmgkb	Drug	haloperidol	3559	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Psychotic Disorders	ABCB5	T131N	7	20643261	C	T	Toxicity
1528	pharmgkb		interferon beta-1a,interferon beta-1b			Multiple Sclerosis	CD58	rs12044852	1	116545157	C	A	Efficacy
1529	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms	GSTP1	A114V	11	67586108	C	T	Efficacy
1530	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N		UGT1A4	rs3732219	2	233718602	C	T	Other
1531	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N		UGT1A4	rs3732218	2	233718658	G	A	Other
1532	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C		CYP2C19	CYP2C19*1, CYP2C19*2					Other
1533	pharmgkb	Drug	benazepril	5362124	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Hypertension	MTHFR	A222V	1	11796321	G	A	Efficacy
1534	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs1570360	6	43770093	A	G	Efficacy
1535	pharmgkb	Drug	daptomycin	16129629	CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C		ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
1536	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	TNFRSF1A	rs767455	12	6341779	T	C	Efficacy
1537	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	ILKAP	rs113095083	2	238197074	T	C	Efficacy
1538	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	TET2	rs12505746	4	105192914	A	K	Efficacy
1539	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	FBXL17	rs7706429	5	108251082	A	G	Efficacy
1540	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	FBXL17	rs4431329	5	108253257	A	T	Efficacy
1541	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	CSMD1	rs11993031	8	2952059	T	A	Efficacy
1542	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	CSMD1	rs7387065	8	3045498	A	K	Efficacy
1543	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	SLIT1	rs11189015	10	97152179	G	M	Efficacy
1544	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	DIAPH3	rs77876672	13	59744885	C	T	Efficacy
1545	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	UGGT2	rs9590353	13	95978967	T	G	Efficacy
1546	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	ANKFN1	rs9915451	17	56355850	A	G	Efficacy
1547	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N		SLC22A3	rs2076828	6	160451754	C	G	Efficacy
1548	pharmgkb		epirubicin,fluorouracil,oxaliplatin			Neoplasms,Stomach Neoplasms	PON1	Q192P	7	95308134	T	C	Efficacy
1549	pharmgkb		anthracyclines and related substances,cyclophosphamide,doxorubicin,epirubicin,fluorouracil,methotrexate,oxaliplatin,Platinum compounds			Neoplasms,Ovarian Neoplasms,Stomach Neoplasms	NOS3	D298E	7	150999023	T	R	Efficacy
1550	pharmgkb	Drug	erlotinib	176870	COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC		CYP1A2	rs2472304	15	74751897	G	A	Metabolism/PK
1551	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	BDNF	V66M	11	27658369	C	T	Efficacy
1552	pharmgkb	Drug Class	antipsychotics			Schizophrenia	IL1B	rs16944	2	112837290	A	G	Toxicity
1553	pharmgkb	Drug Class	antipsychotics			Schizophrenia	IL1B	rs1143634	2	112832813	G	A	Toxicity
1554	pharmgkb	Drug Class	antipsychotics			Schizophrenia	BDNF	V66M	11	27658369	C	T	Toxicity
1555	pharmgkb	Drug	dextromethorphan	5360696	CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*36, CYP2D6*40, CYP2D6*42, CYP2D6*56					Other
1556	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	KCNJ6	rs2835859	21	37645860	T	C	Dosage
1557	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Toxic liver disease	POLG	Q1236H	15	89316763	C	A	Toxicity
1558	pharmgkb		bevacizumab,capecitabine,fluorouracil,irinotecan,leucovorin,oxaliplatin			Colorectal Neoplasms	VEGFA	rs699947	6	43768652	A	Y	Efficacy
1559	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	GALNT17	rs7794356	7	71273743	G	A	Efficacy
1560	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	MLLT3	rs6475448	9	20497144	G	A	Efficacy
1561	pharmgkb		anastrozole,letrozole			Breast Neoplasms	TNFSF11	rs7984870	13	42572346	G	C	Efficacy
1562	pharmgkb		anastrozole,letrozole			Breast Neoplasms	TNFRSF11B	N3K	8	118951813	G	C	Toxicity
1563	pharmgkb	Drug	cytarabine	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia, Myeloid, Acute	ABCB1	rs1128503	7	87550285	A	G	Efficacy
1564	pharmgkb	Drug	liraglutide	44147092	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N	Obesity,Polycystic Ovary Syndrome	GLP1R	P7L	6	39048860	C	T	Efficacy
1565	pharmgkb	Drug	liraglutide	44147092	CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N	Obesity,Polycystic Ovary Syndrome	GLP1R	G168S	6	39066296	G	M	Efficacy
1566	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N		SLC22A2	S270A	6	160249250	A	C	Other
1567	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CYP2B6	R487S	19	41016810	C	D	Efficacy
1568	pharmgkb		aripiprazole,clozapine,haloperidol,olanzapine,quetiapine,risperidone			Psychotic Disorders	FAAH	P129T	1	46405089	C	A	Toxicity
1569	pharmgkb		aripiprazole,clozapine,haloperidol,olanzapine,quetiapine,risperidone			Autism Spectrum Disorder,Psychotic Disorders,Schizophrenia	CNR1	rs1049353	6	88143916	C	T	Toxicity
1570	pharmgkb		clozapine,olanzapine,risperidone			Autism Spectrum Disorder,Schizophrenia	CNR1	rs806378	6	88149832	C	T	Toxicity
1571	pharmgkb		maprotiline,opipramol			Depression	CYP2D6	CYP2D6*1, CYP2D6*4					Dosage,Toxicity
1572	pharmgkb	Drug	ketamine	3821	CNC1(CCCCC1=O)C2=CC=CC=C2Cl	Neoplasms,Pain	CYP2B6	CYP2B6*1, CYP2B6*6					Metabolism/PK
1573	pharmgkb	Drug Class	anthracyclines and related substances			Breast Neoplasms	ECT2L	rs11155012	6	138830647	G	W	Efficacy
1574	pharmgkb	Drug	asparaginase			Precursor Cell Lymphoblastic Leukemia-Lymphoma	HLA-DRB1	R54L	6	32584318	C	T	Toxicity
1575	pharmgkb	Drug	asparaginase			Precursor Cell Lymphoblastic Leukemia-Lymphoma	NFATC2	rs6021191	20	51419700	A	T	Toxicity
1576	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs6838116	4	21354260	A	C	Toxicity
1577	pharmgkb		carboplatin,taxanes			Ovarian Neoplasms	GSR	rs3594	8	30678143	C	A	Toxicity
1578	pharmgkb		carboplatin,taxanes			Ovarian Neoplasms	ATP7B	V933A	13	51941218	A	K	Toxicity
1579	pharmgkb		carboplatin,taxanes			Ovarian Neoplasms	SCN10A	rs9825762	3	38724847	T	C	Toxicity
1580	pharmgkb		carboplatin,taxanes			Ovarian Neoplasms	ATP7B	K670R	13	51950352	T	S	Toxicity
1581	pharmgkb		Drugs used in nicotine dependence,nicotine,varenicline			Tobacco Use Disorder	CHRNA5	rs588765	15	78573083	T	M	Efficacy
1582	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	CXCL8	rs1126647	4	73743328	A	T	Toxicity
1583	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	IL13	rs1800925	5	132657117	C	K	Toxicity
1584	pharmgkb		trandolapril,verapamil			Hypertension	PTPRD	rs4742610	9	9687487	C	K	Efficacy
1585	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O		UGT2B7	Y268H	4	69098620	T	C	Dosage
1586	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Neoplasms	NR1I2	rs6785049	3	119814886	G	A	Toxicity
1587	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Colonic Neoplasms	LGR5	V594A	12	71584007	T	C	Efficacy
1588	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	FMO5	rs7541245	1	147209857	C	A	Efficacy
1589	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	ABCC2	C1515Y	10	99851537	G	A	Toxicity
1590	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	ABCC2	rs717620	10	99782821	C	T	Toxicity
1591	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Disease	FDPS	rs2297480	1	155309691	T	G	Other
1592	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	NR1I2	rs4688040	3	119805244	G	Y	Metabolism/PK
1593	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression,suicide	GRIA3	rs4825476	X	123307628	G	M	Toxicity
1594	pharmgkb	Drug Class	Beta Blocking Agents				GNB3	rs5443	12	6845711	C	T	Other
1595	pharmgkb		follitropin beta,thyrotropin alfa,urofollitropin			Infertility, Female,Ovarian hyperstimulation syndrome	FSHR	S680N	2	48962782	C	T	Efficacy
1596	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F		CYP2B6	R22C	19	40991369	C	T	Metabolism/PK
1597	pharmgkb		farglitazar,glyburide			Diabetes Mellitus, Type 2	SCNN1B	rs889299	16	23370593	G	A	Toxicity
1598	pharmgkb	Drug Class	calcium channel blockers			Hypertension	TANC2	rs2429427	17	63316455	G	A	Efficacy
1599	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs2242480	7	99763843	C	T	Toxicity
1600	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms,hand-foot syndrome	ABCB1	S893A	7	87531302	A	Y	Toxicity
1601	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	IL10	rs1800896	1	206773552	T	C	Toxicity
1602	pharmgkb	Drug	cilostazol	2754	C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4		CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
1603	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Lupus Erythematosus, Systemic	CYP2C19	rs4244285	10	94781859	G	M	Toxicity
1604	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Lupus erythematosus	CYP2B6	rs4802101	19	40990556	T	C	Toxicity,Metabolism/PK
1605	pharmgkb	Drug	varenicline	5310966	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	Tobacco Use Disorder	CHRNA4	S543R	20	63349782	G	M	Efficacy
1606	pharmgkb	Drug Class	Opium alkaloids and derivatives			Pain	CHRNA3	rs1051730	15	78601997	G	A	Toxicity
1607	pharmgkb		fluorouracil,irinotecan,leucovorin			Colorectal Neoplasms	ABCC5	rs10937158	3	183990651	T	C	Toxicity
1608	pharmgkb		fluorouracil,irinotecan,leucovorin			Colorectal Neoplasms	ABCG1	rs225440	21	42232943	C	T	Toxicity
1609	pharmgkb		amlodipine,chlorthalidone,lisinopril				AGT	rs11122576	1	230710933	T	C	Efficacy
1610	pharmgkb		amlodipine,chlorthalidone,lisinopril				AGT	rs11122576	1	230710933	T	C	Efficacy
1611	pharmgkb		fluorouracil,irinotecan,leucovorin			Colorectal Neoplasms	ABCC5	rs3749438	3	183987396	G	A	Toxicity
1612	pharmgkb		acetaminophen,aspirin,diclofenac,propionic acid derivatives,Pyrazolones				PLA2G4A	rs12746200	1	186880054	A	G	Toxicity
1613	pharmgkb		acetaminophen,aspirin,diclofenac,propionic acid derivatives,Pyrazolones				TNFRSF11A	A192V	18	62360008	C	T	Toxicity
1614	pharmgkb		acetaminophen,aspirin,diclofenac,propionic acid derivatives,Pyrazolones				PLCG1	S279G	20	41163423	A	G	Toxicity
1615	pharmgkb	Drug	amodiaquine	2165	CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O		CYP2C8	R139K	10	95067273	C	W	Toxicity
1616	pharmgkb	Drug	amodiaquine	2165	CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O		CYP2C8	K297R	10	95038992	T	C	Toxicity
1617	pharmgkb		antidepressants,citalopram,clomipramine,lithium,nefazodone,paroxetine,venlafaxine			Depression	FKBP5	rs1360780	6	35639794	T	M	Efficacy
1618	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CYP1A2	rs762551	15	74749576	C	A	Efficacy
1619	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease	P2RY12	rs6809699	3	151338810	A	C	Efficacy
1620	pharmgkb		aspirin,Beta Blocking Agents,clopidogrel,hmg coa reductase inhibitors			Coronary Artery Disease	NOS3	D298E	7	150999023	T	R	Toxicity
1621	pharmgkb		aspirin,clopidogrel			Coronary Artery Disease,Coronary Disease,Myocardial Infarction	ITGA2	F253L	5	53051539	C	T	Efficacy
1622	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		P2RY12	rs6787801	3	151381953	A	G	Efficacy
1623	pharmgkb		aspirin,clopidogrel				ITGA2	rs1062535	5	53055583	G	A	Efficacy
1624	pharmgkb		aspirin,clopidogrel			Myocardial Infarction	PTGS1	rs10306114	9	122370243	A	G	Efficacy
1625	pharmgkb		aspirin,clopidogrel				PEAR1	rs12041331	1	156899922	G	A	Efficacy,Toxicity
1626	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Disease	CES1P1	rs3785161	16	55759783	A	C	Efficacy
1627	pharmgkb		aspirin,clopidogrel			Acute coronary syndrome	CYP4F2	V433M	19	15879621	C	T	Other
1628	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	16	31093557	G	M	Efficacy
1629	pharmgkb	Drug	midazolam	4192	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F	Neoplasms	CYP3A4	rs35599367	7	99768693	G	A	Other
1630	pharmgkb		capecitabine,fluorouracil			Colorectal Neoplasms	HLA-G	rs371194629	6	29830805	-	ATTTGT/ATTTGTTCATGCCT	Efficacy
1631	pharmgkb		capecitabine,fluorouracil			Colorectal Neoplasms	HLA-G	rs9380142	6	29831017	A	G	Efficacy
1632	pharmgkb		capecitabine,fluorouracil			Colorectal Neoplasms	HLA-G	rs17179108	6	29830865	C	T	Efficacy
1633	pharmgkb	Drug	letrozole	3902	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs3759811	15	51237068	T	C	Other
1634	pharmgkb	Drug	letrozole	3902	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs4775936	15	51243825	C	T	Other
1635	pharmgkb	Drug	letrozole	3902	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs749292	15	51266534	G	A	Other
1636	pharmgkb	Drug	letrozole	3902	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs700518	15	51236915	T	C	Other
1637	pharmgkb		hmg coa reductase inhibitors,letrozole			Breast Neoplasms,Menopause	CYP19A1	rs1062033	15	51255741	C	G	Other
1638	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NQO1	P187S	16	69711242	G	A	Dosage
1639	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC4	rs1059751	13	95020696	A	G	Toxicity
1640	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Renal Cell	VEGFA	rs1570360	6	43770093	A	G	Efficacy
1641	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Renal Cell	KDR	rs2239702	4	55125972	C	T	Efficacy
1642	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Renal Cell,hand-foot syndrome	VEGFA	rs2010963	6	43770613	C	G	Toxicity
1643	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Renal Cell,Hypertension	ABCB1	I1145M	7	87509329	A	K	Toxicity
1644	pharmgkb		donepezil,galantamine,rivastigmine			Alzheimer Disease	CHAT	rs3793790	10	49632690	G	M	Efficacy
1645	pharmgkb		desloratadine,mizolastine			Urticaria	FCER1A	S101N	1	159304153	G	A	Efficacy
1646	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCC2	rs717620	10	99782821	C	T	Metabolism/PK
1647	pharmgkb		capecitabine,fluorouracil,leucovorin,oxaliplatin			Colonic Neoplasms	SELE	rs3917412	1	169731361	T	V	Efficacy
1648	pharmgkb		exemestane,letrozole			Breast Neoplasms	ESR1	rs9322335	6	151878994	T	C	Toxicity
1649	pharmgkb	Drug	letrozole	3902	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms	ESR1	rs4870061	6	151916333	T	C	Toxicity
1650	pharmgkb	Drug	agomelatine	82148	CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC	Depressive Disorder	ABCB1	I1145M	7	87509329	A	K	Efficacy
1651	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder,Narcolepsy	ABCB1	I1145M	7	87509329	A	K	Efficacy
1652	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder	ABCB1	I1145M	7	87509329	A	K	Efficacy
1653	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	LRRC15	rs11313667	3	194361433	C	-	Efficacy
1654	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension	LRRC15	rs11313667	3	194361433	C	-	Efficacy
1655	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	LRRC15	rs11313667	3	194361433	C	-	Efficacy
1656	pharmgkb	Drug	rivastigmine	77991	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	Alzheimer Disease	CHAT	rs2177370	10	49630828	A	G	Efficacy
1657	pharmgkb	Drug	galantamine	9651	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O	Alzheimer Disease	CHAT	rs2177370	10	49630828	A	G	Efficacy
1658	pharmgkb	Drug	donepezil	3152	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	Alzheimer Disease	CHAT	rs2177370	10	49630828	A	G	Efficacy
1659	pharmgkb	Drug	telmisartan	65999	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C	Essential hypertension	GNB3	rs5443	12	6845711	C	T	Efficacy
1660	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42		DRD3	G9S	3	114171968	C	T	Metabolism/PK
1661	pharmgkb	Drug	modafinil	4236	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	Narcolepsy	ABCB1	I1145M	7	87509329	A	K	Efficacy
1662	pharmgkb	Drug	silibinin	31553	COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O		ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
1663	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	DRD2	rs1076560	11	113412966	C	A	Efficacy
1664	pharmgkb	Drug	modafinil	4236	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	Narcolepsy	ABCB1	rs1128503	7	87550285	A	G	Efficacy
1665	pharmgkb	Drug	amisulpride	2159	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	Schizophrenia	DRD2	rs1079597	11	113425564	C	T	Efficacy
1666	pharmgkb	Drug Class	corticosteroids			Asthma	ST13	rs138335	22	40831082	C	R	Efficacy
1667	pharmgkb	Drug Class	corticosteroids			Asthma	ST13	rs138337	22	40835049	A	G	Efficacy
1668	pharmgkb	Drug	fluvoxamine	3404	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder	FGF2	rs1449683	4	122826931	C	K	Efficacy
1669	pharmgkb	Drug Class	antipsychotics			Schizophrenia	ADCY2	rs1544938	5	7634119	G	H	Efficacy
1670	pharmgkb	Drug Class	antipsychotics			Schizophrenia	NRG1	rs17716295	8	32460401	C	A	Efficacy
1671	pharmgkb		cyclosporine,mycophenolate mofetil,sirolimus,tacrolimus			Kidney Transplantation	UGT1A8	A173G	2	233618225	C	K	Toxicity
1672	pharmgkb		adalimumab,infliximab			Arthritis, Rheumatoid	FCGR2A	H166P	1	161509955	A	S	Efficacy
1673	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Lymphoma, B-Cell	CYP2B6	CYP2B6*1, CYP2B6*6					Metabolism/PK
1674	pharmgkb	Drug	infliximab			Arthritis, Rheumatoid	FCGR3A	F175V	1	161544752	A	B	Efficacy
1675	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	ABCB1	I1145M	7	87509329	A	K	Toxicity
1676	pharmgkb	Drug Class	Antihypertensives			Coronary Artery Disease,Hypertension	ATP2B1	rs12817819	12	89645549	C	T	Efficacy
1677	pharmgkb	Drug Class	antipsychotics			Schizophrenia	GRM3	rs6465084	7	86774159	A	G	Efficacy
1678	pharmgkb	Drug Class	antipsychotics			Schizophrenia	GRM3	rs1468412	7	86804135	A	T	Toxicity
1679	pharmgkb	Drug Class	antipsychotics			Schizophrenia	NRXN1	rs12467557	2	51015132	A	G	Efficacy
1680	pharmgkb	Drug Class	antipsychotics			Schizophrenia	NRXN1	rs10490162	2	51020519	T	C	Efficacy
1681	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	HMGCR	rs17671591	5	75319196	C	T	Efficacy
1682	pharmgkb	Drug	bevacizumab			Macular Degeneration	ARMS2	A69S	10	122454932	G	T	Efficacy
1683	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Tuberculosis	CYP2E1	CYP2E1*1A, CYP2E1*5B					Toxicity
1684	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CAT	rs1001179	11	34438684	C	T	Other
1685	pharmgkb	Drug Class	Hepatitis vaccines				IL13	rs1295686	5	132660151	T	M	Efficacy
1686	pharmgkb	Drug Class	Hepatitis vaccines				IL4R	S488P	16	27362859	T	C	Efficacy
1687	pharmgkb	Drug	imiquimod	57469	CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N	Carcinoma, Basal Cell	TLR7	Q11P	X	12885540	A	T	Efficacy
1688	pharmgkb	Drug	infliximab				TNF	rs361525	6	31575324	G	A	Efficacy
1689	pharmgkb	Drug	voriconazole	71616	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	Mycoses	CYP3A4	rs4646437	7	99767460	G	A	Metabolism/PK
1690	pharmgkb	Drug	regadenoson	219024	CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O		AMPD1	Q45K	1	114693436	G	W	Toxicity
1691	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	ABCG2	rs2231135	4	88158842	A	G	Toxicity
1692	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	DHFR	rs1650723	5	80626211	C	T	Toxicity
1693	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	DHFR	rs1053129	5	80626901	C	W	Efficacy
1694	pharmgkb	Drug	pegloticase			Hemolysis,Methemoglobinemia	G6PD	G6PD A- 202A_376G					Toxicity
1695	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Failure	CYP3A5	rs776746	7	99672916	T	C	Toxicity
1696	pharmgkb		atorvastatin,rifampin				SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
1697	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		CYP3A5	rs776746	7	99672916	T	C	Efficacy
1698	pharmgkb	Drug	lovastatin	53232	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Arteriosclerosis	CYP3A5	rs776746	7	99672916	T	C	Efficacy
1699	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Disease,Myocardial Infarction	ADAMTS1	A227S	21	26844276	C	G	Efficacy
1700	pharmgkb	Drug	peginterferon alfa-2b	71306834		Hepatitis B, Chronic	HLA-DPA1	rs3077	6	33065245	A	G	Efficacy
1701	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:13					Toxicity
1702	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCB1	I1145M	7	87509329	A	K	Toxicity
1703	pharmgkb	Drug Class	selective beta-2-adrenoreceptor agonists			Asthma	VDR	rs1540339	12	47863543	C	T	Efficacy
1704	pharmgkb	Drug Class	selective beta-2-adrenoreceptor agonists			Asthma	VDR	rs2239179	12	47863983	T	C	Efficacy
1705	pharmgkb		adalimumab,certolizumab pegol,etanercept,glucocorticoids,infliximab,methotrexate			Arthritis, Rheumatoid	ATP5F1E	rs1059150	20	59030384	T	C	Efficacy
1706	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	GRIN2B	rs1072388	12	13785842	G	A	Efficacy
1707	pharmgkb		adalimumab,certolizumab pegol,etanercept,glucocorticoids,infliximab,methotrexate			Arthritis, Rheumatoid	HLA-E	G128R	6	30490287	G	W	Efficacy
1708	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depression	PLCB1	rs6108160	20	8591578	G	A	Efficacy
1709	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	GIPR	rs10423928	19	45679046	T	A	Toxicity
1710	pharmgkb		capecitabine,fluorouracil,tegafur			Neoplasms	TYMS	rs183205964	18	657657	G	C	Toxicity
1711	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CCL2	rs4586	17	34256250	T	C	Efficacy
1712	pharmgkb		exemestane,letrozole			Breast Neoplasms	CYP19A1	rs6493497	15	51338638	G	A	Toxicity
1713	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	HTR2A	H452Y	13	46834899	G	A	Efficacy
1714	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	HOTAIR	rs7958904	12	53963768	C	R	Efficacy
1715	pharmgkb	Drug	enalapril	5362032	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Essential hypertension	SLCO1B1	V174A	12	21178615	T	C	Toxicity
1716	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	SLCO1B1	N130H	12	21176804	A	K	Efficacy
1717	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	MALAT1	rs619586	11	65498698	A	G	Efficacy
1718	pharmgkb	Drug Class	Platinum compounds			Lung Neoplasms	H19	rs2839698	11	1997623	G	A	Efficacy
1719	pharmgkb	Drug	milnacipran	65833	CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	Depressive Disorder	ADRA2A	rs1800544	10	111076745	G	C	Efficacy
1720	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		CYP7A1	rs3808607	8	58500365	G	T	Efficacy
1721	pharmgkb		antipsychotics,risperidone			Autism Spectrum Disorder,Mood Disorders	LEP	rs7799039	7	128238730	G	M	Toxicity
1722	pharmgkb	Drug	modafinil	4236	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	Narcolepsy	ABCB1	S893A	7	87531302	A	Y	Efficacy
1723	pharmgkb	Drug	exemestane	60198	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	Breast Neoplasms	ESR1	rs2813543	6	152103343	A	G	Toxicity
1724	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Osteosarcoma	REV3L	T1146I	6	111374684	G	A	Efficacy
1725	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Lupus Nephritis	GSTA1	rs3957356	6	52803872	T	C	Efficacy
1726	pharmgkb	Drug	milnacipran	65833	CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	Depressive Disorder	HTR1A	rs6295	5	63962738	C	G	Efficacy
1727	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F		GRID2	rs1875705	4	93221348	G	A	Efficacy
1728	pharmgkb		cyclophosphamide,dexamethasone,lenalidomide,thalidomide			Multiple Myeloma	CTNNB1	rs4135385	3	41237949	A	G	Efficacy,Toxicity
1729	pharmgkb		lenalidomide,thalidomide			Multiple Myeloma	CTNNB1	rs4533622	3	41200847	C	W	Efficacy,Toxicity
1730	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F		GRM7	rs2069062	3	6992862	G	Y	Efficacy
1731	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Osteosarcoma	REV1	V138M	2	99442408	C	T	Efficacy
1732	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease,Diabetes Mellitus, Type 2	IRS1	rs13431554	2	226732872	A	G	Efficacy
1733	pharmgkb		infliximab,Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	TNFRSF1B	M196R	1	12192898	T	G	Efficacy
1734	pharmgkb	Drug	asparaginase			Precursor Cell Lymphoblastic Leukemia-Lymphoma	SOD2	V16A	6	159692840	A	G	Toxicity
1735	pharmgkb		interferon beta-1a,interferon beta-1b			Multiple Sclerosis	FHIT	rs760316	3	60113241	C	T	Efficacy
1736	pharmgkb		interferon beta-1a,interferon beta-1b			Multiple Sclerosis	GAPVD1	rs10819043	9	125274966	C	T	Efficacy
1737	pharmgkb		Ace Inhibitors, Plain,Angiotensin II Antagonists,Beta Blocking Agents,digoxin,diuretics,spironolactone			Heart Failure	ADRB2	R16G	5	148826877	G	A	Efficacy
1738	pharmgkb	Drug	terbutaline	5403	CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O		ADRB2	Q27E	5	148826910	G	Y	Efficacy
1739	pharmgkb		atenolol,metoprolol			Hypertension	ADRB2	Q27E	5	148826910	G	Y	Toxicity
1740	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ABCB1	I1145M	7	87509329	A	K	Efficacy
1741	pharmgkb	Drug	voriconazole	71616	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O		ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
1742	pharmgkb	Drug	nifedipine	4485	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC	Hypertension	ADRA1A	C347R	8	26770511	A	G	Efficacy
1743	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		EPHX1	Y113H	1	225831932	T	C	Efficacy
1744	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	SLC28A2	S75R	15	45262069	C	A	Efficacy,Toxicity
1745	pharmgkb		carboplatin,cisplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung	NRAS	rs1065634	1	114717147	T	C	Efficacy
1746	pharmgkb	Drug	infliximab			Crohn Disease	IL1B	rs1143634	2	112832813	G	A	Efficacy
1747	pharmgkb		carboplatin,cisplatin,docetaxel,gemcitabine,paclitaxel			Carcinoma, Non-Small-Cell Lung	RAF1	rs11710163	3	12654789	A	G	Efficacy
1748	pharmgkb		carboplatin,cisplatin,docetaxel,paclitaxel			Carcinoma, Non-Small-Cell Lung	MAP3K1	rs16886403	5	56843419	T	C	Efficacy
1749	pharmgkb		carboplatin,cisplatin,docetaxel,gemcitabine,paclitaxel			Carcinoma, Non-Small-Cell Lung	ACSS2	rs17309872	20	34927985	A	B	Efficacy
1750	pharmgkb		carboplatin,cisplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung	GPX5	rs451774	6	28534773	A	G	Efficacy
1751	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		PROC	rs1799808	2	127418286	C	T	Dosage
1752	pharmgkb	Drug Class	catecholamines			Coronary Artery Disease	ADRB1	G389R	10	114045297	G	C	Dosage
1753	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	RRM1	rs183484	11	4119902	C	A	Efficacy
1754	pharmgkb	Drug	enalapril	5362032	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertension	NOS3	rs2070744	7	150992991	C	T	Efficacy
1755	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	SLC28A1	D521N	15	84935498	G	W	Toxicity
1756	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	ABCC2	rs3740065	10	99845936	A	G	Efficacy
1757	pharmgkb	Drug	ramipril	5362129	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O	Hypertension	ACE	rs4344	17	63489363	G	M	Efficacy
1758	pharmgkb	Drug	ramipril	5362129	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O	Hypertension	ACE	rs4359	17	63494982	T	C	Efficacy
1759	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	GGH	rs719235	8	63039122	C	A	Toxicity
1760	pharmgkb	Drug	nitrendipine	4507	CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C	Hypertension	AGTR1	rs5186	3	148742201	A	C	Efficacy
1761	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		AGTR1	rs5186	3	148742201	A	C	Efficacy
1762	pharmgkb	Biological Intermediate	angiotensin II	65143	CC[C@H](C)C(C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N		AGTR1	rs5186	3	148742201	A	C	Efficacy
1763	pharmgkb	Drug	perindopril	107807	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	Hypertension	AGTR1	rs5186	3	148742201	A	C	Efficacy
1764	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Liver Cirrhosis	AGTR1	rs5186	3	148742201	A	C	Efficacy
1765	pharmgkb	Drug	quinapril	54892	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O	Coronary Artery Disease	AGT	M268T	1	230710048	A	G	Efficacy
1766	pharmgkb	Drug	icotinib	22024915	C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Other
1767	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	ABCC10	I920T	6	43445127	T	C	Metabolism/PK
1768	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CCHCR1	rs1265112	6	31150242	T	C	Toxicity
1769	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CCHCR1	R716Q	6	31144707	C	T	Toxicity
1770	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	TCF19	P241L	6	31161930	C	T	Toxicity
1771	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	POLR3G	rs2562519	5	90485154	C	T	Toxicity
1772	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	SLC19A1	rs1051298	21	45514912	G	A	Efficacy
1773	pharmgkb		bevacizumab,pemetrexed			Carcinoma, Non-Small-Cell Lung	GGH	rs3780126	8	63037353	G	A	Efficacy
1774	pharmgkb	Drug	tipifarnib			Neoplasms	ABCB1	rs1128503	7	87550285	A	G	Metabolism/PK
1775	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	DRD2	rs1799732	11	113475530	-	R	Efficacy
1776	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DRD2	rs1799732	11	113475530	-	R	Efficacy
1777	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	GRIN2B	rs1019385	12	13981909	C	A	Dosage
1778	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung	EGFR	rs2293347	7	55201223	C	T	Efficacy
1779	pharmgkb		cetuximab,irinotecan,leucovorin,tegafur			Colorectal Neoplasms	EGFR	rs712830	7	55019087	A	C	Toxicity
1780	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs8192719	19	41012868	C	T	Metabolism/PK
1781	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Neoplasms	EGFR	rs712829	7	55019062	G	Y	Efficacy
1782	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	DAOA	rs778293	13	105516850	C	W	Toxicity
1783	pharmgkb	Drug	salbutamol	2083	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	DUSP1	rs881152	5	172771552	G	M	Efficacy
1784	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	HTR1A	rs878567	5	63960164	A	S	Toxicity
1785	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	TAS2R16	N172K	7	122995119	A	C	Toxicity
1786	pharmgkb		catecholamines,metformin				SLC22A3	T400N	6	160437122	C	W	Metabolism/PK
1787	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		POR	A503V	7	75985688	C	T	Metabolism/PK
1788	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	PROX1	rs340874	1	213985913	T	C	Toxicity
1789	pharmgkb		conjugated estrogens,medroxyprogesterone				VDR	rs1544410	12	47846052	C	D	Efficacy
1790	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	UGT1A9	W208R	2	233682559	T	C	Toxicity
1791	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	L233R	2	233760985	T	G	Metabolism/PK
1792	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	Y218D	2	233772413	T	V	Metabolism/PK
1793	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O		UGT1A9	P229L	2	233760973	C	W	Metabolism/PK
1794	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		CYP3A4	M445T	7	99760901	A	G	Efficacy
1795	pharmgkb		fluvastatin,simvastatin				LIPC	rs1800588	15	58431476	C	K	Efficacy
1796	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		LIPC	rs1800588	15	58431476	C	K	Efficacy
1797	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		ACE	rs4341	17	63488629	G	C	Efficacy
1798	pharmgkb	Drug	lovastatin	53232	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		LDLR	rs688	19	11116926	C	T	Efficacy
1799	pharmgkb	Drug	lovastatin	53232	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		LDLR	rs5925	19	11120205	T	C	Efficacy
1800	pharmgkb		atorvastatin,simvastatin			Hypercholesterolemia	PON1	Q192P	7	95308134	T	C	Efficacy
1801	pharmgkb		atorvastatin,simvastatin			Hypercholesterolemia	PON1	rs705379	7	95324583	G	H	Efficacy
1802	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	ABCB1	rs1128503	7	87550285	A	G	Efficacy
1803	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	ABCB1	rs1128503	7	87550285	A	G	Toxicity
1804	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		ABCC2	rs113646094	10	99804255	C	K	Metabolism/PK
1805	pharmgkb	Drug	nelfinavir	64143	CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O	HIV Infections,Pancreatic Neoplasms	CYP2C19	rs4244285	10	94781859	G	M	Metabolism/PK
1806	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F		CYP2B6	CYP2B6*27, CYP2B6*28					Other
1807	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Acute coronary syndrome	LEPR	K656N	1	65610269	G	Y	Efficacy
1808	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F		FKBP5	rs73748206	6	35640178	C	T	Other
1809	pharmgkb	Drug	cefotaxime	456256	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O		SLC22A8	I214F	11	62995792	T	A	Metabolism/PK
1810	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl		NEDD4L	rs292449	18	58227849	G	C	Efficacy
1811	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	DRD2	rs2283265	11	113414814	C	A	Toxicity
1812	pharmgkb		pravastatin,simvastatin			Hypercholesterolemia	RHOA	rs11716445	3	49368662	G	A	Efficacy
1813	pharmgkb		asparaginase,dexamethasone,methotrexate			Precursor Cell Lymphoblastic Leukemia-Lymphoma	PYGL	rs7142143	14	50936813	T	C	Efficacy
1814	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*5, CYP2C19*6, CYP2C19*7, CYP2C19*8					Metabolism/PK
1815	pharmgkb	Drug Class	Ace Inhibitors, Plain			Hypertension	AGT	M268T	1	230710048	A	G	Efficacy
1816	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ULK3	rs2290573	15	74837253	G	W	Efficacy
1817	pharmgkb	Drug Class	corticosteroids			Asthma	TBX21	H33Q	17	47733553	C	G	Efficacy
1818	pharmgkb	Drug	flupirtine	53276	CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N	drug-induced liver injury	HLA-DRB1	HLA-DRB1*16:01					Toxicity
1819	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-DQB1	HLA-DQB1*05:02					Toxicity
1820	pharmgkb	Drug	flupirtine	53276	CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N	drug-induced liver injury	HLA-DQB1	HLA-DQB1*05:02					Toxicity
1821	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DDC	rs12718541	7	50482446	A	G	Toxicity
1822	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	DRD1	rs265976	5	175435417	G	T	Efficacy
1823	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	ARRB2	rs2036657	17	4721864	G	A	Toxicity
1824	pharmgkb	Drug Class	cannabinoids			Substance-Related Disorders	FAAH	P129T	1	46405089	C	A	Toxicity
1825	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP3A4	rs2740574	7	99784473	C	T	Toxicity
1826	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	RRM1	rs9937	11	4138227	A	G	Efficacy,Toxicity
1827	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C		ABCB1	S893A	7	87531302	A	Y	Dosage
1828	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation,Myasthenia Gravis	ABCB1	rs1128503	7	87550285	A	G	Dosage
1829	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	hypertensive nephrosclerosis	GRK4	V454A	4	3037423	T	S	Efficacy
1830	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOA1	rs2727786	11	116837807	C	G	Efficacy
1831	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	LPL	rs320	8	19961566	T	R	Efficacy
1832	pharmgkb	Drug Class	Thiazides, plain			Diabetes Mellitus	ACE	rs4341	17	63488629	G	C	Toxicity
1833	pharmgkb	Drug Class	Thiazides, plain				AGTR1	rs5186	3	148742201	A	C	Toxicity
1834	pharmgkb	Drug Class	Thiazides, plain			Diabetes Mellitus	GNB3	rs5443	12	6845711	C	T	Toxicity
1835	pharmgkb		antiepileptics,carbamazepine			Epilepsy	ABCB1	S893A	7	87531302	A	Y	Dosage,Efficacy
1836	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCB1	rs3789243	7	87591570	A	G	Efficacy
1837	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	PPARG	P12A	3	12351626	C	G	Toxicity
1838	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs36118214	19	41013401	G	W	Metabolism/PK
1839	pharmgkb		atorvastatin,simvastatin				CYP3A4	rs2740574	7	99784473	C	T	Dosage
1840	pharmgkb		ethambutol,isoniazid,pyrazinamide,rifampin			Tuberculosis	NAT2	rs4646244	8	18390208	T	A	Toxicity,Metabolism/PK
1841	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	PON1	rs705379	7	95324583	G	H	Efficacy
1842	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs1947275	4	61878827	T	C	Efficacy
1843	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs6813183	4	61903413	G	C	Efficacy
1844	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs1355368	4	61914104	A	K	Efficacy
1845	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	N693K	4	61935010	T	M	Efficacy
1846	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	NAT2	rs4271002	8	18390758	G	C	Toxicity
1847	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Stomach Neoplasms	IGFBP3	rs2854744	7	45921476	G	T	Efficacy
1848	pharmgkb	Drug	perindopril	107807	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	Coronary Artery Disease	AGTR1	rs275651	3	148697100	T	A	Efficacy
1849	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17					Efficacy,Metabolism/PK
1850	pharmgkb	Drug	perindopril	107807	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	Coronary Artery Disease	BDKRB1	rs12050217	14	96262416	A	G	Efficacy
1851	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	ABCB1	rs1128503	7	87550285	A	G	Toxicity
1852	pharmgkb	Drug	leflunomide	3899	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	Arthritis, Rheumatoid	ESR1	rs2234693	6	151842200	T	C	Efficacy
1853	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	TBXAS1	rs6962291	7	139971318	T	A	Toxicity
1854	pharmgkb	Drug Class	antipsychotics				LEPR	Q223R	1	65592830	A	G	Toxicity
1855	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	VEGFA	rs2010963	6	43770613	C	G	Efficacy
1856	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	NOS3	rs2070744	7	150992991	C	T	Efficacy
1857	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	NOS3	D298E	7	150999023	T	R	Efficacy
1858	pharmgkb	Prodrug	tegafur	5386			CYP2A6	rs8192725	19	40848807	A	G	Other
1859	pharmgkb	Prodrug	tegafur	5386			CYP2A6	rs28399433	19	40850474	A	B	Other
1860	pharmgkb	Prodrug	tegafur	5386			CYP2A6	L8V	19	40850405	G	A	Other
1861	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DRD2	rs1799978	11	113475629	T	C	Dosage
1862	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs3735451	7	99758352	T	C	Toxicity
1863	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs4646440	7	99763247	G	A	Toxicity
1864	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs4646437	7	99767460	G	A	Toxicity
1865	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP3A4	rs2246709	7	99768096	A	G	Toxicity
1866	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	OR52E2	N5S	11	5059614	T	C	Efficacy
1867	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	ASIC2	rs11869731	17	34011852	G	Y	Efficacy
1868	pharmgkb	Drug	somatropin recombinant				COL1A1	rs1800012	17	50200388	C	A	Dosage
1869	pharmgkb	Drug, Biological Intermediate	testosterone	6013	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C		UGT1A4	UGT1A4*1a, UGT1A4*3a					Metabolism/PK
1870	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2D6	T107N	22	42129770	G	W	Metabolism/PK
1871	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	SLC22A1	rs594709	6	160134722	G	A	Efficacy
1872	pharmgkb	Drug	bevacizumab				CFH	V62I	1	196673103	G	A	Efficacy
1873	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs6600879	4	69094669	C	G	Efficacy,Toxicity
1874	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs6600880	4	69094762	T	A	Efficacy,Toxicity
1875	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs4554144	4	69094837	C	T	Efficacy,Toxicity
1876	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs11940316	4	69095409	T	C	Efficacy,Toxicity
1877	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs7438135	4	69095621	G	A	Efficacy,Toxicity
1878	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs7662029	4	69096194	A	K	Efficacy,Toxicity
1879	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	Y268H	4	69098620	T	C	Efficacy,Toxicity
1880	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs4292394	4	69107231	C	G	Efficacy,Toxicity
1881	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs6600893	4	69113183	T	C	Efficacy,Toxicity
1882	pharmgkb	Drug	topotecan	60700	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O	Brain Neoplasms	ABCG2	rs4148157	4	88099782	G	A	Metabolism/PK
1883	pharmgkb	Metabolite	difluorodeoxyuridine			Neoplasms	CDA	rs4655226	1	20601791	C	T	Metabolism/PK
1884	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	CMPK1	rs1044457	1	47377105	C	T	Efficacy
1885	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	NT5C3A	rs3750117	7	33021334	A	G	Metabolism/PK
1886	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	SH2D5	rs10916852	1	20726200	G	T	Efficacy
1887	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	CMPK1	G8W	1	47333967	G	H	Efficacy
1888	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	TENT4A	rs274713	5	6723447	T	G	Efficacy
1889	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	CMPK1	Q80H	1	47368537	G	T	Efficacy
1890	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	DCTD	rs12507552	4	182892272	C	T	Efficacy
1891	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	TENT4A	rs274717	5	6720954	A	G	Efficacy
1892	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	CDC5L	rs992160	6	44386904	C	T	Efficacy
1893	pharmgkb	Drug	exemestane	60198	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C		AKR1C3	R258C	10	5102576	C	T	Metabolism/PK
1894	pharmgkb	Drug	exemestane	60198	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C		AKR1C4	G135E	10	5205791	G	M	Metabolism/PK
1895	pharmgkb	Drug Class	corticosteroids			Asthma	TAAR6	rs7772821	6	132571367	T	S	Efficacy
1896	pharmgkb		bufuralol,dextromethorphan				CYP2D6	R293Q	22	42127589	C	T	Metabolism/PK
1897	pharmgkb		bufuralol,dextromethorphan				CYP2D6	R440C	22	42126750	G	A	Metabolism/PK
1898	pharmgkb		bufuralol,dextromethorphan				CYP2D6	V342M	22	42127596	C	W	Metabolism/PK
1899	pharmgkb		bufuralol,dextromethorphan				CYP2D6	D336N	22	42127614	C	T	Metabolism/PK
1900	pharmgkb		carboplatin,paclitaxel			Carcinoma, Non-Small-Cell Lung	SLCO1B3	M233I	12	20862826	G	A	Toxicity
1901	pharmgkb		atazanavir,lopinavir,ritonavir,tenofovir				ABCC2	rs717620	10	99782821	C	T	Toxicity
1902	pharmgkb		bufuralol,dextromethorphan				CYP2D6	E164K	22	42128807	C	T	Metabolism/PK
1903	pharmgkb		carboplatin,paclitaxel			Lung Neoplasms	SLCO1B3	S112P	12	20858546	T	S	Toxicity
1904	pharmgkb		bufuralol,dextromethorphan				CYP2D6	F168S	22	42128794	A	G	Metabolism/PK
1905	pharmgkb		bufuralol,dextromethorphan				CYP2D6	R25Q	22	42130718	C	T	Metabolism/PK
1906	pharmgkb		cladribine,fluorouracil,gemcitabine				NT5C1A	L254P	1	39659467	A	G	Other
1907	pharmgkb		cladribine,fluorouracil,gemcitabine				NT5C1A	rs374150125	1	39663330	G	M	Other
1908	pharmgkb	Drug	dimethyl fumarate	637568	COC(=O)/C=C/C(=O)OC	Psoriasis	GSTP1	I105V	11	67585218	A	G	Efficacy
1909	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	COL1A1	rs1800012	17	50200388	C	A	Toxicity
1910	pharmgkb	Drug	ranibizumab			Macular Degeneration	NRP1	rs2070296	10	33263767	C	T	Efficacy
1911	pharmgkb	Drug	topiramate	5284627	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C		INSR	rs2396185	19	7246650	A	S	Efficacy
1912	pharmgkb		cladribine,fluorouracil,gemcitabine				NT5C1A	A214T	1	39661180	C	K	Other
1913	pharmgkb	Drug	asparaginase			Pancreatitis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	CPA2	rs199695765	7	130269008	C	T	Toxicity
1914	pharmgkb	Drug Class	antipsychotics			Schizophrenia	ABCB1	I1145M	7	87509329	A	K	Dosage
1915	pharmgkb	Drug	tolperisone	5511	CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2		CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*5					Metabolism/PK
1916	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP1A2	rs762551	15	74749576	C	A	Metabolism/PK
1917	pharmgkb	Drug Class	antipsychotics			Schizophrenia	ABCB1	S893A	7	87531302	A	Y	Dosage
1918	pharmgkb	Drug	phenobarbital	4763	CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2	Stevens-Johnson Syndrome	HLA-B	HLA-B*51:01					Toxicity
1919	pharmgkb	Metabolite	cotinine	854019	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	PSMA4	rs57064725	15	78540694	C	A	Metabolism/PK
1920	pharmgkb	Metabolite	cotinine	854019	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs7170068	15	78620601	G	M	Metabolism/PK
1921	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hyperglycemia	PRKCB	rs11649514	16	24175240	G	T	Toxicity
1922	pharmgkb	Drug	sulfinpyrazone	5342	C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4		UGT1A9	M33T	2	233672032	T	M	Metabolism/PK
1923	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	NR1I3	rs2307424	1	161232815	G	A	Metabolism/PK
1924	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	NR1I3	rs3003596	1	161234427	A	G	Metabolism/PK
1925	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	NR1I2	rs3814055	3	119781188	C	T	Metabolism/PK
1926	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	NR1I2	rs2461817	3	119805804	A	C	Metabolism/PK
1927	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	NR1I2	rs7643645	3	119806650	A	G	Metabolism/PK
1928	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	UGT2B7	R124S	4	69096892	A	K	Metabolism/PK
1929	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	rs4148740	7	87522787	A	G	Metabolism/PK
1930	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	rs4148739	7	87531733	T	C	Metabolism/PK
1931	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP3A4	rs2740574	7	99784473	C	T	Metabolism/PK
1932	pharmgkb		bupropion,Drugs used in nicotine dependence			Tobacco Use Disorder	CYP2A6	rs4803381	19	40851439	T	C	Efficacy
1933	pharmgkb	Drug Class	Dipeptidyl peptidase 4 (DPP-4) inhibitors			Diabetes Mellitus	CDKAL1	rs7756992	6	20679478	A	K	Efficacy
1934	pharmgkb		citalopram,escitalopram			Depressive Disorder	ERICH3	L1056V	1	74572544	A	C	Efficacy
1935	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Prostatic Neoplasms	VAC14	rs875858	16	70741552	C	W	Toxicity
1936	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	DPYD	rs12132152	1	97057448	G	M	Toxicity
1937	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	rs115632870	1	97828265	C	T	Other
1938	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	rs72728438	1	97382318	T	C	Other
1939	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Pancreatic Neoplasms	TYMS	rs2847153	18	661647	G	A	Efficacy
1940	pharmgkb	Drug	rivastigmine	77991	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	Alzheimer Disease,Lewy Body Disease	BCHE	A567T	3	165773492	C	T	Efficacy
1941	pharmgkb	Drug	donepezil	3152	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	Alzheimer Disease	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6					Other
1942	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Essential hypertension	CYP2C9	I359L	10	94981296	A	S	Efficacy,Metabolism/PK
1943	pharmgkb	Drug	rivastigmine	77991	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	Alzheimer Disease	ACHE	rs2571598	7	100892018	C	K	Efficacy
1944	pharmgkb	Drug	ritonavir	392622	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	HIV Infections	ABCB1	S893A	7	87531302	A	Y	Metabolism/PK
1945	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5		CYP2C9	L90P	10	94941958	T	C	Metabolism/PK
1946	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GRM3	rs274622	7	86643624	C	T	Other
1947	pharmgkb		cyclophosphamide,cytarabine,daunorubicin,mercaptopurine,methotrexate,prednisone,vincristine			Precursor Cell Lymphoblastic Leukemia-Lymphoma	DROSHA	rs639174	5	31433540	C	T	Toxicity
1948	pharmgkb		anastrozole,exemestane			Breast Neoplasms	MAP4K4	rs4550690	2	101806532	T	C	Toxicity
1949	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT1A9	rs3832043	2	233671808	T	-	Other
1950	pharmgkb	Drug Class	antineoplastic agents			Breast Neoplasms	RBFOX1	rs6500843	16	6820854	A	K	Efficacy
1951	pharmgkb	Drug	enalapril	5362032	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Hypertension	VEGFA	rs699947	6	43768652	A	Y	Efficacy
1952	pharmgkb		bevacizumab,capecitabine,oxaliplatin			Colorectal Neoplasms	MGAT4A	rs885036	2	98688331	A	G	Efficacy
1953	pharmgkb		bevacizumab,capecitabine,cetuximab,oxaliplatin			Colorectal Neoplasms	MGAT4A	rs885036	2	98688331	A	G	Efficacy
1954	pharmgkb		citalopram,escitalopram			Depressive Disorder	ERICH3	rs696692	1	74591902	T	M	Efficacy
1955	pharmgkb	Drug	brivaracetam	9837243	CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Metabolism/PK
1956	pharmgkb		succinylcholine,volatile anesthetics			Malignant Hyperthermia	RYR1	A612P	19	38457539	G	A	Toxicity
1957	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	ABCC2	rs717620	10	99782821	C	T	Efficacy
1958	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colonic Neoplasms	NR1I2	rs10934498	3	119785534	G	H	Metabolism/PK
1959	pharmgkb	Drug	vitamin e	14985	CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O		CYP4F2	W12G	19	15897578	A	C	Metabolism/PK
1960	pharmgkb		cisplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung	CMPK1	rs4492666	1	47335173	A	C	Efficacy
1961	pharmgkb		cisplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung	RRM1	rs2284449	11	4099619	T	C	Efficacy
1962	pharmgkb		cisplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung	RRM1	rs720106	11	4118748	T	C	Efficacy
1963	pharmgkb		cisplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung	RRM1	rs232043	11	4117895	G	A	Efficacy
1964	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	Kidney Transplantation	UGT1A9	rs3832043	2	233671808	T	-	Metabolism/PK
1965	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I2	rs3732360	3	119817734	C	K	Toxicity
1966	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Nasopharyngeal Neoplasms	RXRA	rs62576288	9	134324891	G	A	Toxicity
1967	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Nasopharyngeal Neoplasms	RXRA	rs1536475	9	134429310	A	G	Toxicity
1968	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCC2	rs4148386	10	99788711	G	A	Metabolism/PK
1969	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms	LRP2	A2872T	2	169196995	C	D	Toxicity
1970	pharmgkb	Drug	busulfan	2478	CS(=O)(=O)OCCCCOS(=O)(=O)C	Transplantation	GSTA1	rs3957357	6	52803889	A	G	Metabolism/PK
1971	pharmgkb	Drug Class	calcium channel blockers			Hypertension	NUMA1	rs10898815	11	72028377	G	A	Efficacy
1972	pharmgkb	Drug Class	calcium channel blockers			Hypertension	PICALM	rs588076	11	85980619	G	M	Efficacy
1973	pharmgkb	Drug Class	hmg coa reductase inhibitors			Schizophrenia	SREBF1	rs11868035	17	17811787	G	A	Toxicity
1974	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C		SLCO1B1	P155T	12	21176879	C	W	Metabolism/PK
1975	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C		SLCO1B1	N130H	12	21176804	A	K	Metabolism/PK
1976	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	HNF4A	rs2273618	20	44423930	T	C	Toxicity
1977	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	HNF4A	rs3746574	20	44429378	T	C	Toxicity
1978	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	RXRA	rs6413517	9	134429410	T	G	Toxicity
1979	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	HNF4A	rs6130615	20	44430797	C	T	Toxicity
1980	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I3	rs9725457	1	161231784	G	A	Toxicity
1981	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I3	rs2502815	1	161233437	G	A	Toxicity
1982	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I3	rs2501873	1	161234748	C	T	Toxicity
1983	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I3	rs10538494					Toxicity
1984	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Nasopharyngeal Neoplasms,Neutropenia	NR1I3	rs75114882	1	161237587	A	K	Toxicity
1985	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I2	rs3732359	3	119817582	G	A	Toxicity
1986	pharmgkb	Drug	indinavir	5362440	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	HIV Infections	CYP3A4	rs2740574	7	99784473	C	T	Other
1987	pharmgkb		lansoprazole,tacrolimus			Gastroesophageal Reflux,Transplantation	ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
1988	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Drug Toxicity,Neurotoxicity Syndromes	CYP2C8	R139K	10	95067273	C	W	Toxicity
1989	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	SLC22A1	rs622342	6	160151834	C	A	Efficacy
1990	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	NR1I2	rs3814058	3	119818444	T	C	Toxicity
1991	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	RGS4	rs2661319	1	163069987	T	C	Efficacy
1992	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms	RXRA	rs2234753	9	134401915	G	A	Toxicity
1993	pharmgkb	Drug	sulfasalazine	5359476	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O		ABCG2	rs72552713	4	88131805	G	A	Metabolism/PK
1994	pharmgkb		cytarabine,daunorubicin,etoposide,mitoxantrone			Leukemia, Myeloid, Acute	SLCO1B1	rs2291075	12	21178691	C	T	Efficacy
1995	pharmgkb		cytarabine,daunorubicin,etoposide,mitoxantrone			Leukemia, Myeloid, Acute	SLCO1B1	rs2291075	12	21178691	C	T	Efficacy
1996	pharmgkb		doxorubicin,doxorubicinol			Breast Neoplasms	SLC22A16	H49R	6	110456925	T	C	Other
1997	pharmgkb	Drug	cytarabine	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia,Lymphoma	CDA	K27Q	1	20589208	A	C	Toxicity
1998	pharmgkb	Drug Class	opioids			Pain	COMT	V158M	22	19963748	G	A	Other
1999	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	DRD2	rs1799732	11	113475530	-	R	Toxicity
2000	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	HTR2A	H452Y	13	46834899	G	A	Efficacy
2001	pharmgkb		alemtuzumab,chlorambucil,cyclophosphamide,fludarabine,prednisone,rituximab,vincristine			Leukemia, Lymphocytic, Chronic, B-Cell	CXCL12	rs1801157	10	44372809	C	T	Efficacy
2002	pharmgkb	Drug Class	Photodynamic therapy			Choroidal Neovascularization	F13A1	V35L	6	6318562	C	W	Efficacy
2003	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	SLCO1B3	S112P	12	20858546	T	S	Dosage,Toxicity
2004	pharmgkb	Drug Class	interferons			Carcinoma, Renal Cell	STAT3	rs4796793	17	42390192	G	C	Efficacy
2005	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	PICK1	rs713729	22	38059462	T	A	Other
2006	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CTLA4	T17S	2	203867991	A	K	Toxicity
2007	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	FHIT	rs49411	3	59771849	T	C	Efficacy
2008	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	MTRF1L	rs766127	6	152992697	G	W	Efficacy
2009	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	RGS17	rs672170	6	153024050	A	G	Efficacy
2010	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	PON2	rs2299267	7	95432609	A	G	Efficacy
2011	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CTNNA3	rs10997242	10	66576537	T	C	Efficacy
2012	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CACNA1A	rs2112460	19	13479598	G	A	Efficacy
2013	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DRD1	rs4532	5	175443147	C	T	Other
2014	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DRD1	rs686	5	175441697	G	H	Other
2015	pharmgkb	Drug	adalimumab			Crohn Disease	HFE	rs2071303	6	26091108	T	C	Efficacy
2016	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Vascular Diseases	LDLR	rs1433099	19	11131982	T	M	Efficacy
2017	pharmgkb	Drug	adalimumab			Crohn Disease	TF	L247M	3	133756878	C	T	Efficacy
2018	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Vascular Diseases	LDLR	rs2738466	19	11132089	A	G	Efficacy
2019	pharmgkb	Drug	dexamethasone	5743	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SERPINE1	A15T	7	101128436	G	A	Toxicity
2020	pharmgkb	Drug	ticagrelor	9871419	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	UGT2B7	L46P	4	69096657	T	C	Metabolism/PK
2021	pharmgkb	Drug	ticagrelor	9871419	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	CYP3A4	G56D	7	99778079	C	T	Metabolism/PK
2022	pharmgkb	Drug	ticagrelor	9871419	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
2023	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2		TPMT	rs12201199	6	18139571	A	T	Other
2024	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2		TPMT	rs17839843	6	18143623	G	A	Other
2025	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2		TPMT	rs3931660	6	18148874	A	T	Other
2026	pharmgkb		chlorpromazine,clozapine,haloperidol,olanzapine,quetiapine,risperidone,trifluoperazine			Schizophrenia	EPM2A	rs1415744	6	145701395	T	C	Efficacy
2027	pharmgkb	Drug	adalimumab				CRP	rs1130864	1	159713301	G	A	Efficacy
2028	pharmgkb	Drug	adalimumab			Inflammatory Bowel Diseases	ATG5	rs510432	6	106326155	T	C	Efficacy
2029	pharmgkb	Drug	rasagiline	3052776	C#CCN[C@@H]1CCC2=CC=CC=C12	Parkinson Disease	DRD2	rs1076560	11	113412966	C	A	Efficacy
2030	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	CERS6	rs13393173	2	168532581	G	A	Efficacy
2031	pharmgkb	Drug	rasagiline	3052776	C#CCN[C@@H]1CCC2=CC=CC=C12	Parkinson Disease	DRD2	rs2283265	11	113414814	C	A	Efficacy
2032	pharmgkb	Drug	telaprevir	3010818	CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5	Hepatitis C	CYP24A1	rs2585428	20	54170358	C	T	Metabolism/PK
2033	pharmgkb		sitagliptin,vildagliptin			Diabetes Mellitus, Type 2	GLP1R	G168S	6	39066296	G	M	Efficacy
2034	pharmgkb	Drug	bisoprolol	2405	CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O	Hypertension	ACY3	rs2514036	11	67647583	C	T	Efficacy
2035	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Hypertension	NPHS1	rs3814995	19	35851310	C	K	Efficacy
2036	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	Organ Transplantation	ABCC2	I1324M	10	99844450	C	K	Metabolism/PK
2037	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	Kidney Transplantation	SLCO1B1	N130H	12	21176804	A	K	Metabolism/PK
2038	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	NCOA1	P1272S	2	24752089	C	T	Toxicity
2039	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	LRMDA	rs10509373	10	76397814	T	C	Efficacy
2040	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	GALR1	rs2717162	18	77256371	T	C	Efficacy
2041	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	GALR1	rs2717162	18	77256371	T	C	Efficacy
2042	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	Pain	ABCB1	rs1128503	7	87550285	A	G	Toxicity
2043	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	DOT1L	rs2269879	19	2194897	T	C	Efficacy
2044	pharmgkb	Drug	midazolam	4192	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		VDR	rs1544410	12	47846052	C	D	Metabolism/PK
2045	pharmgkb	Drug	midazolam	4192	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		VDR	rs4516035	12	47906043	T	C	Metabolism/PK
2046	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRM2	rs324650	7	137008914	T	A	Other
2047	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ARID5B	rs10994982	10	61950345	A	G	Metabolism/PK
2048	pharmgkb	Drug	dabigatran			Atrial Fibrillation	ABCB1	rs4148738	7	87533733	C	T	Metabolism/PK
2049	pharmgkb	Drug	dabigatran			Atrial Fibrillation	CES1	rs2244613	16	55810697	G	W	Toxicity
2050	pharmgkb	Drug	dabigatran			Atrial Fibrillation	CES1	rs8192935	16	55827882	A	G	Metabolism/PK
2051	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	SLC6A12	C10R	12	209959	A	G	Toxicity
2052	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Organ Transplantation	IMPDH1	rs2228075	7	128394575	C	D	Toxicity
2053	pharmgkb		amantadine,Anticholinergics,Dopamine agonists,levodopa,selegiline			Parkinson Disease	SLC22A1	rs622342	6	160151834	C	A	Dosage,Toxicity
2054	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOB	P2739Q	2	21008652	G	W	Efficacy
2055	pharmgkb	Metabolite	cotinine	854019	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	D398N	15	78590583	G	A	Metabolism/PK
2056	pharmgkb	Drug Class	Opium alkaloids and derivatives			Pain	CHRNA5	D398N	15	78590583	G	A	Toxicity
2057	pharmgkb		nicotine,Opium alkaloids and derivatives			Pain,Tobacco Use Disorder	CHRNA5	rs660652	15	78595490	A	K	Toxicity
2058	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB2	rs2072660	1	154576245	T	S	Toxicity
2059	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	SLC29A1	rs760370	6	44233216	A	G	Efficacy
2060	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB2	rs2072658	1	154567749	G	A	Other
2061	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs2229959	20	63350202	C	W	Other
2062	pharmgkb	Drug	stavudine	18283	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO	HIV Infections	TNF	rs1799964	6	31574531	T	C	Toxicity
2063	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs3813567	15	78642209	G	A	Toxicity
2064	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs3743078	15	78602417	C	R	Toxicity
2065	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs637137	15	78581634	T	A	Toxicity
2066	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs684513	15	78566058	C	K	Toxicity
2067	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP1A2	rs2470890	15	74755085	T	C	Metabolism/PK
2068	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP1A1	rs2606345	15	74724835	C	A	Metabolism/PK
2069	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP1A2	rs762551	15	74749576	C	A	Metabolism/PK
2070	pharmgkb		berberine,coptisine				CYP2D6	CYP2D6*1, CYP2D6*10					Metabolism/PK
2071	pharmgkb		amiodarone,Antibiotics,antipsychotics,diuretics,quinidine,sotalol				KCNE1	D85N	21	34449382	C	T	Toxicity
2072	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	HIV Infections	DRD3	G9S	3	114171968	C	T	Toxicity
2073	pharmgkb		fluoxetine,sertraline			Depressive Disorder	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
2074	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL3	rs4803219	19	39245279	C	T	Efficacy
2075	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic,HIV Infections	IFNL3	rs28416813	19	39245004	C	G	Efficacy
2076	pharmgkb		bumetanide,furosemide,torasemide				GNB3	rs5443	12	6845711	C	T	Efficacy
2077	pharmgkb		bumetanide,furosemide,torasemide				ADD1	G460W	4	2904980	G	W	Efficacy
2078	pharmgkb		fluorouracil,leucovorin,oxaliplatin			Colonic Neoplasms	ABCC2	rs717620	10	99782821	C	T	Toxicity
2079	pharmgkb		fluorouracil,leucovorin,oxaliplatin			Colorectal Neoplasms	ABCC2	rs717620	10	99782821	C	T	Toxicity
2080	pharmgkb		carboplatin,cisplatin			Carcinoma, Non-Small-Cell Lung	PIK3CA	rs2699887	3	179148620	C	T	Toxicity
2081	pharmgkb		carboplatin,cisplatin			Carcinoma, Non-Small-Cell Lung	PTEN	rs2299939	10	87897393	C	W	Toxicity
2082	pharmgkb		bleomycin,dacarbazine,doxorubicin,vinblastine				GSTM1	GSTM1 non-null, GSTM1 null					Efficacy,Toxicity
2083	pharmgkb		irinotecan,oxaliplatin,tegafur / gimeracil / oteracil			Colorectal Neoplasms	UGT1A7	UGT1A7*3					Toxicity
2084	pharmgkb		irinotecan,oxaliplatin,tegafur / gimeracil / oteracil			Colorectal Neoplasms	UGT1A6	UGT1A6*2a					Toxicity
2085	pharmgkb		peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	CYP27B1	rs10877012	12	57768302	G	Y	Efficacy
2086	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C,HIV Infections	IFNL3	rs4803217	19	39243580	C	A	Efficacy
2087	pharmgkb		docetaxel,epirubicin			Breast Neoplasms	MDM4	rs1563828	1	204547449	A	K	Efficacy
2088	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms	CYP1B1	L432V	2	38071060	G	C	Efficacy
2089	pharmgkb		bevacizumab,fluorouracil,irinotecan,leucovorin			Colorectal Neoplasms	RGS5	rs1056515	1	163143470	G	T	Efficacy
2090	pharmgkb		cyclophosphamide,docetaxel			Prostatic Neoplasms	VEGFA	rs1570360	6	43770093	A	G	Efficacy
2091	pharmgkb		peginterferon alfa-2b,protease inhibitors,ribavirin			Hepatitis C	SLC28A2	P22L	15	45253280	C	T	Toxicity
2092	pharmgkb		doxorubicin,methotrexate,prednisolone,vincristine			Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	S400N	7	87550493	C	W	Efficacy
2093	pharmgkb		cyclophosphamide,epirubicin,paclitaxel			Breast Neoplasms	CYP1B1	L432V	2	38071060	G	C	Toxicity
2094	pharmgkb		bleomycin,cyclophosphamide,doxorubicin,prednisone,rituximab,vincristine,vindesine			Lymphoma, Non-Hodgkin	ABCB1	S400N	7	87550493	C	W	Toxicity
2095	pharmgkb		interferons,ribavirin			Hepatitis C, Chronic	IL18	rs1946518	11	112164735	T	G	Efficacy
2096	pharmgkb		interferons,ribavirin			Hepatitis C, Chronic	IL18	rs187238	11	112164265	C	R	Efficacy
2097	pharmgkb		mercaptopurine,methotrexate			Precursor Cell Lymphoblastic Leukemia-Lymphoma	PACSIN2	rs2413739	22	43001030	C	T	Toxicity
2098	pharmgkb		peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Toxicity
2099	pharmgkb		peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IL6	rs1800795	7	22727026	C	G	Toxicity
2100	pharmgkb		cisplatin,fluorouracil,mitoxantrone			Carcinoma, Hepatocellular	GALNT14	rs12613732	2	31026561	T	R	Efficacy
2101	pharmgkb		mercaptopurine,methotrexate			Precursor Cell Lymphoblastic Leukemia-Lymphoma	FOLH1	H460Y	11	49164722	G	A	Toxicity
2102	pharmgkb		Antivirals for treatment of HIV infections, combinations,Drugs For Treatment Of Tuberculosis			HIV Infections,Tuberculosis	CYP2B6	Q172H	19	41006936	G	W	Toxicity
2103	pharmgkb		Antivirals for treatment of HIV infections, combinations,Drugs For Treatment Of Tuberculosis			HIV Infections,Tuberculosis	ABCB1	I1145M	7	87509329	A	K	Toxicity
2104	pharmgkb		cyclosporine,dicloxacillin			Cystic Fibrosis	ABCB1	S893A	7	87531302	A	Y	Metabolism/PK
2105	pharmgkb		cyclophosphamide,fluorouracil,methotrexate			Breast Neoplasms	FGFR4	G388R	5	177093242	G	A	Efficacy
2106	pharmgkb	Drug Class	Dihydropyridine derivatives				NOS1AP	rs10494366	1	162115895	G	T	Toxicity
2107	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CHRNA3	rs1051730	15	78601997	G	A	Other
2108	pharmgkb		capecitabine,oxaliplatin			Colorectal Neoplasms	PTGS2	rs5275	1	186673926	A	K	Efficacy
2109	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	GNB3	rs5443	12	6845711	C	T	Toxicity
2110	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Psychotic Disorders	ESR1	rs2234693	6	151842200	T	C	Toxicity
2111	pharmgkb	Drug	amphetamine	3007	C[C@@H](CC1=CC=CC=C1)N		DRD2	rs12364283	11	113476233	A	G	Other
2112	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	GRIN3A	rs11788456	9	101585868	G	A	Other
2113	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	KCNJ6	rs2070995	21	37714662	T	C	Other
2114	pharmgkb	Drug Class	Analgesics			Pain	KCNJ6	rs2070995	21	37714662	T	C	Efficacy
2115	pharmgkb	Drug	flucloxacillin	21319	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	Toxic liver disease	NR1I2	rs3814055	3	119781188	C	T	Toxicity
2116	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	NOS1AP	rs10494366	1	162115895	G	T	Efficacy
2117	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CHRNA3	rs578776	15	78596058	G	A	Other
2118	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CHRNA5	rs615470	15	78593646	T	C	Other
2119	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CHRNA5	rs684513	15	78566058	C	K	Other
2120	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	IGF2BP2	rs4402960	3	185793899	G	T	Efficacy
2121	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	IGF2BP2	rs1470579	3	185811292	A	C	Efficacy
2122	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	SLC6A3	rs2975226	5	1445501	A	T	Efficacy
2123	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Coronary Disease	CRP	rs1205	1	159712443	C	T	Efficacy
2124	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	DRD2	rs1125394	11	113426463	T	C	Other
2125	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Bipolar Disorder,Depression	DRD2	rs6279	11	113410351	G	C	Other
2126	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Bipolar Disorder,Depression	DRD2	rs6275	11	113412755	A	G	Other
2127	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic,HIV Infections	LDLR	rs14158	19	11131368	G	A	Efficacy
2128	pharmgkb	Drug	ritonavir	392622	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	HIV Infections,Hyperlipidemias	APOC3	rs2854116	11	116829453	C	T	Toxicity
2129	pharmgkb	Drug	ritonavir	392622	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	HIV Infections,Hyperlipidemias	APOC3	rs2854117	11	116829426	T	M	Toxicity
2130	pharmgkb		capecitabine,oxaliplatin			Colorectal Neoplasms	VEGFA	rs2010963	6	43770613	C	G	Efficacy
2131	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		ABCB1	S893A	7	87531302	A	Y	Toxicity
2132	pharmgkb		antidepressants,citalopram			Depression	CREB1	rs7569963	2	207608460	G	A	Efficacy,Toxicity
2133	pharmgkb		doxorubicin,doxorubicinol			Breast Neoplasms	CBR1	rs20572	21	36072675	C	T	Metabolism/PK
2134	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Breast Neoplasms	CBR1	rs9024	21	36073015	G	A	Dosage,Metabolism/PK
2135	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N		HSPA1A	I74M	6	31815978	T	S	Toxicity
2136	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		CYP2C9	rs71486745	10	94936019	GT	-	Dosage
2137	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL3	rs12980275	19	39241143	A	G	Efficacy
2138	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Pancreatic Neoplasms	ESR2	rs944050	14	64233327	T	C	Efficacy
2139	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		ABCG2	rs2199939	8	40053975	C	T	Efficacy
2140	pharmgkb	Drug	perindopril	107807	CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O	Coronary Artery Disease	AGTR1	rs5182	3	148741608	C	T	Efficacy
2141	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	Diabetes Mellitus, Type 2	KCNJ11	K23Q	11	17388025	T	M	Efficacy
2142	pharmgkb		bumetanide,furosemide,torasemide				SLC12A3	G263A	16	56870675	C	G	Efficacy
2143	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CAPN10	rs5030952	2	240603286	C	K	Toxicity
2144	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CCL2	rs4795893	17	34247429	G	A	Efficacy
2145	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,simeprevir			Hepatitis C	IFNL3	rs8099917	19	39252525	T	G	Efficacy
2146	pharmgkb		atorvastatin,Bisphosphonates			Coronary Disease,Osteoporosis	FDPS	rs11264359	1	155313038	A	G	Efficacy
2147	pharmgkb	Drug	alendronate	2088	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN	Bone Diseases	MVK	rs10161126	12	109604543	A	G	Efficacy
2148	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	ERCC1	Q506K	19	45409478	C	D	Toxicity
2149	pharmgkb	Drug Class	antipsychotics			Schizophrenia	IL1B	rs4849127	2	112844982	A	G	Toxicity
2150	pharmgkb		interferon beta-1a,interferon beta-1b			Multiple Sclerosis	ZNF697	rs10494227	1	119594822	A	G	Efficacy
2151	pharmgkb		interferon beta-1a,interferon beta-1b			Multiple Sclerosis	GAPVD1	rs2291858	9	125366503	A	G	Efficacy
2152	pharmgkb		interferon beta-1a,interferon beta-1b			Multiple Sclerosis	GAPVD1	rs10760397	9	125370928	T	C	Efficacy
2153	pharmgkb		anastrozole,exemestane			Breast Neoplasms	TUBB1	rs10485828	20	59025600	G	C	Other
2154	pharmgkb		atazanavir,ritonavir			HIV Infections,nephrolithiasis	UGT1A1	rs1042640	2	233772898	G	H	Toxicity
2155	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	aspirin-induced asthma,Asthma	ZBTB22	T310A	6	33315989	T	C	Toxicity
2156	pharmgkb		carboplatin,taxanes			Ovarian Neoplasms	VEGFA	rs6900017	6	43790748	C	T	Toxicity
2157	pharmgkb		carboplatin,taxanes			Ovarian Neoplasms	VEGFA	rs9369421	6	43794385	T	C	Efficacy
2158	pharmgkb		carboplatin,taxanes			Ovarian Neoplasms	VEGFA	rs879825	6	43796077	A	G	Toxicity
2159	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b			Hepatitis C, Chronic	CXCL10	rs56061981	4	76023632	C	T	Efficacy
2160	pharmgkb		carboplatin,lonafarnib,paclitaxel			Ovarian Neoplasms	FNTB	rs11623866	14	64986345	G	C	Efficacy
2161	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Lupus erythematosus	CYP2B6	rs7254579	19	40988986	T	C	Metabolism/PK
2162	pharmgkb	Metabolite	cotinine	854019	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs10851907	15	78623522	G	A	Metabolism/PK
2163	pharmgkb		atazanavir,ritonavir			HIV Infections,Hyperbilirubinemia	UGT1A7	rs7586110	2	233681881	T	R	Toxicity
2164	pharmgkb		atazanavir,ritonavir			HIV Infections,Hyperbilirubinemia	UGT1A7	N129K	2	233682324	T	R	Toxicity
2165	pharmgkb		atazanavir,ritonavir			HIV Infections,Hyperbilirubinemia	UGT1A7	R131G	2	233682328	C	D	Toxicity
2166	pharmgkb		atazanavir,ritonavir			HIV Infections,Hyperbilirubinemia	UGT1A3	rs3806596	2	233729061	T	C	Toxicity
2167	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Anemia,Nasopharyngeal Neoplasms,Neutropenia	RXRA	rs11185647	9	134323982	G	A	Toxicity
2168	pharmgkb		cyclophosphamide,cytarabine,daunorubicin,dexamethasone,doxorubicin,methotrexate,pegaspargase,prednisone,thioguanine,vincristine			Osteonecrosis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	DOK5	rs117532069	20	54684529	G	A	Toxicity
2169	pharmgkb		cyclophosphamide,cytarabine,daunorubicin,dexamethasone,doxorubicin,methotrexate,pegaspargase,prednisone,thioguanine,vincristine			Osteonecrosis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	BMP7	rs79085477	20	57126159	C	T	Toxicity
2170	pharmgkb		cyclophosphamide,cytarabine,daunorubicin,dexamethasone,doxorubicin,methotrexate,pegaspargase,prednisone,thioguanine,vincristine			Osteonecrosis,Precursor Cell Lymphoblastic Leukemia-Lymphoma	LINC00251	rs141059755	8	65195370	A	G	Toxicity
2171	pharmgkb	Drug	letrozole	3902	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms	ESR2	rs10140457	14	64249975	A	C	Toxicity
2172	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	HNF4A	rs1884613	20	44351775	C	D	Metabolism/PK
2173	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs7091672	10	118836909	T	V	Toxicity
2174	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs4752219	10	118856049	C	T	Toxicity
2175	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs4752220	10	118856097	A	G	Toxicity
2176	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs1409314	10	118856240	A	K	Toxicity
2177	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	EIF3A	rs10510050	10	118867050	A	G	Toxicity
2178	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	RAPGEF5	rs16873129	7	22105466	T	C	Efficacy
2179	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	CRH	rs4737771	8	66280144	T	C	Efficacy
2180	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	PARP11	rs2532560	12	4052705	G	A	Efficacy
2181	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	NBEA	rs9315310	13	34777294	T	M	Efficacy
2182	pharmgkb	Drug	ticagrelor	9871419	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	CYP3A43	rs62471956	7	99823462	G	A	Metabolism/PK
2183	pharmgkb	Drug	ticagrelor	9871419	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO	Acute coronary syndrome	SLCO1B1	rs113681054	12	21250045	T	C	Metabolism/PK
2184	pharmgkb		antipsychotics,aripiprazole,risperidone			Schizophrenia	ANKK1	E713K	11	113400106	G	A	Efficacy
2185	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs2869950	4	88821613	C	W	Toxicity
2186	pharmgkb	Drug	busulfan	2478	CS(=O)(=O)OCCCCOS(=O)(=O)C	Leukemia, Myeloid, Acute	GSTM1	rs3754446	1	109710619	A	C	Metabolism/PK
2187	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	ARRB2	rs4790694	17	4723059	A	C	Toxicity
2188	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	PMCH	rs7973796	12	102202345	G	A	Toxicity
2189	pharmgkb		anastrozole,exemestane,letrozole			Breast Neoplasms	CYP19A1	rs6493497	15	51338638	G	A	Efficacy
2190	pharmgkb	Drug	exemestane	60198	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	Breast Neoplasms	CYP19A1	rs7176005	15	51339082	C	T	Toxicity
2191	pharmgkb	Drug Class	antipsychotics			Schizophrenia	INSIG2	rs17587100	2	118080834	A	C	Toxicity
2192	pharmgkb	Drug	midazolam	4192	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		VDR	rs11568820	12	47908762	C	T	Metabolism/PK
2193	pharmgkb	Drug	asparaginase			Precursor Cell Lymphoblastic Leukemia-Lymphoma	GRIA1	rs4958381	5	154651307	T	C	Toxicity
2194	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Prostatic Neoplasms	PTGS2	rs12042763	1	186682744	G	H	Efficacy
2195	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL3	rs7248668	19	39253181	G	A	Efficacy
2196	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL3	rs8105790	19	39241861	T	C	Efficacy
2197	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CHRNA5	D398N	15	78590583	G	A	Other
2198	pharmgkb	Drug	aripiprazole	60795	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Schizophrenia	TAAR6	rs4305746	6	132572626	G	A	Efficacy
2199	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Asthma	ADORA1	rs16851030	1	203166324	C	T	Toxicity
2200	pharmgkb		cyclosporine,mycophenolate mofetil			Kidney Transplantation	TNF	rs1800629	6	31575254	G	A	Efficacy
2201	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	rs12721646	19	41009202	C	K	Other
2202	pharmgkb	Drug	triamcinolone	31307	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O	Retinal Diseases	HCG22	rs3873352	6	31054336	C	D	Toxicity
2203	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder, Major	DRD2	rs4460839	11	113451074	C	T	Efficacy
2204	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		TGFB1	rs1800469	19	41354391	A	G	Toxicity
2205	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC2	rs7917432	10	68399112	T	C	Toxicity
2206	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	OCRL	rs757639	7	34111163	T	C	Toxicity
2207	pharmgkb		peginterferon alfa-2a,ribavirin			Hepatitis C	ITPA	rs6051702	20	3271278	A	C	Toxicity
2208	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Psychotic Disorders	CYP1A1	rs2472297	15	74735539	C	T	Metabolism/PK
2209	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	IL1A	rs11677416	2	112771663	T	C	Efficacy
2210	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	LTC4S	rs730012	5	179793637	A	Y	Efficacy
2211	pharmgkb	Drug	triamcinolone	31307	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O	Retinal Diseases	HCG22	rs2523864	6	31050769	C	T	Toxicity
2212	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	UGT1A6	R184S	2	233693556	A	C	Dosage
2213	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Myocardial Infarction	CYP3A5	rs776746	7	99672916	T	C	Efficacy
2214	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Hypersensitivity	LTA	rs1800629	6	31575254	G	A	Toxicity
2215	pharmgkb	Drug	leflunomide	3899	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	Arthritis, Rheumatoid	DHODH	rs3213422	16	72008783	A	C	Efficacy
2216	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	PON1	rs854547	7	95294544	G	H	Efficacy
2217	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	PON1	rs854548	7	95296508	A	G	Efficacy
2218	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	PON1	rs854555	7	95301079	A	C	Efficacy
2219	pharmgkb		azathioprine,purine analogues			Lupus Erythematosus, Systemic	ITPA	P32T	20	3213196	C	R	Efficacy
2220	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs9934438	16	31093557	G	M	Efficacy
2221	pharmgkb	Drug	erythromycin	12560	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	Neoplasms	CYP3A4	rs35599367	7	99768693	G	A	Other
2222	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTHFR	E429A	1	11794419	T	G	Efficacy
2223	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	HSPA1L	T493M	6	31810495	G	H	Toxicity
2224	pharmgkb	Drug Class	selective beta-2-adrenoreceptor agonists			Asthma	ARG1	rs2781659	6	131570680	A	G	Efficacy
2225	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	COMT	rs165599	22	19969258	G	A	Efficacy
2226	pharmgkb		cisplatin,cyclophosphamide			Anemia,Ovarian Neoplasms	GSTA1	rs3957357	6	52803889	A	G	Toxicity
2227	pharmgkb		cisplatin,irinotecan			Carcinoma, Non-Small-Cell Lung	UBE2I	rs9597	16	1324950	C	K	Efficacy
2228	pharmgkb	Drug	abacavir	441300	C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N	Drug Hypersensitivity	LST1	rs3093726	6	31579012	T	C	Toxicity
2229	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Anxiety Disorders,Depressive Disorder, Major	HTR1B	rs6296	6	77462543	C	G	Toxicity
2230	pharmgkb	Drug	latanoprost	5282380	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	Glaucoma, Open-Angle	PTGFR	rs3766355	1	78491756	C	W	Efficacy
2231	pharmgkb		cyclophosphamide,docetaxel,doxorubicin,epirubicin,fluorouracil			Breast Neoplasms	SLCO1B1	V174A	12	21178615	T	C	Toxicity
2232	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	UGT1A4	L48M	2	233718962	T	R	Metabolism/PK
2233	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	CD69	rs11052877	12	9753094	A	G	Efficacy
2234	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	GALNT18	rs4910008	11	11458319	C	T	Efficacy
2235	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Urinary Bladder Neoplasms	CSNK2A3	rs7937567	11	11354027	G	A	Efficacy
2236	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Urinary Bladder Neoplasms	MLLT3	rs10964552	9	20405632	C	A	Efficacy
2237	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Urinary Bladder Neoplasms	RARS	rs244898	5	168491921	T	M	Efficacy
2238	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	CYCSP5	rs9469003	6	31440051	T	C	Toxicity
2239	pharmgkb		carboplatin,taxanes				VEGFA	rs9369421	6	43794385	T	C	Toxicity
2240	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Atrial Fibrillation	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Dosage
2241	pharmgkb	Drug	zafirlukast	5717	CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC		CYP2C9	CYP2C9*1, CYP2C9*3, CYP2C9*13					Metabolism/PK
2242	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	ITIH3	rs2535629	3	52799203	G	M	Efficacy
2243	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Hematologic Neoplasms	ADORA2A	rs2298383	22	24429543	C	W	Toxicity
2244	pharmgkb	Drug	valganciclovir	64147	CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N	Kidney Transplantation	ABCC4	G187W	13	95210754	C	A	Toxicity
2245	pharmgkb	Drug	valganciclovir	64147	CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N	Kidney Transplantation	ABCB1	S400N	7	87550493	C	W	Toxicity
2246	pharmgkb		axitinib,sorafenib				HIF1A	P582S	14	61740839	C	T	Efficacy
2247	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	CYP3A5	rs776746	7	99672916	T	C	Metabolism/PK
2248	pharmgkb	Drug	dalcetrapib	6918540	CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C	Acute coronary syndrome	ADCY9	rs1967309	16	4015582	A	G	Efficacy,Toxicity
2249	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	KDR	Q472H	4	55106807	T	A	Efficacy
2250	pharmgkb		capecitabine,fluorouracil			Neoplasms	MIR27A	rs895819	19	13836478	T	C	Toxicity
2251	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Infection	CYP3A5	rs776746	7	99672916	T	C	Toxicity
2252	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GNMT	rs10948059	6	42960723	C	K	Toxicity
2253	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	SLC2A2	rs8192675	3	171007094	T	C	Efficacy
2254	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,hand-foot syndrome	UGT1A9	rs7574296	2	233729603	A	G	Toxicity
2255	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,hand-foot syndrome	VEGFA	rs3025040	6	43785314	C	T	Toxicity
2256	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC2	D312N	19	45364001	C	W	Toxicity
2257	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ERCC2	rs50872	19	45359191	A	K	Toxicity
2258	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	IL16	rs7170924	15	81290798	G	T	Toxicity
2259	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	ABCB1	rs1128503	7	87550285	A	G	Toxicity
2260	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	IL1B	rs12621220	2	112840678	C	T	Toxicity
2261	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	IL1B	rs1143623	2	112838252	C	G	Toxicity
2262	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		POR	rs41301394	7	75983485	C	T	Dosage
2263	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		DDHD1	rs17126068	14	53033179	A	G	Dosage
2264	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NEDD4	rs2288344	15	55830149	T	G	Dosage
2265	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		ASPH	rs4379440	8	61553255	G	T	Efficacy
2266	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	SLCO1B1	N130H	12	21176804	A	K	Toxicity
2267	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Thrombocytopenia	SLCO1B1	V174A	12	21178615	T	C	Toxicity
2268	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Exanthema	ABCC2	rs717620	10	99782821	C	T	Toxicity
2269	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	hand-foot syndrome,Hypertension	KDR	Q472H	4	55106807	T	A	Toxicity
2270	pharmgkb	Drug	captopril	44093	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O	Alzheimer Disease	ACE	rs4291	17	63476833	T	M	Efficacy
2271	pharmgkb	Drug	raloxifene	5035	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	Menopause,Schizophrenia	ESR1	rs11543791	7	110448995	T	C	Efficacy
2272	pharmgkb	Drug	raloxifene	5035	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	Menopause,Schizophrenia	UGT1A8	A173G	2	233618225	C	K	Efficacy
2273	pharmgkb	Drug	clindamycin	29029	CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl		HLA-B	HLA-B*51:01					Toxicity
2274	pharmgkb	Drug	clindamycin	29029	CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl		HLA-B	HLA-B*15:27					Toxicity
2275	pharmgkb		atazanavir,ritonavir			HIV Infections,nephrolithiasis	UGT1A1	rs10929303	2	233772770	T	C	Toxicity
2276	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		B4GALT2	I303M	1	43985562	C	D	Efficacy
2277	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F2	V433M	19	15879621	C	T	Efficacy
2278	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs11676382	2	85550510	C	G	Efficacy
2279	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	R325Q	2	85553413	C	T	Efficacy
2280	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs11676382	2	85550510	C	G	Efficacy
2281	pharmgkb		ephedrine,phenylephrine				ADRB2	R16G	5	148826877	G	A	Dosage
2282	pharmgkb		fentanyl,propofol,remifentanil,sevoflurane			Hypotension	ADRB2	R175W	5	148827354	C	W	Toxicity
2283	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Neoplasms	CYP3A4	rs2740574	7	99784473	C	T	Toxicity,Metabolism/PK
2284	pharmgkb		peginterferon alfa-2a,ribavirin			Hepatitis C, Chronic	SCARB1	rs10846744	12	124827879	G	C	Efficacy
2285	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	HLA-B	HLA-B*40:02					Toxicity
2286	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	HLA-B	HLA-B*15:01					Toxicity
2287	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	HLA-DRB1	HLA-DRB1*04:03					Toxicity
2288	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,simeprevir			Hepatitis C, Chronic	IFNL4	rs11322783	19	39248514	T	-	Efficacy
2289	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL3	rs117648444	19	39247938	G	A	Efficacy
2290	pharmgkb	Drug Class	Antibiotics			Hypersensitivity	LGALS3	Q201H	14	55145121	A	T	Toxicity
2291	pharmgkb	Drug	etanercept			Arthritis, Rheumatoid,Psoriasis	CD84	rs6427528	1	160546518	A	G	Efficacy
2292	pharmgkb	Drug	ustekinumab			Psoriasis	IL12B	rs3213094	5	159323761	C	T	Efficacy
2293	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	CUX2	rs7958375	12	111202213	G	A	Toxicity
2294	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	RIPOR2	rs10946739	6	24992899	C	K	Toxicity
2295	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	AGBL4	rs320003	1	48661106	G	A	Toxicity
2296	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	AGBL4	rs319952	1	48647950	A	K	Toxicity
2297	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	Tuberculosis	AGBL4	rs393994	1	48643073	A	G	Toxicity
2298	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Depression,Substance-Related Disorders	CYP3A4	rs35599367	7	99768693	G	A	Metabolism/PK
2299	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Depression,Substance-Related Disorders	NR1I2	rs1523130	3	119780660	T	C	Metabolism/PK
2300	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Depression,Substance-Related Disorders	NR1I2	rs2276707	3	119815306	C	K	Metabolism/PK
2301	pharmgkb		adalimumab,certolizumab pegol,etanercept,glucocorticoids,infliximab,methotrexate			Arthritis, Rheumatoid	KLRD1	rs2302489	12	10307944	A	K	Efficacy
2302	pharmgkb		adalimumab,certolizumab pegol,etanercept,glucocorticoids,infliximab,methotrexate			Arthritis, Rheumatoid	KLRC1	rs7301582	12	10449091	C	T	Efficacy
2303	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP3A4	rs2242480	7	99763843	C	T	Metabolism/PK
2304	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP3A5	rs776746	7	99672916	T	C	Dosage,Metabolism/PK
2305	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	CYP3A5	rs15524	7	99648291	A	G	Metabolism/PK
2306	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NQO1	rs10517	16	69709857	A	K	Dosage
2307	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement	STX1B	rs72800847	16	31011318	G	A	Dosage
2308	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement	CYP1A1	rs3826041	15	74726549	A	C	Dosage
2309	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement	DNMT3A	rs2304429	2	25235677	C	T	Dosage
2310	pharmgkb		azathioprine,mercaptopurine			Inflammatory Bowel Diseases	ABCC4	E757K	13	95163161	C	T	Toxicity
2311	pharmgkb		azathioprine,mercaptopurine			Irritable Bowel Syndrome,Leukopenia	FTO	A134T	16	53826140	G	A	Toxicity
2312	pharmgkb	Drug	rosiglitazone	77999	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	Diabetes Mellitus, Type 2	SLCO1B1	V174A	12	21178615	T	C	Efficacy
2313	pharmgkb		amitriptyline,antidepressants,citalopram,paroxetine,venlafaxine			Depression,Depressive Disorder,Depressive Disorder, Major	ABCB1	rs2235015	7	87570248	C	A	Efficacy
2314	pharmgkb		amitriptyline,antidepressants,citalopram,fluvoxamine,paroxetine,sertraline,venlafaxine			Depression,Depressive Disorder,Depressive Disorder, Major	ABCB1	rs2032583	7	87531245	A	G	Efficacy
2315	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	TGFB1	rs1800469	19	41354391	A	G	Toxicity
2316	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	TGFBR2	rs3087465	3	30605668	A	G	Toxicity
2317	pharmgkb	Drug	zileuton	60490	CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O	Asthma	PRORP	rs12436663	14	35169914	G	A	Efficacy
2318	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	IL23R	R381Q	1	67240275	G	A	Toxicity
2319	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	CTLA4	rs3087243	2	203874196	G	A	Toxicity
2320	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	SLC12A8	rs651630	3	125092470	G	A	Toxicity
2321	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	FBXL19	rs10782001	16	30931304	G	A	Toxicity
2322	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	COMT	rs5993883	22	19950115	T	G	Efficacy
2323	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	COMT	rs6269	22	19962429	A	G	Efficacy
2324	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	COMT	rs4818	22	19963684	C	K	Efficacy
2325	pharmgkb	Drug	furosemide	3440	C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl	Heart Failure	ABCC4	rs17268282	13	95273060	G	T	Efficacy
2326	pharmgkb		carbamazepine,phenobarbital,phenytoin,valproic acid			Epilepsy	CYP1A1	rs2606345	15	74724835	C	A	Efficacy
2327	pharmgkb	Drug	granisetron	3510	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C		CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
2328	pharmgkb	Drug	granisetron	3510	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C		CYP1A1	CYP1A1*1, CYP1A1*2A					Metabolism/PK
2329	pharmgkb	Drug	interferon beta-1a			Multiple Sclerosis	HLA-DRB1	HLA-DRB1*04:01					Efficacy
2330	pharmgkb	Drug	interferon beta-1a			Multiple Sclerosis	HLA-B	HLA-B*15:01					Efficacy
2331	pharmgkb		adalimumab,etanercept,infliximab			Psoriasis	FCGR3A	F175V	1	161544752	A	B	Efficacy
2332	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung	ABCB1	rs1128503	7	87550285	A	G	Toxicity
2333	pharmgkb	Drug	bevacizumab			Breast Neoplasms	EDN1	K198N	6	12296022	G	T	Efficacy
2334	pharmgkb	Drug	bevacizumab			Breast Neoplasms	VEGFA	rs3025039	6	43784799	C	T	Efficacy
2335	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		ABCB1	I1145M	7	87509329	A	K	Toxicity
2336	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		GSTM1	GSTM1 non-null, GSTM1 null					Toxicity
2337	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		GSTT1	GSTT1 non-null, GSTT1 null					Toxicity
2338	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	NTRK2	rs1439050	9	84673278	G	W	Toxicity
2339	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	GRIK3	rs1334802	1	36930738	C	T	Toxicity
2340	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	SLC18A2	rs363341	10	117250954	C	T	Toxicity
2341	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	DRD2	rs1124491	11	113411368	G	A	Toxicity
2342	pharmgkb	Drug Class	antipsychotics			Psychotic Disorders	HTR2A	rs9567733	13	46827200	A	G	Toxicity
2343	pharmgkb		allopurinol,febuxostat			Gout	UGT1A1	rs34650714	2	233767183	C	T	Dosage
2344	pharmgkb		allopurinol,febuxostat			Gout	AOX1	rs75995567	2	200604661	T	C	Dosage
2345	pharmgkb		allopurinol,febuxostat			Gout	AOX1	H1297R	2	200669666	A	G	Dosage
2346	pharmgkb	Drug	bevacizumab			Colorectal Neoplasms	CXCR4	rs2228014	2	136115514	G	A	Efficacy
2347	pharmgkb	Drug	exemestane	60198	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	Breast Neoplasms	CYP3A4	CYP3A4*1, CYP3A4*22					Metabolism/PK
2348	pharmgkb		fluorouracil,leucovorin,oxaliplatin			Colonic Neoplasms	ERCC1	rs11615	19	45420395	A	G	Toxicity
2349	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	PGLYRP4	rs2916205	1	153348279	C	T	Efficacy
2350	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	CTNNA2	rs11126740	2	79673969	A	G	Efficacy
2351	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	MAP3K1	rs96844	5	56900777	G	A	Efficacy
2352	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	IL12B	rs2546890	5	159332892	A	G	Efficacy
2353	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	CDKAL1	rs6908425	6	20728500	T	C	Efficacy
2354	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	HLA-C	rs12191877	6	31285148	C	T	Efficacy
2355	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	ZNF816	rs9304742	19	52948038	T	C	Efficacy
2356	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	IL17RA	rs4819554	22	17084145	G	A	Efficacy
2357	pharmgkb	Drug, Biological Intermediate	levodopa	6047	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	Parkinson Disease	DRD2	rs1799732	11	113475530	-	R	Toxicity
2358	pharmgkb		busulfan,cyclophosphamide			hemopoietic stem cell transplant	CTH	S403I	1	70439117	G	T	Toxicity
2359	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*38:01					Toxicity
2360	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Drug Hypersensitivity,Epidermal Necrolysis, Toxic,erythema exudativum multiforme,Maculopapular Exanthema,Stevens-Johnson Syndrome	HLA-A	HLA-A*11:01					Toxicity
2361	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*08:01					Toxicity
2362	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epidermal Necrolysis, Toxic,Maculopapular Exanthema,Stevens-Johnson Syndrome	HLA-C	HLA-C*08:01					Toxicity
2363	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	IL6R	rs12083537	1	154408627	A	G	Efficacy
2364	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	IL6R	rs11265618	1	154457616	C	T	Efficacy
2365	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	FOXP3	rs3761548	X	49261784	G	W	Toxicity
2366	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	Colorectal Neoplasms	ABCC1	rs6498588	16	15938949	A	T	Metabolism/PK
2367	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms,Neutropenia	ABCC1	rs17501331	16	15995584	A	G	Toxicity
2368	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	Colorectal Neoplasms	ABCC1	rs35621	16	16074751	C	T	Metabolism/PK
2369	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	ABCC1	rs3743527	16	16141824	C	T	Toxicity
2370	pharmgkb	Drug	ticagrelor	9871419	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO		PEAR1	rs12041331	1	156899922	G	A	Efficacy
2371	pharmgkb	Drug	ticagrelor	9871419	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO		PEAR1	rs4661012	1	156915699	T	G	Efficacy
2372	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		UGT2B7	rs7438135	4	69095621	G	A	Metabolism/PK
2373	pharmgkb	Drug	dabigatran				ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
2374	pharmgkb	Drug	rivaroxaban	9875401			ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
2375	pharmgkb	Drug	dabigatran				ABCB1	S893A	7	87531302	A	Y	Metabolism/PK
2376	pharmgkb	Drug	rivaroxaban	9875401			ABCB1	S893A	7	87531302	A	Y	Metabolism/PK
2377	pharmgkb		ledipasvir,sofosbuvir			Hepatitis C, Chronic,Recurrence	IFNL3	rs12979860	19	39248147	C	T	Efficacy
2378	pharmgkb		ledipasvir,sofosbuvir			Hepatitis C, Chronic	IFNL3	rs8099917	19	39252525	T	G	Efficacy
2379	pharmgkb	Drug	sirolimus	6436030	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	POR	A503V	7	75985688	C	T	Metabolism/PK
2380	pharmgkb	Drug	sirolimus	6436030	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Kidney Transplantation	IL10	rs1800896	1	206773552	T	C	Metabolism/PK
2381	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	VASP	rs10995	19	45526896	G	M	Efficacy
2382	pharmgkb	Drug	cetuximab			Head and Neck Neoplasms	EGFR	R521K	7	55161562	G	H	Efficacy
2383	pharmgkb	Drug Class	Platinum compounds			Neoplasms	GSTP1	I105V	11	67585218	A	G	Efficacy
2384	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	ENOSF1	rs2612091	18	683607	C	T	Toxicity
2385	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		STX1B	rs4889606	16	30999862	A	G	Efficacy
2386	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615	CC(CC1=CC2=C(C=C1)OCO2)NC		CYP2B6	Q172H	19	41006936	G	W	Metabolism/PK
2387	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Colitis, Ulcerative	CYP3A5	rs776746	7	99672916	T	C	Efficacy
2388	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Colitis, Ulcerative	ABCB1	rs1128503	7	87550285	A	G	Efficacy
2389	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Colitis, Ulcerative,Kidney Transplantation	ABCB1	S893A	7	87531302	A	Y	Efficacy
2390	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Colitis, Ulcerative	ABCB1	I1145M	7	87509329	A	K	Efficacy
2391	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N		SLC22A1	P341L	6	160136611	C	K	Metabolism/PK
2392	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	SLC26A9	rs7512462	1	205930467	T	C	Efficacy
2393	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Disease	P2RY12	rs3732759	3	151357137	A	G	Efficacy
2394	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder, Major	SLC6A2	rs2242446	16	55656513	C	W	Efficacy
2395	pharmgkb	Metabolite	cotinine	854019	CN1[C@@H](CCC1=O)C2=CN=CC=C2	Tobacco Use Disorder	UGT2B10	rs2942857	4	68822269	A	B	Metabolism/PK
2396	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	HTR1B	rs9361233	6	77460345	T	C	Efficacy
2397	pharmgkb		atenolol,verapamil			Diabetes Mellitus,Hypertension	PLEKHH2	rs11124945	2	43650017	A	G	Toxicity
2398	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hyperglycemia,Hypertension	DPYS	rs2669429	8	104451462	A	K	Toxicity
2399	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1	rs3217164	16	55821239	G	-	Toxicity
2400	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1	rs2244614	16	55810705	G	A	Toxicity
2401	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1P1	rs11861118	16	55759367	A	G	Toxicity
2402	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1P1	rs7187684	16	55761039	T	C	Toxicity
2403	pharmgkb		peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	CYP2R1	rs10741657	11	14893332	A	G	Efficacy
2404	pharmgkb	Drug Class	opioids				FAAH	rs2295632	1	46413890	T	G	Toxicity
2405	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		FAAH	rs2295632	1	46413890	T	G	Toxicity
2406	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		FAAH	rs4141964	1	46399368	T	C	Toxicity
2407	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		FAAH	rs3766246	1	46399999	A	S	Toxicity
2408	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,lung transplantation	IL18	rs1946518	11	112164735	T	G	Metabolism/PK
2409	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Transplantation	IL18	rs5744247	11	112155433	G	C	Metabolism/PK
2410	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Metabolic Syndrome	C3	rs2277984	19	6679500	C	T	Toxicity
2411	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy,Seizures	UGT1A10	rs2741049	2	233673188	T	C	Efficacy
2412	pharmgkb		lenalidomide,thalidomide			Multiple Myeloma	FGF2	rs308395	4	122825787	C	R	Efficacy
2413	pharmgkb	Drug Class	Antihypertensives			Hypertension	CLNK	rs13144136	4	10665285	G	T	Efficacy
2414	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder, Major	ADRA2A	rs1800544	10	111076745	G	C	Efficacy
2415	pharmgkb	Drug	sulfasalazine	5359476	C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O		ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
2416	pharmgkb	Drug	amisulpride	2159	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	Schizophrenia	ANKS1B	rs7968606	12	99423064	C	T	Efficacy
2417	pharmgkb	Drug	sulindac	5352	CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O		FMO3	E95K	1	171107825	G	A	Metabolism/PK
2418	pharmgkb	Drug	sulindac	5352	CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O		FMO3	E308G	1	171114102	A	G	Metabolism/PK
2419	pharmgkb		atorvastatin,fluvastatin,hmg coa reductase inhibitors,pravastatin,rosuvastatin,simvastatin				HLA-DRB1	HLA-DRB1*01:01, HLA-DRB1*04:06					Toxicity
2420	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CTLA4	rs4553808	2	203866282	A	G	Metabolism/PK
2421	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	IL3	rs181781	5	132059422	G	A	Metabolism/PK
2422	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		PEAR1	rs41273215	1	156912167	C	T	Efficacy
2423	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		PEAR1	rs57731889	1	156912469	C	T	Efficacy
2424	pharmgkb	Drug	rocuronium	441290	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		SLCO1A2	rs3834939	12	21334836	-	T	Metabolism/PK
2425	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Arthralgia,Breast Neoplasms	ABCB1	I1145M	7	87509329	A	K	Toxicity
2426	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	ABCB1	S893A	7	87531302	A	Y	Metabolism/PK
2427	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	CYP19A1	rs727479	15	51242350	C	W	Efficacy
2428	pharmgkb		hmg coa reductase inhibitors,letrozole			Breast Neoplasms,Menopause	CYP19A1	rs1008805	15	51257402	G	A	Other
2429	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		CYP2C19	rs4986893	10	94780653	G	A	Toxicity
2430	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*13:01					Toxicity
2431	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Ototoxicity	TPMT	TPMT*1, TPMT*3A					Toxicity
2432	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms	TPMT	A154T	6	18138997	C	T	Toxicity
2433	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Carcinoma, Non-Small-Cell Lung	SLC31A1	rs10981694	9	113224129	T	G	Toxicity
2434	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	FOXP3	rs3761548	X	49261784	G	W	Efficacy
2435	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Asthenia,Neoplasms	UMPS	rs4678145	3	124731234	G	C	Toxicity
2436	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity,Neoplasms	SLC22A7	rs2270860	6	43302413	C	T	Toxicity
2437	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Diarrhea,Neoplasms	SLC22A7	rs4149178	6	43304450	A	G	Toxicity
2438	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Diarrhea,Neoplasms	TYMS	rs2853741	18	657352	T	S	Toxicity
2439	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Hyperbilirubinemia,Neoplasms	CDA	rs1048977	1	20618562	C	T	Toxicity
2440	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Hyperbilirubinemia,Neoplasms	DPYD	rs12119882	1	97696806	A	G	Toxicity
2441	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Nausea,Vomiting	UMPS	rs2279199	3	124730405	T	S	Toxicity
2442	pharmgkb		gemcitabine,Platinum compounds			Mesothelioma	RRM1	rs1042927	11	4138699	C	A	Efficacy
2443	pharmgkb	Drug	atazanavir	148192	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	HIV Infections	ABCB1	S893A	7	87531302	A	Y	Toxicity
2444	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Diabetes Mellitus, Type 2	TBXA2R	rs1131882	19	3595925	G	A	Efficacy,Toxicity
2445	pharmgkb	Drug	atazanavir	148192	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC		CYP3A	rs2740574	7	99784473	C	T	Metabolism/PK
2446	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Leukopenia,Neutropenia	PIGB	rs12050587	15	55335330	A	G	Toxicity
2447	pharmgkb	Drug	gemtuzumab ozogamicin			Leukemia, Myeloid, Acute	CD33	G304R	19	51235662	G	A	Efficacy
2448	pharmgkb		ethambutol,isoniazid,pyrazinamide,rifampin			Tuberculosis	CYP2B6	CYP2B6*1, CYP2B6*6					Toxicity
2449	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F2	rs2189784	19	15848390	G	H	Dosage
2450	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F11	rs1060467	19	15913728	A	G	Dosage
2451	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Drug Toxicity,Neoplasms,Ototoxicity	COMT	rs4646316	22	19964609	C	K	Toxicity
2452	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Drug Toxicity,Neoplasms,Ototoxicity	COMT	rs9332377	22	19968169	C	W	Toxicity
2453	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms,nephrotoxicity	COMT	rs4646316	22	19964609	C	K	Toxicity
2454	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms,nephrotoxicity	COMT	rs9332377	22	19968169	C	W	Toxicity
2455	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease	ABCB1	S893A	7	87531302	A	Y	Toxicity
2456	pharmgkb		cyclosporine,mycophenolic acid			Kidney Transplantation	ABCC2	rs717620	10	99782821	C	T	Metabolism/PK
2457	pharmgkb	Drug Class	Beta Blocking Agents			major adverse cardiac events (mace)	ADRB1	S49G	10	114044277	A	G	Toxicity
2458	pharmgkb		salbutamol,selective beta-2-adrenoreceptor agonists			Asthma	CRHR2	rs2267715	7	30676471	G	M	Efficacy
2459	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	UGT1A6	UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8					Dosage
2460	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	NUDT15	R34T	13	48037847	G	M	Dosage,Toxicity
2461	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	NUDT15	rs746071566	13	48037783	GGAGTC	-	Dosage,Toxicity
2462	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Epidermal Necrolysis, Toxic,HIV Infections,Stevens-Johnson Syndrome	GSTM1	GSTM1 non-null, GSTM1 null					Toxicity
2463	pharmgkb	Drug	heparin	772	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O	heparin-induced thrombocytopenia	HLA-DRB3	HLA-DRB3*01:01					Toxicity
2464	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	EGFR	rs11506105	7	55152484	A	G	Efficacy
2465	pharmgkb	Drug	everolimus	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,Lymphopenia	ABCB1	S893A	7	87531302	A	Y	Toxicity
2466	pharmgkb	Drug	everolimus	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,mucositis	ABCB1	I1145M	7	87509329	A	K	Toxicity
2467	pharmgkb	Drug	everolimus	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	discontinuation	FGFR4	G388R	5	177093242	G	A	Efficacy
2468	pharmgkb	Drug	everolimus	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,Hyperglycemia,Leukopenia	PIK3R1	rs10515074	5	68270365	A	K	Toxicity
2469	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Anxiety Disorders,Depressive Disorder	COMT	V158M	22	19963748	G	A	Efficacy
2470	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	TPMT	TPMT*1, TPMT*3B, TPMT*3C					Efficacy
2471	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	C6	rs9200	5	41142504	C	W	Metabolism/PK
2472	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	C6	rs10052999	5	41165642	C	T	Metabolism/PK
2473	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
2474	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	M1L	10	94762706	A	K	Metabolism/PK
2475	pharmgkb	Drug	dolutegravir	54726191	C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	HIV Infections	ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
2476	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Bipolar Disorder,Psychotic Disorders	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Dosage,Metabolism/PK
2477	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	M46L	19	40991441	A	G	Metabolism/PK
2478	pharmgkb	Drug Class	hormonal contraceptives for systemic use			Stroke,Venous Thrombosis	F2	rs1799963	11	46739505	G	A	Toxicity
2479	pharmgkb		cytarabine,idarubicin			Leukemia, Myeloid, Acute	DCK	rs2306744	4	70993635	C	D	Efficacy
2480	pharmgkb		cladribine,cytarabine			Leukemia, Myeloid, Acute	RRM2	S59A	2	10122793	T	S	Efficacy
2481	pharmgkb	Drug Class	hmg coa reductase inhibitors			Coronary Artery Disease,Diabetes Mellitus,Hypercholesterolemia	SLCO1B1	N130H	12	21176804	A	K	Toxicity
2482	pharmgkb		codeine,dextromethorphan,n-desmethyltamoxifen				CYP2D6	CYP2D6*1, CYP2D6*24					Metabolism/PK
2483	pharmgkb		cyclophosphamide,doxorubicin			Breast Neoplasms	SLC22A16	M409T	6	110438805	A	G	Toxicity
2484	pharmgkb		Drugs For Treatment Of Tuberculosis,isoniazid			Tuberculosis	ABCB1	I1145M	7	87509329	A	K	Toxicity
2485	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Tuberculosis	NAT2	rs1799929	8	18400484	C	T	Toxicity
2486	pharmgkb		ethambutol,isoniazid,pyrazinamide,rifampin			Toxic liver disease,Tuberculosis	TNF	rs1800629	6	31575254	G	A	Toxicity
2487	pharmgkb	Drug	oseltamivir	65028	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC		CES1	E220G	16	55821399	T	C	Metabolism/PK
2488	pharmgkb	Drug Class	hormonal contraceptives for systemic use				F11	rs2289252	4	186286227	C	T	Toxicity
2489	pharmgkb	Drug Class	hormonal contraceptives for systemic use				KNG1	I581T	3	186742138	T	C	Toxicity
2490	pharmgkb	Drug Class	hormonal contraceptives for systemic use				SUGCT	rs4379368	7	40426601	C	T	Toxicity
2491	pharmgkb	Drug Class	hormonal contraceptives for systemic use				ABO	rs56392308	9	133255670	G	-	Toxicity
2492	pharmgkb	Drug Class	hormonal contraceptives for systemic use				ABO	rs8176719	9	133257522	-	C	Toxicity
2493	pharmgkb	Drug Class	hormonal contraceptives for systemic use				CYP2C9	R144C	10	94942290	C	T	Toxicity
2494	pharmgkb	Drug	ethanol	702	CCO		SLC6A3	N38K	5	1443084	G	M	Toxicity
2495	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CDH2	rs8094439	18	28132643	G	A	Efficacy
2496	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CDH2	rs17446819	18	28136925	A	C	Efficacy
2497	pharmgkb		peginterferon alfa-2b,ribavirin			Hepatitis C	HLA-C	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01					Efficacy
2498	pharmgkb	Drug	etanercept			Arthritis, Rheumatoid	STAT4	rs7574865	2	191099907	T	G	Efficacy
2499	pharmgkb	Drug	etanercept			Arthritis, Rheumatoid	PSORS1C1	rs2233945	6	31139584	C	A	Efficacy
2500	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	FOXF2	rs199564443	6	1388744	TTTT	-	Toxicity
2501	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	HLA-B	Y91S	6	31356759	T	V	Toxicity
2502	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	EHMT2	rs652888	6	31883457	A	G	Toxicity
2503	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	HLA-B	HLA-B*08:01					Toxicity
2504	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis	HLA-B	HLA-B*27:05					Toxicity
2505	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		ABCB1	rs1128503	7	87550285	A	G	Efficacy
2506	pharmgkb	Drug	isoniazid	3767	C1=CN=CC=C1C(=O)NN	drug-induced liver injury,Toxic liver disease	BACH1	rs2070401	21	29343164	A	G	Toxicity
2507	pharmgkb	Drug	salbutamol	2083	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O		ADRB2	T164I	5	148827322	C	T	Other
2508	pharmgkb	Drug	isoniazid	3767	C1=CN=CC=C1C(=O)NN	drug-induced liver injury,Toxic liver disease	XPO1	rs11125883	2	61483438	A	C	Toxicity
2509	pharmgkb	Drug	isoniazid	3767	C1=CN=CC=C1C(=O)NN	drug-induced liver injury,Toxic liver disease	MAFK	rs4720833	7	1534767	A	S	Toxicity
2510	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Myocardial Infarction	ABCB1	I1145M	7	87509329	A	K	Efficacy,Toxicity,Metabolism/PK
2511	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome	CES1	S75N	16	55828800	C	T	Efficacy
2512	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	UGT1A10	Q6R	2	233729143	A	G	Metabolism/PK
2513	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	UGT2B7	Y268H	4	69098620	T	C	Efficacy
2514	pharmgkb		cisplatin,gemcitabine			Mesothelioma	CD3EAP	Q506K	19	45409478	C	D	Efficacy
2515	pharmgkb		cisplatin,pemetrexed			Mesothelioma	ABCC2	V417I	10	99804058	G	A	Efficacy
2516	pharmgkb		cisplatin,gemcitabine			Mesothelioma	ERCC2	rs13181	19	45351661	T	R	Efficacy
2517	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLC19A1	rs2838958	21	45528653	G	A	Efficacy
2518	pharmgkb	Drug	lumefantrine	6437380	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	Malaria	CYP3A5	rs10264272	7	99665212	C	T	Metabolism/PK
2519	pharmgkb	Drug	lumefantrine	6437380	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	Malaria	CYP3A	rs776746	7	99672916	T	C	Metabolism/PK
2520	pharmgkb	Drug	lumefantrine	6437380	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	Malaria	CYP3A4	rs2740574	7	99784473	C	T	Efficacy,Metabolism/PK
2521	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1L1	rs4072879	7	65908864	A	S	Dosage
2522	pharmgkb	Drug	midazolam	4192	CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F		CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
2523	pharmgkb		amisulpride,aripiprazole,clozapine,lithium,mirtazapine,olanzapine,paliperidone,quetiapine,risperidone,valproic acid			Bipolar Disorder,Depressive Disorder,Psychotic Disorders,schizoaffective disorder	SH2B1	rs3888190	16	28878165	C	A	Toxicity
2524	pharmgkb		amisulpride,aripiprazole,clozapine,lithium,mirtazapine,olanzapine,paliperidone,quetiapine,risperidone,valproic acid			Bipolar Disorder,Depressive Disorder,Psychotic Disorders,schizoaffective disorder	RABEP1	rs1000940	17	5379957	A	G	Other
2525	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CYP2B6	K262R	19	41009358	A	G	Efficacy
2526	pharmgkb		remifentanil,sevoflurane			tonsillectomy	ABCB1	rs1128503	7	87550285	A	G	Efficacy,Toxicity
2527	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCB1	I1145M	7	87509329	A	K	Efficacy
2528	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABCB1	rs1128503	7	87550285	A	G	Efficacy
2529	pharmgkb		sirolimus,temsirolimus			adverse events,gastrointestinal toxicity,Myelosuppression,Urinary Bladder Neoplasms	NR1I2	rs3814055	3	119781188	C	T	Toxicity,Metabolism/PK
2530	pharmgkb		sirolimus,temsirolimus			gastrointestinal toxicity,Myelosuppression,Urinary Bladder Neoplasms	NR1I2	rs6785049	3	119814886	G	A	Toxicity,Metabolism/PK
2531	pharmgkb		sirolimus,temsirolimus			hematopoietic stem cell transplantation,Kidney Transplantation,Urinary Bladder Neoplasms	ABCB1	S893A	7	87531302	A	Y	Metabolism/PK
2532	pharmgkb		sirolimus,temsirolimus			Urinary Bladder Neoplasms	ABCB1	rs1128503	7	87550285	A	G	Metabolism/PK
2533	pharmgkb		antipsychotics,aripiprazole,bromperidol,chlorpromazine,clozapine,nemonapride,olanzapine,risperidone			Schizophrenia	DRD2	rs1799732	11	113475530	-	R	Efficacy
2534	pharmgkb	Drug Class	Thiazides, plain			Hypernatremia,Hypertension	SLCO2A1	A396T	3	133947365	C	K	Toxicity
2535	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	EPHX2	rs59724122	8	27567179	C	T	Efficacy
2536	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	GRAMD1B	rs61123830	11	123522138	G	A	Efficacy
2537	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	MYO1H	rs7959663	12	109446562	G	M	Efficacy
2538	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	FAM178B	rs6728642	2	96941334	A	G	Efficacy
2539	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	ZNF804A	rs62200793	2	184885915	T	C	Efficacy
2540	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	ADCY1	rs1521470	7	45607253	A	G	Efficacy
2541	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	FAM177A1	rs79403677	14	35069925	T	G	Efficacy
2542	pharmgkb		fluorouracil,Platinum compounds,radiotherapy			Stomach Neoplasms	ERCC1	rs2298881	19	45423658	C	W	Efficacy
2543	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung,gastrointestinal toxicity,Hematologic Diseases,Leukopenia	XPC	A499V	3	14158387	G	A	Toxicity
2544	pharmgkb		tipiracil hydrochloride,trifluridine			Colorectal Neoplasms	SLC29A1	rs760370	6	44233216	A	G	Efficacy
2545	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Toxicity
2546	pharmgkb		sofosbuvir,velpatasvir,voxilaprevir			Hepatitis C, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
2547	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2,Polycystic Ovary Syndrome	SLC47A1	rs2252281	17	19533874	T	C	Efficacy
2548	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N		SLC47A2	rs12943590	17	19716685	G	A	Metabolism/PK
2549	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2,Polycystic Ovary Syndrome	SLC47A1	rs2289669	17	19560030	G	A	Efficacy
2550	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	SLC47A2	rs12943590	17	19716685	G	A	Efficacy
2551	pharmgkb		atazanavir,ritonavir			HIV Infections	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7					Metabolism/PK
2552	pharmgkb	Drug	atazanavir	148192	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC		CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7					Metabolism/PK
2553	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Asthenia,Nausea,Neoplasms,Vomiting	TYMS	rs699517	18	673016	C	T	Toxicity
2554	pharmgkb		hdl cholesterol,letrozole,triglycerides			Breast Neoplasms,Menopause	CYP19A1	rs2289105	15	51215311	T	C	Other
2555	pharmgkb		hdl cholesterol,letrozole,triglycerides			Breast Neoplasms,Menopause	CYP19A1	rs10046	15	51210789	G	A	Other
2556	pharmgkb		metformin,sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	KCNJ11	K23Q	11	17388025	T	M	Efficacy
2557	pharmgkb		carbamazepine,phenytoin,valproic acid			Epilepsy	GABRA1	rs2279020	5	161895883	G	A	Efficacy
2558	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Gastrointestinal Stromal Tumors	POR	A503V	7	75985688	C	T	Efficacy
2559	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Gastrointestinal Stromal Tumors	SLCO1B3	S112P	12	20858546	T	S	Efficacy
2560	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	BCHE	A567T	3	165773492	C	T	Other
2561	pharmgkb	Drug	ustekinumab			Psoriasis	TIRAP	S180L	11	126292948	C	T	Efficacy
2562	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Inflammatory Bowel Diseases,Psoriasis	TLR2	rs11938228	4	153700794	C	W	Efficacy
2563	pharmgkb	Drug	ustekinumab			Psoriasis	TLR5	F616L	1	223111186	A	G	Efficacy
2564	pharmgkb		Tumor necrosis factor alpha (TNF-alpha) inhibitors,ustekinumab			Psoriasis	IL1B	rs1143627	2	112836810	G	A	Efficacy
2565	pharmgkb		Tumor necrosis factor alpha (TNF-alpha) inhibitors,ustekinumab			Psoriasis	IL1B	rs1143623	2	112838252	C	G	Efficacy
2566	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	TLR9	rs352139	3	52224356	T	C	Efficacy
2567	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	TLR2	rs4696480	4	153685974	T	A	Efficacy
2568	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	LY96	rs11465996	8	73989727	C	G	Efficacy
2569	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	CYP3A4	CYP3A4*1, CYP3A4*22					Metabolism/PK
2570	pharmgkb		fluorouracil,Platinum compounds,radiotherapy			Stomach Neoplasms	XRCC4	rs10040363	5	83177826	A	G	Efficacy
2571	pharmgkb		Platinum compounds,radiotherapy			Anemia,Dermatitis,Leukopenia,mucositis,Myelosuppression,Neutropenia,Thrombocytopenia	MEG3	rs10132552	14	100834675	T	C	Toxicity
2572	pharmgkb	Drug	ritodrine	33572	C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O	adverse events,Premature Birth	CACNA1C	M1821V	12	2681966	A	S	Toxicity
2573	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Exanthema	HLA-B	HLA-B*35:05					Toxicity
2574	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:10					Toxicity
2575	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*51:01					Toxicity
2576	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*51:02					Toxicity
2577	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*54:01					Toxicity
2578	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*55:01					Toxicity
2579	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*55:02					Toxicity
2580	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*56:01					Toxicity
2581	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*56:06					Toxicity
2582	pharmgkb		bupropion,nicotine,varenicline			Tobacco Use Disorder	CHRNA5	rs503464	15	78565554	T	A	Efficacy,Toxicity
2583	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs2236196	20	63346204	G	M	Other
2584	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs55781567	15	78565644	C	G	Toxicity
2585	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*78:01					Toxicity
2586	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*13:02					Toxicity
2587	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*38:01					Toxicity
2588	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:05					Toxicity
2589	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:06					Toxicity
2590	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:09					Toxicity
2591	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:12					Toxicity
2592	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:24					Toxicity
2593	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:25					Toxicity
2594	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:27					Toxicity
2595	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:32					Toxicity
2596	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:35					Toxicity
2597	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*52:01					Toxicity
2598	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*35:10					Toxicity
2599	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*04:03					Toxicity
2600	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*01:02					Toxicity
2601	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*10:01					Toxicity
2602	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*08:01					Toxicity
2603	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*04:04					Toxicity
2604	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-DRB1	HLA-DRB1*01:03					Toxicity
2605	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*04:06					Toxicity
2606	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*04:07					Toxicity
2607	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*05:01					Toxicity
2608	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*05:09					Toxicity
2609	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-C	HLA-C*18:01					Toxicity
2610	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	ABCB1	rs1128503	7	87550285	A	G	Toxicity
2611	pharmgkb		capecitabine,fluorouracil			Neoplasms	TYMP	S471L	22	50525807	G	H	Toxicity
2612	pharmgkb		gemcitabine,Platinum compounds			Carcinoma, Non-Small-Cell Lung	RRM1	rs12806698	11	4094744	C	A	Efficacy
2613	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	ABCG2	rs13120400	4	88112375	T	C	Efficacy,Metabolism/PK
2614	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs145489027	4	21389571	G	A	Toxicity
2615	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs1495509	4	21391993	T	C	Toxicity
2616	pharmgkb		isoniazid,rifampin			drug-induced liver injury,Tuberculosis	GSTP1	I105V	11	67585218	A	G	Toxicity
2617	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell,Neutropenia	ABCB1	S893A	7	87531302	A	Y	Toxicity
2618	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Carcinoma, Renal Cell	ABCB1	S893A	7	87531302	A	Y	Efficacy
2619	pharmgkb		fluorouracil,Platinum compounds,radiotherapy			Stomach Neoplasms	TMEM167A	rs2075685	5	83076846	G	W	Efficacy
2620	pharmgkb		cyclosporine,mycophenolic acid			Kidney Transplantation	ABCC2	V417I	10	99804058	G	A	Metabolism/PK
2621	pharmgkb	Drug	atazanavir	148192	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	Acquired Immunodeficiency Syndrome,HIV Infections,nephrolithiasis	NR1I2	rs2472677	3	119799570	C	T	Metabolism/PK
2622	pharmgkb		atorvastatin,simvastatin			Cardiovascular Diseases	RYR2	rs2819742	1	237826822	A	K	Toxicity
2623	pharmgkb	Drug	bevacizumab			Breast Neoplasms,Colorectal Neoplasms	VEGFA	rs3025039	6	43784799	C	T	Efficacy
2624	pharmgkb	Drug	pazopanib	11525740		Kidney Neoplasms	KDR	C482R	4	55106779	A	G	Efficacy,Metabolism/PK
2625	pharmgkb		tipiracil hydrochloride,trifluridine			Colorectal Neoplasms	SLC29A1	rs9394992	6	44228255	C	T	Efficacy
2626	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	UGT1A3	rs3806596	2	233729061	T	C	Efficacy,Metabolism/PK
2627	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DBH	rs1611131	9	133657065	A	G	Toxicity
2628	pharmgkb	Drug	letrozole	3902	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms,Menopause	CYP19A1	rs4646	15	51210647	A	C	Other
2629	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	liver transplantation	CYP3A5	rs776746	7	99672916	T	C	Dosage,Metabolism/PK
2630	pharmgkb		atazanavir,ritonavir			HIV Infections,nephrolithiasis	UGT1A1	rs8330	2	233772999	G	C	Toxicity
2631	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	XRCC3	T241M	14	103699416	G	A	Efficacy
2632	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	OPRD1	rs529520	1	28848434	A	S	Efficacy
2633	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5		CYP2C9	R144C	10	94942290	C	T	Efficacy
2634	pharmgkb	Drug	ethanol	702	CCO	Alcoholism,Death	DRD2	E713K	11	113400106	G	A	Toxicity
2635	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	NOTCH4	rs367398	6	32223953	G	A	Toxicity
2636	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	FMO3	E308G	1	171114102	A	G	Metabolism/PK
2637	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP24A1	rs927650	20	54156202	T	M	Metabolism/PK
2638	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP24A1	rs2585428	20	54170358	C	T	Metabolism/PK
2639	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP24A1	rs2248359	20	54174979	C	T	Metabolism/PK
2640	pharmgkb	Drug	aripiprazole	60795	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Schizophrenia	DRD2	rs6277	11	113412737	G	A	Efficacy
2641	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids				IL10	rs1800896	1	206773552	T	C	Toxicity
2642	pharmgkb	Drug Class	Antiinflammatory agents, non-steroids				CTLA4	T17S	2	203867991	A	K	Toxicity
2643	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		ABCB1	rs1128503	7	87550285	A	G	Metabolism/PK
2644	pharmgkb	Drug Class	corticosteroids			Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCL2L11	rs724710	2	111150114	T	M	Toxicity
2645	pharmgkb	Drug Class	corticosteroids			Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCL2L11	rs2241843	2	111121804	C	D	Toxicity
2646	pharmgkb	Drug	caffeine	2519	CN1C=NC2=C1C(=O)N(C(=O)N2C)C		CYP1A2	rs2069514	15	74745879	G	A	Metabolism/PK
2647	pharmgkb	Drug	caffeine	2519	CN1C=NC2=C1C(=O)N(C(=O)N2C)C		CYP1A2	rs762551	15	74749576	C	A	Metabolism/PK
2648	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GATA4	rs2645400	8	11751907	T	G	Dosage
2649	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GATA4	rs4841588	8	11756716	G	T	Dosage
2650	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VDR	rs11168292	12	47899822	C	R	Dosage
2651	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VDR	rs11168293	12	47899933	G	W	Dosage
2652	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VDR	rs4760658	12	47902703	A	G	Dosage
2653	pharmgkb	Drug	sildenafil	5212	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Heart Failure	CYP3A4	CYP3A4*1, CYP3A4*22					Metabolism/PK
2654	pharmgkb	Drug	somatropin recombinant			Turner Syndrome	CDK4	rs2069502	12	57750882	C	T	Other
2655	pharmgkb	Drug	somatropin recombinant				CDK4	rs2270777	12	57751373	C	K	Other
2656	pharmgkb		doxorubicin,idarubicin			Neoplasms	CYBA	Y72N	16	88646828	A	K	Toxicity
2657	pharmgkb		doxorubicin,idarubicin			Neoplasms	CYBA	Y72N	16	88646828	A	K	Efficacy,Toxicity
2658	pharmgkb		doxorubicin,idarubicin			Neoplasms	NCF4	rs1883112	22	36860804	G	A	Toxicity
2659	pharmgkb		doxorubicin,idarubicin			Neoplasms	RAC2	rs13058338	22	37236730	T	R	Toxicity
2660	pharmgkb	Drug	idarubicin	42890	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	Leukemia, Myeloid, Acute	NCF4	rs1883112	22	36860804	G	A	Efficacy
2661	pharmgkb	Drug	idarubicin	42890	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	Leukemia, Myeloid, Acute	RAC2	rs13058338	22	37236730	T	R	Efficacy
2662	pharmgkb	Drug Class	Drugs Used In Diabetes			Diabetes Mellitus, Type 2	IRS1	G971R	2	226795828	C	K	Efficacy
2663	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC22A1	L160F	6	160130172	G	H	Toxicity
2664	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC22A5	rs274558	5	132385482	A	G	Toxicity
2665	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	EGFR	rs10258429	7	55170394	C	T	Toxicity
2666	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	ABCB1	rs2235040	7	87536434	C	T	Toxicity
2667	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615	CC(CC1=CC2=C(C=C1)OCO2)NC		SLC6A2	rs2242446	16	55656513	C	W	Other
2668	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615	CC(CC1=CC2=C(C=C1)OCO2)NC		SLC6A2	rs36029	16	55662844	A	G	Other
2669	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615	CC(CC1=CC2=C(C=C1)OCO2)NC		SLC6A2	rs1861647	16	55694494	G	M	Other
2670	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCG2	Q141K	4	88131171	G	Y	Toxicity
2671	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N		SLC22A1	R61C	6	160122116	C	T	Metabolism/PK
2672	pharmgkb		cetuximab,panitumumab			Neoplasms	KRAS	rs61764370	12	25207290	A	C	Efficacy
2673	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	POR	A503V	7	75985688	C	T	Metabolism/PK
2674	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Organ Transplantation	CYP3A4	rs35599367	7	99768693	G	A	Other
2675	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	SUMO4	V55L	6	149400554	G	A	Metabolism/PK
2676	pharmgkb	Drug	omeprazole	4594	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	Gastroesophageal Reflux	ABCB1	I1145M	7	87509329	A	K	Efficacy,Metabolism/PK
2677	pharmgkb	Drug	dapoxetine	71353	CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98					Metabolism/PK
2678	pharmgkb		caffeine,chlorocresol			Malignant Hyperthermia	RYR1	T84R	19	38442434	C	K	Other
2679	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Organ Transplantation	TLR4	rs1927907	9	117710486	C	T	Other
2680	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	severe cutaneous adverse reactions	PSORS1C1	rs3131003	6	31125705	G	A	Toxicity
2681	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	rs408626	5	80655314	T	C	Efficacy,Toxicity
2682	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	rs442767	5	80655677	G	T	Toxicity
2683	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs4803381	19	40851439	T	C	Metabolism/PK
2684	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	rs56113850	19	40847202	T	C	Metabolism/PK
2685	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	SP1	rs784888	12	53430724	G	C	Efficacy,Metabolism/PK
2686	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus	AMHR2	rs784892	12	53429100	G	A	Efficacy,Metabolism/PK
2687	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRL1	rs6090041	20	64081323	G	A	Toxicity
2688	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	LKAAEAR1	rs6090043	20	64086577	C	T	Toxicity
2689	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Neoplasms	CDA	K27Q	1	20589208	A	C	Toxicity
2690	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PEBP4	rs17685420	8	22927888	C	T	Efficacy
2691	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ZDHHC7	rs3210967	16	84975857	T	C	Efficacy
2692	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ZNF134	A46S	19	57620255	G	W	Efficacy
2693	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ARSA	N352S	22	50625988	T	C	Efficacy
2694	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SPSB2	rs12302749	12	6867132	C	T	Efficacy
2695	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ZNF211	rs10420097	19	57633193	A	S	Efficacy
2696	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CORO7	E384V	16	4382028	A	Y	Efficacy
2697	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	FXR2	A350T	17	7581494	G	A	Efficacy
2698	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ZNF565	I188S	19	36183403	A	G	Efficacy
2699	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ELP5	V197E	17	7260420	A	G	Efficacy
2700	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CDH23	V1675I	10	71777857	G	A	Efficacy
2701	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ARHGAP12	rs2799018	10	31913141	C	K	Efficacy
2702	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PIGM	F365L	1	160030645	A	T	Efficacy
2703	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CHURC1	rs4902333	14	64909368	C	T	Efficacy
2704	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	TRIB3	Q84R	20	388261	A	K	Efficacy
2705	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CMTM8	rs4627790	3	32259860	T	C	Efficacy
2706	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PDIA2	P502T	16	286916	C	W	Efficacy
2707	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	OPCML	rs751655	11	132623600	C	T	Efficacy
2708	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ETFDH	T31I	4	158680524	C	T	Efficacy
2709	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	NFIB	rs7858	9	14087770	C	T	Efficacy
2710	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ARHGEF28	rs929740	5	73621913	G	A	Efficacy
2711	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SENP3	G67R	17	7559238	G	M	Efficacy
2712	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ESYT2	rs1061735	7	158733764	G	W	Efficacy
2713	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	RRP7A	V88L	22	42516091	C	K	Efficacy
2714	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	HTT	V2788F	4	3233253	G	W	Efficacy
2715	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	FARP2	T260I	2	241431686	C	W	Efficacy
2716	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	GGH	rs17279558	8	63015187	T	C	Efficacy
2717	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PURA	rs2013169	5	140118020	T	A	Efficacy
2718	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	NRXN1	rs4971678	2	50438029	T	A	Efficacy
2719	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9873889	3	21753431	C	K	Efficacy
2720	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9879065	3	21754288	C	K	Efficacy
2721	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9310658	3	21756084	C	T	Efficacy
2722	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs7616119	3	21756203	G	H	Efficacy
2723	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs7653345	3	21756949	A	G	Efficacy
2724	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9819548	3	21757051	G	W	Efficacy
2725	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs13093500	3	21757155	T	V	Efficacy
2726	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs12630569	3	21757421	G	M	Efficacy
2727	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9824595	3	21757835	G	H	Efficacy
2728	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs4334661	3	21757936	T	C	Efficacy
2729	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TTC37	rs12657120	5	95466585	G	M	Efficacy
2730	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TTC37	rs4639250	5	95481198	C	G	Efficacy
2731	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TREML4	rs13204353	6	41237497	G	M	Efficacy
2732	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	INVS	rs10123866	9	100301363	G	M	Efficacy
2733	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	F911L	9	100302248	G	A	Efficacy
2734	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs10124893	9	100302983	G	A	Efficacy
2735	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs6479008	9	100311309	C	A	Efficacy
2736	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs10989064	9	100349683	C	T	Efficacy
2737	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	FCN2	rs3124955	9	134882699	T	C	Efficacy
2738	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	FCN2	rs3128624	9	134883293	A	G	Efficacy
2739	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908402	12	5915594	T	C	Efficacy
2740	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908403	12	5915639	G	A	Efficacy
2741	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908404	12	5916105	C	T	Efficacy
2742	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908405	12	5916164	C	A	Efficacy
2743	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17724452	12	5916322	C	A	Efficacy
2744	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17724464	12	5916418	G	C	Efficacy
2745	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17786394	12	5916924	T	C	Efficacy
2746	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17786400	12	5916985	A	K	Efficacy
2747	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908406	12	5917081	G	A	Efficacy
2748	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17786412	12	5917148	G	W	Efficacy
2749	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908407	12	5917207	A	G	Efficacy
2750	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908408	12	5917289	A	G	Efficacy
2751	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908409	12	5917405	C	G	Efficacy
2752	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908410	12	5917412	T	A	Efficacy
2753	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs78482393	12	5917824	G	A	Efficacy
2754	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs78615940	12	5917867	A	C	Efficacy
2755	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs17724494	12	5918126	C	T	Efficacy
2756	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ANO2	rs61908411	12	5918478	C	T	Efficacy
2757	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ATP10A	rs12595802	15	25806438	G	M	Efficacy
2758	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	MIEF2	rs3889402	17	18264083	G	W	Efficacy
2759	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	MIEF2	G324E	17	18264370	G	A	Efficacy
2760	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	MIEF2	rs56355515	17	18265930	G	W	Efficacy
2761	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs9310657	3	21756083	T	G	Efficacy
2762	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TREML4	rs9369266	6	41232816	A	G	Efficacy
2763	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	TEX10	rs7035619	9	100309102	A	T	Efficacy
2764	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	UGT2B7	rs7668258	4	69096360	T	C	Metabolism/PK
2765	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	UGT2B7	A71T	4	69096731	G	H	Metabolism/PK
2766	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Hemorrhage,Myocardial Infarction	CYP2C19	rs11568732	10	94761817	T	S	Toxicity
2767	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		AGTR1	rs5186	3	148742201	A	C	Metabolism/PK
2768	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		BDKRB2	rs1799722	14	96204802	C	T	Metabolism/PK
2769	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Colonic Neoplasms	UGT1A6	R184S	2	233693556	A	C	Efficacy
2770	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Colonic Neoplasms	UGT1A6	T181A	2	233693545	A	G	Efficacy
2771	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	ABCC2	rs717620	10	99782821	C	T	Efficacy
2772	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-A	HLA-A*02:07					Toxicity
2773	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Maculopapular Exanthema	HLA-A	HLA-A*33:03					Toxicity
2774	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	drug reaction with eosinophilia and systemic symptoms,Stevens-Johnson Syndrome	PSORS1C1	R37H	6	31138722	G	A	Toxicity
2775	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	drug reaction with eosinophilia and systemic symptoms,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	CYCSP5	rs3099844	6	31481199	C	A	Toxicity
2776	pharmgkb		granisetron,palonosetron			Nausea,Neoplasms,Vomiting	ERCC1	Q506K	19	45409478	C	D	Efficacy
2777	pharmgkb	Drug	granisetron	3510	CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C	Neoplasms	ABCB1	I1145M	7	87509329	A	K	Efficacy
2778	pharmgkb		dexamethasone,lenalidomide			Multiple Myeloma,progression-free survival	ABCB1	S400N	7	87550493	C	W	Efficacy
2779	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2B6	R22C	19	40991369	C	T	Metabolism/PK
2780	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2B6	R487S	19	41016810	C	D	Metabolism/PK
2781	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	SOD2	rs5746136	6	159682052	C	T	Toxicity
2782	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP3A7	CYP3A7*1A, CYP3A7*1C					Metabolism/PK
2783	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2J2	rs890293	1	59926822	C	A	Toxicity
2784	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCC2	I1324M	10	99844450	C	K	Metabolism/PK
2785	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2C8	CYP2C8*1, CYP2C8*3					Metabolism/PK
2786	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP2C8	CYP2C8*1, CYP2C8*3					Toxicity
2787	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	PPARA	rs4253728	22	46214170	G	A	Toxicity
2788	pharmgkb		fluvoxamine,milnacipran,paroxetine			Depressive Disorder, Major	MDGA2	rs1160351	14	47546779	A	C	Toxicity
2789	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		CALU	rs1043550	7	128769171	A	G	Dosage
2790	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs7294	16	31091000	C	T	Other
2791	pharmgkb		cotinine,nicotine				OPRM1	rs6912029	6	154039373	G	T	Metabolism/PK
2792	pharmgkb		cotinine,nicotine				OPRM1	rs1074287	6	154027674	A	G	Metabolism/PK
2793	pharmgkb		cotinine,nicotine				OPRM1	N40D	6	154039662	A	G	Metabolism/PK
2794	pharmgkb		cotinine,nicotine				OPRM1	rs12209447	6	154039913	C	T	Metabolism/PK
2795	pharmgkb		cotinine,nicotine				OPRM1	rs510769	6	154040884	C	T	Metabolism/PK
2796	pharmgkb		cotinine,nicotine				OPRM1	rs3798676	6	154043004	C	T	Metabolism/PK
2797	pharmgkb		cotinine,nicotine				OPRM1	rs553202	6	154043682	C	T	Metabolism/PK
2798	pharmgkb		cotinine,nicotine				OPRM1	rs7748401	6	154059015	T	G	Metabolism/PK
2799	pharmgkb		cotinine,nicotine				OPRM1	rs495491	6	154061407	A	G	Metabolism/PK
2800	pharmgkb		cotinine,nicotine				OPRM1	rs10457090	6	154069938	A	K	Metabolism/PK
2801	pharmgkb		cotinine,nicotine				OPRM1	rs589046	6	154072003	C	T	Metabolism/PK
2802	pharmgkb		cotinine,nicotine				OPRM1	rs3778152	6	154072696	A	G	Metabolism/PK
2803	pharmgkb		cotinine,nicotine				OPRM1	rs563649	6	154086832	C	T	Metabolism/PK
2804	pharmgkb		cotinine,nicotine				OPRM1	rs2075572	6	154090869	G	C	Metabolism/PK
2805	pharmgkb		chlorothiazide,hydrochlorothiazide			Hyperglycemia,Hypertension	HMGCS2	rs9943291	1	119749667	T	G	Toxicity
2806	pharmgkb	Drug Class	antineoplastic agents			Neoplasms	ABCB1	I1145M	7	87509329	A	K	Toxicity
2807	pharmgkb		cocaine,heroin			Cocaine-Related Disorders,Heroin Dependence	OPRM1	C192F	6	154090110	G	T	Toxicity
2808	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms,Neutropenia	ABCB1	rs12720066	7	87540386	A	C	Toxicity
2809	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	G970R	7	117603782	G	M	Efficacy
2810	pharmgkb		(R)-methadone,methadone,S-EDDP			Opioid-Related Disorders	UGT2B7	Y268H	4	69098620	T	C	Metabolism/PK
2811	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	ABCB1	N21H	7	87600124	T	C	Metabolism/PK
2812	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain	UGT2B7	Y268H	4	69098620	T	C	Efficacy
2813	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Disease,Hemorrhage	ABCB1	I1145M	7	87509329	A	K	Toxicity
2814	pharmgkb		Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan			Substance Withdrawal Syndrome	OPRM1	N40D	6	154039662	A	G	Other
2815	pharmgkb	Drug	apixaban	10182969	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N	Atrial Fibrillation	ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
2816	pharmgkb	Drug	apixaban	10182969	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N	Atrial Fibrillation	CYP3A5	rs776746	7	99672916	T	C	Metabolism/PK
2817	pharmgkb		acenocoumarol,warfarin			Hemorrhage,venous thromboembolism	APOE	C130R	19	44908684	T	C	Toxicity
2818	pharmgkb	Drug Class	Vitamin K				CYP4F2	V433M	19	15879621	C	T	Metabolism/PK
2819	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	KLB	rs11940694	4	39413373	A	G	Dosage
2820	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	IRS1	rs115457081	2	226804325	G	A	Toxicity
2821	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	GNL3	rs112242273	3	52741044	C	T	Toxicity
2822	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	HMMR	rs299293	5	163482208	C	T	Toxicity
2823	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	HMMR	rs299313	5	163486945	G	M	Toxicity
2824	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PERP	rs117101815	6	138131313	G	W	Toxicity
2825	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PERP	rs78428806	6	138114070	G	A	Toxicity
2826	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PPP2R5D	rs3805945	6	43039244	T	C	Toxicity
2827	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	HMMR	rs299314	5	163487994	T	C	Toxicity
2828	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PERP	rs9402944	6	138132382	G	T	Toxicity
2829	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PERP	rs9389568	6	138145853	T	C	Toxicity
2830	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	CYP2C8	rs117458836	10	95013625	G	W	Toxicity
2831	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	TP53AIP1	rs118088833	11	128937143	C	T	Toxicity
2832	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	NOS1	rs149212925	12	117191508	A	G	Toxicity
2833	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	FOXO1	rs144991623	13	40694197	C	T	Toxicity
2834	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	CCNK	rs77769901	14	99447319	A	G	Toxicity
2835	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	TP53	rs4968187	17	7669124	C	T	Toxicity
2836	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	TOP2A	rs181501757	17	40398140	G	A	Toxicity
2837	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	INSR	rs142244113	19	7164496	C	T	Toxicity
2838	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	INSR	rs41412545	19	7172515	C	A	Toxicity
2839	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs118129530	19	18120913	G	A	Toxicity
2840	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	T196M	19	18123979	C	T	Toxicity
2841	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs117341846	19	18125871	C	T	Toxicity
2842	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs117951771	19	18129161	C	W	Toxicity
2843	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs148235907	19	18129545	G	A	Toxicity
2844	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs138602176	19	18131325	G	A	Toxicity
2845	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs150688309	19	18131482	C	G	Toxicity
2846	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs79430272	19	18132742	C	T	Toxicity
2847	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs55633228	19	18134954	C	T	Toxicity
2848	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs148013902	19	18137528	C	T	Toxicity
2849	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs145623321	19	18145130	C	T	Toxicity
2850	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs58695150	19	18151561	C	T	Toxicity
2851	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	PIK3R2	rs8110364	19	18162822	G	A	Toxicity
2852	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	CBR3	rs74743371	21	36183667	G	H	Toxicity
2853	pharmgkb		buprenorphine,methadone			Opioid-Related Disorders	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
2854	pharmgkb		cocaine,ethanol,nicotine			Substance-Related Disorders	OPRM1	A6V	6	154039561	C	D	Toxicity
2855	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Anemia, Sickle Cell	UGT2B7	rs7668282	4	69096396	T	C	Metabolism/PK
2856	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	RBX1	rs141084494	22	40972293	G	A	Toxicity
2857	pharmgkb	Drug	caffeine	2519	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	insomnia	CYP1A2	rs762551	15	74749576	C	A	Toxicity
2858	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	CPA6	rs2162145	8	67747912	T	S	Efficacy
2859	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	NBEA	rs57081354	13	35202457	T	C	Efficacy
2860	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	PRPF31	rs254271	19	54127382	C	R	Efficacy
2861	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Nephrotic Syndrome	CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
2862	pharmgkb		Analgesics,Antiinflammatory agents, non-steroids,Ergot alkaloids,opioids,sumatriptan				COMT	V158M	22	19963748	G	A	Other
2863	pharmgkb		diuretics,hydrochlorothiazide,Thiazides, plain			Hypertension	NELFCD	rs2273359	20	58987047	C	K	Efficacy
2864	pharmgkb		mercaptopurine,methotrexate			Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	V174A	12	21178615	T	C	Dosage
2865	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	TPMT	Y240C	6	18130687	T	S	Dosage,Toxicity
2866	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		SLCO1B1	V174A	12	21178615	T	C	Efficacy
2867	pharmgkb		propofol,remifentanil				ABCB1	rs1128503	7	87550285	A	G	Efficacy
2868	pharmgkb	Drug	bevacizumab			Hypertension	HSP90AB1	rs3734704	6	44234210	A	Y	Toxicity
2869	pharmgkb	Drug	bevacizumab			Hypertension	HSP90AB1	rs6929249	6	44235246	A	G	Toxicity
2870	pharmgkb	Drug	bevacizumab			Hypertension	HSP90AB1	rs834576	6	44238042	C	A	Toxicity
2871	pharmgkb	Drug	bevacizumab			Hypertension	PRKCA	rs9381299	6	44244130	T	C	Toxicity
2872	pharmgkb		mercaptopurine,methotrexate			Leukopenia,Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ITPA	rs7270101	20	3213247	A	C	Dosage,Toxicity
2873	pharmgkb		acenocoumarol,phenprocoumon				VKORC1	rs7294	16	31091000	C	T	Dosage
2874	pharmgkb	Drug	donepezil	3152	COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC	Alzheimer Disease,cognitive dysfunction	BCHE	A567T	3	165773492	C	T	Efficacy
2875	pharmgkb		antidepressants,citalopram,paroxetine			Depressive Disorder	BDNF	V66M	11	27658369	C	T	Efficacy
2876	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	ABCG2	Q141K	4	88131171	G	Y	Efficacy,Toxicity
2877	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	POLR2A	N764K	17	7501672	T	C	Toxicity
2878	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Psoriasis	ABCC1	rs35592	16	16047966	T	C	Efficacy
2879	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement	UGT1A1	rs887829	2	233759924	C	T	Dosage
2880	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Drug Toxicity	CYP2C9	L294F	10	94972166	G	W	Toxicity
2881	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Drug Toxicity	CYP2C9	R307K	10	94972204	G	A	Toxicity
2882	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-A	HLA-A*24:02					Toxicity
2883	pharmgkb	Drug Class	Platinum compounds			overall survival,Thrombocytopenia	SLC31A1	rs4979223	9	113219836	A	C	Efficacy,Toxicity
2884	pharmgkb	Drug Class	Platinum compounds			Thrombocytopenia	SLC31A1	rs4978536	9	113220123	A	G	Toxicity
2885	pharmgkb	Drug Class	Platinum compounds			Drug Toxicity,overall survival	SLC31A1	rs2233914	9	113221260	G	A	Efficacy,Toxicity
2886	pharmgkb	Drug Class	Platinum compounds			Anemia,Leukopenia,Nausea,Neutropenia,Thrombocytopenia,Vomiting	SLC31A1	rs10817464	9	113230217	T	M	Toxicity
2887	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	N893S	1	97098577	T	C	Other
2888	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	H807R	1	97234874	T	S	Other
2889	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	V434L	1	97573799	C	R	Other
2890	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	rs1184321568	1	97593251	T	-	Other
2891	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	T298M	1	97595124	G	W	Other
2892	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F		DPYD	Y109N	1	97721668	A	T	Other
2893	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Mesothelioma	MTHFR	A222V	1	11796321	G	A	Efficacy
2894	pharmgkb		atenolol,hydrochlorothiazide			Hypertension	ALDH1A2	rs261316	15	58341621	C	T	Efficacy
2895	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	UGT1A3	rs7604115	2	233749470	C	T	Metabolism/PK
2896	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	UGT1A3	UGT1A3*1, UGT1A3*2					Metabolism/PK
2897	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	ABCC9	rs704212	12	21891410	C	T	Metabolism/PK
2898	pharmgkb	Drug	montelukast	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	Asthma	CYP2C8	CYP2C8*1, CYP2C8*3, CYP2C8*4					Metabolism/PK
2899	pharmgkb	Drug Class	HMG CoA reductase inhibitors, other combinations			Cardiovascular Diseases,Rhabdomyolysis	EYS	rs9342288	6	64477153	G	A	Toxicity
2900	pharmgkb	Drug Class	hmg coa reductase inhibitors			Rhabdomyolysis	EYS	rs1337512	6	64483927	T	G	Toxicity
2901	pharmgkb	Drug Class	hmg coa reductase inhibitors			Rhabdomyolysis	EYS	rs3857532	6	64523772	G	A	Toxicity
2902	pharmgkb		cyclophosphamide,doxorubicin			Breast Neoplasms	NQO2	L47I	6	3010156	C	T	Efficacy
2903	pharmgkb		cyclophosphamide,doxorubicin,prednisone,rituximab,vincristine			Lymphoma, Large B-Cell, Diffuse	GSTA1	rs3957357	6	52803889	A	G	Efficacy
2904	pharmgkb		cisplatin,cyclophosphamide,doxorubicin,methotrexate,vincristine			Osteosarcoma	ABCB1	rs4148737	7	87541836	T	C	Efficacy
2905	pharmgkb		cisplatin,cyclophosphamide,doxorubicin,methotrexate,vincristine			Osteosarcoma	ABCB1	rs1128503	7	87550285	A	G	Efficacy
2906	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil,methotrexate			Breast Neoplasms	NOS3	D298E	7	150999023	T	R	Efficacy
2907	pharmgkb		cyclophosphamide,doxorubicin			Breast Neoplasms	ALDH1A1	rs6151031	9	72953468	-	CTGGTGAGGAGAGAACC	Efficacy
2908	pharmgkb		cyclophosphamide,doxorubicin			Breast Neoplasms	CYP2C19	rs4244285	10	94781859	G	M	Efficacy
2909	pharmgkb		cyclophosphamide,doxorubicin			Breast Neoplasms	CYP2B6	K139E	19	41004377	A	G	Efficacy
2910	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	S8P	16	29461407	T	C	Metabolism/PK
2911	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	S8P	16	29461407	T	C	Metabolism/PK
2912	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	S8P	16	29461407	T	C	Metabolism/PK
2913	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	S8P	16	29461407	T	C	Metabolism/PK
2914	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	P10R	16	29461414	C	K	Metabolism/PK
2915	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	P10R	16	29461414	C	K	Metabolism/PK
2916	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	P10R	16	29461414	C	K	Metabolism/PK
2917	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	P10R	16	29461414	C	K	Metabolism/PK
2918	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	T7P	16	30200747	A	C	Metabolism/PK
2919	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	T7P	16	30200747	A	C	Metabolism/PK
2920	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	T7P	16	30200747	A	C	Metabolism/PK
2921	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	R9C	16	30200753	C	T	Metabolism/PK
2922	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	R9C	16	30200753	C	T	Metabolism/PK
2923	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	R9C	16	30200753	C	T	Metabolism/PK
2924	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	R9C	16	30200753	C	T	Metabolism/PK
2925	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	V15M	16	30200771	G	A	Metabolism/PK
2926	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	V15M	16	30200771	G	A	Metabolism/PK
2927	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	V15M	16	30200771	G	A	Metabolism/PK
2928	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	V18F	16	30200780	G	T	Metabolism/PK
2929	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	V18F	16	30200780	G	T	Metabolism/PK
2930	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	V18F	16	30200780	G	T	Metabolism/PK
2931	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	V18F	16	30200780	G	T	Metabolism/PK
2932	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	P101L	16	30201223	C	W	Metabolism/PK
2933	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	P101L	16	30201223	C	W	Metabolism/PK
2934	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	P101L	16	30201223	C	W	Metabolism/PK
2935	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	P101L	16	30201223	C	W	Metabolism/PK
2936	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	R144C	16	30202747	C	T	Metabolism/PK
2937	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	R144C	16	30202747	C	T	Metabolism/PK
2938	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	R144C	16	30202747	C	T	Metabolism/PK
2939	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	R144C	16	30202747	C	T	Metabolism/PK
2940	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A3	K234N	16	30203612	G	W	Metabolism/PK
2941	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		SULT1A3	K234N	16	30203612	G	W	Metabolism/PK
2942	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A3	K234N	16	30203612	G	W	Metabolism/PK
2943	pharmgkb		o-desmethyltramadol,tramadol				SULT1A3	K234N	16	30203612	G	W	Metabolism/PK
2944	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	ABCB1	I1145M	7	87509329	A	K	Efficacy,Metabolism/PK
2945	pharmgkb	Drug	levetiracetam	441341	CC[C@H](C(=O)N)N1CCCC1=O	adverse events,Epilepsy	HLA-A	HLA-A*11:01					Toxicity
2946	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	ANKK1	E713K	11	113400106	G	A	Efficacy
2947	pharmgkb		interferon beta-1a,interferon beta-1b			drug-induced liver injury,Multiple Sclerosis	IRF6	rs2205986	1	209942767	G	A	Toxicity
2948	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Hypertension	ABCB1	I1145M	7	87509329	A	K	Efficacy
2949	pharmgkb	Drug	pioglitazone	4829	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3		CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3					Other
2950	pharmgkb		carboplatin,docetaxel,trastuzumab			Breast Neoplasms	BARD1	rs2070096	2	214780821	C	D	Efficacy
2951	pharmgkb		fluorouracil,irinotecan,leucovorin			Colorectal Neoplasms	ABCG2	rs7699188	4	88174909	G	M	Efficacy,Toxicity
2952	pharmgkb		carboplatin,docetaxel,trastuzumab			Breast Neoplasms	ERBB3	rs2229046	12	56093417	T	C	Efficacy
2953	pharmgkb		carboplatin,docetaxel,trastuzumab			Breast Neoplasms	RNF8	rs2284922	6	37381257	G	A	Efficacy
2954	pharmgkb		carboplatin,docetaxel,trastuzumab			Breast Neoplasms	ERBB3	S1119C	12	56101214	A	T	Efficacy
2955	pharmgkb		carboplatin,docetaxel,trastuzumab			Breast Neoplasms	ERBB2	I655V	17	39723335	A	K	Efficacy
2956	pharmgkb	Drug	etanercept			Spondylitis, Ankylosing	TNFRSF1B	M196R	1	12192898	T	G	Efficacy
2957	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	UGT2B7	rs4587017	4	69081680	T	G	Efficacy
2958	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	UGT2B7	rs10028494	4	69105219	A	C	Efficacy
2959	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative,Respiratory Insufficiency	ABCB1	I1145M	7	87509329	A	K	Toxicity
2960	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative,Respiratory Insufficiency	ABCB1	S893A	7	87531302	A	Y	Toxicity
2961	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative,Respiratory Insufficiency	ABCB1	rs1128503	7	87550285	A	G	Toxicity
2962	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	ATF2	rs7583431	2	175057654	A	C	Efficacy
2963	pharmgkb	Drug Class	opioids			Pain, Postoperative	IL17A	rs2275913	6	52186235	G	A	Dosage
2964	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Neoplasms,Pain	ABCB1	S893A	7	87531302	A	Y	Toxicity
2965	pharmgkb		anastrozole,letrozole			Neoplasms	ESR1	rs9340799	6	151842246	A	G	Toxicity
2966	pharmgkb	Drug	acetylcysteine	12035	CC(=O)N[C@@H](CS)C(=O)O	Pulmonary Fibrosis	TOLLIP	rs3750920	11	1288726	C	T	Efficacy
2967	pharmgkb	Drug	cangrelor	9854012	CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F		P2RY12	rs6787801	3	151381953	A	G	Efficacy
2968	pharmgkb		Opioid anesthetics,Other general anesthetics,volatile anesthetics				OPRM1	N40D	6	154039662	A	G	Efficacy
2969	pharmgkb		Opioid anesthetics,Other general anesthetics,volatile anesthetics				ABCG2	Q141K	4	88131171	G	Y	Efficacy
2970	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	CYP1B1	L432V	2	38071060	G	C	Toxicity
2971	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	ABCG2	Q141K	4	88131171	G	Y	Toxicity
2972	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	SLC22A16	rs6907567	6	110456759	A	G	Efficacy,Toxicity
2973	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	SLC22A16	H49R	6	110456925	T	C	Efficacy,Toxicity
2974	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	CYP2C19	rs12248560	10	94761900	C	W	Toxicity
2975	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	CYP2C19	rs4244285	10	94781859	G	M	Toxicity
2976	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	ABCC2	V417I	10	99804058	G	A	Toxicity
2977	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	ABCC2	I1324M	10	99844450	C	K	Toxicity
2978	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	ATM	D1853N	11	108304735	G	A	Toxicity
2979	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	ALDH3A1	P329S	17	19739639	G	C	Toxicity
2980	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	ERCC1	Q506K	19	45409478	C	D	Toxicity
2981	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	ERCC1	rs11615	19	45420395	A	G	Toxicity
2982	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	CBR1	rs20572	21	36072675	C	T	Toxicity
2983	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	XRCC1	Q399R	19	43551574	T	C	Toxicity
2984	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	GSTP1	I105V	11	67585218	A	G	Toxicity
2985	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms	ABCB1	I1145M	7	87509329	A	K	Toxicity
2986	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Maculopapular Exanthema	HLA-B	HLA-B*44:03					Toxicity
2987	pharmgkb	Drug	stavudine	18283	CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO	HIV Infections,Peripheral Nervous System Diseases	SAMHD1	rs8124728	20	36892303	G	A	Toxicity
2988	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation	CYP3A5	rs15524	7	99648291	A	G	Metabolism/PK
2989	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation	CYP3A5	rs4646450	7	99668695	G	A	Metabolism/PK
2990	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	CYP3A5	CYP3A5*1, CYP3A5*3					Toxicity
2991	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	KIF6	W170R	6	39357302	A	G	Efficacy
2992	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C	Hypercholesterolemia	KIF6	W170R	6	39357302	A	G	Efficacy
2993	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,lung transplantation	ABCB1	N21H	7	87600124	T	C	Metabolism/PK
2994	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCB1	S400N	7	87550493	C	W	Efficacy
2995	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	NR1I2	rs2276707	3	119815306	C	K	Metabolism/PK
2996	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC		NR1I2	rs3814055	3	119781188	C	T	Metabolism/PK
2997	pharmgkb	Drug	cetuximab			Colorectal Neoplasms	RASSF1	rs2236947	3	50334001	C	A	Efficacy
2998	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	ZNF385D	rs4261893	3	21753382	C	K	Efficacy
2999	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	KMT2E	G999C	7	105107452	G	T	Efficacy
3000	pharmgkb	Drug	duloxetine	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	Depressive Disorder, Major	NCAM1	rs2303377	11	113240779	T	C	Efficacy
3001	pharmgkb	Drug	phenazepam	40113	C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3Cl	Alcoholism	CYP2C19	rs12248560	10	94761900	C	W	Efficacy
3002	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	CYP3A5	rs17161788	7	99648286	T	C	Efficacy
3003	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O		ABCB1	I1145M	7	87509329	A	K	Toxicity
3004	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Psoriasis	IL6	rs1800795	7	22727026	C	G	Efficacy
3005	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ATIC	T116S	2	215325297	C	G	Efficacy
3006	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ITPA	P32T	20	3213196	C	R	Efficacy,Toxicity
3007	pharmgkb	Drug	cetuximab			Colorectal Neoplasms,Head and Neck Neoplasms	FCGR2A	H166P	1	161509955	A	S	Efficacy
3008	pharmgkb	Drug	cetuximab			Neoplasms	FCGR3A	F175V	1	161544752	A	B	Efficacy
3009	pharmgkb		bevacizumab,carboplatin,cisplatin,cyanocobalamin,folic acid,pemetrexed			Neoplasms	MTHFR	E429A	1	11794419	T	G	Efficacy
3010	pharmgkb		carboplatin,cisplatin			Neoplasms	MTR	D919G	1	236885200	A	G	Efficacy,Toxicity
3011	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	MDM2	rs1690924	12	68811541	T	C	Efficacy
3012	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	XRCC1	R194W	19	43553422	G	A	Efficacy
3013	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	SLC19A1	H27R	21	45537880	T	S	Efficacy
3014	pharmgkb	Drug	oxaliplatin	6857599	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]	Colorectal Neoplasms	PIN1	rs2233678	19	9834503	G	M	Efficacy
3015	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	PIN1	rs2233678	19	9834503	G	M	Efficacy
3016	pharmgkb	Drug	dapsone	2955	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-DRB1	M171L	6	32581698	T	C	Toxicity
3017	pharmgkb	Drug	dapsone	2955	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-DRB1	S133L	6	32581811	G	A	Toxicity
3018	pharmgkb	Drug	dapsone	2955	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-DRB1	rs17211071	6	32589759	G	A	Toxicity
3019	pharmgkb	Drug	dapsone	2955	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-DRB1	HLA-DRB1*15:01, HLA-DRB1*16:02					Toxicity
3020	pharmgkb	Drug	dapsone	2955	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	Drug Hypersensitivity	HLA-A	HLA-A*24:02					Toxicity
3021	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Hyperprolactinemia	UGT1A1	rs10929302	2	233757136	G	A	Toxicity
3022	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Hyperprolactinemia	UGT1A1	rs1976391	2	233757337	A	G	Toxicity
3023	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Hyperprolactinemia	UGT1A1	rs887829	2	233759924	C	T	Toxicity
3024	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	NEDD4L	rs4149601	18	58149559	G	A	Efficacy
3025	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Colonic Neoplasms,Colorectal Neoplasms,Neoplasms,Rectal Neoplasms,Uterine Cervical Neoplasms	XRCC1	Q399R	19	43551574	T	C	Efficacy
3026	pharmgkb		fluorouracil,leucovorin,oxaliplatin			Colorectal Neoplasms	ERCC1	rs11615	19	45420395	A	G	Efficacy
3027	pharmgkb		bumetanide,furosemide,torasemide				ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
3028	pharmgkb	Drug	clonidine	2803	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	Liver Cirrhosis	ADRA2C	rs11269124	4	3768063	-	GGGGAGCTTTCCCAGAGACCC	Efficacy
3029	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs144854329	6	43768679	GGTCCCACTCTTCCCACA	-	Efficacy
3030	pharmgkb		benazepril,perindopril			Diabetes Mellitus	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
3031	pharmgkb	Drug	thioridazine	5452	CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC		CYP2D6	rs1080985	22	42132375	G	M	Other
3032	pharmgkb	Drug Class	antipsychotics			Dystonia	CYP2D6	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*14					Toxicity
3033	pharmgkb		chlorthalidone,lisinopril			Hypertension	MMP3	rs35068180	11	102845217	-	M	Efficacy
3034	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease	MMP3	rs35068180	11	102845217	-	M	Efficacy
3035	pharmgkb	Drug	ceftriaxone	5479530	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O	Central Nervous System Infections	ABCG2	rs13120400	4	88112375	T	C	Metabolism/PK
3036	pharmgkb	Drug	ceftriaxone	5479530	CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O	Central Nervous System Infections	ABCC2	V417I	10	99804058	G	A	Metabolism/PK
3037	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	UGT1A1	rs4148324	2	233764076	T	G	Metabolism/PK
3038	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	ABCG2	rs12505410	4	88109689	T	S	Metabolism/PK
3039	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	ABCG2	rs13120400	4	88112375	T	C	Metabolism/PK
3040	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma	ABCG2	rs13137622	4	88141361	G	T	Metabolism/PK
3041	pharmgkb	Drug	ethanol	702	CCO	Alcoholism,Substance-Related Disorders	DRD2	E713K	11	113400106	G	A	Toxicity
3042	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Acquired Immunodeficiency Syndrome	CYCSP5	rs3099844	6	31481199	C	A	Toxicity
3043	pharmgkb	Drug	ondansetron	4595	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C		CYP3A5	rs776746	7	99672916	T	C	Other
3044	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Nephrotic Syndrome	ABCB1	S893A	7	87531302	A	Y	Efficacy
3045	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Nephrotic Syndrome	ABCB1	rs1128503	7	87550285	A	G	Efficacy
3046	pharmgkb	Drug	acamprosate	71158	CC(=O)NCCCS(=O)(=O)O	Alcoholism	GRIN2B	rs2058878	12	13800184	T	M	Efficacy
3047	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	FCGR3A	F175V	1	161544752	A	B	Efficacy
3048	pharmgkb	Drug	rituximab			Arthritis, Rheumatoid	FCGR2A	H166P	1	161509955	A	S	Efficacy
3049	pharmgkb	Drug	maraviroc	3002977	CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C	HIV Infections	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7					Efficacy,Metabolism/PK
3050	pharmgkb		Drugs For Treatment Of Tuberculosis,rifampin			Tuberculosis	RIPOR2	rs10946737	6	24967012	G	A	Toxicity
3051	pharmgkb	Drug, Biological Intermediate	levodopa	6047	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	Parkinson Disease	SLC6A3	rs3836790	5	1411741	-		Efficacy
3052	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRM1	V214I	6	152994560	C	T	Efficacy
3053	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	IL1B	rs1143634	2	112832813	G	A	Dosage,Efficacy
3054	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	IL1B	rs1143634	2	112832813	G	A	Dosage,Efficacy
3055	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	UGT2A1	rs11249454	4	69633516	T	C	Toxicity
3056	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	ABCB4	rs1202283	7	87452976	G	A	Efficacy
3057	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	ABCC2	V417I	10	99804058	G	A	Efficacy
3058	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	CHST1	rs9787901	11	45674603	G	M	Toxicity
3059	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	NQO1	rs10517	16	69709857	A	K	Efficacy
3060	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	CYP2F1	rs305968	19	41116284	G	W	Toxicity
3061	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC19A1	rs12659	21	45531642	A	G	Toxicity
3062	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	SLC19A1	H27R	21	45537880	T	S	Toxicity
3063	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neutropenia,Pancreatic Neoplasms	CDA	rs471760	1	20590713	G	A	Toxicity
3064	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neutropenia,Pancreatic Neoplasms	SLC28A1	rs3825876	15	84892637	G	A	Toxicity
3065	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neutropenia,Pancreatic Neoplasms	SLC28A1	rs12148896	15	84891963	G	A	Toxicity
3066	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	KCNJ6	rs6517442	21	37917643	C	T	Efficacy
3067	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O	Pain	TRPV1	T469I	17	3583408	G	A	Efficacy
3068	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O	Pain	UGT2B15	Y85D	4	68670366	A	C	Efficacy
3069	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ABCB1	S893A	7	87531302	A	Y	Toxicity
3070	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	TH	rs2070762	11	2165105	A	G	Efficacy
3071	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	DRD2	rs2283265	11	113414814	C	A	Toxicity
3072	pharmgkb		bleomycin,cisplatin,etoposide			Testicular Neoplasms,Vomiting	ABCB1	I1145M	7	87509329	A	K	Toxicity
3073	pharmgkb		bleomycin,cisplatin,etoposide			Alopecia,Testicular Neoplasms	CYP3A	rs2740574	7	99784473	C	T	Toxicity
3074	pharmgkb		bleomycin,cisplatin,etoposide			Infection,Nausea,Testicular Neoplasms	GSTP1	I105V	11	67585218	A	G	Toxicity
3075	pharmgkb		bleomycin,cisplatin,etoposide			Alopecia,Pain,Testicular Neoplasms	BLMH	I443V	17	30249058	T	C	Toxicity
3076	pharmgkb		bleomycin,cisplatin,etoposide			Alopecia,Testicular Neoplasms	ERCC2	rs13181	19	45351661	T	R	Toxicity
3077	pharmgkb		bleomycin,cisplatin,etoposide			Anemia,Testicular Neoplasms	ERCC2	D312N	19	45364001	C	W	Toxicity
3078	pharmgkb		bleomycin,cisplatin,etoposide			Leukopenia,Testicular Neoplasms	ERCC2	rs238406	19	45365051	T	G	Toxicity
3079	pharmgkb		bleomycin,cisplatin,etoposide			Testicular Neoplasms,Vomiting	ERCC1	Q506K	19	45409478	C	D	Toxicity
3080	pharmgkb		bleomycin,cisplatin,etoposide			febrile neutropenia,Testicular Neoplasms	ERCC1	rs11615	19	45420395	A	G	Toxicity
3081	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
3082	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		ABCB1	S893A	7	87531302	A	Y	Metabolism/PK
3083	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		NTNG1	rs61816456	1	105853440	G	A	Efficacy
3084	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		GREM2	rs77567654	1	240549089	A	G	Efficacy
3085	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		GREM2	rs10802887	1	240550730	A	G	Efficacy
3086	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		GREM2	rs1934341	1	240558252	C	K	Efficacy
3087	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		GREM2	rs4659982	1	240566955	T	M	Efficacy
3088	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		MYT1L	rs79663562	2	2269048	T	C	Efficacy
3089	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		TRIB2	rs10193126	2	14177682	T	C	Efficacy
3090	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		TBL1XR1	rs57449396	3	176534890	C	T	Efficacy
3091	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		PKD2	rs2725215	4	88040419	C	T	Efficacy
3092	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		ABCG2	rs4148157	4	88099782	G	A	Efficacy
3093	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		ABCG2	rs76979899	4	88104089	C	T	Efficacy
3094	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		ABCG2	rs4148155	4	88133515	A	G	Efficacy
3095	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		HLA-C	rs9366772	6	31261561	G	A	Efficacy
3096	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	TAOK3	rs795484	12	118152057	T	C	Dosage,Efficacy
3097	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	TAOK3	rs1277441	12	118168184	G	M	Dosage,Efficacy
3098	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Diabetes Mellitus, Type 2	KCNJ11	K23Q	11	17388025	T	M	Toxicity
3099	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Maculopapular Exanthema	CFHR4	rs78239784	1	196899970	T	G	Toxicity
3100	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SLC6A2	rs28386840	16	55652906	T	M	Efficacy
3101	pharmgkb		isoniazid,phenytoin			Drug interaction with drug,Drug Toxicity	NAT2	rs1041983	8	18400285	C	T	Toxicity
3102	pharmgkb		isoniazid,phenytoin			Drug interaction with drug,Drug Toxicity	NAT2	I114T	8	18400344	T	C	Toxicity
3103	pharmgkb		isoniazid,phenytoin			Drug interaction with drug,Drug Toxicity	NAT2	rs1799929	8	18400484	C	T	Toxicity
3104	pharmgkb		isoniazid,phenytoin			Drug interaction with drug,Drug Toxicity	NAT2	R197Q	8	18400593	G	A	Toxicity
3105	pharmgkb		isoniazid,phenytoin			Drug interaction with drug,Drug Toxicity	NAT2	R268I	8	18400806	G	W	Toxicity
3106	pharmgkb		isoniazid,phenytoin			Drug interaction with drug,Drug Toxicity	NAT2	G286E	8	18400860	G	A	Toxicity
3107	pharmgkb		cyclosporine,sirolimus,tacrolimus			Kidney Transplantation,liver transplantation	TCF7L2	rs7903146	10	112998590	C	K	Toxicity
3108	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	TCF7L2	rs290487	10	113149972	C	T	Toxicity
3109	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*57:01					Toxicity
3110	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus	ABCC8	A1369S	11	17396930	C	W	Efficacy
3111	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs2075572	6	154090869	G	C	Toxicity
3112	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	COMT	V158M	22	19963748	G	A	Toxicity
3113	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs9479757	6	154090209	G	A	Dosage
3114	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	DRD2	E713K	11	113400106	G	A	Toxicity
3115	pharmgkb	Drug	sibutramine	5210	CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C	Obesity	GNB3	rs5443	12	6845711	C	T	Efficacy
3116	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	methamphetamine dependence	OPRM1	rs2075572	6	154090869	G	C	Toxicity
3117	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	rs511435	6	154047412	C	K	Toxicity
3118	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	rs524731	6	154053957	C	A	Toxicity
3119	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs524731	6	154053957	C	A	Toxicity
3120	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	rs3823010	6	154058017	G	A	Toxicity
3121	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs3823010	6	154058017	G	A	Toxicity
3122	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	rs3778156	6	154083178	A	G	Toxicity
3123	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs3778156	6	154083178	A	G	Toxicity
3124	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs609148	6	154109880	G	A	Toxicity
3125	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs495491	6	154061407	A	G	Toxicity
3126	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs548646	6	154097012	T	C	Toxicity
3127	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs648893	6	154117494	A	G	Toxicity
3128	pharmgkb	Drug	disopyramide	3114	CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C	short qt syndrome 1	KCNH2	N588K	7	150951629	G	Y	Efficacy
3129	pharmgkb	Drug	quinidine	441074	COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	short qt syndrome 1	KCNH2	N588K	7	150951629	G	Y	Efficacy
3130	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CYP2E1	rs2031920	10	133526341	C	T	Toxicity
3131	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CHRNA4	C226W	20	63350733	A	G	Toxicity
3132	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	OPRM1	N40D	6	154039662	A	G	Efficacy
3133	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CYP2B6	CYP2B6*1, CYP2B6*6					Efficacy
3134	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRK1	rs1051660	8	53251002	C	W	Toxicity
3135	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2B6	K262R	19	41009358	A	G	Metabolism/PK
3136	pharmgkb		cotinine,nicotine			Tobacco Use Disorder	CYP2B6	CYP2B6*1, CYP2B6*6					Metabolism/PK
3137	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs553202	6	154043682	C	T	Efficacy
3138	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs524731	6	154053957	C	A	Efficacy
3139	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs548646	6	154097012	T	C	Efficacy
3140	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs648007	6	154101476	A	G	Efficacy
3141	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs3778148	6	154059877	G	T	Efficacy
3142	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs1461773	6	154070234	G	A	Efficacy
3143	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs2075572	6	154090869	G	C	Efficacy
3144	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs681243	6	154106606	T	C	Efficacy
3145	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	GAL	rs694066	11	68685517	G	A	Toxicity
3146	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	HTR3B	rs3758987	11	113904553	T	C	Toxicity
3147	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRK1	rs6473797	8	53240422	T	C	Toxicity
3148	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	CSNK1E	rs1534891	22	38299094	T	C	Toxicity
3149	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		DRD2	rs6277	11	113412737	G	A	Efficacy
3150	pharmgkb	Drug	nimodipine	4497	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC		CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
3151	pharmgkb	Drug	nimodipine	4497	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC		CACNA1C	rs2239128	12	2648603	T	C	Efficacy
3152	pharmgkb	Drug	dextropropoxyphene	441275			CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
3153	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CHRNA7	rs2337980	15	32151995	C	T	Efficacy
3154	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CRHBP	rs10055255	5	76968168	A	T	Toxicity
3155	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
3156	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	ANKK1	E713K	11	113400106	G	A	Toxicity
3157	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A13	rs1709083	19	41095991	C	D	Toxicity
3158	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A13	rs72552266	19	41089049	C	K	Toxicity
3159	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	rs28399433	19	40850474	A	B	Toxicity
3160	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2B6	CYP2B6*1, CYP2B6*4					Toxicity
3161	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	HTR3B	rs3758987	11	113904553	T	C	Toxicity
3162	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	HTR3B	rs11606194	11	113910259	T	C	Toxicity
3163	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CYP2B6	rs8109525	19	40986013	A	G	Efficacy
3164	pharmgkb	Drug	varenicline	5310966	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	Tobacco Use Disorder	HYKK	rs7164594	15	78510715	C	T	Efficacy
3165	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	methamphetamine dependence	BDNF	V66M	11	27658369	C	T	Toxicity
3166	pharmgkb	Drug	modafinil	4236	C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N	methamphetamine dependence	COMT	V158M	22	19963748	G	A	Efficacy
3167	pharmgkb	Drug Class	highly active antiretroviral therapy (haart)			HIV Infections	OPRM1	rs671531	6	154119607	A	K	Efficacy
3168	pharmgkb		l-methylfolate,Vitamin B-complex, Incl. Combinations			Depressive Disorder, Major	MTHFR	E429A	1	11794419	T	G	Efficacy
3169	pharmgkb		l-methylfolate,Vitamin B-complex, Incl. Combinations			Depressive Disorder, Major	MTHFR	A222V	1	11796321	G	A	Efficacy
3170	pharmgkb	Drug	ethanol	702	CCO		DRD2	E713K	11	113400106	G	A	Dosage
3171	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs2236256	6	154157305	C	A	Toxicity
3172	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	GABRA2	rs11503014	4	46388848	C	G	Toxicity
3173	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	ACE	rs8075924	17	63505531	C	T	Efficacy
3174	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	HTR2A	rs2770296	13	46866425	C	T	Efficacy
3175	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	DBH	rs2873804	9	133640522	T	C	Efficacy
3176	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SLC18A2	rs363225	10	117264991	C	W	Efficacy
3177	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	SLC18A2	rs363226	10	117265701	G	Y	Efficacy
3178	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Depressive Disorder, Major	FKBP5	rs17614642	6	35654144	T	C	Efficacy
3179	pharmgkb	Drug	pitavastatin	5282452			ABCC2	rs717620	10	99782821	C	T	Metabolism/PK
3180	pharmgkb	Drug	pioglitazone	4829	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	Diabetes Mellitus, Type 2	PPARG	P12A	3	12351626	C	G	Efficacy
3181	pharmgkb	Drug	pioglitazone	4829	CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3	Diabetes Mellitus, Type 2	PTPRD	rs17584499	9	8879118	C	T	Efficacy
3182	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	PPA2	rs2636697	4	105376356	G	M	Efficacy
3183	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	TJP1	rs813676	15	29901113	T	M	Efficacy
3184	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	ATP1A2	rs6688363	1	160108064	C	T	Efficacy
3185	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	SPOPL	rs10170310	2	138521352	G	M	Efficacy
3186	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	TNFRSF11A	rs2980976	18	62412879	G	A	Efficacy
3187	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	PDE4D	rs17382202	5	59684120	C	T	Efficacy
3188	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	MIR582	rs17742120	5	59703216	A	G	Efficacy
3189	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	TJP1	rs711355	15	29901265	T	C	Efficacy
3190	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	TJP1	rs785423	15	29882173	A	G	Efficacy
3191	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	PPA2	rs2636719	4	105432212	A	C	Efficacy
3192	pharmgkb	Drug	everolimus	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	pneumonitis,progression-free survival	RPTOR	rs9906827	17	80691605	C	W	Efficacy,Toxicity
3193	pharmgkb	Drug	prochlorperazine	4917	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	Nausea	ANKK1	E713K	11	113400106	G	A	Efficacy
3194	pharmgkb	Drug	prochlorperazine	4917	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	Nausea	DRD2	rs1079597	11	113425564	C	T	Efficacy
3195	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs6090378	20	63344026	A	G	Toxicity
3196	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs3787138	20	63347872	G	A	Toxicity
3197	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA4	rs3787140	20	63357759	T	C	Toxicity
3198	pharmgkb		amiloride,spironolactone			Hypertension	CYP4A11	F402S	1	46932824	A	G	Efficacy
3199	pharmgkb	Drug	spironolactone	5833	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C	Hypertension	CYP4A11	rs3890011	1	46933071	G	C	Efficacy
3200	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs9479757	6	154090209	G	A	Toxicity
3201	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Colorectal Neoplasms	TYMS	rs11280056	18	673447	AAGTTA	-	Efficacy
3202	pharmgkb	Drug	pemetrexed	60843	C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O	Mesothelioma	TYMS	rs11280056	18	673447	AAGTTA	-	Efficacy
3203	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	N40D	6	154039662	A	G	Toxicity
3204	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs2298897	1	28839325	C	G	Toxicity
3205	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs2236855	1	28835487	C	R	Toxicity
3206	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRD1	rs678849	1	28818676	C	T	Toxicity
3207	pharmgkb	Drug	rifampin	5381226	C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C	drug-induced liver injury	SLCO1B1	SLCO1B1*1, SLCO1B1*15					Toxicity
3208	pharmgkb		antidepressants,antipsychotics,benzodiazepine derivatives,opioids,Sympathomimetics			Heart Arrest,Overdose,Respiratory Insufficiency	OPRM1	N40D	6	154039662	A	G	Toxicity
3209	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	ABCB1	I1145M	7	87509329	A	K	Other
3210	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	ANKK1	E713K	11	113400106	G	A	Toxicity
3211	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	cessation,Tobacco Use Disorder	HINT1	rs3852209	5	131160322	C	T	Other
3212	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	HINT1	rs3852209	5	131160322	C	T	Efficacy
3213	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs3778150	6	154062523	T	C	Toxicity
3214	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	L445M	6	154093438	C	T	Toxicity
3215	pharmgkb		heroin,opioids			Heroin Dependence,Opioid-Related Disorders	OPRM1	rs3823010	6	154058017	G	A	Toxicity
3216	pharmgkb		heroin,opioids			Heroin Dependence,Opioid-Related Disorders	OPRM1	rs524731	6	154053957	C	A	Toxicity
3217	pharmgkb		heroin,opioids			Heroin Dependence,Opioid-Related Disorders	OPRM1	rs511435	6	154047412	C	K	Toxicity
3218	pharmgkb		Drugs used in nicotine dependence,nicotine			Tobacco Use Disorder	CHRNA3	rs1051730	15	78601997	G	A	Dosage
3219	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	OPRM1	rs10485057	6	154092120	A	G	Toxicity
3220	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs10485057	6	154092120	A	G	Dosage
3221	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		OPRM1	rs10485057	6	154092120	A	G	Dosage
3222	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	rs10485057	6	154092120	A	G	Toxicity
3223	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CHRNA3	D398N	15	78590583	G	A	Dosage,Efficacy
3224	pharmgkb		amphetamine,cannabinoids,cocaine,opioids			Substance-Related Disorders	KAT2B	rs9829896	3	20135980	C	W	Toxicity
3225	pharmgkb		aripiprazole,risperidone			Psychotic Disorders,schizoaffective disorder,Schizophrenia	DRD2	rs2514218	11	113522272	C	T	Efficacy
3226	pharmgkb	Drug	aripiprazole	60795	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Psychomotor Agitation	DRD2	rs2514218	11	113522272	C	T	Toxicity
3227	pharmgkb	Drug Class	cannabinoids			Marijuana Abuse	OPRM1	N40D	6	154039662	A	G	Toxicity
3228	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		ANKK1	E713K	11	113400106	G	A	Toxicity
3229	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		DRD2	E713K	11	113400106	G	A	Toxicity
3230	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	OPRM1	N40D	6	154039662	A	G	Toxicity
3231	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs3778150	6	154062523	T	C	Efficacy
3232	pharmgkb	Drug	ethanol	702	CCO		OPRM1	rs3778150	6	154062523	T	C	Dosage
3233	pharmgkb	Drug	oxazepam	4616	C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O		UGT2B15	Y85D	4	68670366	A	C	Metabolism/PK
3234	pharmgkb	Drug	lorazepam	3958	C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl		UGT2B15	Y85D	4	68670366	A	C	Metabolism/PK
3235	pharmgkb	Drug	ethanol	702	CCO		SLC6A3	rs28363170	5	1393748	-	GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT	Other
3236	pharmgkb	Drug	ethanol	702	CCO		SLC6A3	rs28363170	5	1393748	-	GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT	Other
3237	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain,Pain, Postoperative	ABCB1	rs1128503	7	87550285	A	G	Dosage,Efficacy
3238	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	ACSS2	rs6088638	20	34882711	T	C	Toxicity
3239	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HTT	rs362306	4	3240373	G	A	Efficacy
3240	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HRH3	rs3787429	20	62216348	C	K	Efficacy
3241	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CYP1B1	A119S	2	38075034	C	A	Efficacy
3242	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	UGT1A10	E27D	2	233729207	G	A	Efficacy
3243	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CYP1B1	R48G	2	38075247	G	C	Efficacy
3244	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HTT	rs362267	4	3241491	C	T	Efficacy
3245	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	CYP2E1	F421L	10	133537858	C	K	Efficacy
3246	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs4818	22	19963684	C	K	Efficacy
3247	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	AKT1	rs3803300	14	104803442	T	M	Efficacy
3248	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HRH4	rs4483927	18	24464436	G	T	Efficacy
3249	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	DRD3	G9S	3	114171968	C	T	Efficacy
3250	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	AKT1	rs2494732	14	104772855	T	C	Efficacy
3251	pharmgkb		aspirin,prasugrel				NTRK1	rs2768759	1	156882671	A	S	Efficacy
3252	pharmgkb	Drug	ethanol	702	CCO		OPRM1	N40D	6	154039662	A	G	Dosage
3253	pharmgkb	Drug	varenicline	5310966	C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23	Tobacco Use Disorder	CHRNA5	rs2036527	15	78559273	G	A	Efficacy
3254	pharmgkb	Drug	bupropion	444	CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C	Tobacco Use Disorder	CHRNA5	rs2036527	15	78559273	G	A	Efficacy
3255	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA5	rs2036527	15	78559273	G	A	Efficacy
3256	pharmgkb		bupropion,Drugs used in nicotine dependence,nicotine,varenicline			Tobacco Use Disorder	CHRNA5	D398N	15	78590583	G	A	Efficacy
3257	pharmgkb	Drug Class	opioids			Pain	TAOK3	rs1277441	12	118168184	G	M	Efficacy
3258	pharmgkb	Drug Class	opioids			Pain	TAOK3	rs1277441	12	118168184	G	M	Dosage
3259	pharmgkb	Drug Class	opioids			Pain	TAOK3	rs795484	12	118152057	T	C	Efficacy
3260	pharmgkb	Drug Class	opioids			Pain	TAOK3	rs795484	12	118152057	T	C	Dosage
3261	pharmgkb		Drugs used in nicotine dependence,nicotine			Tobacco Use Disorder	CHRNA3	rs1051730	15	78601997	G	A	Efficacy
3262	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Pregnancy	CHRNA3	rs1051730	15	78601997	G	A	Other
3263	pharmgkb		Drugs used in nicotine dependence,nicotine			Tobacco Use Disorder	CHRNA3	rs1051730	15	78601997	G	A	Other
3264	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CHRNA3	rs1051730	15	78601997	G	A	Toxicity
3265	pharmgkb	Drug Class	opioids			Pain,Pain, Postoperative	ABCB1	I1145M	7	87509329	A	K	Dosage
3266	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain	ABCB1	I1145M	7	87509329	A	K	Dosage
3267	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs508448	1	28855013	A	G	Other
3268	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs3778151	6	154072545	T	C	Toxicity
3269	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	BDNF	rs16917234	11	27676827	T	M	Other
3270	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs4654327	1	28863626	G	A	Toxicity
3271	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	XIRP2	rs7606603	2	167134845	C	W	Efficacy
3272	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	TXNDC11	rs3784921	16	11680345	G	T	Efficacy
3273	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	K97N	15	78617110	T	M	Toxicity
3274	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs7178270	15	78628735	C	K	Toxicity
3275	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB4	rs1948	15	78625057	A	K	Toxicity
3276	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PIP5K1C	rs2074957	19	3653527	C	W	Toxicity
3277	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PIP5K1C	rs4807493	19	3631038	A	G	Toxicity
3278	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PIP5K1C	rs10432303	19	3656654	G	A	Toxicity
3279	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PIP5K1C	rs8109485	19	3664096	A	G	Toxicity
3280	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PIP5K1C	rs4432372	19	3698844	A	K	Toxicity
3281	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PIP5K1C	rs10405681	19	3634021	C	W	Toxicity
3282	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PIP5K1C	rs1476592	19	3679742	A	K	Toxicity
3283	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PIP5K1C	rs10419980	19	3685118	C	T	Toxicity
3284	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PNPLA3	I148M	22	43928847	C	G	Toxicity
3285	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		ADRB2	R175W	5	148827354	C	W	Other
3286	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Neoplasms,Pain	CYP3A5	CYP3A5*1, CYP3A5*3					Toxicity
3287	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major	GNB3	rs5441	12	6839862	A	K	Efficacy
3288	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	CYP3A4	rs2242480	7	99763843	C	T	Efficacy
3289	pharmgkb		ethambutol,isoniazid,pyrazinamide,rifampin			Maculopapular Exanthema,Tuberculosis	CYP2C9	rs9332096	10	94937118	C	T	Toxicity
3290	pharmgkb		ethambutol,isoniazid,pyrazinamide,rifampin			Maculopapular Exanthema,Tuberculosis	CYP2C19	rs4986893	10	94780653	G	A	Toxicity
3291	pharmgkb		fluorouracil,leucovorin,oxaliplatin			Colonic Neoplasms	MTHFR	A222V	1	11796321	G	A	Efficacy
3292	pharmgkb		capecitabine,fluorouracil,leucovorin,oxaliplatin			Neoplasms	MTHFR	E429A	1	11794419	T	G	Toxicity
3293	pharmgkb		capecitabine,fluorouracil,leucovorin,oxaliplatin			Neoplasms	MTHFR	E429A	1	11794419	T	G	Efficacy
3294	pharmgkb		buprenorphine,fentanyl,tramadol			Opioid-Related Disorders,Sexual Dysfunctions, Psychological	OPRD1	rs2234918	1	28863085	C	T	Toxicity
3295	pharmgkb		buprenorphine,fentanyl,tramadol			adverse events,Opioid-Related Disorders	ARRB2	rs1045280	17	4719343	C	T	Toxicity
3296	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	CYP27B1	rs10877012	12	57768302	G	Y	Efficacy
3297	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	UGT1A1	rs887829	2	233759924	C	T	Efficacy
3298	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	GC	D432E	4	71752617	A	Y	Efficacy
3299	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	UGT1A3	rs1983023	2	233728376	T	C	Efficacy
3300	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	VDR	rs731236	12	47844974	A	G	Efficacy
3301	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	beta-Thalassemia	VDR	rs1544410	12	47846052	C	D	Efficacy
3302	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Psoriatic,Psoriasis	TNFAIP3	rs610604	6	137878280	G	T	Efficacy
3303	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Psoriatic,Psoriasis	SH3BP2	rs6920220	6	137685367	G	A	Efficacy
3304	pharmgkb	Drug	ethanol	702	CCO	Alcoholism,Attention Deficit Disorder with Hyperactivity	MAP2K4	rs2159140	17	12073183	T	C	Toxicity
3305	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	ADGRL3	rs2271339	4	61996667	A	G	Toxicity
3306	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	ADGRL3	rs1456862	4	61380610	A	T	Toxicity
3307	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Neoplasms	SLC22A1	M408V	6	160139813	A	S	Efficacy,Toxicity,Metabolism/PK
3308	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Gastrointestinal Stromal Tumors	CYP1A2	rs762551	15	74749576	C	A	Dosage
3309	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Drug Toxicity,Gastrointestinal Stromal Tumors	ABCG2	V12M	4	88139962	C	T	Dosage
3310	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	Drug Toxicity,Gastrointestinal Stromal Tumors	ABCB1	rs28656907	7	87714706	T	M	Dosage
3311	pharmgkb	Drug	mexiletine	4178	CC1=C(C(=CC=C1)C)OCC(C)N	Myotonic Disorders	SCN4A	I1310N					Efficacy
3312	pharmgkb	Drug	mexiletine	4178	CC1=C(C(=CC=C1)C)OCC(C)N	Myotonic Disorders	SCN4A	N1297K	17	63944694	G	T	Efficacy
3313	pharmgkb	Drug	flecainide	3356	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	Myotonic Disorders	SCN4A	I1310N					Efficacy
3314	pharmgkb	Drug	mexiletine	4178	CC1=C(C(=CC=C1)C)OCC(C)N	Myotonic Disorders	SCN4A	F1298C	17	63944692	A	S	Efficacy
3315	pharmgkb		flecainide,mexiletine			Myotonia	SCN4A	G1306V	17	63943846	C	D	Efficacy
3316	pharmgkb	Drug	mexiletine	4178	CC1=C(C(=CC=C1)C)OCC(C)N	Myotonic Disorders	SCN4A	T1313M	17	63943825	G	A	Efficacy
3317	pharmgkb	Drug	flecainide	3356	C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F	Myotonic Disorders	SCN4A	T1313M	17	63943825	G	A	Efficacy
3318	pharmgkb	Drug	rocuronium	441290	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		ABCB1	rs1128503	7	87550285	A	G	Efficacy
3319	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	D33G	X	101407806	T	C	Efficacy
3320	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	A156T	X	101401713	C	T	Efficacy
3321	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	G85A					Efficacy
3322	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	G183D	X	101400757	C	A	Efficacy
3323	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	R356W	X	101398033	G	A	Efficacy
3324	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	R112H	X	101403845	C	W	Efficacy
3325	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	M187I	X	101400744	C	T	Efficacy
3326	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	P205T	X	101400692	G	Y	Efficacy
3327	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	L300P	X	101398470	A	G	Efficacy
3328	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	D313Y	X	101398432	C	W	Efficacy
3329	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	L36W	X	101407797	A	C	Efficacy
3330	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	Y216C	X	101398939	T	C	Efficacy
3331	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	L243F	X	101398857	C	K	Efficacy
3332	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	I253T	X	101398828	A	G	Efficacy
3333	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	P259L	X	101398810	G	M	Efficacy
3334	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	R301L	X	101398467	C	W	Efficacy
3335	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	D322E	X	101398403	G	Y	Efficacy
3336	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	G373S	X	101397982	C	T	Efficacy
3337	pharmgkb	Drug	migalastat	176077		Fabry Disease	GLA	D264N	X	101398796	C	A	Efficacy
3338	pharmgkb		azathioprine,mercaptopurine			Pancytopenia,Thrombocytopenia	NUDT15	rs746071566	13	48037783	GGAGTC	-	Toxicity
3339	pharmgkb		azathioprine,mercaptopurine			Pancytopenia,Thrombocytopenia	NUDT15	R139C	13	48045719	C	T	Toxicity
3340	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	P2RX7	rs1718125	12	121155216	C	T	Dosage
3341	pharmgkb	Drug	tianeptine	68870		Depressive Disorder, Major,suicidal ideation	OPRM1	N40D	6	154039662	A	G	Toxicity
3342	pharmgkb	Drug	ibuprofen	3672	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O		CYP2C8	CYP2C8*1, CYP2C8*3					Dosage
3343	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	CYP2C19*1, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*9, CYP2C19*10, CYP2C19*11, CYP2C19*13, CYP2C19*14, CYP2C19*15, CYP2C19*16, CYP2C19*18, CYP2C19*19, CYP2C19*22, CYP2C19*23, CYP2C19*24, CYP2C19*25, CYP2C19*26					Metabolism/PK
3344	pharmgkb	Drug	tolbutamide	5505	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	P73L	10	94941907	C	T	Metabolism/PK
3345	pharmgkb	Drug	tolbutamide	5505	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	I264S	10	94949256	T	S	Metabolism/PK
3346	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	A173D	10	94780535	C	W	Metabolism/PK
3347	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	V113I	10	94775395	G	A	Metabolism/PK
3348	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	Q193R	10	94780595	A	G	Metabolism/PK
3349	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	Q22R	10	94762770	A	G	Metabolism/PK
3350	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Drug Toxicity,Tuberculosis	XPO1	rs4430924	2	61476721	A	S	Toxicity
3351	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	M77I	16	28608521	C	T	Metabolism/PK
3352	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	M77I	16	28608521	C	T	Metabolism/PK
3353	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		NPIPB8	F247L	16	28606092	A	S	Metabolism/PK
3354	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		NPIPB8	F247L	16	28606092	A	S	Metabolism/PK
3355	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		NPIPB8	F247L	16	28606092	A	S	Metabolism/PK
3356	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	R135H	16	28606193	C	T	Metabolism/PK
3357	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	R135H	16	28606193	C	T	Metabolism/PK
3358	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	R135H	16	28606193	C	T	Metabolism/PK
3359	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	R37L	16	28608746	C	W	Metabolism/PK
3360	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	R37L	16	28608746	C	W	Metabolism/PK
3361	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	R37L	16	28608746	C	W	Metabolism/PK
3362	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	H71Y	16	28607005	G	A	Metabolism/PK
3363	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	H71Y	16	28607005	G	A	Metabolism/PK
3364	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	H71Y	16	28607005	G	A	Metabolism/PK
3365	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	Y91D	16	28606850	A	C	Metabolism/PK
3366	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	Y91D	16	28606850	A	C	Metabolism/PK
3367	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	Y91D	16	28606850	A	C	Metabolism/PK
3368	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	V165A	16	28606103	A	K	Metabolism/PK
3369	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	V165A	16	28606103	A	K	Metabolism/PK
3370	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	V165A	16	28606103	A	K	Metabolism/PK
3371	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	P47S	16	28608717	G	A	Metabolism/PK
3372	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	P47S	16	28608717	G	A	Metabolism/PK
3373	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	P47S	16	28608717	G	A	Metabolism/PK
3374	pharmgkb	Drug	tapentadol	9838022	CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C		SULT1A1	T149P	16	28606152	T	G	Metabolism/PK
3375	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O		SULT1A1	T149P	16	28606152	T	G	Metabolism/PK
3376	pharmgkb	Metabolite	desmethylnaproxen	162920	CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O		SULT1A1	T149P	16	28606152	T	G	Metabolism/PK
3377	pharmgkb	Drug, Biological Intermediate	conjugated estrogens	23667301	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]	Endometrial Neoplasms	SULT1A1	R135H	16	28606193	C	T	Toxicity
3378	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O	Pain	SULT1A1	R135H	16	28606193	C	T	Efficacy
3379	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Mesothelioma,Thrombocytopenia	AQP1	rs1049305	7	30924207	G	C	Toxicity
3380	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Thrombocytopenia	AQP1	G165D	7	30922175	G	A	Toxicity
3381	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Alopecia,Mesothelioma	AQP1	rs1049305	7	30924207	G	C	Toxicity
3382	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Anemia,Mesothelioma	AQP1	rs1049305	7	30924207	G	C	Toxicity
3383	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Leukopenia,Mesothelioma	AQP1	rs1049305	7	30924207	G	C	Toxicity
3384	pharmgkb	Drug	ethanol	702	CCO		SRPRB	rs17376019	3	133822039	C	T	Metabolism/PK
3385	pharmgkb	Metabolite	acetaldehyde	177			ADH1A	rs1229976	4	99280921	C	W	Metabolism/PK
3386	pharmgkb	Drug	ABT-751			Neoplasms	UGT1A8	rs6431558	2	233620997	C	T	Other
3387	pharmgkb	Drug Class	Beta Blocking Agents				KL	rs36217263	13	33015697	A	-	Efficacy
3388	pharmgkb	Drug Class	calcium channel blockers			Hypertension	CACNA1C	rs2238032	12	2113566	T	S	Efficacy
3389	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	hematopoietic stem cell transplantation,Neurotoxicity Syndromes	ABCB1	rs1128503	7	87550285	A	G	Toxicity
3390	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension	ADRB1	S49G	10	114044277	A	G	Efficacy
3391	pharmgkb	Drug Class	glucocorticoids			Asthma	HSD3B1	T367I	1	119514623	C	A	Efficacy
3392	pharmgkb		fluorouracil,irinotecan,leucovorin			Colorectal Neoplasms	KLC1	T241M	14	103699416	G	A	Efficacy
3393	pharmgkb		isoniazid,rifampin			Toxic liver disease,Tuberculosis	NOS2	rs11080344	17	27777485	T	C	Toxicity
3394	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b			Myeloproliferative Disorders	IFNL3	rs12979860	19	39248147	C	T	Efficacy
3395	pharmgkb	Drug	caffeine	2519	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	Anxiety Disorders	ADORA2A	rs3761422	22	24430704	T	C	Toxicity
3396	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular	SLC15A2	L350V	3	121924957	C	K	Efficacy
3397	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Cardiovascular Diseases	HMGCR	rs3846662	5	75355259	A	G	Other
3398	pharmgkb	Drug Class	calcium channel blockers			Hypertension	CACNA1C	rs2239128	12	2648603	T	C	Efficacy
3399	pharmgkb	Drug Class	calcium channel blockers				CACNA1C	rs2239050	12	2338248	G	M	Efficacy
3400	pharmgkb		aspirin,clopidogrel,prasugrel				PEAR1	rs12041331	1	156899922	G	A	Efficacy
3401	pharmgkb	Drug	rosiglitazone	77999	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3	Diabetes Mellitus, Type 2,Weight gain	PLIN1	rs894160	15	89668592	C	T	Toxicity
3402	pharmgkb	Metabolite	acetaldehyde	177			ADH1B	H48R	4	99318162	T	S	Metabolism/PK
3403	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	CCL11	A23P	17	34285875	G	H	Toxicity
3404	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	OPRD1	rs678849	1	28818676	C	T	Efficacy
3405	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		MYD88	rs6853	3	38142879	A	G	Toxicity
3406	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ALDH1L1	V330L	3	126146923	C	A	Efficacy
3407	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms,Neutropenia	CBR3	rs112783657	21	36183988	C	T	Toxicity
3408	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	DRD2	rs1799732	11	113475530	-	R	Toxicity
3409	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	CACNA1E	rs3845446	1	181797301	T	C	Dosage
3410	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Schizophrenia	PDE4D	rs2164660	5	59715681	G	A	Efficacy
3411	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms	SLC22A2	S270A	6	160249250	A	C	Toxicity
3412	pharmgkb	Drug	l-phenylalanine	6140	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	R158P	12	102866632	C	K	Metabolism/PK
3413	pharmgkb	Drug	carbocisteine	193653			PAH	I65S	12	102894893	A	B	Metabolism/PK
3414	pharmgkb	Drug	carbocisteine	193653			PAH	R158P	12	102866632	C	K	Metabolism/PK
3415	pharmgkb	Drug	carbocisteine	193653			PAH	R68S	12	102894883	T	A	Metabolism/PK
3416	pharmgkb	Drug	l-phenylalanine	6140	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	I174N	12	102855321	A	K	Metabolism/PK
3417	pharmgkb	Drug	carbocisteine	193653			PAH	I174N	12	102855321	A	K	Metabolism/PK
3418	pharmgkb	Drug	l-phenylalanine	6140	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	R261Q	12	102852875	C	K	Metabolism/PK
3419	pharmgkb	Drug	carbocisteine	193653			PAH	R261Q	12	102852875	C	K	Metabolism/PK
3420	pharmgkb	Drug	carbocisteine	193653			PAH	V388L	12	102843683	C	K	Metabolism/PK
3421	pharmgkb	Drug	l-phenylalanine	6140	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	V388L	12	102843683	C	K	Metabolism/PK
3422	pharmgkb	Drug	l-phenylalanine	6140	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	R408W	12	102840493	G	A	Metabolism/PK
3423	pharmgkb	Drug	carbocisteine	193653			PAH	R408W	12	102840493	G	A	Metabolism/PK
3424	pharmgkb	Drug	carbocisteine	193653			PAH	Y414C	12	102840474	T	C	Metabolism/PK
3425	pharmgkb	Drug	l-phenylalanine	6140	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	Y414C	12	102840474	T	C	Metabolism/PK
3426	pharmgkb	Drug	l-phenylalanine	6140	C1=CC=C(C=C1)C[C@@H](C(=O)O)N		PAH	R68S	12	102894883	T	A	Metabolism/PK
3427	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung,pneumonitis	ERCC2	D312N	19	45364001	C	W	Toxicity
3428	pharmgkb	Drug Class	Platinum compounds			adverse events,Carcinoma, Non-Small-Cell Lung	ERCC2	D312N	19	45364001	C	W	Toxicity
3429	pharmgkb		atenolol,hydrochlorothiazide,metoprolol			Hypertension	SLC25A31	rs201279313	4	127735886	TTA	-	Efficacy
3430	pharmgkb	Drug Class	antipsychotics			Schizophrenia	NRG1	rs13250975	8	32535292	A	G	Efficacy
3431	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	ZMAT4	rs1367094	8	40544855	C	T	Efficacy
3432	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADGRL3	rs6551665	4	61873823	G	A	Efficacy
3433	pharmgkb	Drug	adalimumab			Inflammatory Bowel Diseases	ATG5	rs9373839	6	106207742	T	C	Efficacy
3434	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	SLC22A2	S270A	6	160249250	A	C	Toxicity
3435	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Constriction, Pathologic,Ischemic Attack, Transient,Stroke	CES1	rs8192950	16	55808492	T	G	Efficacy
3436	pharmgkb	Drug	ticagrelor	9871419	CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO		PEAR1	rs12566888	1	156899255	G	T	Efficacy
3437	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615	CC(CC1=CC2=C(C=C1)OCO2)NC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17					Toxicity
3438	pharmgkb	Drug	3,4-methylenedioxymethamphetamine	1615	CC(CC1=CC2=C(C=C1)OCO2)NC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17					Metabolism/PK
3439	pharmgkb	Drug	tolterodine	60774	CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98					Metabolism/PK
3440	pharmgkb		Antivirals for treatment of HIV infections, combinations,ritonavir			HIV Infections,Hyperlipidemias	APOE	C130R	19	44908684	T	C	Toxicity
3441	pharmgkb		Antivirals for treatment of HIV infections, combinations,ritonavir			HIV Infections,Hyperlipidemias,Hypertriglyceridemia	APOE	R176C	19	44908822	C	T	Toxicity
3442	pharmgkb	Drug Class	hmg coa reductase inhibitors			Alzheimer Disease	APOE	C130R	19	44908684	T	C	Efficacy
3443	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		APOE	R176C	19	44908822	C	T	Efficacy
3444	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		APOE	R176C	19	44908822	C	T	Efficacy
3445	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOE	R176C	19	44908822	C	T	Efficacy
3446	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		APOE	R176C	19	44908822	C	T	Efficacy
3447	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		APOE	C130R	19	44908684	T	C	Efficacy
3448	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Myocardial Infarction	APOE	C130R	19	44908684	T	C	Efficacy
3449	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Artery Disease	ABCB1	I1145M	7	87509329	A	K	Efficacy
3450	pharmgkb		cytarabine,daunorubicin,dexrazoxane,idarubicin			Leukemia, Myeloid, Acute	ABCB1	S893A	7	87531302	A	Y	Efficacy
3451	pharmgkb	Drug	propranolol	4946	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O	Liver Cirrhosis	ADRB2	R16G	5	148826877	G	A	Efficacy
3452	pharmgkb	Drug Class	Antihypertensives			Hypertension	PTPRD	rs324498	9	9059545	G	A	Efficacy
3453	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*9, CYP2D6*29					Metabolism/PK
3454	pharmgkb		o-desmethyltramadol,tramadol				RGL4	L90Q	22	23692424	T	A	Metabolism/PK
3455	pharmgkb		o-desmethyltramadol,tramadol				ICA1	rs62435418	7	8148016	G	W	Metabolism/PK
3456	pharmgkb		o-desmethyltramadol,tramadol				HCN1	rs79983226	5	45595553	G	C	Metabolism/PK
3457	pharmgkb		o-desmethyltramadol,tramadol				RFPL4B	rs9384825	6	112346991	C	T	Metabolism/PK
3458	pharmgkb	Metabolite	acetaldehyde	177			PGM1	rs4643	1	63659768	A	C	Metabolism/PK
3459	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	lung transplantation,overall survival	SLCO1B3	S112P	12	20858546	T	S	Efficacy
3460	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	chronic lung allograft dysfunction,lung transplantation	SLCO1B3	S112P	12	20858546	T	S	Efficacy
3461	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	lung transplantation,overall survival	SLCO1B3	M233I	12	20862826	G	A	Efficacy
3462	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	lung transplantation,transplant rejection	SLCO1B3	S112P	12	20858546	T	S	Efficacy
3463	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	lung transplantation,transplant rejection	SLCO1B3	M233I	12	20862826	G	A	Efficacy
3464	pharmgkb	Drug	mycophenolic acid	446541	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC	chronic lung allograft dysfunction,lung transplantation	SLCO1B3	M233I	12	20862826	G	A	Efficacy
3465	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRK1	rs6473797	8	53240422	T	C	Toxicity
3466	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	rs495491	6	154061407	A	G	Toxicity
3467	pharmgkb	Drug	botulinum toxin type a			Migraine NOS	TRPV1	P91S	17	3592080	G	A	Efficacy
3468	pharmgkb	Drug	botulinum toxin type a			Migraine NOS	CALCA	rs3781719	11	14972978	A	G	Efficacy
3469	pharmgkb	Drug	letermovir	45138674			SLCO1B1	rs4149032	12	21164857	C	T	Metabolism/PK
3470	pharmgkb	Drug	letermovir	45138674			SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
3471	pharmgkb	Drug	letermovir	45138674			UGT1A1	G71R	2	233760498	G	A	Metabolism/PK
3472	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	DRD2	rs12364283	11	113476233	A	G	Toxicity
3473	pharmgkb	Drug Class	opioids			Heroin Dependence,Opioid-Related Disorders	DRD2	rs1076560	11	113412966	C	A	Other
3474	pharmgkb		atenolol,metoprolol			Hypertension	SLC4A1	rs45545233	17	44260984	T	C	Efficacy
3475	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	SYT1	rs2251214	12	79430071	A	K	Toxicity
3476	pharmgkb	Drug	disulfiram	3117	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	SLC6A3	rs28363170	5	1393748	-	GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT	Efficacy
3477	pharmgkb		atenolol,metoprolol			Tachycardia	ADRB2	R16G	5	148826877	G	A	Efficacy
3478	pharmgkb		atenolol,metoprolol			Tachycardia	ADRB2	Q27E	5	148826910	G	Y	Efficacy
3479	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	RABGAP1L	rs61826952	1	174668799	A	G	Toxicity
3480	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	adverse events,Arthritis, Rheumatoid	SLC19A1	rs2838956	21	45525110	A	G	Toxicity
3481	pharmgkb	Drug	atazanavir	148192	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	HIV Infections	SORCS2	rs73208473	4	7322869	C	W	Metabolism/PK
3482	pharmgkb	Drug	Vitamin K1	5284607			CYP4F2	CYP4F2*1, CYP4F2*3					Metabolism/PK
3483	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement,Hemorrhage	APOB	A618V	2	21028042	G	A	Toxicity
3484	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	heart valve replacement,Hemorrhage	APOB	T98I	2	21041028	G	A	Toxicity
3485	pharmgkb	Drug	lopinavir	92727	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	HIV Infections	CYP3A	rs776746	7	99672916	T	C	Metabolism/PK
3486	pharmgkb	Drug	amprenavir	65016	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N	HIV Infections	SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
3487	pharmgkb	Drug	lopinavir	92727	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	HIV Infections	CYP3A4	CYP3A4*1, CYP3A4*22					Metabolism/PK
3488	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	NUCB2	Q338E	11	17330136	C	G	Efficacy
3489	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	RRP1B	L436P	21	43687681	T	C	Efficacy
3490	pharmgkb	Drug	candesartan	2541	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	SH2B3	W262G	12	111446804	T	V	Efficacy
3491	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	C5orf56	rs12521868	5	132448701	G	T	Efficacy
3492	pharmgkb	Drug	candesartan	2541	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	KCNK3	rs1275988	2	26691496	C	T	Efficacy
3493	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	CSK	rs1378942	15	74785026	C	W	Efficacy
3494	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PDE3A	rs12579720	12	20020830	C	D	Efficacy
3495	pharmgkb	Drug	candesartan	2541	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	SULT1C3	M194T	2	108258788	T	C	Efficacy
3496	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	STN1	rs4387287	10	103918139	A	C	Efficacy
3497	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension	TBX2	rs8068318	17	61406405	C	T	Efficacy
3498	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PLCE1	rs932764	10	94136183	A	G	Efficacy
3499	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	ADO	P39A	10	62805174	C	G	Efficacy
3500	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PRKAG2	rs10224002	7	151717955	A	G	Efficacy
3501	pharmgkb	Drug	candesartan	2541	CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O	Hypertension	DOT1L	rs740406	19	2232222	A	K	Efficacy
3502	pharmgkb	Drug	remifentanil	60815	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC		ABCB1	I1145M	7	87509329	A	K	Dosage
3503	pharmgkb	Drug	remifentanil	60815	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC		ABCB1	I1145M	7	87509329	A	K	Efficacy
3504	pharmgkb	Drug Class	opioids			Overdose	MCOLN1	rs114077267	19	7522131	C	W	Toxicity
3505	pharmgkb	Drug Class	opioids			Overdose	MCOLN1	rs115208233	19	7524175	C	G	Toxicity
3506	pharmgkb	Drug Class	opioids			Overdose	MCOLN1	rs116181528	19	7529361	C	W	Toxicity
3507	pharmgkb		docetaxel,FEC100,gemcitabine,trastuzumab,zoledronate			Amenorrhea	PPCDC	rs147451859	15	75039102	C	G	Toxicity
3508	pharmgkb		phenobarbital,phenytoin			Epilepsy,Psychotic Disorders	MTHFR	A222V	1	11796321	G	A	Toxicity
3509	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CHRNA3	rs578776	15	78596058	G	A	Toxicity
3510	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CHRNA4	S543R	20	63349782	G	M	Toxicity
3511	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CHRNA4	rs2229959	20	63350202	C	W	Toxicity
3512	pharmgkb	Drug Class	Beta blocking agents, selective			Hypertension	BST1	rs28404156	4	15736109	G	A	Efficacy
3513	pharmgkb	Drug Class	antipsychotics			Weight gain	DGKB	rs1525085	7	14600073	G	A	Toxicity
3514	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	ANKS1B	rs2133896	12	99455122	G	T	Toxicity
3515	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	ANKS1B	rs2133896	12	99455122	G	T	Toxicity
3516	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	methamphetamine dependence	ANKS1B	rs2133896	12	99455122	G	T	Toxicity
3517	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		OPRD1	rs581111	1	28848861	A	G	Efficacy
3518	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Drug Toxicity	ERCC1	rs11615	19	45420395	A	G	Toxicity
3519	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	PDYN	rs910080	20	1979580	A	G	Toxicity
3520	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	PDYN	rs1997794	20	1994212	T	C	Toxicity
3521	pharmgkb	Drug	artemether	9796294	C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)OC)C		CYP2B6	CYP2B6*1, CYP2B6*6					Metabolism/PK
3522	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	PDYN	rs1022563	20	1973693	C	K	Toxicity
3523	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CES1	rs778068631	16	55820390	A	-	Metabolism/PK
3524	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Toxicity
3525	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	SLC6A4	rs2066713	17	30224647	G	A	Toxicity
3526	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	SLC6A4	rs25531	17	30237328	T	C	Toxicity
3527	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	SLC6A4	rs4251417	17	30224840	C	T	Toxicity
3528	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	UGT2B7	Y268H	4	69098620	T	C	Efficacy
3529	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		UGT2B7	Y268H	4	69098620	T	C	Metabolism/PK
3530	pharmgkb		cisplatin,fluorouracil			Liver Neoplasms	GALNT14	rs9679162	2	31024648	G	T	Efficacy
3531	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hepatitis C,Liver Neoplasms	GALNT14	rs9679162	2	31024648	G	T	Efficacy
3532	pharmgkb	Drug	thioguanine	2723601	C1=NC2=C(N1)C(=S)N=C(N2)N	Crohn Disease	TPMT	TPMT*1, TPMT*3A, TPMT*3C					Metabolism/PK
3533	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	C6orf15	rs2233980	6	31111867	G	A	Toxicity
3534	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	SERPINC1	rs5877	1	173909724	T	M	Toxicity
3535	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	ATAT1	rs9262132	6	30643573	C	W	Toxicity
3536	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	PPP1R18	G339R	6	30685004	C	K	Toxicity
3537	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	CDSN	rs3130985	6	31117579	C	T	Toxicity
3538	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	HLA-C	rs1049709	6	31269077	T	C	Toxicity
3539	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	MUCL3	rs3094086	6	30951614	G	A	Toxicity
3540	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	HCP5	rs3130907	6	31464036	A	G	Toxicity
3541	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	PRRC2A	rs11229	6	31635993	A	G	Toxicity
3542	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	TNF	rs1800629	6	31575254	G	A	Toxicity
3543	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	PRRC2A	P2006S	6	31636814	C	T	Toxicity
3544	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	MSH5	rs3115672	6	31760120	C	T	Toxicity
3545	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	DOCK8	rs10491684	9	449798	G	A	Toxicity
3546	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	CYP2C8	rs1058932	10	95037104	G	A	Toxicity
3547	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	CYP2C8	rs11572078	10	95067363	-	AA/A	Toxicity
3548	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	SERPINA5	K105E	14	94587675	A	G	Toxicity
3549	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	XYLT2	T801I	17	50360095	C	K	Toxicity
3550	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	SERPINA5	rs6113	14	94587512	T	C	Toxicity
3551	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	SERPINA5	A55V	14	94587526	C	T	Toxicity
3552	pharmgkb		carboplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung,Thrombocytopenia	ETS2	A19T	21	38805401	G	A	Toxicity
3553	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764		HIV Infections,nephrotoxicity	SLC28A2	P22L	15	45253280	C	T	Toxicity
3554	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764		HIV Infections,nephrotoxicity	CYP24A1	rs2248359	20	54174979	C	T	Toxicity
3555	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764		HIV Infections,nephrotoxicity	CYP27B1	rs4646536	12	57764205	A	G	Toxicity
3556	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC2	rs717620	10	99782821	C	T	Toxicity
3557	pharmgkb	Drug	temozolomide	5394	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	Glioma	ABCB1	S400N	7	87550493	C	W	Efficacy
3558	pharmgkb	Drug	creatine	586	CN(CC(=O)O)C(=N)N	Amyotrophic Lateral Sclerosis	MOBP	rs616147	3	39492990	A	G	Efficacy
3559	pharmgkb	Drug	desloratadine	124087	C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4	sedation,Urticaria	HRH1	rs901865	3	11259021	T	C	Toxicity
3560	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms	OTOS	rs2291767	2	240140715	T	C	Toxicity
3561	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms	TPMT	rs12201199	6	18139571	A	T	Toxicity
3562	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Ototoxicity	SLC22A2	S270A	6	160249250	A	C	Toxicity
3563	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Drug Toxicity,Neoplasms,Ototoxicity	ABCC3	rs1051640	17	50691125	A	G	Toxicity
3564	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms,Ototoxicity,Testicular Neoplasms	SLC16A5	L41M	17	75093757	T	C	Toxicity
3565	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCB1	rs3842	7	87504050	T	C	Other
3566	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCB1	I1145M	7	87509329	A	K	Other
3567	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2A6	rs28399433	19	40850474	A	B	Other
3568	pharmgkb	Drug	ethanol	702	CCO	Alcoholism,Bipolar Disorder	CACNA1C	rs1034936	12	2551994	C	T	Toxicity
3569	pharmgkb	Drug	lurasidone	213046	C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O	Schizophrenia	HTR1A	rs6295	5	63962738	C	G	Efficacy
3570	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Toxic liver disease,Tuberculosis	ABCC2	rs3740065	10	99845936	A	G	Toxicity
3571	pharmgkb	Drug	interferon beta-1a			Multiple Sclerosis	RORA	rs4774388	15	61174799	C	T	Efficacy
3572	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Toxic liver disease	RELA	rs11227247	11	65655382	A	C	Toxicity
3573	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	IKBKB	rs2272733	8	42300384	T	C	Efficacy
3574	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Diarrhea	IKBKE	rs2151222	1	206480926	A	G	Toxicity
3575	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	IKBKE	rs12142086	1	206484465	T	S	Toxicity
3576	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Diarrhea	NFKBIA	rs2233406	14	35405593	G	A	Toxicity
3577	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Toxic liver disease	NFKBIA	rs2233407	14	35405317	T	M	Toxicity
3578	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	IKBKB	rs9694958	8	42298528	A	G	Toxicity
3579	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	IKBKE	P713L	1	206496132	C	T	Toxicity
3580	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Diarrhea	NFKBIA	rs2233409	14	35405064	G	A	Toxicity
3581	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Toxic liver disease	NFKBIB	rs2053071	19	38900291	C	G	Toxicity
3582	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Diarrhea	NR1H2	rs2695121	19	50377484	T	C	Toxicity
3583	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Diarrhea	TAB2	rs577001	6	149325172	C	T	Toxicity
3584	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung,Exanthema	NFKBIA	rs8904	14	35402011	G	H	Toxicity
3585	pharmgkb	Drug	progesterone	5994	CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*17					Metabolism/PK
3586	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	ANKK1	E713K	11	113400106	G	A	Toxicity
3587	pharmgkb	Drug Class	opioids			Dizziness	COMT	rs4633	22	19962712	C	T	Toxicity
3588	pharmgkb	Drug Class	opioids			Sexual Dysfunctions, Psychological	COMT	rs4633	22	19962712	C	T	Toxicity
3589	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		CYP3A5	CYP3A5*1, CYP3A5*3					Dosage
3590	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		CYP3A5	CYP3A5*1, CYP3A5*3					Dosage
3591	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		ABCB1	rs1128503	7	87550285	A	G	Dosage
3592	pharmgkb	Drug	methamphetamine	10836	C[C@@H](CC1=CC=CC=C1)NC	Substance-Related Disorders	FAAH	P129T	1	46405089	C	A	Other
3593	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	ADGRV1	rs2366929	5	90730817	T	C	Toxicity
3594	pharmgkb	Drug	diclofenac	3033	C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl		CYP2C8	CYP2C8*1, CYP2C8*3, CYP2C8*4					Metabolism/PK
3595	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs10457090	6	154069938	A	K	Toxicity
3596	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs589046	6	154072003	C	T	Toxicity
3597	pharmgkb	Drug	hydralazine / isosorbide dinitrate	9954530		Heart Failure	GNB3	rs5443	12	6845711	C	T	Efficacy
3598	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	GAD1	rs3749034	2	170816965	G	W	Dosage
3599	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	GAD1	rs3762556	2	170815568	C	R	Dosage
3600	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	GAD1	H37Q	2	170822115	T	C	Dosage
3601	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		OPRD1	rs204047	1	28818612	G	Y	Dosage
3602	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		OPRD1	rs797397	1	28824671	G	A	Metabolism/PK
3603	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		OPRD1	rs204047	1	28818612	G	Y	Metabolism/PK
3604	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRK1	rs3802279	8	53228388	C	T	Dosage
3605	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRK1	rs3802281	8	53228603	T	C	Dosage
3606	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRK1	rs963549	8	53229264	C	T	Dosage
3607	pharmgkb	Drug	dipyrone	522325	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]		CYP2C19	CYP2C19*1, CYP2C19*2					Metabolism/PK
3608	pharmgkb	Drug	dipyrone	522325	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]		CYP2C9	CYP2C9*1, CYP2C9*3					Metabolism/PK
3609	pharmgkb	Drug	dipyrone	522325	CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]		NAT2	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14					Metabolism/PK
3610	pharmgkb	Drug Class	opioids			Nausea,Vomiting	CRYBG2	S902Y	1	26343953	G	T	Toxicity
3611	pharmgkb	Drug Class	opioids			Nausea,Vomiting	CLCC1	S318R	1	108937356	G	T	Toxicity
3612	pharmgkb	Drug Class	opioids			Nausea,Vomiting	POM121L2	A967P	6	27309272	C	K	Toxicity
3613	pharmgkb	Drug Class	opioids			Nausea,Vomiting	ZNF165	rs9393888	6	28091439	G	Y	Toxicity
3614	pharmgkb	Drug Class	opioids			Nausea,Vomiting	MUC16	V8969M	19	8949865	C	T	Toxicity
3615	pharmgkb	Drug Class	opioids			Nausea,Vomiting	PDE3A	D12N	12	20369318	G	A	Toxicity
3616	pharmgkb	Drug Class	opioids			Nausea,Vomiting	ZNF568	Y488D	19	36997153	T	G	Toxicity
3617	pharmgkb	Drug	cytarabine	6253	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O	Leukemia, Myeloid, Acute	ABCB1	I1145M	7	87509329	A	K	Efficacy
3618	pharmgkb	Drug	hydralazine	3637	C1=CC=C2C(=C1)C=NN=C2NN	Hypertension	NAT2	NAT2*5, NAT2*6, NAT2*7, NAT2*14					Toxicity
3619	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	ABCC3	rs4793665	17	50634726	C	W	Other
3620	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms	ERCC1	Q506K	19	45409478	C	D	Toxicity
3621	pharmgkb	Drug	alprazolam	2118	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4		CYP3A	rs35599367	7	99768693	G	A	Metabolism/PK
3622	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CHRNA5	rs588765	15	78573083	T	M	Toxicity
3623	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	CHRNA3	D398N	15	78590583	G	A	Toxicity
3624	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TH	rs2070762	11	2165105	A	G	Toxicity
3625	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TH	rs10770141	11	2172610	A	S	Toxicity
3626	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TH	rs10770140	11	2172367	C	T	Toxicity
3627	pharmgkb	Drug	dexmedetomidine	68602	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	Pain, Postoperative	ADRA2A	N266K	10	111078794	C	K	Efficacy
3628	pharmgkb	Drug	dexmedetomidine	68602	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	Pain, Postoperative	ADRA2A	R3C	10	111078003	C	T	Efficacy
3629	pharmgkb	Drug	dexmedetomidine	68602	CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C	Pain, Postoperative	ADRA2A	P15L	10	111078040	C	T	Efficacy
3630	pharmgkb	Drug	imatinib	5291	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5		CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22					Metabolism/PK
3631	pharmgkb	Drug	amlodipine	2162	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN		CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7					Metabolism/PK
3632	pharmgkb	Drug	fesoterodine	6918558	CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2		CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22					Metabolism/PK
3633	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	UGT2B7	Y268H	4	69098620	T	C	Efficacy
3634	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	COMT	rs933271	22	19943884	T	M	Efficacy
3635	pharmgkb	Drug Class	opioids			Hyperalgesia	COMT	V158M	22	19963748	G	A	Toxicity
3636	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		CYP2C9	N218I	10	94949118	A	T	Metabolism/PK
3637	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	N218I	10	94949118	A	T	Metabolism/PK
3638	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*29					Metabolism/PK
3639	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	SLC6A4	rs1042173	17	30197993	A	C	Dosage
3640	pharmgkb	Drug	vancomycin	14969	C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O	drug reaction with eosinophilia and systemic symptoms	HLA-A	HLA-A*32:01					Toxicity
3641	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	PDE4B	rs6421482	1	65954222	A	K	Toxicity
3642	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	GCKR	L446R	2	27508073	T	C	Toxicity
3643	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	THSD7B	rs13382553	2	137506661	A	G	Toxicity
3644	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	CADM2	rs62250713	3	85464643	A	G	Toxicity
3645	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	ADH1B	R370H	4	99307859	C	T	Toxicity
3646	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	ADH1B	H48R	4	99318162	T	S	Toxicity
3647	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	ADH1C	rs13125415	4	99349295	A	G	Toxicity
3648	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	SLC39A8	rs13135092	4	102276925	A	G	Toxicity
3649	pharmgkb	Drug Class	antineoplastic agents			Drug Toxicity	TP53	P33H	17	7676154	G	Y	Toxicity
3650	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	DPP6	rs2533200	7	153791989	C	G	Toxicity
3651	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	MED19	rs576859	11	57713151	C	R	Toxicity
3652	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	SLC4A8	rs12296477	12	51510076	C	G	Toxicity
3653	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	ARID4A	rs61974485	14	58299185	T	C	Toxicity
3654	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	TNRC6A	rs72768626	16	24681727	A	G	Toxicity
3655	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	FTO	rs9937709	16	53786901	A	G	Toxicity
3656	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	FUT2	rs492602	19	48703160	A	G	Toxicity
3657	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	ABCB1	I1145M	7	87509329	A	K	Efficacy
3658	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	HTR2A	rs6313	13	46895805	G	A	Efficacy
3659	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia	HTR2A	rs6313	13	46895805	G	A	Efficacy
3660	pharmgkb	Drug	ethylmorphine	5359271			CYP2D6	CYP2D6*1, CYP2D6*4					Metabolism/PK
3661	pharmgkb	Drug	hydrocodone	5284569	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4					Toxicity
3662	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4					Toxicity
3663	pharmgkb	Drug, Metabolite	dihydrocodeine	5284543			CYP2D6	CYP2D6*1, CYP2D6*4					Metabolism/PK
3664	pharmgkb	Drug	hydrocodone	5284569	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	Drug Toxicity	CYP2D6	CYP2D6*1, CYP2D6*2xN					Toxicity
3665	pharmgkb		cisplatin,cyclophosphamide			Drug Toxicity	GSTM3	rs36120609	1	109737631	TCC	-	Toxicity
3666	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		GSTM3	rs36120609	1	109737631	TCC	-	Metabolism/PK
3667	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	HLA-G	rs371194629	6	29830805	-	ATTTGT/ATTTGTTCATGCCT	Efficacy
3668	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	N40D	6	154039662	A	G	Toxicity
3669	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl		UGT1A1	UGT1A1*1, UGT1A1*28					Metabolism/PK
3670	pharmgkb	Drug	raloxifene	5035	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	bone density	UGT1A1	UGT1A1*1, UGT1A1*28					Efficacy
3671	pharmgkb	Drug	raloxifene	5035	C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O	Osteoporosis	UGT1A1	UGT1A1*1, UGT1A1*28					Metabolism/PK
3672	pharmgkb	Drug	metronidazole	4173	CC1=NC=C(N1CCO)[N+](=O)[O-]		CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17					Metabolism/PK
3673	pharmgkb	Drug	tranilast	5282230		Hyperbilirubinemia	UGT1A1	UGT1A1*1, UGT1A1*28					Toxicity
3674	pharmgkb	Drug	nilotinib	644241	CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5	Hyperbilirubinemia	UGT1A1	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28					Toxicity
3675	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	drug reaction with eosinophilia and systemic symptoms	HLA-A	HLA-A*31:01					Toxicity
3676	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		ABCB1	rs1128503	7	87550285	A	G	Metabolism/PK
3677	pharmgkb	Drug	dabigatran				CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
3678	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*10					Dosage
3679	pharmgkb		ketoprofen,tramadol				CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41					Toxicity
3680	pharmgkb	Drug Class	opioids			Death,Opioid-Related Disorders	ABCB1	N21H	7	87600124	T	C	Toxicity
3681	pharmgkb	Drug Class	opioids			Death,Opioid-Related Disorders	COMT	V158M	22	19963748	G	A	Toxicity
3682	pharmgkb	Drug	indinavir	5362440	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	HIV Infections	UGT1A1	UGT1A1*1, UGT1A1*28					Toxicity
3683	pharmgkb	Drug	peginterferon alfa-2a			Hepatitis B, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
3684	pharmgkb	Drug	sofosbuvir	45375808	C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	Hepatitis C, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
3685	pharmgkb	Drug Class	interferons			Hepatitis C	IFNL3	rs12979860	19	39248147	C	T	Efficacy
3686	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	CYP2B6	K262R	19	41009358	A	G	Toxicity
3687	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	PNOC	rs351776	8	28333789	A	C	Toxicity
3688	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	PNOC	rs351776	8	28333789	A	C	Toxicity
3689	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	CYP2A7P1	Q172H	19	41006936	G	W	Toxicity
3690	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	COMT	V158M	22	19963748	G	A	Toxicity
3691	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	PNOC	rs4732636	8	28310063	C	A	Toxicity
3692	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	PNOC	rs4732636	8	28310063	C	A	Toxicity
3693	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	COMT	rs740603	22	19957654	A	G	Toxicity
3694	pharmgkb		carboplatin,cisplatin,oxaliplatin,platinum,Platinum compounds			Neoplasms	ERCC1	rs11615	19	45420395	A	G	Toxicity
3695	pharmgkb	Drug Class	Platinum compounds			overall survival,Thrombocytopenia	SLC31A1	rs10759637	9	113262744	A	C	Efficacy
3696	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	SLC28A2	P22L	15	45253280	C	T	Efficacy
3697	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP2B6	I328T	19	41012316	T	C	Metabolism/PK
3698	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2B6	CYP2B6*1, CYP2B6*6					Toxicity
3699	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2B6	CYP2B6*1, CYP2B6*6					Efficacy
3700	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*13, CYP2C9*59, CYP2C9*62					Metabolism/PK
3701	pharmgkb	Drug	atazanavir	148192	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	HIV Infections	UGT1A1	rs887829	2	233759924	C	T	Other
3702	pharmgkb	Drug Class	antidepressants			Depression	HTR7	rs7905446	10	90859404	T	R	Efficacy
3703	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depression	HTR7	rs7905446	10	90859404	T	R	Efficacy
3704	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Bipolar Disorder	HTR7	rs7905446	10	90859404	T	R	Efficacy
3705	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression	HTR7	rs7905446	10	90859404	T	R	Efficacy
3706	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs495491	6	154061407	A	G	Toxicity
3707	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs495491	6	154061407	A	G	Toxicity
3708	pharmgkb		cisplatin,oxaliplatin,platinum,Platinum compounds			Colorectal Neoplasms,Esophageal Neoplasms,Osteosarcoma,Ovarian Neoplasms,Pancreatic Neoplasms	ERCC2	rs13181	19	45351661	T	R	Efficacy
3709	pharmgkb	Drug Class	Platinum compounds			overall survival	TP53	P33H	17	7676154	G	Y	Efficacy
3710	pharmgkb	Drug Class	corticosteroids			Asthma	CRHR1	rs1876828	17	45834159	C	T	Efficacy
3711	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	hand-foot syndrome,Neoplasms	CDA	rs3215400	1	20589097	C	-	Toxicity
3712	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms,Osteosarcoma,Ototoxicity,Testicular Neoplasms	XPC	Q939E	3	14145949	G	T	Toxicity
3713	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neutropenia,Urinary Bladder Neoplasms	TMEM43	Q939E	3	14145949	G	T	Toxicity
3714	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Drug Toxicity,Urinary Bladder Neoplasms	TMEM43	Q939E	3	14145949	G	T	Toxicity
3715	pharmgkb	Drug	dapsone	2955	C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N	severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:02					Toxicity
3716	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Neoplasms	ABCG2	Q141K	4	88131171	G	Y	Toxicity
3717	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,Hyperbilirubinemia	UGT1A1	UGT1A1*1, UGT1A1*28					Toxicity
3718	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC3	rs9895420	17	50634677	T	A	Efficacy
3719	pharmgkb	Drug	omeprazole	4594	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC		CYP2C19	CYP2C19*1, CYP2C19*23, CYP2C19*29, CYP2C19*30, CYP2C19*31, CYP2C19*33					Metabolism/PK
3720	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	VKORC1	rs9923231	16	31096368	C	D	Toxicity
3721	pharmgkb		pravastatin,simvastatin				HMGCR	rs17244841	5	75347030	A	T	Efficacy
3722	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		HMGCR	rs17244841	5	75347030	A	T	Efficacy
3723	pharmgkb	Metabolite	lovastatin acid	64727	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C		SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
3724	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Hyperprolactinemia,Schizophrenia	ANKK1	E713K	11	113400106	G	A	Toxicity
3725	pharmgkb	Drug	clobazam	2789	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	Epilepsy	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Metabolism/PK
3726	pharmgkb	Drug	clobazam	2789	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	Epilepsy	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Efficacy
3727	pharmgkb	Drug	clobazam	2789	CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3	Epilepsy	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Dosage
3728	pharmgkb	Drug Class	corticosteroids			Asthma	ADRB2	R16G	5	148826877	G	A	Efficacy
3729	pharmgkb		corticosteroids,selective beta-2-adrenoreceptor agonists			Asthma	ADRB2	R16G	5	148826877	G	A	Efficacy
3730	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		LPA	rs10455872	6	160589086	A	G	Efficacy
3731	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	COMT	V158M	22	19963748	G	A	Efficacy
3732	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	COMT	V158M	22	19963748	G	A	Toxicity
3733	pharmgkb	Drug	enalapril	5362032	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O	Arteriosclerosis,Coronary Disease,Essential hypertension,glomerular disease,Glomerulonephritis, IGA,Kidney Diseases	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
3734	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung,Mesothelioma,Pancreatic Neoplasms	CDA	K27Q	1	20589208	A	C	Toxicity
3735	pharmgkb	Drug	caffeine	2519	CN1C=NC2=C1C(=O)N(C(=O)N2C)C	Anxiety Disorders	ADORA2A	rs5751876	22	24441333	T	C	Toxicity
3736	pharmgkb		debrisoquine,dextromethorphan				CYP2D6	CYP2D6*1, CYP2D6*29					Other
3737	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Carcinoma, Non-Small-Cell Lung	EGFR	rs11568315					Efficacy
3738	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depression	CYP2C19	CYP2C19*2					Metabolism/PK
3739	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	EPHX1	Y113H	1	225831932	T	C	Metabolism/PK
3740	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	EPHX1	Y113H	1	225831932	T	C	Dosage
3741	pharmgkb	Drug	lapatinib	208908	CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	Toxic liver disease	HLA-DRB1	HLA-DRB1*07:01					Toxicity
3742	pharmgkb	Prodrug	tegafur	5386		Drug Toxicity	UMPS	G213A	3	124737895	G	M	Toxicity
3743	pharmgkb		cisplatin,oxaliplatin,Platinum compounds			Neoplasms	MTHFR	A222V	1	11796321	G	A	Toxicity
3744	pharmgkb	Drug	lopinavir	92727	CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O	HIV Infections	SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
3745	pharmgkb		interferon alfa-2b, recombinant,ribavirin			Hepatitis C, Chronic	ITPA	P32T	20	3213196	C	R	Dosage
3746	pharmgkb		fluorouracil,FOLFOX			Neoplasms	TYMS	rs11280056	18	673447	AAGTTA	-	Toxicity
3747	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Gout	ABCG2	Q141K	4	88131171	G	Y	Efficacy
3748	pharmgkb		cisplatin,oxaliplatin,Platinum compounds			Carcinoma, Non-Small-Cell Lung,Colorectal Neoplasms,Gastrointestinal Neoplasms,Ovarian Neoplasms	GSTP1	I105V	11	67585218	A	G	Toxicity
3749	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	ANKK1	E713K	11	113400106	G	A	Efficacy
3750	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Drug Toxicity	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Toxicity
3751	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	SCN1A	rs3812718	2	166053034	C	T	Efficacy
3752	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CALU	rs339097	7	128759170	A	G	Dosage
3753	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP4F2	V433M	19	15879621	C	T	Dosage
3754	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	EPHX1	H139R	1	225838705	A	K	Dosage
3755	pharmgkb		diuretics,hydrochlorothiazide			Hypertension	NEDD4L	rs4149601	18	58149559	G	A	Efficacy
3756	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3		CYP2C9	CYP2C9*1, CYP2C9*19, CYP2C9*27, CYP2C9*36, CYP2C9*40, CYP2C9*41, CYP2C9*47, CYP2C9*49, CYP2C9*51, CYP2C9*53, CYP2C9*54, CYP2C9*56					Metabolism/PK
3757	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CCHCR1	rs746647	6	31146405	A	G	Toxicity
3758	pharmgkb	Drug Class	hmg coa reductase inhibitors			Hyperlipidemias	CETP	rs1532624	16	56971567	C	A	Efficacy
3759	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNB2	rs2072661	1	154576404	G	A	Efficacy,Toxicity
3760	pharmgkb	Drug	digoxin	30322	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O		ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
3761	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		UGT2B10	D67Y	4	68816218	G	W	Metabolism/PK
3762	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Breast Neoplasms	SOD2	V16A	6	159692840	A	G	Efficacy
3763	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Transplantation	POR	A503V	7	75985688	C	T	Metabolism/PK
3764	pharmgkb	Drug	rosiglitazone	77999	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3		CYP2C8	CYP2C8*1, CYP2C8*3					Metabolism/PK
3765	pharmgkb	Drug	rosiglitazone	77999	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3		CYP2C8	CYP2C8*1, CYP2C8*3					Toxicity
3766	pharmgkb	Drug	sunitinib	5329102	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	Leukopenia,Myelosuppression,Neutropenia,Thrombocytopenia	FLT3	T227M	13	28050157	G	A	Toxicity
3767	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	MTRR	I49M	5	7870860	A	G	Efficacy
3768	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs7196161	16	31099660	G	M	Dosage
3769	pharmgkb	Drug Class	Bisphosphonates			Osteoporosis,Osteoporosis, Postmenopausal	FDPS	rs2297480	1	155309691	T	G	Efficacy
3770	pharmgkb	Drug	salbutamol	2083	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	CRHR2	rs7793837	7	30687161	A	Y	Efficacy
3771	pharmgkb		etoposide,Platinum compounds				DYNC2H1	rs716274	11	103547430	A	G	Efficacy
3772	pharmgkb		cisplatin,oxaliplatin,Platinum compounds			Neoplasms	GSTM1	GSTM1 non-null, GSTM1 null					Efficacy
3773	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
3774	pharmgkb	Drug	nortriptyline	4543	CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31	Depressive Disorder, Major	GNB3	rs5443	12	6845711	C	T	Efficacy
3775	pharmgkb	Drug	mirtazapine	4205	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Toxicity
3776	pharmgkb		antidepressants,Selective serotonin reuptake inhibitors			Depressive Disorder,Mood Disorders	FKBP5	rs4713916	6	35702206	A	B	Efficacy
3777	pharmgkb	Drug	fluindione			Thromboembolism	VKORC1	rs9934438	16	31093557	G	M	Efficacy
3778	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Hemorrhage	EPHA7	rs78132896	6	93420339	T	C	Toxicity
3779	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	CYP19A1	rs1008805	15	51257402	G	A	Toxicity
3780	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs10497203	2	158994911	A	C	Toxicity
3781	pharmgkb	Drug Class	anthracyclines and related substances			Heart Failure,Neoplasms	CBR3	V244M	21	36146408	G	A	Toxicity
3782	pharmgkb	Drug Class	anthracyclines and related substances			Cardiomyopathies,Neoplasms	CBR1	rs9024	21	36073015	G	A	Toxicity
3783	pharmgkb	Drug	esomeprazole	9568614	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	eosinophilic esophagitis	STAT6	rs1059513	12	57095926	T	C	Efficacy
3784	pharmgkb	Drug Class	antipsychotics			Mental Disorders	HTR2C	rs3813929	X	114584047	C	K	Toxicity
3785	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Mental Disorders,Schizophrenia	HTR2C	rs3813929	X	114584047	C	K	Toxicity
3786	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Mental Disorders,Schizophrenia	HTR2C	rs3813929	X	114584047	C	K	Toxicity
3787	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Mental Disorders,Schizophrenia	HTR2C	rs3813929	X	114584047	C	K	Toxicity
3788	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Metabolic Syndrome,Schizophrenia	HTR2C	rs1414334	X	114903581	C	G	Toxicity
3789	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Metabolic Syndrome	HTR2C	rs1414334	X	114903581	C	G	Toxicity
3790	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	HTR2C	rs518147	X	114584109	C	R	Toxicity
3791	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia,Weight gain	HTR2C	C23S	X	114731326	C	K	Toxicity
3792	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	neuropathic pain	HTR2C	C23S	X	114731326	C	K	Efficacy
3793	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Weight gain	HTR2C	rs2497538	X	114733932	A	C	Toxicity
3794	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms,Menopause	CYP19A1	rs4646	15	51210647	A	C	Efficacy
3795	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	Breast Neoplasms	CYP19A1	rs4646	15	51210647	A	C	Efficacy
3796	pharmgkb	Drug	amitriptyline	2160	CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98					Metabolism/PK
3797	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		CYP2C19	CYP2C19*1, CYP2C19*14, CYP2C19*23					Metabolism/PK
3798	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs1051730	15	78601997	G	A	Toxicity
3799	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs1051730	15	78601997	G	A	Dosage
3800	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Neoplasms	NT5C2	rs11598702	10	103138228	T	S	Metabolism/PK
3801	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs7582141	2	159042977	G	T	Toxicity
3802	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs6432512	2	159043401	C	T	Toxicity
3803	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs264631	2	159094353	C	G	Toxicity
3804	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs264588	2	159079879	C	W	Toxicity
3805	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Hypertension	PRKCA	rs16960228	17	66792709	G	A	Efficacy
3806	pharmgkb	Drug	salbutamol	2083	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	COL22A1	rs6988229	8	138872266	C	T	Efficacy
3807	pharmgkb	Drug Class	radiotherapy			Prostatic Neoplasms	TANC1	rs264651	2	159072919	A	G	Toxicity
3808	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Brain Neoplasms,Deafness,Ototoxicity	ACYP2	rs1872328	2	54168122	G	A	Toxicity
3809	pharmgkb		furosemide,spironolactone			Liver Cirrhosis	ADD1	G460W	4	2904980	G	W	Efficacy
3810	pharmgkb	Drug	caffeine	2519	CN1C=NC2=C1C(=O)N(C(=O)N2C)C		ADORA2A	rs2298383	22	24429543	C	W	Toxicity
3811	pharmgkb	Drug	cerivastatin	446156	CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC	Rhabdomyolysis	SLCO1B1	V174A	12	21178615	T	C	Toxicity
3812	pharmgkb	Drug	clodronate	25419	C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl		VDR	rs1544410	12	47846052	C	D	Efficacy
3813	pharmgkb	Drug	sirolimus	6436030	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	Transplantation	CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
3814	pharmgkb	Drug	sirolimus	6436030	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC		CYP3A5	CYP3A5*1, CYP3A5*3					Dosage
3815	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O		ADRB1	G389R	10	114045297	G	C	Efficacy
3816	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Psoriatic,Arthritis, Rheumatoid	SLCO1C1	rs3794271	12	20707159	G	A	Efficacy
3817	pharmgkb		cyclosporine,tacrolimus			Transplantation	CRTC2	rs8450	1	153947810	G	A	Toxicity
3818	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depression	CYP2D6	CYP2D6*1, CYP2D6*4					Dosage
3819	pharmgkb		peginterferon alfa-2a,peginterferon alfa-2b,ribavirin,simeprevir			Hepatitis C, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
3820	pharmgkb		daclatasvir,peginterferon alfa-2a,peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
3821	pharmgkb	Drug Class	sulfonamides, urea derivatives				TCF7L2	rs7903146	10	112998590	C	K	Efficacy
3822	pharmgkb	Drug	trastuzumab			Breast Neoplasms	FCGR3A	F175V	1	161544752	A	B	Efficacy
3823	pharmgkb	Drug Class	anthracyclines and related substances			Cardiomyopathies	HAS3	rs2232228	16	69109674	A	S	Toxicity
3824	pharmgkb	Drug	trastuzumab			Breast Neoplasms	FCGR2A	H166P	1	161509955	A	S	Efficacy
3825	pharmgkb		asparaginase,cyclophosphamide,daunorubicin,prednisolone,vincristine			Precursor Cell Lymphoblastic Leukemia-Lymphoma	PNPLA3	I148M	22	43928847	C	G	Toxicity
3826	pharmgkb		azathioprine,mercaptopurine,thioguanine			Inflammatory Bowel Diseases,Myelosuppression	NUDT15	rs746071566	13	48037783	GGAGTC	-	Toxicity
3827	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			Depressive Disorder, Major	COMT	rs13306278	22	19941504	C	T	Efficacy
3828	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs7089580	10	94945466	A	K	Dosage
3829	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	rs4149015	12	21130388	G	M	Metabolism/PK
3830	pharmgkb		atorvastatin,hmg coa reductase inhibitors,rosuvastatin			Muscular Diseases	COQ2	rs4693075	4	83271015	G	H	Toxicity
3831	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs11676382	2	85550510	C	G	Dosage
3832	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia	ABCB1	S893A	7	87531302	A	Y	Efficacy
3833	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC28A3	rs885004	9	84294635	G	A	Toxicity
3834	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC28A3	rs7853758	9	84286011	G	A	Toxicity
3835	pharmgkb	Drug	ibuprofen	3672	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O		CYP2C8	CYP2C8*1, CYP2C8*3					Metabolism/PK
3836	pharmgkb		peginterferon alfa-2b,ribavirin			Hepatitis C, Chronic	VDR	M51T	12	47879112	A	B	Efficacy
3837	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	SEMA3C	rs7779029	7	80902796	T	C	Toxicity
3838	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	SCN1A	rs3812718	2	166053034	C	T	Dosage
3839	pharmgkb	Drug	sildenafil	5212	CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C	Erectile Dysfunction	GNB3	rs5443	12	6845711	C	T	Efficacy
3840	pharmgkb	Drug	rituximab				FCGR3A	F175V	1	161544752	A	B	Efficacy
3841	pharmgkb	Drug	naloxone	5284596	C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O		OPRM1	N40D	6	154039662	A	G	Efficacy
3842	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	C8orf34	rs1517114	8	68476982	C	D	Toxicity
3843	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	severe cutaneous adverse reactions	HLA-B	HLA-B*58:01					Toxicity
3844	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C19	rs3814637	10	94761288	C	D	Dosage
3845	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C19	rs3814637	10	94761288	C	D	Toxicity
3846	pharmgkb	Drug	gliclazide	3475	CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2	Diabetes Mellitus	KCNJ11	K23Q	11	17388025	T	M	Efficacy
3847	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus	KCNJ11	K23Q	11	17388025	T	M	Efficacy
3848	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Essential hypertension	GNB3	rs5443	12	6845711	C	T	Efficacy
3849	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Coronary Artery Disease	CETP	rs708272	16	56962376	G	A	Efficacy
3850	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2B6	rs4803419	19	41006887	C	T	Metabolism/PK
3851	pharmgkb	Drug	alfentanil	51263	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	Pain	OPRM1	N40D	6	154039662	A	G	Efficacy
3852	pharmgkb	Drug	alfentanil	51263	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC		OPRM1	N40D	6	154039662	A	G	Toxicity
3853	pharmgkb	Drug	alfentanil	51263	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	Pain	OPRM1	N40D	6	154039662	A	G	Metabolism/PK
3854	pharmgkb	Drug	alfentanil	51263	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC	Pain	OPRM1	N40D	6	154039662	A	G	Dosage
3855	pharmgkb		buprenorphine,fentanyl,tramadol			adverse events,Opioid-Related Disorders	OPRM1	N40D	6	154039662	A	G	Toxicity
3856	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	somnolence	OPRM1	N40D	6	154039662	A	G	Toxicity
3857	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Vomiting	OPRM1	Q402H	6	154093311	A	Y	Toxicity
3858	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Nausea,Pain, Postoperative,Vomiting	OPRM1	rs9397685	6	154112099	A	G	Toxicity
3859	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain	OPRM1	N40D	6	154039662	A	G	Efficacy
3860	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain,Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Dosage
3861	pharmgkb	Drug	hydrocodone	5284569	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	Constipation,dry mouth,Respiratory Insufficiency	OPRM1	N40D	6	154039662	A	G	Toxicity
3862	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Neonatal Abstinence Syndrome	OPRM1	N40D	6	154039662	A	G	Toxicity
3863	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O		OPRM1	N40D	6	154039662	A	G	Dosage
3864	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		OPRM1	rs1323040	6	154010889	A	G	Dosage
3865	pharmgkb		acetaminophen,tramadol			neuropathic pain	OPRM1	N40D	6	154039662	A	G	Efficacy
3866	pharmgkb		buprenorphine,fentanyl,tramadol			Exanthema,Opioid-Related Disorders	COMT	V158M	22	19963748	G	A	Toxicity
3867	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	COMT	V158M	22	19963748	G	A	Toxicity
3868	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	COMT	V158M	22	19963748	G	A	Toxicity
3869	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Neonatal Abstinence Syndrome	COMT	rs740603	22	19957654	A	G	Toxicity
3870	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain	COMT	V158M	22	19963748	G	A	Efficacy
3871	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	somnolence	COMT	V158M	22	19963748	G	A	Toxicity
3872	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain,Pain, Postoperative	COMT	V158M	22	19963748	G	A	Dosage
3873	pharmgkb	Drug	remifentanil	60815	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC	Pain	COMT	V158M	22	19963748	G	A	Efficacy
3874	pharmgkb	Drug Class	opioids			Pain	COMT	V158M	22	19963748	G	A	Efficacy
3875	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		COMT	V158M	22	19963748	G	A	Efficacy
3876	pharmgkb	Drug Class	opioids			adverse events,Nausea,Vomiting	OPRM1	N40D	6	154039662	A	G	Toxicity
3877	pharmgkb	Drug Class	opioids			Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Efficacy
3878	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		OPRM1	N40D	6	154039662	A	G	Efficacy
3879	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	OPRM1	rs2075572	6	154090869	G	C	Toxicity
3880	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders,Sleep Disorders	OPRM1	N40D	6	154039662	A	G	Toxicity
3881	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	OPRM1	rs558025	6	154120830	A	G	Dosage
3882	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	OPRM1	N40D	6	154039662	A	G	Toxicity
3883	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Neonatal Abstinence Syndrome	COMT	V158M	22	19963748	G	A	Toxicity
3884	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6					Efficacy
3885	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*6					Metabolism/PK
3886	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6					Dosage
3887	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	rs4917639	10	94965778	A	Y	Dosage
3888	pharmgkb		fluorouracil,FOLFIRI,FOLFOX			overall survival,progression-free survival	TYMS	rs45445694					Efficacy
3889	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Drug Toxicity	TYMS	rs45445694					Toxicity
3890	pharmgkb	Metabolite	acetaldehyde	177			ALDH2	E457K	12	111803962	G	A	Metabolism/PK
3891	pharmgkb	Drug	ethanol	702	CCO		ALDH2	E457K	12	111803962	G	A	Metabolism/PK
3892	pharmgkb	Drug	ivacaftor / lumacaftor	71494926	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs113993960	7	117559592	CTT	-	Toxicity
3893	pharmgkb	Drug	ivacaftor / lumacaftor	71494926	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	A455E	7	117548795	C	W	Efficacy
3894	pharmgkb	Drug	ivacaftor / lumacaftor	71494926	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R334W	7	117540230	C	T	Efficacy
3895	pharmgkb	Drug	esomeprazole	9568614	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Metabolism/PK
3896	pharmgkb	Drug Class	Platinum compounds			Neoplasms	NQO1	P187S	16	69711242	G	A	Efficacy
3897	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A5	CYP3A5*1, CYP3A5*3					Dosage
3898	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
3899	pharmgkb	Drug Class	antidepressants			Depressive Disorder	GRIK4	rs1954787	11	120792654	T	C	Efficacy
3900	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O		GP1BA	T161M	17	4933086	C	T	Efficacy
3901	pharmgkb	Drug Class	hmg coa reductase inhibitors			Coronary Artery Disease	LPA	rs10455872	6	160589086	A	G	Efficacy
3902	pharmgkb	Drug Class	hmg coa reductase inhibitors			Coronary Artery Disease	LPA	rs10455872	6	160589086	A	G	Toxicity
3903	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors				TNF	rs1800629	6	31575254	G	A	Efficacy
3904	pharmgkb	Drug	lapatinib	208908	CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	Toxic liver disease	HLA-DQA1	HLA-DQA1*02:01					Toxicity
3905	pharmgkb	Drug	cetuximab			Colorectal Neoplasms,Rectal Neoplasms	EGF	rs4444903	4	109912954	A	G	Efficacy
3906	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Medulloblastoma,Neoplasms,Ototoxicity,Testicular Neoplasms	GSTP1	I105V	11	67585218	A	G	Toxicity
3907	pharmgkb	Drug Class	antipsychotics			Weight gain	MC4R	rs17782313	18	60183864	T	C	Toxicity
3908	pharmgkb	Drug Class	antipsychotics			Weight gain	MC4R	rs489693	18	60215554	C	W	Toxicity
3909	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Urticaria	LTC4S	rs730012	5	179793637	A	Y	Toxicity
3910	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Coronary Artery Disease,Myocardial Infarction	PTGS1	rs10306114	9	122370243	A	G	Efficacy
3911	pharmgkb		carbimazole,methimazole			Graves Disease	HLA-B	HLA-B*38:02					Toxicity
3912	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	DRD2	rs1076560	11	113412966	C	A	Toxicity
3913	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Neoplasms	GSTP1	I105V	11	67585218	A	G	Efficacy
3914	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7		UGT1A1	UGT1A1*1, UGT1A1*6					Dosage
3915	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain,Pain, Postoperative	ABCB1	I1145M	7	87509329	A	K	Dosage
3916	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs2236857	1	28835097	T	C	Toxicity
3917	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Drug Hypersensitivity	HLA-B	HLA-B*35:01					Toxicity
3918	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	rs510769	6	154040884	C	T	Toxicity
3919	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs3766951	1	28843047	T	C	Toxicity
3920	pharmgkb	Drug	tolterodine	60774	CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10					Metabolism/PK
3921	pharmgkb	Metabolite	SN-38	104842	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O	Carcinoma, Non-Small-Cell Lung	UGT1A9	rs3832043	2	233671808	T	-	Metabolism/PK
3922	pharmgkb	Drug	ondansetron	4595	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Postoperative Nausea and Vomiting,Vomiting	ABCB1	I1145M	7	87509329	A	K	Efficacy
3923	pharmgkb	Drug	ondansetron	4595	CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C	Postoperative Nausea and Vomiting,Vomiting	ABCB1	S893A	7	87531302	A	Y	Efficacy
3924	pharmgkb	Drug Class	opioids			Pain,Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Dosage
3925	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CHRNA3	rs578776	15	78596058	G	A	Efficacy,Toxicity
3926	pharmgkb	Drug	hydrochlorothiazide	3639	C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl	Essential hypertension,Hypertension	YEATS4	rs7297610	12	69430244	C	T	Efficacy
3927	pharmgkb	Drug	latanoprost	5282380	CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	Glaucoma, Open-Angle	PTGFR	rs3753380	1	78490747	T	C	Efficacy
3928	pharmgkb	Drug	propafenone	4932	CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O	Arrhythmias, Cardiac	CYP2D6	CYP2D6*1, CYP2D6*10					Efficacy
3929	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT1A4	L48M	2	233718962	T	R	Metabolism/PK
3930	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Panic Disorder	HTR1A	rs6295	5	63962738	C	G	Efficacy
3931	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections,Toxic liver disease	ABCB1	I1145M	7	87509329	A	K	Toxicity
3932	pharmgkb	Drug	hydralazine	3637	C1=CC=C2C(=C1)C=NN=C2NN		NAT2	NAT2*4, NAT2*5, NAT2*6, NAT2*7					Metabolism/PK
3933	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		SLC22A1	G465R	6	160154805	G	A	Metabolism/PK
3934	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		ABCB1	rs3842	7	87504050	T	C	Metabolism/PK
3935	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	somnolence	ABCB1	rs10248420	7	87535670	A	K	Toxicity
3936	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	somnolence	CYP3A5	CYP3A5*1, CYP3A5*3					Toxicity
3937	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		APOC3	rs5128	11	116832924	G	C	Metabolism/PK
3938	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Asthenia	ABCB1	rs4728709	7	87604286	G	A	Toxicity
3939	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Arrhythmias, Cardiac	ABCB1	rs3842	7	87504050	T	C	Toxicity
3940	pharmgkb	Drug	tamoxifen	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*95, CYP2D6*98					Metabolism/PK
3941	pharmgkb	Drug	atomoxetine	54841	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98					Metabolism/PK
3942	pharmgkb		atorvastatin,lovastatin,simvastatin			Hyperlipidemias	APOA5	rs662799	11	116792991	G	A	Efficacy
3943	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Efficacy
3944	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,Carcinoma, Renal Cell	KDR	rs2071559	4	55126199	A	G	Efficacy
3945	pharmgkb	Drug Class	Platinum compounds			Neoplasms	GSTP1	I105V	11	67585218	A	G	Toxicity
3946	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hypercholesterolemia	ABCB1	S893A	7	87531302	A	Y	Efficacy
3947	pharmgkb	Drug	alendronate	2088	C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN	Osteoporosis	VDR	rs1544410	12	47846052	C	D	Efficacy
3948	pharmgkb		cisplatin,fluorouracil,mitoxantrone			Carcinoma, Hepatocellular,Liver Neoplasms	GALNT14	rs9679162	2	31024648	G	T	Efficacy
3949	pharmgkb		ethambutol,isoniazid,pyrazinamide,rifampin			Toxic liver disease,Tuberculosis	NAT2	rs1041983	8	18400285	C	T	Toxicity
3950	pharmgkb		isoniazid,pyrazinamide,rifampin			Toxic liver disease,Tuberculosis	NAT2	rs1041983	8	18400285	C	T	Toxicity
3951	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Ovarian Neoplasms,Peripheral Nervous System Diseases	EPHA5	rs7349683	4	65332086	C	W	Toxicity
3952	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung	HSPA5	rs430397	9	125238840	C	T	Efficacy
3953	pharmgkb	Drug Class	direct acting antivirals			sustained virological response (svr)	IFNL4	rs11322783	19	39248514	T	-	Efficacy
3954	pharmgkb	Drug	telmisartan	65999	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C		UGT1A3	UGT1A3*1, UGT1A3*2, UGT1A3*3					Metabolism/PK
3955	pharmgkb	Drug	telmisartan	65999	CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C		SLCO1B3	G256A	12	20875274	G	C	Metabolism/PK
3956	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections,Tuberculosis	CYP2B6	rs2279345	19	41009797	T	M	Metabolism/PK
3957	pharmgkb	Drug	cysteamine	6058	C(CS)N	Cystic Fibrosis	CFTR	rs113993960	7	117559592	CTT	-	Efficacy
3958	pharmgkb	Drug	lumacaftor	16678941	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O	Cystic Fibrosis	CFTR	rs113993960	7	117559592	CTT	-	Efficacy
3959	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2		CES1	G144E	16	55823658	C	T	Metabolism/PK
3960	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CES1	G144E	16	55823658	C	T	Dosage
3961	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	C18orf56	rs45445694					Efficacy
3962	pharmgkb	Drug	indomethacin	3715	CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O		CYP2C9	CYP2C9*1, CYP2C9*3					Toxicity
3963	pharmgkb		Antiinflammatory agents, non-steroids,celecoxib,diclofenac				CYP2C9	I359L	10	94981296	A	S	Toxicity
3964	pharmgkb	Drug	naproxen	1302	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O		CYP2C9	N218I	10	94949118	A	T	Metabolism/PK
3965	pharmgkb		irinotecan,raltitrexed			Colorectal Neoplasms	TYMS	rs45445694					Toxicity
3966	pharmgkb	Drug	cavosonstat	56960912	C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O	Cystic Fibrosis	CFTR	rs113993960	7	117559592	CTT	-	Efficacy
3967	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	ALDH2	E457K	12	111803962	G	A	Other
3968	pharmgkb		ivacaftor,tezacaftor			Cystic Fibrosis	CFTR	G551D	7	117587806	G	A	Efficacy
3969	pharmgkb	Drug	lumacaftor	16678941	CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O	Cystic Fibrosis	CFTR	A561E	7	117590355	C	A	Efficacy
3970	pharmgkb	Drug	enalapril	5362032	CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O		CES1	G144E	16	55823658	C	T	Metabolism/PK
3971	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R334W	7	117540230	C	T	Efficacy
3972	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs77010898	7	117642566	G	M	Efficacy
3973	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	G1249R	7	117642465	G	A	Efficacy
3974	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C		CES1	G144E	16	55823658	C	T	Metabolism/PK
3975	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R668C	7	117592169	C	T	Efficacy
3976	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	L997F	7	117610521	G	C	Efficacy
3977	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	M1V	7	117480095	A	G	Efficacy
3978	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	R1066L	7	117611638	G	W	Efficacy
3979	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	H1054D	7	117611601	C	K	Efficacy
3980	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	E92K	7	117530899	G	W	Efficacy
3981	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	I336K	7	117540237	T	M	Efficacy
3982	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	S1235R	7	117627758	T	G	Efficacy
3983	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	T338I	7	117540243	C	T	Efficacy
3984	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	L927P	7	117603654	T	M	Efficacy
3985	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	A561E	7	117590355	C	A	Efficacy
3986	pharmgkb	Drug Class	hmg coa reductase inhibitors			Muscular Diseases	RYR1	R614C	19	38457545	C	T	Toxicity
3987	pharmgkb		curcumin,ivacaftor			Cystic Fibrosis	CFTR	rs77010898	7	117642566	G	M	Efficacy
3988	pharmgkb		penicillin g,penicillin v			Drug Hypersensitivity	HLA-B	HLA-B*55:01					Toxicity
3989	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Sleep Apnea Syndromes	OPRM1	N40D	6	154039662	A	G	Toxicity
3990	pharmgkb	Drug Class	opioids			Pain,Pain, Postoperative	COMT	V158M	22	19963748	G	A	Dosage
3991	pharmgkb	Drug Class	opioids			Sleep Disorders	OPRM1	N40D	6	154039662	A	G	Toxicity
3992	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		OPRM1	R181C	6	154090076	C	T	Efficacy
3993	pharmgkb	Drug	remifentanil	60815	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC		OPRM1	R181C	6	154090076	C	T	Efficacy
3994	pharmgkb	Drug	sofosbuvir	45375808	C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	Hepatitis C, Chronic	IFNL4	rs11322783	19	39248514	T	-	Efficacy
3995	pharmgkb	Drug Class	opioids			Low Back Pain	KCNJ6	rs6517442	21	37917643	C	T	Dosage
3996	pharmgkb	Drug Class	opioids			Low Back Pain	ABCB1	I1145M	7	87509329	A	K	Toxicity
3997	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Pain,Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Dosage
3998	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Pain, Postoperative	ABCB1	S893A	7	87531302	A	Y	Dosage
3999	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	V66M	16	31093399	C	T	Dosage,Efficacy
4000	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CNR1	rs806368	6	88140381	T	C	Dosage
4001	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	TPH2	rs1386493	12	71961399	A	G	Dosage
4002	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	OPRL1	rs2229205	20	64098078	C	T	Dosage
4003	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP2B6	rs16974799	19	40998172	C	K	Dosage
4004	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	NFIB	rs28379954	9	14163908	T	C	Metabolism/PK
4005	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders,Pruritus	NECTIN4	rs11265549	1	161081736	A	G	Toxicity
4006	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	NECTIN4	rs11265549	1	161081736	A	G	Dosage
4007	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	NECTIN4	rs11265549	1	161081736	A	G	Metabolism/PK
4008	pharmgkb	Drug	ethanol	702	CCO		OPRM1	N40D	6	154039662	A	G	Toxicity
4009	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		SLCO1B1	V174A	12	21178615	T	C	Efficacy
4010	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Pain, Postoperative	NFKBIA	rs696	14	35401887	C	T	Dosage
4011	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	CSMD1	rs6990851	8	3269991	A	G	Efficacy
4012	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	DLG2	rs2449598	11	83983729	T	R	Efficacy
4013	pharmgkb	Drug	anastrozole	2187	CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N	Breast Neoplasms	CSMD1	rs6981827	8	3217516	C	W	Efficacy
4014	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence,Memory Disorders	DBH	rs1611114	9	133635081	C	T	Toxicity
4015	pharmgkb	Drug	propranolol	4946	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O	Temporomandibular joint-pain-dysfunction syndrome	COMT	V158M	22	19963748	G	A	Efficacy
4016	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Breast Neoplasms,Drug Toxicity	ABCC4	rs9561778	13	95061461	G	W	Toxicity
4017	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Essential hypertension	GNB3	rs2301339	12	6845460	G	W	Efficacy
4018	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Essential hypertension	GNB3	rs11064426	12	6844093	A	B	Efficacy
4019	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Coronary Artery Disease,Hemorrhage,Myocardial Infarction	CYP2C19	CYP2C19*1, CYP2C19*17					Toxicity
4020	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Autistic Disorder	HTR2C	rs3813928	X	114583809	G	A	Efficacy
4021	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	STRBP	rs9032	9	123104493	C	K	Efficacy
4022	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	PYROXD2	rs1061115	10	98417292	G	A	Efficacy
4023	pharmgkb		cyclophosphamide,doxorubicin			Breast Neoplasms	ABCB1	S893A	7	87531302	A	Y	Efficacy
4024	pharmgkb	Drug	deferasirox	5493381	C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1	Drug Toxicity,Thalassemia	UGT1A1	rs4124874	2	233757013	T	R	Toxicity
4025	pharmgkb	Drug	pregabalin	5486971	CC(C)C[C@@H](CC(=O)O)CN	adverse events,neuropathic pain	SLC7A5	rs4240803	16	87855597	G	H	Toxicity
4026	pharmgkb	Drug	gabapentin	3446	C1CCC(CC1)(CC(=O)O)CN	adverse events,neuropathic pain	SLC7A5	rs4240803	16	87855597	G	H	Toxicity
4027	pharmgkb	Drug	gabapentin	3446	C1CCC(CC1)(CC(=O)O)CN	neuropathic pain	SLC7A5	rs4240803	16	87855597	G	H	Efficacy
4028	pharmgkb	Drug	gabapentin	3446	C1CCC(CC1)(CC(=O)O)CN	neuropathic pain	SLC7A5	rs4240803	16	87855597	G	H	Dosage
4029	pharmgkb	Drug	pregabalin	5486971	CC(C)C[C@@H](CC(=O)O)CN	neuropathic pain	SLC7A5	rs4240803	16	87855597	G	H	Efficacy
4030	pharmgkb	Drug	propylthiouracil	657298	CCCC1=CC(=O)NC(=S)N1	Agranulocytosis,Graves Disease	HLA-B	HLA-B*38:02					Toxicity
4031	pharmgkb	Drug	carvedilol	2585	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O		ADRB1	S49G	10	114044277	A	G	Efficacy
4032	pharmgkb	Drug	carvedilol	2585	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Heart Failure	ADRB1	G389R	10	114045297	G	C	Dosage
4033	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Mood Disorders	FKBP5	rs4713916	6	35702206	A	B	Efficacy
4034	pharmgkb	Drug	mirtazapine	4205	CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4	Mood Disorders	FKBP5	rs4713916	6	35702206	A	B	Efficacy
4035	pharmgkb		cyclophosphamide,epirubicin			Breast Neoplasms,Drug Toxicity	GSTP1	I105V	11	67585218	A	G	Toxicity
4036	pharmgkb		cyclophosphamide,epirubicin			Breast Neoplasms,Neutropenia	GSTP1	I105V	11	67585218	A	G	Toxicity
4037	pharmgkb		capecitabine,epirubicin,platinum			Colorectal Neoplasms	GSTP1	I105V	11	67585218	A	G	Efficacy
4038	pharmgkb		cyclophosphamide,epirubicin			Breast Neoplasms	GSTP1	I105V	11	67585218	A	G	Efficacy
4039	pharmgkb		epirubicin,fluorouracil,oxaliplatin			Neoplasm Metastasis,Stomach Neoplasms	NQO1	P187S	16	69711242	G	A	Efficacy
4040	pharmgkb	Drug	bucindolol	51045	CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O	Heart Failure	ADRB1	G389R	10	114045297	G	C	Efficacy
4041	pharmgkb	Drug, Metabolite	paliperidone	115237	CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Weight gain	MC4R	rs489693	18	60215554	C	W	Efficacy
4042	pharmgkb	Drug, Metabolite	paliperidone	115237	CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Weight gain	MC4R	rs17782313	18	60183864	T	C	Toxicity
4043	pharmgkb		cyclophosphamide,epirubicin,fluorouracil			Breast Neoplasms	NQO1	P187S	16	69711242	G	A	Efficacy
4044	pharmgkb	Drug	haloperidol	3559	C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F	Hypertriglyceridemia,schizoaffective disorder,Schizophrenia,Weight gain	MC4R	rs489693	18	60215554	C	W	Toxicity
4045	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Hypertriglyceridemia,schizoaffective disorder,Schizophrenia,Weight gain	MC4R	rs489693	18	60215554	C	W	Toxicity
4046	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42	Weight gain	MC4R	rs17782313	18	60183864	T	C	Toxicity
4047	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Weight gain	MC4R	rs489693	18	60215554	C	W	Toxicity
4048	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Weight gain	MC4R	rs17782313	18	60183864	T	C	Toxicity
4049	pharmgkb	Drug	amisulpride	2159	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	Hypertriglyceridemia,Weight gain	MC4R	rs489693	18	60215554	C	W	Toxicity
4050	pharmgkb	Drug	amisulpride	2159	CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC	Weight gain	MC4R	rs17782313	18	60183864	T	C	Toxicity
4051	pharmgkb	Drug	aripiprazole	60795	C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl	Weight gain	MC4R	rs489693	18	60215554	C	W	Toxicity
4052	pharmgkb	Drug	ataluren	11219835	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	Cystic Fibrosis	CFTR	rs77010898	7	117642566	G	M	Other
4053	pharmgkb	Drug	ataluren	11219835	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	Cystic Fibrosis	CFTR	rs75039782	7	117639961	C	K	Other
4054	pharmgkb	Drug	ataluren	11219835	C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F	Cystic Fibrosis	CFTR	G542R	7	117587778	G	W	Other
4055	pharmgkb	Drug	cetuximab			Colorectal Neoplasms	KRAS	G13V					Efficacy
4056	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	APOA5	S19L	11	116791691	G	M	Efficacy
4057	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs4149081	12	21225087	G	A	Toxicity
4058	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
4059	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	BDNF-AS	rs11030096	11	27643996	T	M	Toxicity
4060	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	GABRB3	rs4906902	15	26774621	A	G	Toxicity
4061	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD2	rs1079596	11	113425897	C	W	Toxicity
4062	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD3	rs2654754	3	114136949	G	A	Toxicity
4063	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD2	rs1125394	11	113426463	T	C	Toxicity
4064	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD3	rs9288993	3	114140326	A	G	Toxicity
4065	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TACR1	rs735668	2	75135918	A	S	Toxicity
4066	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	ZNF804A	rs7597593	2	184668853	T	C	Toxicity
4067	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CNR1	rs2023239	6	88150763	T	C	Toxicity
4068	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	rs510769	6	154040884	C	T	Toxicity
4069	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CNR1	rs6928499	6	88151570	G	C	Toxicity
4070	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CYP2A7P1	Q172H	19	41006936	G	W	Toxicity
4071	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD3	G9S	3	114171968	C	T	Toxicity
4072	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CYP2D6	P34A	22	42130692	G	A	Toxicity
4073	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	DRD3	rs324029	3	114162776	A	G	Toxicity
4074	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	EXOC4	rs718656	7	133436098	C	K	Toxicity
4075	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	TACR3	rs1384401	4	103643921	G	A	Toxicity
4076	pharmgkb	Drug	rocuronium	441290	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		SLCO1A2	rs7967354	12	21271069	T	C	Dosage
4077	pharmgkb	Drug	rocuronium	441290	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C		IAPP	rs11045995	12	21355244	T	C	Dosage
4078	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Fractures, Bone,Pain,Pain, Postoperative	ABCB1	I1145M	7	87509329	A	K	Efficacy
4079	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Efficacy
4080	pharmgkb	Drug	ibuprofen	3672	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O		PTGS2	rs20417	1	186681189	C	K	Efficacy
4081	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Fractures, Bone,Pain,Pain, Postoperative	ABCB1	S893A	7	87531302	A	Y	Efficacy
4082	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Colitis, Ulcerative,Crohn Disease,Irritable Bowel Syndrome,Leukopenia,Neutropenia	FTO	rs16952570	16	53831818	T	C	Toxicity
4083	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Colitis, Ulcerative,Crohn Disease,Irritable Bowel Syndrome,Leukopenia,Neutropenia	FTO	rs16952570	16	53831818	T	C	Toxicity
4084	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Neoplasms,Pain	OPRK1	rs1051660	8	53251002	C	W	Dosage
4085	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain	COMT	V158M	22	19963748	G	A	Efficacy
4086	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain,Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Efficacy
4087	pharmgkb	Drug	butorphanol	5361092	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O		OPRK1	rs702764	8	53229597	T	S	Efficacy
4088	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		COMT	rs6269	22	19962429	A	G	Efficacy
4089	pharmgkb	Drug	butorphanol	5361092	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O		COMT	rs4633	22	19962712	C	T	Efficacy
4090	pharmgkb	Drug	butorphanol	5361092	C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O		COMT	rs6269	22	19962429	A	G	Efficacy
4091	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		ABCA1	R219K	9	104858586	C	T	Efficacy
4092	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		ABCA1	R219K	9	104858586	C	T	Efficacy
4093	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		ABCA1	R219K	9	104858586	C	T	Efficacy
4094	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4					Efficacy
4095	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4					Efficacy
4096	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4					Efficacy
4097	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		CYP2D6	CYP2D6*1, CYP2D6*4					Efficacy
4098	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		CETP	rs708272	16	56962376	G	A	Efficacy
4099	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		CETP	V422I	16	56982180	G	M	Efficacy
4100	pharmgkb	Metabolite	cotinine glucuronide	178540			UGT1A9	rs12471326	2	233767812	T	C	Metabolism/PK
4101	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs145014075	19	40843881	G	T	Metabolism/PK
4102	pharmgkb	Drug	everolimus	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,heart transplantation,Kidney Neoplasms,Kidney Transplantation,lung transplantation,Neuroendocrine Tumors	CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
4103	pharmgkb	Drug	everolimus	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,Kidney Neoplasms,Neuroendocrine Tumors	MTOR	rs2024627	1	11238733	T	C	Efficacy
4104	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-B	HLA-B*08:01, HLA-B*39:01					Toxicity
4105	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-C	HLA-C*12:03					Toxicity
4106	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-DQB1	HLA-DQB1*02:01					Toxicity
4107	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-DPB1	HLA-DPB1*10:01					Toxicity
4108	pharmgkb	Drug	infliximab			drug-induced liver injury	HLA-DRB1	HLA-DRB1*03:01, HLA-DRB1*04:04					Toxicity
4109	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid	MICA	V152M	6	31411200	G	A	Efficacy
4110	pharmgkb	Drug Class	Ace Inhibitors, Plain			Angioedema	KCNMA1	rs2253201	10	77596639	G	A	Toxicity
4111	pharmgkb	Drug	voriconazole	71616	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O		SLCO2B1	rs3781727	11	75204976	T	C	Metabolism/PK
4112	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	adverse events,Arthritis, Rheumatoid	ADORA2A	rs2236624	22	24440056	T	C	Toxicity
4113	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A	rs2298383	22	24429543	C	W	Toxicity
4114	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ADORA2A-AS1	rs17004921	22	24444708	C	T	Efficacy
4115	pharmgkb		cisplatin,fluorouracil,radiotherapy			Carcinoma, Squamous Cell,overall survival	APEX1	rs1760944	14	20454990	T	S	Efficacy
4116	pharmgkb		cisplatin,fluorouracil,radiotherapy			Carcinoma, Squamous Cell,overall survival	XRCC1	R194W	19	43553422	G	A	Efficacy
4117	pharmgkb		cisplatin,fluorouracil,radiotherapy			Carcinoma, Squamous Cell,progression-free survival	MUTYH	Q335H	1	45331833	C	G	Efficacy
4118	pharmgkb	Drug	glyburide	3488	COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	Diabetes Mellitus, Type 2,Hypoglycemia	NOS1AP	rs10494366	1	162115895	G	T	Toxicity
4119	pharmgkb	Drug	glimepiride	3476	CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C	Diabetes Mellitus, Type 2,Hypoglycemia	NOS1AP	rs10494366	1	162115895	G	T	Toxicity
4120	pharmgkb	Drug	glipizide	3478	CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3	Diabetes Mellitus, Type 2,Hypoglycemia	NOS1AP	rs10494366	1	162115895	G	T	Toxicity
4121	pharmgkb	Drug	oseltamivir	65028	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC		ABCB1	I1145M	7	87509329	A	K	Toxicity
4122	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	ABCG2	rs3114020	4	88162514	T	C	Metabolism/PK
4123	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
4124	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	SLC22A1	M408V	6	160139813	A	S	Metabolism/PK
4125	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT1A4	UGT1A4*1a, UGT1A4*1b, UGT1A4*2					Metabolism/PK
4126	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT2B7	rs7668258	4	69096360	T	C	Dosage
4127	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis,Graves Disease	HLA-DRB1	HLA-DRB1*08:03					Toxicity
4128	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis,Graves Disease	HLA-B	HLA-B*39:01					Toxicity
4129	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis,Graves Disease	HLA-DQB1	HLA-DQB1*06:01					Toxicity
4130	pharmgkb	Drug Class	Antithyroid Preparations			Agranulocytosis,Graves Disease	HLA-DQA1	HLA-DQA1*01:03					Toxicity
4131	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	R414C	3	165829794	G	A	Toxicity
4132	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	postanesthesia apnea	BCHE	D98G	3	165830741	T	C	Toxicity
4133	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	postanesthesia apnea	BCHE	A567T	3	165773492	C	T	Toxicity
4134	pharmgkb	Drug Class	antidepressants			adverse events,Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs6313	13	46895805	G	A	Toxicity
4135	pharmgkb	Drug Class	antidepressants			adverse events,Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Toxicity
4136	pharmgkb	Drug Class	antidepressants			Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs7997012	13	46837850	A	G	Efficacy
4137	pharmgkb	Drug	FOLFIRINOX			Pancreatic Neoplasms,Thrombocytopenia	UGT1A1	UGT1A1*1, UGT1A1*28					Toxicity
4138	pharmgkb		gemcitabine,paclitaxel			Nausea,Pancreatic Neoplasms	CDA	K27Q	1	20589208	A	C	Toxicity
4139	pharmgkb	Drug	temozolomide	5394	CN1C(=O)N2C=NC(=C2N=N1)C(=O)N	Glioma	ABCB1	rs1128503	7	87550285	A	G	Metabolism/PK
4140	pharmgkb	Drug	carvedilol	2585	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Heart Diseases	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10					Metabolism/PK
4141	pharmgkb	Drug	carvedilol	2585	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O	Heart Failure	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*10					Dosage
4142	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F		CYP2D6	CYP2D6*1, CYP2D6*4, CYP2D6*10					Metabolism/PK
4143	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F		CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN					Efficacy
4144	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F		CYP2D6	CYP2D6*1, CYP2D6*4					Dosage
4145	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major,Mental Disorders	CYP2D6	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17					Metabolism/PK
4146	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Adenocarcinoma,Carcinoma, Non-Small-Cell Lung,Drug Toxicity,Exanthema,Toxic liver disease	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10					Toxicity
4147	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	CYP2D6	CYP2D6*2, CYP2D6*10					Toxicity
4148	pharmgkb		atomoxetine,methylphenidate				CYP2D6	CYP2D6*4, CYP2D6*5					Metabolism/PK
4149	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4					Toxicity
4150	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Opioid-Related Disorders	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4					Toxicity
4151	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depression	CYP2D6	CYP2D6*1, CYP2D6*4					Dosage
4152	pharmgkb	Drug	metoprolol	4171	CC(C)NCC(COC1=CC=C(C=C1)CCOC)O	Hypertension	CYP2D6	CYP2D6*1, CYP2D6*45, CYP2D6*46					Metabolism/PK
4153	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98					Metabolism/PK
4154	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O		CYP2D6	CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98					Metabolism/PK
4155	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*56:02					Toxicity
4156	pharmgkb	Drug	isepamicin	3037209		Ototoxicity	MT-ND1	rs267606617					Toxicity
4157	pharmgkb	Drug	micronomicin	3037206		Ototoxicity	MT-ND1	rs267606619					Toxicity
4158	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-RNR1	rs1556422499					Toxicity
4159	pharmgkb	Drug Class	aminoglycoside antibacterials			Ototoxicity	MT-ND1	rs1603218569					Toxicity
4160	pharmgkb	Drug	dihydrostreptomycin	439369		Ototoxicity	MT-RNR1	rs1556422499					Toxicity
4161	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Kidney Transplantation	CYP3A4	rs2740574	7	99784473	C	T	Metabolism/PK
4162	pharmgkb	Drug	streptomycin	19649	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs28358569					Toxicity
4163	pharmgkb	Drug	gentamicin	3467	CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC	Ototoxicity	MT-RNR1	rs28358569					Toxicity
4164	pharmgkb	Drug	neomycin	8378	C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N	Ototoxicity	MT-ND1	rs267606617					Toxicity
4165	pharmgkb	Drug	streptomycin	19649	C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O	Ototoxicity	MT-RNR1	rs1556422499					Toxicity
4166	pharmgkb		cyclosporine,tacrolimus			Kidney Transplantation,transplant rejection	CYP3A	rs2740574	7	99784473	C	T	Toxicity
4167	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	CYP3A4	rs2740574	7	99784473	C	T	Dosage
4168	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP3A	rs2740574	7	99784473	C	T	Metabolism/PK
4169	pharmgkb	Drug	tolbutamide	5505	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*62					Metabolism/PK
4170	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		COMT	V158M	22	19963748	G	A	Dosage
4171	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		SLCO2B1	R168Q	11	75172532	G	W	Efficacy
4172	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	PACSIN2	rs2413739	22	43001030	C	T	Toxicity
4173	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Irritable Bowel Syndrome	PACSIN2	rs2413739	22	43001030	C	T	Efficacy
4174	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Leukopenia	NUDT15	NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6					Toxicity
4175	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2		NUDT15	NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6					Dosage
4176	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Neutropenia	NUDT15	NUDT15*1, NUDT15*6					Toxicity
4177	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	V174A	12	21178615	T	C	Efficacy
4178	pharmgkb	Drug Class	hmg coa reductase inhibitors			Coronary Artery Disease	CETP	rs708272	16	56962376	G	A	Efficacy
4179	pharmgkb	Drug Class	hmg coa reductase inhibitors				ABCB1	rs1128503	7	87550285	A	G	Other
4180	pharmgkb	Drug Class	hmg coa reductase inhibitors			Hypercholesterolemia,Myocardial Infarction	GNB3	rs5443	12	6845711	C	T	Efficacy
4181	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ARID5B	rs4948496	10	62045858	T	C	Metabolism/PK
4182	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukopenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ARID5B	rs4948496	10	62045858	T	C	Toxicity
4183	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasms	SLCO1B1	rs11045879	12	21229685	T	C	Metabolism/PK
4184	pharmgkb		Ace Inhibitors, Plain,Angiotensin II Antagonists,Beta Blocking Agents,digoxin,diuretics,spironolactone			Heart Failure	ADRB1	G389R	10	114045297	G	C	Efficacy
4185	pharmgkb		cisplatin,doxorubicin,methotrexate			Osteosarcoma	MTHFD1	R653Q	14	64442127	G	A	Efficacy
4186	pharmgkb		cisplatin,doxorubicin,methotrexate			Osteosarcoma	ABCC2	rs717620	10	99782821	C	T	Efficacy
4187	pharmgkb		cisplatin,doxorubicin,methotrexate			Osteosarcoma	GSTP1	I105V	11	67585218	A	G	Efficacy
4188	pharmgkb		cisplatin,doxorubicin,methotrexate			Osteosarcoma	GSTT1	GSTT1 non-null, GSTT1 null					Efficacy
4189	pharmgkb		cisplatin,doxorubicin,methotrexate			Osteosarcoma	CCND1	rs9344	11	69648142	G	A	Efficacy
4190	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukopenia,Osteosarcoma	ABCC2	V1188E	10	99836239	T	A	Toxicity
4191	pharmgkb		cisplatin,doxorubicin			mucositis,Osteosarcoma	ERCC1	rs11615	19	45420395	A	G	Toxicity
4192	pharmgkb		cisplatin,doxorubicin			Anemia,mucositis,Osteosarcoma	CYBA	Y72N	16	88646828	A	K	Toxicity
4193	pharmgkb		cisplatin,doxorubicin,methotrexate			cardiotoxicity,Osteosarcoma	GSTP1	I105V	11	67585218	A	G	Toxicity
4194	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Leukopenia,Osteosarcoma	GSTP1	I105V	11	67585218	A	G	Toxicity
4195	pharmgkb		cisplatin,doxorubicin,methotrexate			nephrotoxicity,Osteosarcoma	CLCN6	A222V	1	11796321	G	A	Toxicity
4196	pharmgkb		cisplatin,doxorubicin,methotrexate			nephrotoxicity,Osteosarcoma	ERCC2	rs13181	19	45351661	T	R	Toxicity
4197	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O		SOD2	V16A	6	159692840	A	G	Other
4198	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRD1	rs2236861	1	28813244	G	A	Toxicity
4199	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension,Hypertrophy, Left Ventricular	AGT	T207M	1	230710231	G	A	Efficacy
4200	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension,Hypertrophy, Left Ventricular	AGT	M268T	1	230710048	A	G	Efficacy
4201	pharmgkb	Drug	atenolol	2249	CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O	Hypertension,Hypertrophy, Left Ventricular	AGT	M268T	1	230710048	A	G	Efficacy
4202	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension,Hypertrophy, Left Ventricular	AGTR1	rs5186	3	148742201	A	C	Efficacy
4203	pharmgkb	Drug	irbesartan	3749	CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5	Hypertension,Hypertrophy, Left Ventricular	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
4204	pharmgkb	Drug	diazepam	3016	CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Metabolism/PK
4205	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	SOD2	rs2758339	6	159691552	A	Y	Toxicity
4206	pharmgkb	Drug	sulfamethoxazole	5329	CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N	Hemolysis	G6PD	G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like					Toxicity
4207	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs774072493	3	165830599	-	C	Toxicity
4208	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	rs568724445	3	165830419	C	W	Toxicity
4209	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	L222R	3	165830369	A	B	Toxicity
4210	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	E469Q					Toxicity
4211	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	F56I	3	165830868	A	T	Toxicity
4212	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C	Apnea	BCHE	G143D	3	165830606	C	T	Toxicity
4213	pharmgkb	Drug	succinylcholine	5314	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C		BCHE	G418A	3	165829781	C	D	Toxicity
4214	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Mesothelioma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFD1	R653Q	14	64442127	G	A	Efficacy
4215	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma	TYMS	rs45445694					Efficacy
4216	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	V174A	12	21178615	T	C	Efficacy
4217	pharmgkb	Drug	rivaroxaban	9875401			ABCB1	I1145M	7	87509329	A	K	Toxicity
4218	pharmgkb	Drug	apixaban	10182969	COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N		ABCB1	rs4148738	7	87533733	C	T	Toxicity
4219	pharmgkb	Drug	pegaspargase				ARHGAP28	rs9958628	18	6739625	A	T	Toxicity
4220	pharmgkb	Drug	pegaspargase				HLA-DQB1	HLA-DQB1*02:02					Toxicity
4221	pharmgkb	Drug	pegaspargase				HLA-DRB1	HLA-DRB1*07:01					Toxicity
4222	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	rs3758149	8	63039169	G	A	Metabolism/PK
4223	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLC19A1	rs1051296	21	45514947	A	C	Metabolism/PK
4224	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Dosage
4225	pharmgkb	Drug	phenprocoumon	9908	CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Metabolism/PK
4226	pharmgkb	Drug, Biological Intermediate	conjugated estrogens	23667301	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+]		SLCO1B1	SLCO1B1*1, SLCO1B1*12, SLCO1B1*13					Metabolism/PK
4227	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F	Hypercholesterolemia	SLCO1B1	SLCO1B1*1, SLCO1B1*14					Efficacy
4228	pharmgkb	Drug	olmesartan	130881	CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O		SLCO1B1	SLCO1B1*15, SLCO1B1*37					Metabolism/PK
4229	pharmgkb	Drug	repaglinide	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O		SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37					Metabolism/PK
4230	pharmgkb	Drug	atrasentan				SLCO1B1	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37					Metabolism/PK
4231	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	CNIH3	rs10799590	1	224634780	G	A	Toxicity
4232	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	FPGS	rs1544105	9	127800446	C	T	Efficacy
4233	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	drug-induced liver injury,Leukopenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	DHFR	rs70991108	5	80654345	-	TGGCGCGTCCCGCCCAGGT	Toxicity
4234	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	gastrointestinal toxicity,mucositis,Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ENOSF1	rs11280056	18	673447	AAGTTA	-	Toxicity
4235	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ENOSF1	rs11280056	18	673447	AAGTTA	-	Efficacy
4236	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain, Postoperative	TLR2	rs3804100	4	153704257	T	C	Dosage
4237	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Esophageal Neoplasms,Ovarian Neoplasms,Stomach Neoplasms	ERCC1	rs11615	19	45420395	A	G	Efficacy
4238	pharmgkb		cisplatin,gemcitabine			Carcinoma, Non-Small-Cell Lung	ERCC1	rs11615	19	45420395	A	G	Efficacy
4239	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Pancreatic Neoplasms	ERCC1	rs11615	19	45420395	A	G	Efficacy
4240	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Ovarian Neoplasms	ERCC1	D396N	19	45409148	G	A	Efficacy
4241	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	rs3758149	8	63039169	G	A	Efficacy
4242	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	A31S	8	63038678	C	W	Efficacy
4243	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	GGH	rs11545076	8	63038892	A	C	Efficacy
4244	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		CYP2A7P1	Q172H	19	41006936	G	W	Metabolism/PK
4245	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Lymphoma, Non-Hodgkin,Precursor Cell Lymphoblastic Leukemia-Lymphoma	TYMS	rs45445694					Toxicity
4246	pharmgkb	Drug	salbutamol	2083	CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O	Asthma	ADRB2	R16G	5	148826877	G	A	Efficacy
4247	pharmgkb		bupropion,naltrexone			Obesity	ANKK1	E713K	11	113400106	G	A	Efficacy
4248	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R533H	19	38455472	G	A	Toxicity
4249	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	UGT2B7	rs7668258	4	69096360	T	C	Efficacy
4250	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT2B7	rs7668258	4	69096360	T	C	Metabolism/PK
4251	pharmgkb		desflurane,enflurane,halothane,isoflurane,methoxyflurane,sevoflurane,succinylcholine			Malignant Hyperthermia	RYR1	R530H	19	38455463	G	W	Toxicity
4252	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	ABCB1	S893A	7	87531302	A	Y	Metabolism/PK
4253	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	ASTN2	rs7858836	9	117194009	T	C	Dosage
4254	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	ASTN2	rs958804	9	117196574	T	C	Dosage
4255	pharmgkb	Drug Class	antiepileptics			Epilepsy	SCN2A	rs2304016	2	165311993	A	G	Efficacy
4256	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	SCN2A	rs2304016	2	165311993	A	G	Efficacy
4257	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	SCN2A	rs2304016	2	165311993	A	G	Efficacy
4258	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Epilepsy	SCN2A	rs2304016	2	165311993	A	G	Efficacy
4259	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Epilepsy	SCN2A	rs2304016	2	165311993	A	G	Efficacy
4260	pharmgkb	Drug	topiramate	5284627	CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C	Epilepsy	SCN2A	rs2304016	2	165311993	A	G	Efficacy
4261	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*67:01					Toxicity
4262	pharmgkb		morphine,nortriptyline			Pain	ABCB1	I1145M	7	87509329	A	K	Efficacy
4263	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Colorectal Neoplasms	VDR	rs11574077	12	47859144	T	C	Metabolism/PK
4264	pharmgkb		ledipasvir,sofosbuvir			Hepatitis C, Chronic	IFNL3	rs12979860	19	39248147	C	T	Efficacy
4265	pharmgkb	Drug Class	interferons			Hepatitis C	IFNL3	rs12979860	19	39248147	C	T	Efficacy
4266	pharmgkb	Drug	flurbiprofen	3394	CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O		CYP2C9	N218I	10	94949118	A	T	Metabolism/PK
4267	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	GAD1	rs3762555	2	170815885	C	R	Dosage
4268	pharmgkb	Drug	rosiglitazone	77999	CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3		CYP2C8	CYP2C8*1, CYP2C8*3					Efficacy
4269	pharmgkb	Drug	talinolol				ABCC2	V417I	10	99804058	G	A	Metabolism/PK
4270	pharmgkb	Drug	thiotepa			Neoplasms	GSTP1	A114V	11	67586108	C	T	Metabolism/PK
4271	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs9606186	22	19932836	C	G	Efficacy
4272	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	Q30R	16	31087690	T	C	Dosage
4273	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Colonic Neoplasms	CCND1	rs9344	11	69648142	G	A	Efficacy
4274	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	Acute coronary syndrome,Hyperlipoproteinemia Type II	ABCB1	S893A	7	87531302	A	Y	Efficacy
4275	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O		SLC22A1	R61C	6	160122116	C	T	Metabolism/PK
4276	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia	MC4R	rs11872992	18	60373354	G	A	Toxicity
4277	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	MC4R	rs11872992	18	60373354	G	A	Toxicity
4278	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Schizophrenia,Weight gain	GLP1R	rs2268639	6	39082846	T	A	Toxicity
4279	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C	Schizophrenia,Weight gain	GLP1R	rs2268639	6	39082846	T	A	Toxicity
4280	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	Thrombosis	NQO1	P187S	16	69711242	G	A	Efficacy
4281	pharmgkb	Drug Class	Dipeptidyl peptidase 4 (DPP-4) inhibitors			Diabetes Mellitus	CDKAL1	rs7754840	6	20661019	G	H	Efficacy
4282	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	rs1381376	6	154072123	C	D	Toxicity
4283	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	rs3778156	6	154083178	A	G	Toxicity
4284	pharmgkb	Drug	tolbutamide	5505	CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C		CYP2C9	S115R	10	94942203	A	C	Metabolism/PK
4285	pharmgkb	Drug	mephenytoin	4060	CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2		CYP2C19	R186C	10	94780573	C	T	Metabolism/PK
4286	pharmgkb		docetaxel,doxorubicin			Breast Neoplasms	AKR1C3	rs1937840	10	5099115	C	G	Efficacy
4287	pharmgkb	Drug	doxorubicin	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O	Breast Neoplasms	AKR1C3	rs1937840	10	5099115	C	G	Other
4288	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		OPRM1	N40D	6	154039662	A	G	Other
4289	pharmgkb		cyclophosphamide,doxorubicin,fluorouracil			Breast Neoplasms,Neoplasms	ABCC4	rs9561778	13	95061461	G	W	Toxicity
4290	pharmgkb	Drug, Biological Intermediate	levodopa	6047	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O	gastrointestinal toxicity,Hallucinations,Parkinson Disease	DRD3	G9S	3	114171968	C	T	Toxicity
4291	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DRD2	rs6275	11	113412755	A	G	Dosage
4292	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
4293	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Carcinoma, Non-Small-Cell Lung,Drug Toxicity,Leukemia, B-Cell, Acute	ABCC2	rs3740065	10	99845936	A	G	Toxicity
4294	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	V174A	12	21178615	T	C	Metabolism/PK
4295	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs4149081	12	21225087	G	A	Metabolism/PK
4296	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	N130H	12	21176804	A	K	Metabolism/PK
4297	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1A2	rs4149009	12	21267537	C	T	Metabolism/PK
4298	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	FPGS	rs1544105	9	127800446	C	T	Metabolism/PK
4299	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCB1	I1145M	7	87509329	A	K	Efficacy,Toxicity
4300	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Drug Toxicity	SLC19A1	H27R	21	45537880	T	S	Toxicity
4301	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTHFR	E429A	1	11794419	T	G	Toxicity
4302	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Lymphoma,mucositis,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	rs1128503	7	87550285	A	G	Toxicity
4303	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Drug Toxicity,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	I1145M	7	87509329	A	K	Toxicity
4304	pharmgkb		folic acid,hydroxychloroquine,methotrexate,sulfasalazine			Arthritis, Rheumatoid	MTR	D919G	1	236885200	A	G	Efficacy
4305	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTR	D919G	1	236885200	A	G	Efficacy
4306	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	MTR	D919G	1	236885200	A	G	Toxicity
4307	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukemia,Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC2	rs717620	10	99782821	C	T	Toxicity
4308	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	CCND1	rs9344	11	69648142	G	A	Toxicity
4309	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	CCND1	rs9344	11	69648142	G	A	Efficacy
4310	pharmgkb		cisplatin,doxorubicin,methotrexate			Osteosarcoma	CCND1	rs9344	11	69648142	G	A	Efficacy
4311	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Anemia,Leukopenia,Lymphoma, Non-Hodgkin,mucositis,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia,Toxic liver disease	MTHFD1	R653Q	14	64442127	G	A	Toxicity
4312	pharmgkb		mercaptopurine,methotrexate			Drug Toxicity,Precursor Cell Lymphoblastic Leukemia-Lymphoma	GSTP1	I105V	11	67585218	A	G	Toxicity
4313	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Drug Toxicity,Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTRR	I49M	5	7870860	A	G	Toxicity
4314	pharmgkb	Drug	disulfiram	3117	CCN(CC)C(=S)SSC(=S)N(CC)CC	Cocaine-Related Disorders	OPRD1	rs678849	1	28818676	C	T	Efficacy
4315	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	gastrointestinal toxicity,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs11045879	12	21229685	T	C	Toxicity
4316	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	adverse events	WBP2NL	rs9620007	22	42009653	C	G	Toxicity
4317	pharmgkb	Drug	hydrocodone	5284569	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	adverse events	OPRM1	rs62436463	6	154069472	C	T	Toxicity
4318	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	adverse events	OPRM1	rs62436463	6	154069472	C	T	Toxicity
4319	pharmgkb	Drug	meperidine	4058	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2	adverse events	FIP1L1	rs113100019	4	53421530	T	G	Toxicity
4320	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	adverse events	OPRM1	rs62436463	6	154069472	C	T	Toxicity
4321	pharmgkb	Prodrug	codeine	5284371	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O	adverse events	SEPTIN3	rs739296	22	41993944	G	A	Toxicity
4322	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	adverse events	SEPTIN3	rs739296	22	41993944	G	A	Toxicity
4323	pharmgkb	Drug	hydrocodone	5284569	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4	adverse events	SEPTIN3	rs739296	22	41993944	G	A	Toxicity
4324	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	adverse events	SEPTIN3	rs739296	22	41993944	G	A	Toxicity
4325	pharmgkb	Drug	meperidine	4058	CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2	adverse events	SERINC5	rs185462714	5	80184547	A	C	Toxicity
4326	pharmgkb	Drug	ketorolac	3826	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O	Pain, Postoperative	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Efficacy
4327	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Peripheral Nervous System Diseases	ABCB1	rs1128503	7	87550285	A	G	Toxicity
4328	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*46:01					Toxicity
4329	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:21					Toxicity
4330	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-A	HLA-A*24:02					Toxicity
4331	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	CYP2B6	K262R	19	41009358	A	G	Dosage
4332	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Pain	ABCB1	I1145M	7	87509329	A	K	Dosage
4333	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DRD1	rs5326	5	175443193	C	T	Dosage
4334	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O		CYP3A4	CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*7, CYP3A4*8, CYP3A4*9, CYP3A4*10, CYP3A4*11, CYP3A4*12, CYP3A4*13, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*18, CYP3A4*19, CYP3A4*20, CYP3A4*21, CYP3A4*22, CYP3A4*23, CYP3A4*24, CYP3A4*26, CYP3A4*28, CYP3A4*29, CYP3A4*30, CYP3A4*31, CYP3A4*32, CYP3A4*33, CYP3A4*34					Metabolism/PK
4335	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	ADAMTSL2	rs756770	9	133533736	C	A	Efficacy
4336	pharmgkb	Drug	naltrexone	5360515	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	ADH1C	I350V	4	99339632	T	M	Efficacy
4337	pharmgkb	Drug	naltrexone	5360515	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	ADH1B	R370C	4	99307860	G	A	Efficacy
4338	pharmgkb	Drug	naltrexone	5360515	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism	ALDH2	E457K	12	111803962	G	A	Efficacy
4339	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain,Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Dosage
4340	pharmgkb	Drug	naltrexone	5360515	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O		AKR1C4	L311V	10	5218719	C	G	Metabolism/PK
4341	pharmgkb	Drug	naltrexone	5360515	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O		AKR1C4	S145Y	10	5205821	C	G	Metabolism/PK
4342	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRK1	rs997917	8	53239818	T	C	Toxicity
4343	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRK1	rs997917	8	53239818	T	C	Toxicity
4344	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Peptic Ulcer	EYA1	rs12678747	8	71202541	A	T	Toxicity
4345	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46					Toxicity
4346	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	V110I	19	40849833	C	D	Metabolism/PK
4347	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	R64S	19	40849971	G	W	Metabolism/PK
4348	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	R190H	19	40848304	C	W	Metabolism/PK
4349	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	rs61605570	19	40845458	T	A	Metabolism/PK
4350	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	E419K	19	40844679	C	T	Metabolism/PK
4351	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	I434V	19	40844634	T	C	Metabolism/PK
4352	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	M275I	19	40846881	C	A	Metabolism/PK
4353	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	E330D	19	40845465	C	A	Metabolism/PK
4354	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	T378I	19	40845322	G	W	Metabolism/PK
4355	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	I61F	19	40849980	T	R	Metabolism/PK
4356	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	M368I	19	40845351	C	G	Metabolism/PK
4357	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	G115D	19	40848763	C	T	Metabolism/PK
4358	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	R257C	19	40846937	G	H	Metabolism/PK
4359	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	I300T	19	40846030	A	K	Metabolism/PK
4360	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	V323M	19	40845962	C	T	Metabolism/PK
4361	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	F362S	19	40845370	A	S	Metabolism/PK
4362	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	R64H	19	40849970	C	T	Metabolism/PK
4363	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	V140A	19	40848688	A	G	Metabolism/PK
4364	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	E97K	19	40849872	C	T	Metabolism/PK
4365	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		CYP2A6	I471T	19	40843869	A	G	Metabolism/PK
4366	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	OPRD1	rs678849	1	28818676	C	T	Efficacy
4367	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Constipation,Delirium,Lung Neoplasms,Nausea,Pain,Postoperative Nausea and Vomiting,Pruritus,Respiratory Insufficiency,somnolence,Urinary Retention	FAAH	P129T	1	46405089	C	A	Toxicity
4368	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	adverse events,Constipation,Delirium,Dizziness,Nausea,Pain, Postoperative,Postoperative Nausea and Vomiting,Pruritus,Respiratory Insufficiency,somnolence,Urinary Retention,Vomiting	OPRM1	N40D	6	154039662	A	G	Toxicity
4369	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain,Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Dosage
4370	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain,Pain, Postoperative	CYP3A5	CYP3A5*1, CYP3A5*3, CYP3A5*6					Metabolism/PK
4371	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	CYP2B6	Q172H	19	41006936	G	W	Dosage
4372	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	OPRM1	rs10485058	6	154124080	A	G	Efficacy
4373	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DAO	rs55944529	12	108898654	C	T	Metabolism/PK
4374	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence	DAO	rs55944529	12	108898654	C	T	Dosage
4375	pharmgkb	Drug	abiraterone	132971	C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O	Prostatic Neoplasms	SRD5A2	L89I	2	31580636	G	H	Efficacy
4376	pharmgkb		abiraterone,prednisolone			Prostatic Neoplasms	DSE	P62T	6	116279647	G	W	Efficacy
4377	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		ABCG2	Q141K	4	88131171	G	Y	Other
4378	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
4379	pharmgkb	Drug	fluvastatin	1548972	CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F		ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
4380	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Leukemia,Lymphoma,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	A222V	1	11796321	G	A	Metabolism/PK
4381	pharmgkb		folic acid,vitamin b-complex, plain				MTHFR	A222V	1	11796321	G	A	Efficacy
4382	pharmgkb	Drug	folic acid	6037	C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N		MTHFR	A222V	1	11796321	G	A	Metabolism/PK
4383	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	A222V	1	11796321	G	A	Efficacy
4384	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Graft vs Host Disease,Leukemia,Leukemia, Myelogenous, Chronic, BCR-ABL Positive	MTHFR	A222V	1	11796321	G	A	Efficacy
4385	pharmgkb		interferon alfa-2a, recombinant,ribavirin			Hepatitis C	HLA-B	HLA-B*44:02					Efficacy
4386	pharmgkb	Prodrug	sacubitril				CES1	G144E	16	55823658	C	T	Metabolism/PK
4387	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		Respiratory Insufficiency	HLA-B	HLA-B*07:02					Toxicity
4388	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		Respiratory Insufficiency	HLA-C	HLA-C*07:02					Toxicity
4389	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		Acquired Immunodeficiency Syndrome	GSTM1	GSTM1 non-null, GSTM1 null					Toxicity
4390	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		adverse events,Hypersensitivity	NAT2	G286E	8	18400860	G	A	Toxicity
4391	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		adverse events,Hypersensitivity	NAT2	R197Q	8	18400593	G	A	Toxicity
4392	pharmgkb	Drug	Glucarpidase			nephrotoxicity	INSRR	rs10908521	1	156843858	T	C	Toxicity
4393	pharmgkb	Drug	Glucarpidase			nephrotoxicity	GATA3	rs3824662	10	8062245	C	W	Toxicity
4394	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Confusion,Drug Toxicity,Headache,Muscle Rigidity,Schizophrenia,sedation,Seizures,Tachycardia	CYP1A2	CYP1A2*1A, CYP1A2*1C, CYP1A2*1F					Toxicity
4395	pharmgkb	Drug	quetiapine	5002	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42		CYP3A4	CYP3A4*1, CYP3A4*3					Metabolism/PK
4396	pharmgkb	Drug	alprazolam	2118	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	adverse events,Alcoholism,Anxiety Disorders	CYP3A4	CYP3A4*1, CYP3A4*22					Toxicity
4397	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Neoplasms,Neurotoxicity Syndromes	CYP3A5	CYP3A5*1, CYP3A5*3					Toxicity
4398	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Ovarian Neoplasms	CYP3A4	CYP3A4*1, CYP3A4*8, CYP3A4*20, CYP3A4*22					Toxicity
4399	pharmgkb		aspirin,clopidogrel			Acute coronary syndrome,major adverse cardiac events (mace)	JMJD8	rs11640115	16	685794	A	G	Efficacy
4400	pharmgkb		aspirin,clopidogrel			Acute coronary syndrome,major adverse cardiac events (mace)	EFR3A	rs4736529	8	132010916	G	Y	Efficacy
4401	pharmgkb		aspirin,clopidogrel			Acute coronary syndrome,major adverse cardiac events (mace)	NECAB1	rs74569896	8	90925381	A	G	Efficacy
4402	pharmgkb		aspirin,clopidogrel			Acute coronary syndrome,major adverse cardiac events (mace)	AGAP3	rs75750968	7	151128719	T	M	Efficacy
4403	pharmgkb		aspirin,clopidogrel			Acute coronary syndrome,major adverse cardiac events (mace)	ECHS1	rs140410716	10	133368948	C	T	Efficacy
4404	pharmgkb	Drug	diclofenac	3033	C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8, CYP2C9*13, CYP2C9*36, CYP2C9*37, CYP2C9*38, CYP2C9*39, CYP2C9*40, CYP2C9*42, CYP2C9*43, CYP2C9*44, CYP2C9*45, CYP2C9*46, CYP2C9*47, CYP2C9*48, CYP2C9*50, CYP2C9*52, CYP2C9*53, CYP2C9*54, CYP2C9*55, CYP2C9*59, CYP2C9*60, CYP2C9*62					Metabolism/PK
4405	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Coronary Disease,Hypercholesterolemia,Myocardial Infarction	KIF6	W170R	6	39357302	A	G	Efficacy
4406	pharmgkb		aspirin,clopidogrel			Acute coronary syndrome,major adverse cardiac events (mace)	MYOM2	rs17064642	8	2069296	T	C	Efficacy
4407	pharmgkb	Drug	acetaminophen	1983	CC(=O)NC1=CC=C(C=C1)O	severe cutaneous adverse reactions	HLA-DQB1	HLA-DQB1*02:02					Toxicity
4408	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34					Toxicity
4409	pharmgkb	Drug	thioguanine	2723601	C1=NC2=C(N1)C(=S)N=C(N2)N	Neutropenia,Precursor Cell Lymphoblastic Leukemia-Lymphoma,Thrombocytopenia	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34					Toxicity
4410	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34					Dosage
4411	pharmgkb	Drug	thioguanine	2723601	C1=NC2=C(N1)C(=S)N=C(N2)N	Precursor Cell Lymphoblastic Leukemia-Lymphoma	TPMT	TPMT*1, TPMT*21, TPMT*33, TPMT*34					Dosage
4412	pharmgkb	Drug	thioguanine	2723601	C1=NC2=C(N1)C(=S)N=C(N2)N		TPMT	TPMT*1, TPMT*19, TPMT*20, TPMT*21, TPMT*22, TPMT*30, TPMT*32, TPMT*33, TPMT*34					Metabolism/PK
4413	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Lupus Erythematosus, Systemic,Precursor Cell Lymphoblastic Leukemia-Lymphoma	TPMT	TPMT*1, TPMT*21, TPMT*24, TPMT*25, TPMT*32, TPMT*33, TPMT*34, TPMT*37					Metabolism/PK
4414	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	schizoaffective disorder,Schizophrenia	CYP1A2	CYP1A2*1A, CYP1A2*1F					Metabolism/PK
4415	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC4	rs3742106	13	95021537	A	C	Metabolism/PK
4416	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections	ABCC4	K1116N	13	95062722	C	K	Metabolism/PK
4417	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764		HIV Infections,nephrotoxicity	ABCC10	rs9349256	6	43436773	G	A	Toxicity
4418	pharmgkb	Drug	tenofovir disoproxil fumarate	6398764		HIV Infections,nephrotoxicity	ABCC4	rs3742106	13	95021537	A	C	Toxicity
4419	pharmgkb	Drug	digoxin	30322	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O	Shortened QT interval	NOS1AP	rs10494366	1	162115895	G	T	Toxicity
4420	pharmgkb	Drug Class	highly active antiretroviral therapy (haart)			HIV Infections	ABCB1	I1145M	7	87509329	A	K	Efficacy
4421	pharmgkb		Antivirals for treatment of HIV infections, combinations,Drugs For Treatment Of Tuberculosis			drug-induced liver injury,HIV Infections,Tuberculosis	NAT2	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*12, NAT2*13					Toxicity
4422	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		adverse events,Hypersensitivity,severe cutaneous adverse reactions	NAT2	NAT2*4, NAT2*5A, NAT2*5B, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*14A, NAT2*14B					Toxicity
4423	pharmgkb		carboplatin,paclitaxel			Leukopenia,Neutropenia,Ovarian Neoplasms	CYP3A5	CYP3A5*1, CYP3A5*3					Toxicity
4424	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	AHRR	P185A	5	422840	C	K	Efficacy
4425	pharmgkb	Drug	phenytoin	1775	C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3	Stevens-Johnson Syndrome	CYP2C9	CYP2C9*1, CYP2C9*3					Toxicity
4426	pharmgkb	Drug	ketoprofen	3825	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	Dyspepsia,Pain, Postoperative	CYP2C9	CYP2C9*1, CYP2C9*2					Toxicity
4427	pharmgkb	Drug	ketoprofen	3825	CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O	Pain, Postoperative	CYP2C9	CYP2C9*1, CYP2C9*3					Efficacy
4428	pharmgkb	Drug	methoxsalen	4114	COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2		CYP2A6	CYP2A6*1, CYP2A6*15, CYP2A6*21, CYP2A6*22					Metabolism/PK
4429	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*46					Dosage
4430	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12					Toxicity
4431	pharmgkb		naloxone,oxycodone			Erythema	OPRM1	N40D	6	154039662	A	G	Toxicity
4432	pharmgkb		naloxone,oxycodone			Vomiting	COMT	V158M	22	19963748	G	A	Toxicity
4433	pharmgkb		naloxone,oxycodone			Erythema	COMT	V158M	22	19963748	G	A	Toxicity
4434	pharmgkb	Drug	hydralazine	3637	C1=CC=C2C(=C1)C=NN=C2NN	Hypertension	NAT2	NAT2*4, NAT2*5D, NAT2*6B, NAT2*7A, NAT2*12A, NAT2*13A, NAT2*14A					Efficacy
4435	pharmgkb	Prodrug	tegafur	5386		Neoplasms	CYP2A6	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*18, CYP2A6*19, CYP2A6*46					Metabolism/PK
4436	pharmgkb	Drug	letrozole	3902	C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3	Breast Neoplasms	CYP2A6	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35, CYP2A6*46					Metabolism/PK
4437	pharmgkb	Drug	coumarin				CYP2A6	CYP2A6*1, CYP2A6*4, CYP2A6*5, CYP2A6*6, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*12, CYP2A6*17, CYP2A6*18, CYP2A6*19, CYP2A6*20					Metabolism/PK
4438	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	CYP2A6	CYP2A6*1, CYP2A6*1x2, CYP2A6*2					Toxicity
4439	pharmgkb	Drug	buprenorphine / naloxone			Opioid-Related Disorders	UGT2B7	rs7662029	4	69096194	A	K	Metabolism/PK
4440	pharmgkb		buprenorphine,fentanyl,tramadol			adverse events,Opioid-Related Disorders	COMT	V158M	22	19963748	G	A	Toxicity
4441	pharmgkb	Drug	buprenorphine / naloxone			Opioid-Related Disorders	UGT2B7	Y268H	4	69098620	T	C	Metabolism/PK
4442	pharmgkb	Drug	tramadol	33741	CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O	Opioid-Related Disorders	ABCB1	I1145M	7	87509329	A	K	Toxicity
4443	pharmgkb	Drug	nifedipine	4485	CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC		CYP3A4	CYP3A4*1, CYP3A4*17					Metabolism/PK
4444	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	major adverse cardiac events (mace)	N6AMT1	rs2254638	21	28883961	A	S	Efficacy
4445	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	major adverse cardiac events (mace)	P2RY12	rs2046934	3	151339854	G	M	Efficacy
4446	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	major adverse cardiac events (mace)	PTGS1	rs1330344	9	122369409	C	T	Efficacy
4447	pharmgkb	Drug	nimodipine	4497	CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC		CACNA1C	rs2239050	12	2338248	G	M	Efficacy
4448	pharmgkb	Drug Class	Beta Blocking Agents			Cardiomyopathy, Dilated,Death	ADRA2C	rs61767072	4	3767570	GGGGCGGGGCCG	-	Efficacy
4449	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Artery Disease	GRK5	rs10787959	10	119371801	A	G	Efficacy
4450	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Artery Disease	GRK5	rs3740563	10	119335888	A	C	Efficacy
4451	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Artery Disease	GRK5	rs11198893	10	119348388	G	M	Efficacy
4452	pharmgkb	Drug Class	Beta Blocking Agents			Coronary Artery Disease	GRK5	rs4752292	10	119340641	T	G	Efficacy
4453	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Carcinoma, Hepatocellular,hand-foot syndrome	TNF	rs1800629	6	31575254	G	A	Toxicity
4454	pharmgkb	Drug	Glucarpidase			nephrotoxicity	SLCO1B1	V174A	12	21178615	T	C	Toxicity
4455	pharmgkb	Drug	Glucarpidase			nephrotoxicity	ABCC4	rs7317112	13	95271269	A	G	Toxicity
4456	pharmgkb		atenolol,verapamil			Coronary Artery Disease,Hypertension	GRK4	A142V	4	3004316	C	D	Toxicity
4457	pharmgkb	Drug	alprazolam	2118	CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4	Alcoholism,Anxiety Disorders	CYP3A4	CYP3A4*1, CYP3A4*22					Efficacy
4458	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Pain	CYP3A4	rs2740574	7	99784473	C	T	Efficacy
4459	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl		CYP2C9	rs1934969	10	94988738	A	T	Other
4460	pharmgkb	Drug Class	sulfonamides, urea derivatives			Diabetes Mellitus, Type 2	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Efficacy
4461	pharmgkb	Drug	clozapine	2818	CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl	Agranulocytosis	HLA-DRB1	HLA-DRB1*04:02					Toxicity
4462	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Maculopapular Exanthema	HLA-DRB1	HLA-DRB1*03:01					Toxicity
4463	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hypertension	PIK3R5	rs444904	17	8900750	C	T	Toxicity
4464	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	EGFR	rs917881	7	55094612	A	G	Toxicity
4465	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	VEGFB	D136E	11	64237220	C	K	Toxicity
4466	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	EPAS1	rs4035887	2	46340088	A	K	Toxicity
4467	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	KDR	rs4864950	4	55080735	T	A	Toxicity
4468	pharmgkb	Drug	regorafenib			Drug Toxicity	KDR	rs4864950	4	55080735	T	A	Toxicity
4469	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	EPAS1	rs1868089	2	46327507	C	T	Toxicity
4470	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hypertension	PRKCE	rs11125039	2	45869545	A	G	Toxicity
4471	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hypertension	ADAMTS18	rs1346563	16	77402386	G	A	Toxicity
4472	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Hypertension	EGFR	rs2330951	7	55106649	C	A	Toxicity
4473	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	MAP2K6	rs11651488	17	69478057	T	C	Toxicity
4474	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	CDH13	rs17682789	16	82981129	T	C	Toxicity
4475	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	WWOX	rs9927200	16	78170090	A	C	Toxicity
4476	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Diarrhea	EGFR	rs917881	7	55094612	A	G	Toxicity
4477	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	MAP2K6	rs12948059	17	69498353	A	G	Toxicity
4478	pharmgkb	Drug	sorafenib	216239	CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F	Drug Toxicity	EPAS1	rs9973653	2	46320970	G	T	Toxicity
4479	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Essential hypertension	CAMK1D	rs10737062	10	12690744	G	M	Efficacy
4480	pharmgkb	Drug	losartan	3961	CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl	Essential hypertension	CAMK1D	rs10752271	10	12662192	G	A	Efficacy
4481	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	IL10	rs1800871	1	206773289	A	G	Metabolism/PK
4482	pharmgkb	Drug	rivaroxaban	9875401			ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
4483	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Respiratory Insufficiency	CYP3A4	rs2242480	7	99763843	C	T	Toxicity
4484	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	Pain	CYP3A4	rs2242480	7	99763843	C	T	Dosage
4485	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		CYP3A4	rs2242480	7	99763843	C	T	Efficacy
4486	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC		CYP3A4	rs2242480	7	99763843	C	T	Metabolism/PK
4487	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	liver transplantation	CYP3A4	rs2242480	7	99763843	C	T	Toxicity
4488	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4	Hyperlipidemias	CYP3A4	rs2242480	7	99763843	C	T	Efficacy
4489	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP3A4	rs2242480	7	99763843	C	T	Metabolism/PK
4490	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3		CYP3A4	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22					Metabolism/PK
4491	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F	sedation	FASTKD3	I49M	5	7870860	A	G	Efficacy
4492	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		FASTKD3	I49M	5	7870860	A	G	Other
4493	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		GABRA2	K132N	4	46312576	T	C	Other
4494	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		FASTKD3	rs2307116	5	7861872	G	A	Other
4495	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		KCNK3	rs1275988	2	26691496	C	T	Other
4496	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		CYP2E1	rs2031920	10	133526341	C	T	Other
4497	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		CYP2E1	rs3813867	10	133526101	G	M	Other
4498	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F	sedation	KCNK2	rs6686529	1	215236763	G	Y	Efficacy
4499	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		GRIN2B	rs1806201	12	13564574	G	A	Other
4500	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		FASTKD3	rs3733784	5	7862813	T	C	Efficacy
4501	pharmgkb	Drug	sevoflurane	5206	C(OC(C(F)(F)F)C(F)(F)F)F		FASTKD3	rs2307116	5	7861872	G	A	Efficacy
4502	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*39:01					Toxicity
4503	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Stevens-Johnson Syndrome	HLA-B	HLA-B*15:18, HLA-B*40:01					Toxicity
4504	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Psoriasis	HLA-C	HLA-C*06:02					Efficacy
4505	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	Drug Hypersensitivity	HLA-DQB1	HLA-DQB1*05:01					Toxicity
4506	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*15:01					Toxicity
4507	pharmgkb	Drug	minocycline	5281021	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)/C(=C(/N)\O)/C1=O)O)O)O)N(C)C	drug-induced liver injury	HLA-B	HLA-B*35:02					Toxicity
4508	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	liver transplantation,transplant rejection	ITPA	P32T	20	3213196	C	R	Efficacy
4509	pharmgkb		aspirin,clopidogrel			Acute coronary syndrome,major adverse cardiac events (mace)	ZDHHC3	rs3749187	3	44945082	G	A	Efficacy
4510	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Drug Toxicity	CES1	rs2244613	16	55810697	G	W	Toxicity
4511	pharmgkb	Drug	cyclosporine	6435893	CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	Psoriasis	CALM1	rs12885713	14	90397013	C	D	Efficacy
4512	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Drug Toxicity,Neoplasms,Ototoxicity	TPMT	Y240C	6	18130687	T	S	Toxicity
4513	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression,Depressive Disorder	HTR2A	rs7997012	13	46837850	A	G	Efficacy
4514	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Anxiety Disorders	HTR2A	rs7997012	13	46837850	A	G	Efficacy
4515	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major,Nausea,Vomiting	HTR2A	rs6311	13	46897343	C	T	Toxicity
4516	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Anxiety Disorders,Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Toxicity
4517	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depression,Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Toxicity
4518	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major,Sexual Dysfunctions, Psychological	HTR2A	rs6313	13	46895805	G	A	Toxicity
4519	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depression	HTR2A	rs6313	13	46895805	G	A	Toxicity
4520	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder	HTR2A	rs9316233	13	46859220	C	K	Efficacy
4521	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors			ability to concentrate,Depressive Disorder, Major,Diarrhea,Dizziness,Tremor	HTR2A	rs6311	13	46897343	C	T	Toxicity
4522	pharmgkb	Drug	fluvoxamine	3404	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
4523	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depression	SLC6A4	rs57098334					Efficacy
4524	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major,Mood Disorders,Panic Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
4525	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Toxicity
4526	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depression,Depressive Disorder, Major	SLC6A4	rs57098334					Efficacy
4527	pharmgkb	Drug Class	antidepressants			Depression	SLC6A4	rs57098334					Toxicity
4528	pharmgkb	Drug Class	Selective serotonin reuptake inhibitors				SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Toxicity
4529	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP2D6	P34A	22	42130692	G	A	Efficacy
4530	pharmgkb	Drug	vincristine	5978	CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	Peripheral Nervous System Diseases	CEP72	rs924607	5	609978	C	T	Toxicity
4531	pharmgkb	Drug	mianserin	4184	CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42	Depression	CYP2D6	CYP2D6*1, CYP2D6*5, CYP2D6*10					Metabolism/PK
4532	pharmgkb	Drug	rabeprazole	5029	CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC	Gastroesophageal Reflux,Helicobacter Infections,Peptic Ulcer	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Efficacy
4533	pharmgkb	Drug	esomeprazole	9568614	CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC	Gastroesophageal Reflux,Helicobacter Infections	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Efficacy
4534	pharmgkb	Drug	prasugrel	6918456	CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4	Acute coronary syndrome	CYP2C19	CYP2C19*1, CYP2C19*17					Toxicity
4535	pharmgkb		anthracyclines and related substances,daunorubicin,doxorubicin			cardiotoxicity,Neoplasms	RARG	S416L	12	53211761	G	A	Toxicity
4536	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		ABCG2	Q141K	4	88131171	G	Y	Toxicity
4537	pharmgkb	Drug	Glucarpidase			nephrotoxicity	ARID5B	rs10821936	10	61963818	C	T	Toxicity
4538	pharmgkb		bufuralol,dextromethorphan				CYP2D6	CYP2D6*1, CYP2D6*7, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*27, CYP2D6*29, CYP2D6*36, CYP2D6*37, CYP2D6*39, CYP2D6*40, CYP2D6*47, CYP2D6*48, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*53, CYP2D6*54, CYP2D6*55, CYP2D6*62, CYP2D6*71, CYP2D6*72, CYP2D6*75, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98, CYP2D6*114					Other
4539	pharmgkb	Metabolite	n-desmethyltamoxifen	3032890	CC/C(=C(/C1=CC=CC=C1)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3		CYP2D6	CYP2D6*1, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*22, CYP2D6*23, CYP2D6*24, CYP2D6*25, CYP2D6*26, CYP2D6*27, CYP2D6*28, CYP2D6*29, CYP2D6*30, CYP2D6*31, CYP2D6*32, CYP2D6*33, CYP2D6*36, CYP2D6*37, CYP2D6*40, CYP2D6*43, CYP2D6*45, CYP2D6*46, CYP2D6*47, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*52, CYP2D6*54, CYP2D6*55, CYP2D6*61, CYP2D6*62, CYP2D6*63, CYP2D6*64, CYP2D6*65, CYP2D6*70, CYP2D6*71, CYP2D6*114					Metabolism/PK
4540	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	HIV Infections	CYP3A5	rs776746	7	99672916	T	C	Other
4541	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	A222V	1	11796321	G	A	Toxicity
4542	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCB1	S893A	7	87531302	A	Y	Efficacy
4543	pharmgkb	Prodrug	cyclophosphamide	2907	C1CNP(=O)(OC1)N(CCCl)CCCl	Neoplasms,Ovarian Neoplasms	XRCC1	Q399R	19	43551574	T	C	Efficacy,Toxicity
4544	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C		CYP2C8	I199F	10	95058349	T	A	Dosage
4545	pharmgkb		Bisphosphonates,pamidronate,zoledronate			Multiple Myeloma,Osteonecrosis	CYP2C8	rs1934951	10	95038791	C	T	Toxicity
4546	pharmgkb	Drug	leflunomide	3899	CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F	Arthritis, Rheumatoid	CYP1A2	rs762551	15	74749576	C	A	Toxicity
4547	pharmgkb	Drug Class	antipsychotics			Schizophrenia	CYP1A2	rs2069514	15	74745879	G	A	Toxicity
4548	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		EPHX1	rs1131873	1	225831952	G	A	Dosage
4549	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	CLOCK	rs1801260	4	55435202	A	G	Toxicity
4550	pharmgkb		mycophenolate mofetil,mycophenolic acid			Kidney Transplantation	IMPDH2	rs11706052	3	49026677	A	G	Efficacy,Toxicity
4551	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT1A9	rs17868320	2	233669782	C	T	Efficacy
4552	pharmgkb	Drug Class	antidepressants			Depressive Disorder, Major	GNB3	rs5443	12	6845711	C	T	Efficacy
4553	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		SCAP	V798F	3	47418189	C	T	Other
4554	pharmgkb	Drug	pravastatin	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O		SLCO1B1	N130H	12	21176804	A	K	Efficacy
4555	pharmgkb	Drug	amlodipine	2162	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	Hypertension	CYP3A4	rs2740574	7	99784473	C	T	Efficacy
4556	pharmgkb	Drug	fenofibrate	3339	CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl	Hypertriglyceridemia	FABP1	T94A	2	88124547	T	C	Efficacy
4557	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	BDNF	V66M	11	27658369	C	T	Toxicity
4558	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Breast Neoplasms	RRM1	rs1042858	11	4138236	G	W	Efficacy
4559	pharmgkb	Drug	benazepril	5362124	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	Essential hypertension	ADRB2	R16G	5	148826877	G	A	Efficacy
4560	pharmgkb	Drug	ranibizumab			Macular Degeneration	VEGFA	rs833069	6	43774842	T	S	Efficacy
4561	pharmgkb	Drug	propranolol	4946	CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O		CYP2D6	CYP2D6*1, CYP2D6*10					Other
4562	pharmgkb	Drug	mefloquine	4046	C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O	Malaria	G6PD	G6PD A- 202A_376G, G6PD B (reference)					Toxicity
4563	pharmgkb		cisplatin,cyclophosphamide			Ovarian Neoplasms	RAD52	rs11226	12	912647	G	A	Toxicity
4564	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Carcinoma, Non-Small-Cell Lung	UGT1A9	rs3832043	2	233671808	T	-	Toxicity
4565	pharmgkb	Drug	chloroquine	2719	CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl	Anemia, Hemolytic	G6PD	G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham					Toxicity
4566	pharmgkb		antiepileptics,carbamazepine,phenobarbital,phenytoin,valproic acid			Epilepsy	SCN2A	R19K	2	165295879	G	A	Efficacy
4567	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCC2	I1324M	10	99844450	C	K	Efficacy
4568	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Mental Disorders	HTR3B	Y129S	11	113932306	A	C	Toxicity
4569	pharmgkb	Drug	ranibizumab			Macular Degeneration	VEGFA	rs699947	6	43768652	A	Y	Efficacy
4570	pharmgkb		antiepileptics,carbamazepine,oxcarbazepine			Epilepsy	ABCC2	V417I	10	99804058	G	A	Toxicity
4571	pharmgkb		carbamazepine,phenytoin,valproic acid			Epilepsy	ABCB1	S893A	7	87531302	A	Y	Efficacy
4572	pharmgkb	Prodrug	capecitabine	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	Colorectal Neoplasms	ADCY2	rs4702484	5	7649747	C	T	Efficacy
4573	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Hypertension	CYP3A5	rs776746	7	99672916	T	C	Toxicity
4574	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Muscular Diseases	SLCO1B1	rs4363657	12	21215788	T	C	Toxicity
4575	pharmgkb	Drug	carisoprodol	2576	CCCC(C)(COC(=O)N)COC(=O)NC(C)C		CYP2C19	CYP2C19*1, CYP2C19*2					Metabolism/PK
4576	pharmgkb		cyclosporine,mycophenolate mofetil			Kidney Transplantation	IMPDH2	rs11706052	3	49026677	A	G	Efficacy
4577	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Angina Pectoris,Coronary Artery Disease,Myocardial Infarction,Myocardial Ischemia,Thrombosis	PON1	Q192P	7	95308134	T	C	Efficacy,Toxicity
4578	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3		P2RY12	N6K	3	151338828	G	W	Efficacy,Toxicity
4579	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	I1145M	7	87509329	A	K	Efficacy
4580	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Deafness,Neoplasms,Ototoxicity	GSTT1	GSTT1 non-null, GSTT1 null					Toxicity
4581	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	HIV Infections,Kidney Diseases	ABCC2	V417I	10	99804058	G	A	Toxicity
4582	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	VEGFA	rs699947	6	43768652	A	Y	Efficacy
4583	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	UGT2B7	Y268H	4	69098620	T	C	Other
4584	pharmgkb		Drugs For Treatment Of Tuberculosis,ethambutol,isoniazid,pyrazinamide,rifampin,streptomycin			Tuberculosis	GSTM1	GSTM1 non-null, GSTM1 null					Toxicity
4585	pharmgkb		Drugs For Treatment Of Tuberculosis,ethambutol,isoniazid,pyrazinamide,rifampin,streptomycin			Tuberculosis	GSTT1	GSTT1 non-null, GSTT1 null					Toxicity
4586	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Neurotoxicity Syndromes	CYP3A5	rs776746	7	99672916	T	C	Toxicity
4587	pharmgkb	Drug	atorvastatin	60823	CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4		CETP	rs708272	16	56962376	G	A	Efficacy,Toxicity
4588	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia,Hyperlipoproteinemia Type II	CETP	rs708272	16	56962376	G	A	Efficacy
4589	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2A6	rs8192726	19	40848591	C	A	Other
4590	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP2A6	V365M	19	40845362	C	T	Other
4591	pharmgkb	Drug Class	Photodynamic therapy			Macular Degeneration	CFH	H402Y	1	196690107	C	T	Efficacy
4592	pharmgkb	Drug	gefitinib	123631	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4	Lung Neoplasms	ABCG2	Q141K	4	88131171	G	Y	Toxicity
4593	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCB1	rs1128503	7	87550285	A	G	Efficacy
4594	pharmgkb		bevacizumab,ranibizumab			Macular Degeneration	HTRA1	rs11200638	10	122461028	G	A	Efficacy
4595	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	UGT2B7	rs28365062	4	69098553	A	K	Metabolism/PK
4596	pharmgkb		dolasetron,granisetron			Postoperative Nausea and Vomiting	CYP2D6	CYP2D6*1, CYP2D6*1xN					Efficacy
4597	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Hypercholesterolemia,Myalgia unspecified	CYP3A5	rs776746	7	99672916	T	C	Other
4598	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Substance-Related Disorders	DRD2	rs6277	11	113412737	G	A	Efficacy
4599	pharmgkb		bevacizumab,ranibizumab			Macular Degeneration	CFH	H402Y	1	196690107	C	T	Efficacy
4600	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC		IMPDH1	rs2278293	7	128400698	C	T	Toxicity
4601	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCB1	S893A	7	87531302	A	Y	Efficacy
4602	pharmgkb		citalopram,escitalopram			Depressive Disorder	TSPAN5	rs11947402	4	98680790	A	G	Other
4603	pharmgkb		hmg coa reductase inhibitors,simvastatin			Myocardial Infarction	GATM	rs9806699	15	45448194	G	A	Toxicity
4604	pharmgkb	Drug	mycophenolate mofetil	5281078	CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC	Kidney Transplantation	UGT1A9	rs6714486	2	233671659	T	A	Efficacy
4605	pharmgkb	Drug	lithium	28486	[Li+]	Bipolar Disorder	NTRK2	rs1387923	9	85025721	A	G	Efficacy
4606	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	CYP3A5	rs776746	7	99672916	T	C	Other
4607	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	FMO3	V194M	1	171110939	G	A	Toxicity
4608	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	HNMT	rs17583889	2	137988469	C	A	Toxicity
4609	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	UGT1A6	rs4261716	2	233684471	G	T	Toxicity
4610	pharmgkb	Drug Class	anthracyclines and related substances				UGT1A6	S7A	2	233693023	T	G	Toxicity
4611	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	UGT1A6	rs17863783	2	233693631	G	T	Toxicity
4612	pharmgkb	Drug Class	anthracyclines and related substances				ADH7	rs729147	4	99412110	G	A	Toxicity
4613	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC22A2	S270A	6	160249250	A	C	Toxicity
4614	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	ABCB4	rs1149222	7	87444459	G	T	Toxicity
4615	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	ABCB4	rs4148808	7	87476479	T	C	Toxicity
4616	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	ABCB1	rs2235047	7	87509216	A	S	Toxicity
4617	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC28A3	rs4877847	9	84331502	A	C	Toxicity
4618	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC10A2	rs9514091	13	103061904	G	A	Toxicity
4619	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC10A2	rs7319981	13	103071372	G	A	Toxicity
4620	pharmgkb	Drug Class	anthracyclines and related substances				SLC28A1	rs2290271	15	84904404	A	C	Toxicity
4621	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	ABCC1	rs4148350	16	16076620	G	T	Toxicity
4622	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SLC28A1	rs2305364	15	84909044	T	C	Toxicity
4623	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SPG7	rs2019604	16	89549357	T	R	Toxicity
4624	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	CYP4F2	rs2108623	19	15906196	G	A	Toxicity
4625	pharmgkb	Drug Class	anthracyclines and related substances			Neoplasms	SULT2B1	rs10426377	19	48588977	C	A	Toxicity
4626	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	HNF4A	rs2071197	20	44401795	G	A	Efficacy,Metabolism/PK
4627	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms	CYP2C8	rs1934951	10	95038791	C	T	Toxicity
4628	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms	ERCC2	rs13181	19	45351661	T	R	Toxicity
4629	pharmgkb	Drug	ustekinumab			Psoriasis	TNFAIP3	rs610604	6	137878280	G	T	Efficacy
4630	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	rs1128503	7	87550285	A	G	Metabolism/PK
4631	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	ABCB1	I1145M	7	87509329	A	K	Dosage,Metabolism/PK
4632	pharmgkb	Drug Class	antiepileptics			Epilepsy	ABCC2	rs717620	10	99782821	C	T	Efficacy
4633	pharmgkb		adalimumab,etanercept,infliximab			Psoriasis	FCGR2A	H166P	1	161509955	A	S	Efficacy
4634	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Neoplasms	SLCO1B1	N130H	12	21176804	A	K	Toxicity
4635	pharmgkb		capecitabine,fluorouracil,leucovorin,oxaliplatin			Colorectal Neoplasms	ABCG2	Q141K	4	88131171	G	Y	Efficacy
4636	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Colorectal Neoplasms	ABCB1	I1145M	7	87509329	A	K	Toxicity
4637	pharmgkb		cisplatin,fluorouracil			Esophageal Neoplasms	ABCB1	I1145M	7	87509329	A	K	Efficacy
4638	pharmgkb	Drug	tocilizumab			Arthritis, Rheumatoid	IL6R	rs4329505	1	154459944	T	C	Efficacy
4639	pharmgkb	Drug	sirolimus	6436030	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC		CYP3A4	CYP3A4*1, CYP3A4*22					Metabolism/PK
4640	pharmgkb	Drug	propofol	4943	CC(C)C1=C(C(=CC=C1)C(C)C)O		CYP2B6	K262R	19	41009358	A	G	Metabolism/PK
4641	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Angina Pectoris	P2RY12	rs2046934	3	151339854	G	M	Efficacy
4642	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Transplantation	IL10	rs1800896	1	206773552	T	C	Metabolism/PK
4643	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C	Chronic Disease	CYP3A4	rs35599367	7	99768693	G	A	Efficacy
4644	pharmgkb		salbutamol,selective beta-2-adrenoreceptor agonists			Asthma	CRHR2	rs255100	7	30689292	A	K	Efficacy
4645	pharmgkb		salbutamol,selective beta-2-adrenoreceptor agonists			Asthma	CRHR2	rs2284220	7	30678487	G	A	Efficacy
4646	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Epilepsy	HNF4A	rs2071197	20	44401795	G	A	Metabolism/PK
4647	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs10841753	12	21168436	T	C	Metabolism/PK
4648	pharmgkb	Drug	lumefantrine	6437380	CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O	Malaria	CYP3A5	rs41303343	7	99652771	-	A	Metabolism/PK
4649	pharmgkb		carbamazepine,oxcarbazepine			Epilepsy	SCN1A	A1056P	2	166036278	C	T	Efficacy
4650	pharmgkb		carbamazepine,clobazam,ethosuximide,lamotrigine,levetiracetam,oxcarbazepine,valproic acid			Epilepsy	SCN1A	A1056P	2	166036278	C	T	Efficacy
4651	pharmgkb		atazanavir,ritonavir			HIV Infections	ABCB1	I1145M	7	87509329	A	K	Other
4652	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Stevens-Johnson Syndrome	HLA-B	HLA-B*38:02					Toxicity
4653	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs16870989	4	21385141	T	A	Toxicity
4654	pharmgkb	Drug	nevirapine	4463	CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4	drug reaction with eosinophilia and systemic symptoms,HIV Infections,Stevens-Johnson Syndrome,Toxic liver disease	CYP2B6	Q172H	19	41006936	G	W	Toxicity
4655	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs7661530	4	21349637	T	C	Toxicity
4656	pharmgkb	Drug Class	Ace Inhibitors, Plain				KCNIP4	rs7675300	4	21383914	C	A	Toxicity
4657	pharmgkb	Drug	buprenorphine	40400	CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O	Opioid-Related Disorders	OPRD1	rs581111	1	28848861	A	G	Efficacy
4658	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1	Epidermal Necrolysis, Toxic,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	PSORS1C1	rs3815087	6	31125810	G	A	Toxicity
4659	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NR1I3	rs2501873	1	161234748	C	T	Dosage
4660	pharmgkb		capecitabine,fluorouracil			Neoplasms	MTHFR	A222V	1	11796321	G	A	Toxicity
4661	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation,liver transplantation	ABCB1	S893A	7	87531302	A	Y	Dosage,Metabolism/PK
4662	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Transplantation	ABCB1	rs1128503	7	87550285	A	G	Dosage,Metabolism/PK
4663	pharmgkb		cyclosporine,tacrolimus			Kidney Transplantation,transplant rejection	CYP3A5	CYP3A5*1, CYP3A5*3					Toxicity
4664	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	platelet reactivity	ABCB1	I1145M	7	87509329	A	K	Efficacy
4665	pharmgkb	Drug	acenocoumarol	9052	CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs11676382	2	85550510	C	G	Dosage
4666	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	rs12714145	2	85560218	C	T	Dosage
4667	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		GGCX	R325Q	2	85553413	C	T	Dosage
4668	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	BDNF	rs7103411	11	27678578	C	T	Efficacy
4669	pharmgkb	Prodrug	gemcitabine	60750	C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	Carcinoma, Non-Small-Cell Lung	SLC29A3	S158F	10	71351651	C	T	Efficacy
4670	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	PTPRM	rs6506569	18	8275859	T	C	Efficacy
4671	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		ABCB1	I1145M	7	87509329	A	K	Dosage
4672	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	transplant rejection	CYP3A5	rs776746	7	99672916	T	C	Efficacy
4673	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	ABCB1	I1145M	7	87509329	A	K	Toxicity
4674	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	AMPD1	Q45K	1	114693436	G	W	Efficacy,Toxicity
4675	pharmgkb	Drug Class	Platinum compounds			Neoplasms	ERCC2	D312N	19	45364001	C	W	Efficacy,Toxicity
4676	pharmgkb		adefovir dipivoxil,cidofovir,tenofovir				SLC22A6	R50H	11	62984542	C	D	Other
4677	pharmgkb	Prodrug	adefovir dipivoxil	60871	CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C		SLC22A6	R454Q	11	62979488	C	T	Other
4678	pharmgkb	Drug	lisinopril	5362119	C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O	Diabetes Mellitus, Type 1,Heart Failure	ACE	rs1799752	17	63488530	-	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/G	Efficacy
4679	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Bipolar Disorder,Depression,Psychotic Disorders,Schizophrenia,Substance-Related Disorders	ABCB1	I1145M	7	87509329	A	K	Metabolism/PK
4680	pharmgkb	Drug	allopurinol	2094	C1=C2C(=NC=NC2=O)NN1		ABCG2	rs10011796	4	88169725	T	S	Efficacy
4681	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	SLC6A2	rs5569	16	55697923	G	M	Efficacy
4682	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	A6V	6	154039561	C	D	Toxicity
4683	pharmgkb	Drug	cocaine	5760	CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC	Cocaine-Related Disorders	OPRM1	N40D	6	154039662	A	G	Toxicity
4684	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2	Tobacco Use Disorder	OPRM1	N40D	6	154039662	A	G	Toxicity
4685	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Coronary Artery Disease	CYP3A4	rs2242480	7	99763843	C	T	Efficacy
4686	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	rs4633	22	19962712	C	T	Efficacy
4687	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	COMT	V158M	22	19963748	G	A	Efficacy
4688	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	ANKK1	E713K	11	113400106	G	A	Efficacy
4689	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain	ABCB1	I1145M	7	87509329	A	K	Efficacy
4690	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Pain,Pain, Postoperative	ABCB1	I1145M	7	87509329	A	K	Dosage
4691	pharmgkb	Drug	heroin	5462328	CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C	Heroin Dependence	OPRM1	N40D	6	154039662	A	G	Toxicity
4692	pharmgkb		heroin,methamphetamine			Substance-Related Disorders	BDNF	V66M	11	27658369	C	T	Other
4693	pharmgkb	Drug Class	Drugs For Treatment Of Tuberculosis			Tuberculosis	CYP2E1	rs2031920	10	133526341	C	T	Toxicity
4694	pharmgkb	Drug	amlodipine	2162	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	Hypertension	CYP3A4	rs2246709	7	99768096	A	G	Efficacy
4695	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Organ Transplantation	ABCB1	I1145M	7	87509329	A	K	Dosage,Metabolism/PK
4696	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O	over-anticoagulation	CYP4F2	V433M	19	15879621	C	T	Other
4697	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Toxicity
4698	pharmgkb	Drug	simvastatin	54454	CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C		ABCB1	I1145M	7	87509329	A	K	Efficacy
4699	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		UGT2B7	Y268H	4	69098620	T	C	Dosage
4700	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Neoplasms	LRP2	rs2075252	2	169154475	T	M	Toxicity
4701	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	HIV Infections	ABCB1	rs1128503	7	87550285	A	G	Metabolism/PK
4702	pharmgkb	Drug	efavirenz	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F		CYP2B6	R487S	19	41016810	C	D	Metabolism/PK
4703	pharmgkb		antidepressants,citalopram,escitalopram,fluoxetine,paroxetine			Depressive Disorder, Major	TPH1	rs1800532	11	18026269	G	T	Efficacy
4704	pharmgkb	Drug	carvedilol	2585	COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O		UGT1A1	UGT1A1*1, UGT1A1*28					Metabolism/PK
4705	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Opioid-Related Disorders	CYP2B6	CYP2B6*1, CYP2B6*6					Dosage
4706	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
4707	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Metabolism/PK
4708	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3					Metabolism/PK
4709	pharmgkb		artesunate,chlorproguanil,dapsone			Malaria	G6PD	V68M	X	154536002	C	T	Toxicity
4710	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	hematopoietic stem cell transplantation,Kidney Transplantation,transplant rejection	CYP3A5	CYP3A5*1, CYP3A5*3					Efficacy
4711	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O		CYP2C19	CYP2C19*1, CYP2C19*2					Efficacy
4712	pharmgkb	Drug	oxaliplatin	6857599	C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2]		GSTP1	I105V	11	67585218	A	G	Efficacy
4713	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	ADRA2A	rs1800544	10	111076745	G	C	Efficacy
4714	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	Kidney Transplantation	POR	A503V	7	75985688	C	T	Toxicity
4715	pharmgkb	Drug Class	Platinum compounds			Carcinoma, Non-Small-Cell Lung,Ovarian Neoplasms	ERCC1	Q506K	19	45409478	C	D	Efficacy
4716	pharmgkb		Drugs used in nicotine dependence,nicotine			Tobacco Use Disorder	OPRM1	N40D	6	154039662	A	G	Efficacy
4717	pharmgkb	Prodrug	clopidogrel	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	Acute coronary syndrome,Coronary Artery Disease	CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Efficacy
4718	pharmgkb	Drug	azathioprine	2265	CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]	Inflammatory Bowel Diseases	ITPA	rs7270101	20	3213247	A	C	Toxicity
4719	pharmgkb	Drug	aspirin	2244	CC(=O)OC1=CC=CC=C1C(=O)O	Acute coronary syndrome,Coronary Artery Disease	ITGB3	L59P	17	47283364	T	C	Efficacy
4720	pharmgkb	Drug Class	Tumor necrosis factor alpha (TNF-alpha) inhibitors			Arthritis, Rheumatoid,Crohn Disease,Psoriasis,Spondylitis, Ankylosing	TNF	rs1799724	6	31574705	C	T	Efficacy
4721	pharmgkb	Drug, Metabolite	mercaptopurine	667490	C1=NC2=C(N1)C(=S)N=CN2	Myelosuppression,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ITPA	P32T	20	3213196	C	R	Toxicity
4722	pharmgkb	Drug	metformin	4091	CN(C)C(=N)N=C(N)N	Diabetes Mellitus, Type 2	ATM	rs11212617	11	108412434	C	A	Efficacy
4723	pharmgkb	Drug	tacrolimus	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	nephrotoxicity	CYP3A5	CYP3A5*1, CYP3A5*3					Toxicity
4724	pharmgkb	Drug	risperidone	5073	CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F	Schizophrenia	DRD2	rs1799978	11	113475629	T	C	Efficacy
4725	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2		CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*87, CYP2D6*89, CYP2D6*90, CYP2D6*93, CYP2D6*95, CYP2D6*97, CYP2D6*98					Metabolism/PK
4726	pharmgkb	Drug	olanzapine	4585	CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C		CYP3A5	CYP3A5*1, CYP3A5*3					Metabolism/PK
4727	pharmgkb	Drug Class	antiepileptics			Epilepsies, Partial,Epilepsy,Epilepsy, Generalized	ABCB1	I1145M	7	87509329	A	K	Efficacy
4728	pharmgkb	Drug	naproxen	1302	CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29					Metabolism/PK
4729	pharmgkb	Drug	fluorouracil	3385	C1=C(C(=O)NC(=O)N1)F	Neoplasms	DPYD	rs3918290	1	97450058	C	K	Efficacy
4730	pharmgkb	Drug	ivacaftor	16220172	CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C	Cystic Fibrosis	CFTR	rs113993960	7	117559592	CTT	-	Efficacy
4731	pharmgkb	Prodrug	tenofovir	464205	C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O	Fanconi Syndrome,HIV Infections	ABCC2	C1515Y	10	99851537	G	A	Toxicity
4732	pharmgkb	Drug	ethanol	702	CCO	Alcoholism	OPRM1	N40D	6	154039662	A	G	Toxicity
4733	pharmgkb	Drug	sufentanil	41693	CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC	adverse events,Pain, Postoperative	OPRM1	N40D	6	154039662	A	G	Toxicity
4734	pharmgkb	Drug	naltrexone	5360515	C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O	Alcoholism,hypersexuality state,Tobacco Use Disorder	OPRM1	N40D	6	154039662	A	G	Efficacy
4735	pharmgkb	Drug	rosuvastatin	6439133	CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C		SLCO1B1	V174A	12	21178615	T	C	Efficacy
4736	pharmgkb		cannabinoids,cocaine,ethanol,nicotine,opioids			Substance-Related Disorders	OPRM1	N40D	6	154039662	A	G	Toxicity
4737	pharmgkb	Drug Class	opioids			Opioid-Related Disorders	OPRM1	N40D	6	154039662	A	G	Toxicity
4738	pharmgkb	Drug	ibuprofen	3672	CC(C)CC1=CC=C(C=C1)C(C)C(=O)O	Pain, Postoperative	CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4					Efficacy
4739	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	Neoplasms,Pain,Pain, Postoperative	COMT	rs6269	22	19962429	A	G	Dosage
4740	pharmgkb	Drug	everolimus	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	Breast Neoplasms,Kidney Neoplasms,Kidney Transplantation,Neuroendocrine Tumors	CYP3A4	CYP3A4*1, CYP3A4*22					Metabolism/PK
4741	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O		OPRM1	N40D	6	154039662	A	G	Metabolism/PK
4742	pharmgkb	Drug	pantoprazole	4679	COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC	Helicobacter Infections	ABCB1	I1145M	7	87509329	A	K	Efficacy
4743	pharmgkb	Drug	lamotrigine	3878	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N	Epilepsy	UGT2B7	R124S	4	69096892	A	K	Metabolism/PK
4744	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	cns depression,Drug Toxicity	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6					Toxicity
4745	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	CYP2D6	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41					Toxicity
4746	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Efficacy
4747	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		CYP2C9	CYP2C9*1, CYP2C9*2, CYP2C9*3					Efficacy
4748	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	E429A	1	11794419	T	G	Dosage
4749	pharmgkb	Prodrug	irinotecan	60838	CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7	Lymphoma,Neoplasms	UGT1A1	rs4124874	2	233757013	T	R	Toxicity
4750	pharmgkb	Drug	sulfamethoxazole / trimethoprim	358641		Anemia, Hemolytic,Hemolysis	G6PD	G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like					Toxicity
4751	pharmgkb	Drug	sulfametopyrazine	9047	COC1=NC=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N	Hemolysis	G6PD	G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham					Toxicity
4752	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasms,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLC19A1	H27R	21	45537880	T	S	Efficacy
4753	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	E429A	1	11794419	T	G	Efficacy
4754	pharmgkb	Drug	cisplatin	441203	N.N.Cl[Pt+2]Cl	Esophageal Neoplasms,Ovarian Neoplasms,Stomach Neoplasms	ERCC1	Q506K	19	45409478	C	D	Efficacy
4755	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C18orf56	rs45445694					Metabolism/PK
4756	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCB1	I1145M	7	87509329	A	K	Efficacy
4757	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Neoplasms	SLC19A1	H27R	21	45537880	T	S	Toxicity
4758	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		VKORC1	rs17708472	16	31094032	G	A	Dosage
4759	pharmgkb	Drug	oxcarbazepine	34312	C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N	Maculopapular Exanthema	HLA-B	HLA-B*15:02					Toxicity
4760	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid,Drug Toxicity,hematopoietic stem cell transplantation,Psoriasis,Toxic liver disease	TYMS	rs11280056	18	673447	AAGTTA	-	Toxicity
4761	pharmgkb	Drug	warfarin	54678486	CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O		NQO1	P187S	16	69711242	G	A	Dosage
4762	pharmgkb	Drug	nicotine	942	CN1CCCC1C2=CN=CC=C2		OPRM1	N40D	6	154039662	A	G	Dosage
4763	pharmgkb	Drug	valproic acid	3121	CCCC(CCC)C(=O)O	Epilepsy	UGT2B7	Y268H	4	69098620	T	C	Metabolism/PK
4764	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Lymphoma, T-Cell,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCG2	Q141K	4	88131171	G	Y	Metabolism/PK
4765	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukemia, Lymphoid,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC2	rs717620	10	99782821	C	T	Metabolism/PK
4766	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Leukemia, B-Cell, Acute,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCC2	rs3740065	10	99845936	A	G	Metabolism/PK
4767	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Leukemia,Lymphoma, T-Cell,Neoplasms,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLC19A1	H27R	21	45537880	T	S	Metabolism/PK
4768	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCC2	V417I	10	99804058	G	A	Toxicity
4769	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Rheumatoid	ABCB1	rs1128503	7	87550285	A	G	Toxicity
4770	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	ABCB1	I1145M	7	87509329	A	K	Efficacy
4771	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Brain Diseases,Drug Toxicity,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTR	D919G	1	236885200	A	G	Toxicity
4772	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Arthritis, Juvenile Rheumatoid,Arthritis, Rheumatoid	FASTKD3	I49M	5	7870860	A	G	Toxicity
4773	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Drug Toxicity,Lymphoma, T-Cell,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABCG2	Q141K	4	88131171	G	Y	Toxicity
4774	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Lymphoma,Osteosarcoma,Precursor Cell Lymphoblastic Leukemia-Lymphoma	SLCO1B1	rs11045879	12	21229685	T	C	Toxicity
4775	pharmgkb	Drug	methotrexate	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Burkitt Lymphoma,Lymphoma, Non-Hodgkin,Lymphoma, T-Cell,Precursor Cell Lymphoblastic Leukemia-Lymphoma	MTHFR	E429A	1	11794419	T	G	Toxicity
4776	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-B	HLA-B*58:01					Toxicity
4777	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	ABCB1	rs1128503	7	87550285	A	G	Dosage
4778	pharmgkb	Drug	methadone	4095	CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2	Heroin Dependence,Opioid-Related Disorders	ABCB1	I1145M	7	87509329	A	K	Dosage
4779	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	Pain	CYP2D6	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6					Efficacy
4780	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	OPRM1	N40D	6	154039662	A	G	Toxicity
4781	pharmgkb	Drug, Metabolite	morphine	5288826	CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O	adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	COMT	V158M	22	19963748	G	A	Toxicity
4782	pharmgkb	Drug	oxycodone	5284603	CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O	adverse events,Constipation,Delirium,Nausea,Pruritus,somnolence,Urinary Retention	COMT	V158M	22	19963748	G	A	Toxicity
4783	pharmgkb	Drug	methylphenidate	4158	COC(=O)C(C1CCCCN1)C2=CC=CC=C2	Attention Deficit Disorder with Hyperactivity	COMT	V158M	22	19963748	G	A	Efficacy
4784	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major,Obsessive-Compulsive Disorder	CYP2C19	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17					Efficacy
4785	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Breast Neoplasms,Neoplasms	ABCB1	I1145M	7	87509329	A	K	Efficacy
4786	pharmgkb	Drug	docetaxel	148124	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O	Breast Neoplasms,Neoplasms	ABCB1	I1145M	7	87509329	A	K	Efficacy
4787	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Drug Toxicity,Neoplasms,Neutropenia,Peripheral Nervous System Diseases	ABCB1	I1145M	7	87509329	A	K	Toxicity
4788	pharmgkb	Drug	paclitaxel	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	Drug Toxicity,Neutropenia,Peripheral Nervous System Diseases,Toxic liver disease	CYP2C8	CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4					Toxicity
4789	pharmgkb	Drug Class	Beta Blocking Agents			Cardiomyopathy, Dilated,Heart Failure	ADRB1	G389R	10	114045297	G	C	Efficacy
4790	pharmgkb	Drug Class	Beta Blocking Agents			Heart Failure	GRK5	Q41L	10	119326585	A	T	Efficacy
4791	pharmgkb	Drug Class	Beta Blocking Agents			Cardiomyopathy, Dilated,Heart Failure	ADRB2	R16G	5	148826877	G	A	Efficacy
4792	pharmgkb	Drug	carbamazepine	2554	C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N	Drug Hypersensitivity,drug reaction with eosinophilia and systemic symptoms,Epidermal Necrolysis, Toxic,Maculopapular Exanthema,severe cutaneous adverse reactions,Stevens-Johnson Syndrome	HLA-A	HLA-A*02:01					Toxicity
4793	pharmgkb	Drug	fentanyl	3345	CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3	Pain, Postoperative	CYP3A4	CYP3A4*1, CYP3A4*18					Dosage
4794	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F		HTR2A	rs6313	13	46895805	G	A	Efficacy
4795	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F		HTR2A	rs6311	13	46897343	C	T	Efficacy
4796	pharmgkb	Drug Class	antidepressants			Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Efficacy
4797	pharmgkb	Drug Class	antidepressants			Bipolar Disorder,Depression,Depressive Disorder, Major	HTR2A	rs6313	13	46895805	G	A	Efficacy
4798	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Anxiety Disorders,Depression	HTR2A	rs6313	13	46895805	G	A	Efficacy
4799	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder, Major	HTR2A	rs6313	13	46895805	G	A	Efficacy
4800	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Efficacy
4801	pharmgkb	Drug	fluvoxamine	3404	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs6313	13	46895805	G	A	Efficacy
4802	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	HTR2A	rs6313	13	46895805	G	A	Efficacy
4803	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major,Obsessive-Compulsive Disorder	HTR2A	rs6311	13	46897343	C	T	Efficacy
4804	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs6313	13	46895805	G	A	Efficacy
4805	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Efficacy
4806	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Efficacy
4807	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs6313	13	46895805	G	A	Efficacy
4808	pharmgkb	Drug	venlafaxine	5656	CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O	Anxiety Disorders,Depression	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
4809	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	HTR2A	rs7997012	13	46837850	A	G	Efficacy
4810	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs7997012	13	46837850	A	G	Efficacy
4811	pharmgkb	Drug	fluvoxamine	3404	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Toxicity
4812	pharmgkb	Drug	fluvoxamine	3404	COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Efficacy
4813	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Toxicity
4814	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major,Sexual Dysfunctions, Psychological	HTR2A	rs6311	13	46897343	C	T	Toxicity
4815	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major	HTR2A	rs6311	13	46897343	C	T	Efficacy
4816	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major,Sexual Dysfunctions, Psychological	HTR2A	rs6313	13	46895805	G	A	Toxicity
4817	pharmgkb	Drug	paroxetine	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Depressive Disorder, Major	HTR2A	rs7997012	13	46837850	A	G	Efficacy
4818	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Anxiety Disorders,Depression	HTR2A	rs7997012	13	46837850	A	G	Efficacy
4819	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
4820	pharmgkb	Drug	citalopram	2771	CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F		SLC6A4	rs25531	17	30237328	T	C	Efficacy
4821	pharmgkb	Drug	escitalopram	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	Depression,Depressive Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
4822	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major,Panic Disorder	SLC6A4	rs57098334					Efficacy
4823	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Depressive Disorder, Major,Panic Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
4824	pharmgkb	Drug	sertraline	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	Anxiety Disorders,Depressive Disorder, Major	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Toxicity
4825	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major	SLC6A4	rs25531	17	30237328	T	C	Efficacy
4826	pharmgkb	Drug	fluoxetine	3386	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	Depressive Disorder, Major,Obsessive-Compulsive Disorder	SLC6A4	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)					Efficacy
4827	pharmgkb	Drug Class	Ace Inhibitors, Plain			Cough	BDKRB2	rs1799722	14	96204802	C	T	Toxicity
